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Many herbal medicines have over the years become a component of self-care by the 
general public. Despite their increasing popularity, there are currently limited data 
available on the use and safety of these medicines during breastfeeding. The use of 
herbal medicines by lactating women during breastfeeding remains a relatively 
under-researched, yet increasingly important area of research. The advantages of 
breastfeeding have been well documented, which have led to the development of 
many strategies and efforts to encourage successful breastfeeding practices in 
Australia. Providing women with continuity of care during the postnatal transition 
period is vital to successful breastfeeding practices. The accessibility of community 
pharmacists places the profession in an ideal position to intervene and ensure women 
receive appropriate continuity of support and care after birthing, at the community 
level. Furthermore, herbal medicines and other complementary products are available 
in most community pharmacies, and pharmacists and pharmacy support staff are a 
common source of advice and information on the use of these products. Pharmacists 
have legal and ethical obligations to ensure the safe and effective use of all 
medicines, including complementary medicines. This study explored breastfeeding 
women and community pharmacists’ perspectives on herbal medicine use in 
breastfeeding. This research comprised three stages: Stage 1 investigated the 
prevalence and pattern of use of herbal medicines amongst breastfeeding women; 
Stage 2 explored breastfeeding women’s experiences of the use of herbal 
galactagogues and their perspectives on pharmacists’ roles; Stage 3 explored 
community pharmacists’ perspectives of their role in promoting safe and effective 
use of these medicines and supporting breastfeeding in the community. 
 
Stage 1 involved a population-based survey of 304 breastfeeding women who had 
breastfed in the past 12 months. Participants were recruited through four avenues: i) 
mothers and parenting groups, ii) community pharmacies, iii) immunisation clinics 
and child health centres, and iv) advertising in newspapers and local parenting 
papers. Simple descriptive statistics were used to summarise the demographic profile 
and attitudes of respondents. The mean ages of respondents were 32.8 ± 4.2 years for 
users of herbal medicines and 32.3 ± 5.0 years for non-users. The majority of 
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respondents resided in the Perth metropolitan area, were born in Australia or New 
Zealand, had completed secondary school education, had a relatively high total 
annual household income (≥ AUD$ 80, 000), had only one child and were not living 
with their parents. Of the 304 participants, 182 (59.9%) indicated that they had used 
one or more herbal preparations for various medicinal purposes during breastfeeding 
(95% confidence interval 54.4-65.4%), while 60.4% of these users indicated that the 
reasons for use of these herbal medicines were breastfeeding-related. Seventy-four 
participants (24.3%, 95% CI: 19.5% - 29.1%) took one or more herbal medicines 
specifically to help increase milk production or supply during breastfeeding. 
Respondents with an Asian birthplace and those from middle income families (total 
annual household income of AUD$ 37, 000 – 80, 000) were more likely to use herbal 
medicines.  
 
Amongst the 51 herbal medicines identified by the participants, the top ten most 
commonly used were fenugreek (18.4%), ginger (11.8%), dong quai (7.9%), 
chamomile (7.2%), garlic (6.6%), blessed thistle (5.9%), cranberry (4.9%), fennel 
(4.9%), aloe vera (3.3%) and peppermint (3.3%). The proportion of women who 
perceived the herbal medicine as helpful varied from 20.0% to 83.3%. The top seven 
herbal medicines commonly used as galactagogues were fenugreek (18.4%), blessed 
thistle (5.9%), fennel (4.9%), goat’s rue (2.3%), nettle (1.6%), blackthorn berry 
(1.6%) and shatavari (1.3%). Approximately two-thirds of the users (n = 112) had 
chosen to use herbal medicines during breastfeeding based on recommendations 
from their families. The majority of the users (n = 105) had obtained or purchased 
their herbal products from community pharmacies. Only 52 (28.6%) of the users had 
made their doctors aware of their decision to use herbal medicines whilst 
breastfeeding. Over 70% of respondents (n = 304) agreed that there was a lack of 
information resources available to them. Many of the respondents (43.4%) believed 
that herbal medicines were generally safer when compared to conventional 
medicines when used in breastfeeding. Most (71.6%) indicated a previous refusal or 
avoidance of medicine treatments during breastfeeding due to concerns regarding 
safety of their infants. When given a choice, 75.9% of respondents preferred more 
information to be available regarding the use of herbal medicines during 




Stage 2 was exploratory research conducted through in-depth semi-structured 
interviews with 20 women living in Western Australia, who were using herbal 
galactagogues during breastfeeding. The study employed purposeful and subsequent 
snowball sampling methods to recruit participants. Interviews took an average of 
33.9 minutes (18 - 78 minutes). All of the 20 participants had used fenugreek either 
as a sole ingredient or in combination with other herbal ingredients. Reasons for 
using herbal galactagogues were perceived insufficient milk supply (n = 9), 
diagnosed insufficient milk supply (n = 8), as a supplement in the absence of 
perceived or diagnosed insufficient milk supply (n = 2), or as part of tradition (n = 1). 
Most of the participants (n = 16) had “perceived” or “observed” that these herbal 
galactagogues were effective in promoting breastfeeding performance. Overall, most 
participants reported a positive experience on milk supply with the use of herbal 
galactagogues during breastfeeding. 
 
Five main themes emerged when participants were asked to describe their 
experiences and general perspectives: i) perseverance and determination to 
breastfeed, ii) confidence, self-empowerment and reassurance, iii) concerns over 
breastfed infants’ safety, iv) role and expectations of health professionals, and v) 
peer and parental influence. Four main themes were apparent in the interviews as 
participants described their views on the resources available to them regarding the 
effectiveness and safety of herbal medicines in breastfeeding: i) information needs ii) 
credibility and reliability of information iii) expectations of health professionals, and 
iv) role of community pharmacy. Although their views varied widely, participants 
perceived community pharmacy in general as a convenient source of information that 
can be trusted. The facilitators for an increased role of community pharmacists were 
convenience and accessibility, client-pharmacist relationship, staff knowledge and 
credibility and cost factors. The barriers were a lack of advertisement, publicity and 
promotion, inconsistent approach by pharmacists, pharmacists’ lack of breastfeeding-
related experience or awareness, pre-conceived negative perception towards herbal 
medicines, concerns over the potential for overlap of roles with other health 
professionals, and privacy issues associated with inappropriate pharmacy layout. The 
issues raised by breastfeeding women through the interviews in this stage of the 
research identified areas of pharmacy practice which require improvement and 
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revealed opportunities for expansion of the community pharmacists’ role to better 
support breastfeeding women and promoting breastfeeding in the community.  
  
Stage 3 was an exploratory study conducted through in-depth semi-structured 
interviews with 30 pharmacists practising in community pharmacies in Western 
Australia. Interviews took an average of 39.4 minutes (26.2 - 70 minutes). 
Participants’ experience in community pharmacy practice ranged from one month to 
42 years and they represented a range of positions or roles in the pharmacy. The 
majority of the participants received enquiries from the public about the use of 
various medicines during breastfeeding on a weekly basis. Common health issues 
presented by breastfeeding women to pharmacists were cough and cold, allergies, 
pain and inflammation, general health using complementary and alternative 
medicines and inadequate breast milk supply.  
 
Five major themes emerged regarding participants’ attitudes, knowledge and 
confidence level towards promoting the safe and effective use of non-prescription 
medicines and other over-the-counter products during breastfeeding and their role in 
supporting breastfeeding in the community: i) attitudes towards complementary 
medicines use in breastfeeding and pharmacy practice, ii) perception of roles, iii) 
self-awareness of knowledge level and confidence, iv) facilitators and v) barriers and 
challenges to achieving effective support for breastfeeding women in the Australian 
community pharmacy context. Five subthemes or issues were apparent in terms of 
participants’ attitudes towards the use of CMs in breastfeeding and pharmacists’ 
responsibilities: i) complexity and dilemma in making clinical recommendations, ii) 
duty of care, legal and ethical obligations of the pharmacist, iii) pharmacists’ support 
and willingness for expanded professional roles, iv) provision of evidence-based 
recommendations and v) process and approach in handling health and medicine-
related enquiries. The study also explored participants’ perspectives of implementing 
breastfeeding-related strategies and public health services within the community 
pharmacy setting. A need for on-going training was also highlighted in this study, 
where participants identified topics of continuing professional development.  
 
The use of herbal medicines is common amongst survey respondents of this study, 
however there was a mismatch between the perceptions of breastfeeding women and 
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pharmacists with regards to the issue of safety and toxicity of herbal medicines. In 
conclusion, this study has revealed that community pharmacists are perceived 
favourably by breastfeeding women in the Western Australian community. There 
was a high level of trust in community pharmacists which could be seen as a main 
facilitator for expanding pharmacy services in meeting the needs and expectations of 
breastfeeding women. The findings arising from the perspectives of breastfeeding 
women and community pharmacists in this research support the argument that 
community pharmacists are well placed to provide advice and support to 
breastfeeding women using herbal medicines as galactagogues, at least amongst the 
participants of this research, with due consideration of the barriers and challenges 
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Chapter 1 provides an introduction to the study and an overview of the thesis. The 
synopsis includes an overview and background of the study, the definitions and 
descriptions of the terminologies used in this study, significance, the overall 
objectives and an outline of this thesis. 
 
 
1.1 Overview and Background of the Study 
 
Over the years, many herbal medicines (HMs) have gained recognition and a positive 
reputation by the general public and health professionals. Despite the increasing 
popularity, there are currently limited data available on the use and safety of these 
medicines during breastfeeding. The use of herbal medicines by lactating women 
during breastfeeding remains a relatively under-researched, yet increasingly 
important, area of study. A review of the literature (Chapter 2) has revealed that the 
attitudes and perspectives of breastfeeding women and community pharmacists 
towards the use of herbal medicines in breastfeeding is an area that has not been well 
researched.  
 
The advantages of breastfeeding have been well documented, which has led to the 
development of many strategies and efforts to encourage successful breastfeeding 
practices in Australia (1). Previous studies have reported the various factors which 
may affect a woman’s decision to initiate or continue breastfeeding (1-3). 
Breastfeeding women’s attitudes and perspectives were seen as influential to their 
breastfeeding practices. Women’s perceptions of inadequate breast milk supply, their 
concerns over infants’ safety while using medicines, and their experiences of the lack 
of continuity of care and support at the community level may all hinder breastfeeding 
initiation or contribute to unnecessary early cessation of breastfeeding (1, 2).  
 
Pharmacists practising in the community have regular contact with the public, 
including breastfeeding women and their families (4, 5). Furthermore, herbal 
medicines and other complementary products are available in most community 
pharmacies, and pharmacists are a common source of advice and information on the 
use of these products (6, 7). Hence, community pharmacists and pharmacy support 
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staff are ideally placed to provide advice and information to breastfeeding women, 
particularly where complementary medicines, including herbal medicines, are 
purchased from pharmacies. Considering the skills and accessibility of community 
pharmacists, these health professionals may be able to support breastfeeding 
women’s experiences and contribute to successful breastfeeding practices or 
outcomes. This may be achieved by promoting the safe and effective use of 
medicines if required in breastfeeding, including both conventional medicines and 
herbal medicines, and the provision of support or continuity of care to women in the 
form of advice and relevant professional services in the community pharmacy 
setting. 
 
The issues and arguments mentioned above formed the background and also 
informed the design of this research. An overview of the present research is shown in 
Figure 1.1.  
 
This research comprised three stages:  
 
 Stage 1 of the research involved a population-based survey to determine the 
prevalence and explore the patterns of herbal medicine use amongst 
breastfeeding women in Western Australia, using a self-administered 
structured questionnaire.  
 
 Stage 2 of the research employed an interview-based qualitative approach 
using a semi-structured interview guide to explore breastfeeding women’s 
perspectives on the use of herbal galactagogues during breastfeeding, as well 
as their perception of the pharmacist’s involvement and potential role.  
 
 Stage 3 of the research involved in-depth interviews with community 
pharmacists to explore their perspectives on the use of non-prescription 
medicines, including herbal medicines during breastfeeding, and their role in 
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A population-based survey in Western Australia on the use of herbal 




Promoting safe and effective use of herbal and non-prescription 
medicines during breastfeeding and supporting breastfeeding in the 
community: The pharmacists’ perspectives 
 
Figure 1.1: An overview of the research plan 
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1.2 Definitions and Descriptions 
 
1.2.1 Complementary and Alternative Medicine (CAM), Complementary 
Medicines (CMs) and Herbal Medicines (HMs)  
 
A review of the Australian and international literature identified that there is no 
consistent and internationally agreed definitions for complementary and alternative 
medicine (CAM) and complementary medicines (CMs) due to their diversity and the 
varying cultures in different countries. The umbrella term, CAM, commonly refers to 
a collection of diverse approaches to prevention, diagnosis and treatment (8, 9). 
Medicines and health-related terminologies used in Australia show some 
resemblance to those of the United Kingdom (UK). In a review of CMs in the UK, 
Barnes (9) describes that “over 50 diverse complementary therapies have been listed, 
from homeopathy (which involves the use of infinitely dilute preparations) to herbal 
medicine (which involves the use of chemically rich preparations of plant material), 
and from acupuncture (which involves the insertion of needles into specific points on 
the body) to spiritual healing (including ‘distant’ healing, which does not require the 
laying on of hands).” Several organisations within Australia and in other countries 
have defined CAM and CMs in different manners, therefore the definitions of 
terminologies used by the authors in their publications have to be given thorough 
consideration when interpreting findings from the studies.  
 
The Cochrane Collaboration is an independent international network of contributors 
from over 120 countries, working collaboratively to prepare, update and promote the 
Cochrane Reviews, aiming to assist policy-makers, healthcare practitioners, patients 
and carers in making well-informed healthcare-related decisions based on reliable, 
accessible and evidence-based health information (10). The Cochrane 
Collaboration’s work in Australia is funded by the Australian Government through 
the National Health and Medical Research Council (NHMRC), and their work has 
gained international recognition as the benchmark for high quality information about 
healthcare effectiveness (11). Personal communication with the Systematic Review 
Trainer at the Australasian Cochrane Centre, with confirmation from the Coordinator 
of Cochrane Collaboration Complementary Medicine Field, revealed that there is 
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currently no official Cochrane Collaboration definition for CAM (Kelly A 2015, 
personal communication, February 10). However, an operational CAM definition 
(12) was drafted by the staff of the Cochrane Collaboration Complementary 
Medicine Field for the purpose of screening Cochrane reviews for their relevancy 
with CAM (Kelly A 2015, personal communication, February 10). In a review 
published by Zollman and Vickers (8) in 1999, the authors stated that the CAM 
definition adopted by Cochrane Collaboration was the following:  
 
Complementary and alternative medicine (CAM) is a broad domain of healing 
resources that encompasses all health systems, modalities, and practices and their 
accompanying theories and beliefs, other than those intrinsic to the politically 
dominant health system of a particular society or culture in a given historical period. 
CAM includes all such practices and ideas self-defined by their users as preventing 
or treating illness or promoting health and well-being. Boundaries within CAM and 
between the CAM domain and that of the dominant system are not always sharp or 
fixed. (8) 
 
This Cochrane Collaboration definition of CAM, as provided by Zollman and 
Vickers (8), is commonly used and has also been cited by other researchers and 
organisation in this field, for example the National Institute of Complementary 
Medicine in Australia (13) as well as in a review published by Barnes (9). The above 
definition of CAM was originally formulated by the National Institutes of Health 
Panel on Definition and Description at the Office of Alternative Medicine CAM 
Research Methodology Conference in the United States of America in 1995 (14).   
 
Nevertheless, for the purpose of this thesis, it is important to explore the 
understanding of CAM and CMs from an Australian perspective. In Australia, 
therapeutic goods including vaccines, sunscreens, medical devices, blood and blood 
products, conventional medicines and CMs, are all regulated by the TGA (15). The 
definition for CMs provided by the TGA excludes alternative therapies that fall 
outside of the scope of what is categorised as a “therapeutic good” within Australia, 
for example, acupuncture. According to the TGA, “In Australia, medicinal products 
containing such ingredients as herbs, vitamins, minerals, nutritional supplements, 
homeopathic and certain aromatherapy preparations are referred to as 
‘complementary medicines’ and are regulated as medicines under the Therapeutic 
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Goods Act 1989” (16). The supporting Therapeutic Goods Regulations 1990 defines 
a CM as “a therapeutic good consisting principally of one or more designated active 
ingredients mentioned in Schedule 14 of the Regulations, each of which has a clearly 
established identity and traditional use” (16). As previously mentioned, the use of 
terminologies may differ in different countries. For example, CMs are referred to as 
natural health products (NHPs) in Canada, which are governed by the Natural Health 
Products Regulations since January 2004 and include herbal remedies, vitamins and 
minerals, traditional medicines, homeopathic medicines, probiotics, essential fatty 
acids and amino acids (17). The term “NHP” used by the Canadian regulatory 
authorities is therefore almost synonymous with the term “CM” used by the 
Australian TGA. This supports the premise that it is essential to consider the context 
of the terms and definitions used by specific authors of publications in this field, so 
as to accurately understand and compare research findings.  
 
The terms and definitions used in this field may differ from one organisation to 
another, even within a specific country. For example, in Australia, the definition of 
CM given by the National Institute of Complementary Medicine (NICM) is broader 
than the one provided by the TGA. NICM, hosted by the University of Western 
Sydney, Australia, was established following the 2003 recommendation by the 
Expert Committee on Complementary Medicines in the Australian Health System in 
recognition of the popularity of complementary medicines and therapies in the 
Australian community. NICM provides support and leadership for research into 
complementary medicine and related therapies with the final aim of benefiting the 
health of Australians by improving relevant policy and clinical practice. NICM 
adopted but further modified the Cochrane Collaboration definition of CAM by 
substituting the term CAM with the term complementary medicine (CM)  (13). As 
part of their definition of CM in the Australian context, NICM included the statement 
provided by Zollman and Vickers (8), “We use it synonymously with the terms 
‘complementary therapies’ and ‘complementary and alternative medicine’ found in 
other texts, according to the definition used by the Cochrane Collaboration” (8, 13). 
NICM further states that “We use the term complementary medicine to describe 
healthcare practices such as those listed: acupressure, chiropractic, naturopathy, 
acupuncture, osteopathy, cranial osteopathy, nutritional therapy, Alexander 
technique, environmental medicine, reflexology, applied kinesiology, healing, Reiki, 
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anthroposophic medicine, herbal medicine, relaxation and visualisation, 
aromatherapy, homeopathy, autogenic training, hypnosis, Shiatsu, Ayurveda, 
massage, therapeutic touch, meditation and yoga” (13). NICM’s decision to 
substitute “CAM” with “CM” may create confusion unless careful attention is given 
to consider the context of the findings in the relevant studies. NICM classifies CM 
into four domains, namely “mind-body medicine”, “biologically-based practices”, 
“manipulative and body-based practices”, and “energy medicine”. Of these four 
domains, “biologically-based practices” is of relevance to this thesis. According to 
the definition provided by NICM (13), “Biologically based practices in CM use 
substances found in nature, such as herbs, foods, and vitamins. This includes what 
the Australian TGA defines and regulates as Complementary Medicines”. Examples 
of this approach include herbal medicines, vitamins and minerals, and other nutrient 
and non-nutrient substances derived from plant, animal and marine sources (18).  
    
Herbal medicine conventionally falls under the broader definition of CMs, although 
review of the literature suggests that there is no clear, specific definition for herbal 
medicine in Australia. The Therapeutic Goods Regulations 1990 (19) defines herbal 
substances as “all or part of a plant or substance (other than a pure chemical or a 
substance of bacterial origin)”. Barnes (9) describes herbal medicines from a UK 
perspective as preparations which are “made from plants or plant parts”. These 
include crude drug, for example, dried leaves used by herbalists, and also 
manufactured products containing one or more herbal ingredients in various 
formulations such as tablets, capsules, lozenges, tinctures and creams. A herbal 
ingredient is defined as “a specific individual medicinal plant and the plant part, 
present in a herbal medicine, e.g. St John’s wort herb present in St John’s wort 
tablets” (20). As a herbal medicine may contain multiple herbal constituents and 
because these constituents are directly related to the safety profile of the specific 
herbal medicine in breastfeeding, it is important to define herbal constituents in this 
context. Using St John’s wort as an example, hyperforin is a specific chemical 
compound found in this herbal ingredient, hence hyperforin is known to be a herbal 
constituent of St John’s wort (20).    
 
This thesis adopts the Australian TGA definition of CMs (which include herbal 
medicines, vitamins and minerals, nutritional supplements and homeopathic 
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medicines). Where the term CAM is used in this thesis, it refers to the use of CMs as 
per the Australian TGA definition, as well as inclusion of other alternative therapies, 
for example, acupuncture.   
 
1.2.2 Breastfeeding Practices 
 
Internationally agreed terms exist when defining breastfeeding practices, as 
recommended by the World Health Organization (WHO) (21). Those of relevance to 
this thesis are: 
 
 Exclusive breastfeeding: Infant receives only breast milk (including 
expressed milk or milk from a wet nurse) and medicines (including vitamins 
and minerals, oral rehydration solutions), but precludes any other solids or 
liquids (that is, no non-human milk or infant formula).  
 
 Complementary feeding or partial breastfeeding: Infant receives solid or 
semi-solid foods (including any food or liquid, non-human milk and formula) 
in addition to breast milk.  
 
 Breastfeeding or any breastfeeding: Include the above, or when any breast 
milk is given to the infant, with or without other solids, semi-solids or liquids.  
 
1.2.3 Community Pharmacists 
 
Community pharmacists refer to those registered to practise as a pharmacist with the 
relevant professional organisations, such as the Australian Health Practitioner 
Regulation Agency (AHPRA) in Australia (22) and the General Pharmaceutical 




1.3 Significance of Study 
 
Breastfeeding may increase the risk of medicine exposure to nursing infants via 
breast milk if lactating mothers are receiving medicine treatment. Another concern is 
the effect of medication administration on the quantity and quality of breast milk, 
which may impact on the exclusivity, duration and thus success of breastfeeding. 
While medicine treatments include both conventional and complementary medicines, 
most available studies have focused on evaluating the compatibility of conventional 
medicines with breastfeeding. Many herbal medicines have gained recognition over 
the years and the general public as well as many health professionals are supportive 
of their use (7, 24, 25). Despite their increasing popularity, there are currently very 
limited data available on the use, safety and efficacy of herbal medicines during 
breastfeeding. A study published in 2006 in Australia showed that 36% of the survey 
respondents had used at least one herbal medicine whilst pregnant (26). It was also 
suggested that women were more likely to use medicines in breastfeeding compared 
to while they were pregnant (27). To date, no study exists to investigate the 
prevalence and pattern of use of herbal medicines specifically amongst breastfeeding 
women living in Australia, their attitudes towards herbal medicines and information-
seeking behaviour. This study will provide current information on the prevalence and 
pattern of herbal medicines used during breastfeeding. Identification of the 
commonly used herbal medicines in this population will also help inform and direct 
further clinical research. 
 
Many studies have been conducted to investigate the factors which may hinder the 
initiation and/or continuation of breastfeeding (1, 28). Women’s negative attitudes 
towards breastfeeding, inaccurate perception of insufficient milk supply, concerns 
over breastfed infants’ safety while mothers are receiving medical treatments, and 
the lack of continuity of support and care at the community level have all been 
associated with unsuccessful breastfeeding practices (28). Previous studies have also 
shown that women constantly seek reassurance and self-empowerment during 
breastfeeding (29-31). It has also been shown that some women may choose to use 
herbal remedies or alternative therapies to combat the sense of an inadequate milk 
supply (30). Ayers (29) suggested that breastfeeding women’s confidence can be 
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bolstered with the use of galactagogues. Therefore, it is important to appreciate 
breastfeeding women’s perspectives, as their perceptions and attitudes may influence 
their decision to initiate or discontinue breastfeeding. It will also be instructive to 
explore the perspectives of women who have used herbal galactagogues during 
breastfeeding in Australia, to explore the potential value of specific herbal medicines 
as galactagogues, and at the same time to gain an appreciation of why women have 
chosen to use alternative therapies instead of conventional medicines to enhance 
breastfeeding performance.  
 
In acknowledging the advantages and health benefits of breastfeeding, several 
national strategies have been implemented to promote successful breastfeeding 
practices in Australia, for example, the National Breastfeeding Strategy (1996-2001) 
(32) and the current Australian National Breastfeeding Strategy 2010-2015 (1). The 
latter strategy supports “collaborative care”, which encourages health professionals 
from different disciplinary backgrounds to work collaboratively to support 
breastfeeding women and their families at the primary healthcare level (1). 
“Continuity of care” is also regarded as one of the principles of this strategy, 
emphasizing the importance of continuing support and postnatal care for 
breastfeeding women and their infants during the transition period between birthing 
at hospital and living in their own home, and through the following months 
postpartum (1).  
 
Providing women with continuity of care during the postnatal transition period is 
vital to successful breastfeeding practices. The accessibility of community 
pharmacists places the profession in an ideal position to intervene and ensure women 
receive appropriate continuity of support and care after birthing, at the community 
level. Pharmacists have an obligation to ensure the safe and effective use of all 
medicines including non-prescription medicines, classified as Pharmacists Only 
Medicines (Schedule 3), Pharmacy Medicine (Schedule 2) and other non-scheduled 
products sold in the pharmacy (33, 34). Prior to implementation of strategies to 
enable greater involvement or to expand the role of pharmacists, it is important to 
understand the perspectives and attitudes of them towards the current topic of 
discussion. However, limited studies have explored the practical and professional 
roles of pharmacists in this context. This study will provide an insight into the 
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perspectives and views of stakeholders, in this case community pharmacists 
practising in Western Australia.   
 
Understanding the attitudes and perspectives of breastfeeding women in terms of 
their experiences, specific breastfeeding-related needs and expectations of 
pharmacists at a community level will assist in the identification of research gaps and 
evaluate the potential for role expansion of pharmacists. It will also serve as a guide 
to the development of university teaching tools, training packages or modules for 
pharmacists and pharmacy staff, and support programs in community pharmacies, 
which could ultimately improve health outcomes of breastfeeding women and their 
infants. Utilising the knowledge, skills and accessibility of community pharmacists 
as part of a breastfeeding woman’s postnatal healthcare team provides an opportunity 
to promote the safe and effective use of medicines, including herbal medicines and 
other over-the-counter (OTC) products, as well as supporting breastfeeding in the 
community. From the profession’s perspective, the expanded role of community 
pharmacists in the provision of breastfeeding and postnatal-related health services 
may lead to greater recognition of the profession by the public as part of the primary 




1.4 Outline of Thesis 
 
This thesis comprises six chapters. Chapter 1 provides an introduction to the 
research, a brief background, overall objectives and significance of the study. 
 
Chapter 2 is a review of the relevant literature, and includes an overview of the 
advantages and significance of breastfeeding, the prevalence and pattern of use of 
herbal medicines amongst breastfeeding women, the perspectives and attitudes of 
breastfeeding women and community pharmacists on the topic of study. It also 
includes the primary aims of the thesis. 
 
Chapter 3 reports on the process and findings of Stage 1 of the research, which 
involved a population-based survey of women living in Western Australia on the use 
of herbal medicines during breastfeeding.  
 
Chapter 4 reports on the process and findings of Stage 2 of the research, which 
explored breastfeeding women’s perspectives and attitudes towards the use of herbal 
galactagogues during breastfeeding and their views on the involvement and potential 
role of community pharmacists. 
 
Chapter 5 reports on the process and findings of Stage 3 of the research. This stage 
further explored community pharmacists’ perspectives and attitudes towards their 
role in promoting safe and effective use of herbal and other non-prescription 
medicines during breastfeeding and supporting breastfeeding in the community. The 
potential for role expansion and increased involvement of community pharmacists in 
supporting mothers with infants is also discussed.  
 
Within Chapters 3, 4 and 5, an introduction, objectives, research methods, results 
and discussion specific to the respective stages of the research are provided.  
 
Chapter 6 concludes this thesis by providing a general discussion of the research 
work and findings, presenting the conclusions arising from the studies and 
recommendations for future studies arising from this research.  
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Lastly, the Participant Information Sheets, Consent Forms, Questionnaires, Interview 
Guides, paper publications arising from this thesis and other relevant documents are 


















Chapter 2 provides an extensive critical review of the literature relevant to the area of 
the study up until June 2014. This chapter begins with an overview of the advantages 
and significance of breastfeeding, followed by a review of breastfeeding practices in 
Australia, including the relevant national breastfeeding-related strategies, and the 
factors that may affect successful breastfeeding practices. The clinical implication of 
using medicines in breastfeeding, factors that affect infants’ exposure to medicines in 
breast milk, and the effects of medicines including CMs on the quantity and quality 
of breast milk are also presented. This is followed by a review of the use of herbal 
medicines by the general population in Australia and other countries and the use of 
herbal medicines in lactation, with particular emphasis on herbal galactagogues. As 
the thesis focuses on the perspectives of breastfeeding women and pharmacists, a 
review of the perspectives of women and pharmacists towards the use of medicines 
including CMs in breastfeeding was conducted and presented in this chapter. Finally, 
the current role of pharmacists in the Australian context in presented.   
 
 
2.1 Advantages of Breastfeeding 
 
There have been numerous published studies over the years demonstrating the 
advantages of breastfeeding for newborn infants, postpartum women and society 
(35). Acknowledging these benefits, the Australian Breastfeeding Association, 
American Academy of Paediatrics and WHO all recommend exclusive breastfeeding 
during the first six months after birth (1, 36). In Australia, the percentage of women 
who choose breastfeeding instead of bottle-feeding immediately postpartum has 
increased from approximately 48% in the 1970s to over 90% in the recent decade (3). 
Breastfeeding provides tailored nourishment to the growing needs of infants, offering 
better nutrition, improved cognitive performance and neurological development (37), 
enhanced immunity (38), reduced mortality and incidence of Sudden Infant Death 
Syndrome (SIDS), reduced allergic/hypersensitivity diseases and Type 1 and Type 2 
diabetes mellitus (36, 39-42).   
 
Besides health benefits to the breastfed infants, initiation of breastfeeding 
immediately postpartum has been shown to reduce postpartum bleeding and assist 
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women in the recovery process after childbirth (43). As suggested by Baghurst et al. 
(44) and Baker et al. (45), breastfeeding may also accelerate weight loss in women in 
the postpartum period. Furthermore, breastfeeding also plays a significant role in 
decreasing post-partum depression, and the incidences of breast and ovarian cancers 
are lower in women who have breastfed (43, 46-54). A study conducted by Schnatz 
et al. (55, 56) demonstrated a benefit of breastfeeding in decreasing the risk of 
postmenopausal osteoporosis. Although lactational amenorrhoea is not considered a 
reliable contraceptive method, it may prolong the intervals between pregnancies, 
thereby allowing a longer time for maternal health to improve following birth (43, 
57). Besides these noteworthy advantages, mothers and their babies are brought into 
closer contact through nursing itself (58). Immediate skin-to-skin contact after 
delivery and the act of breastfeeding may help to develop the mother-infant 
relationship, at the same time providing women and their breastfed infants with 
reassurance (59). Breastfeeding has an impact on society by reducing the overall 
burden on the health system and reducing the costs involved with healthcare and 
hospitalisations especially during the first year of an infant’s life (60). Moreover, 
formula-feeding an infant would incur additional costs and time, specifically in the 
purchase and process involved in preparing the formula. In summary, breastfeeding 
is the most beneficial, economical, efficient, and the only natural way of feeding an 
infant. With our expanding knowledge in this field and increasing awareness of the 
advantages of breastfeeding, health professionals from all disciplines should work 
together to promote breastfeeding (61, 62). 
 
 
2.2 Breastfeeding in Australia 
 
In the nineteenth century, breastfeeding by a wet nurse and cross-nursing were 
considered common practices of infant feeding in Australia (63, 64). Although wet 
nursing and cross-nursing both refer to breastfeeding an infant by a woman other 
than his or her own mother, their definitions and involvement differ. Wet nursing is 
defined as breastfeeding an infant by a woman who normally receives payment by 
her employer to do so and is not a reciprocal practice, whereas cross-nursing refers to 
the informal practice of sharing breastfeeding between women of social equivalence, 
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and may sometimes be reciprocal but normally unpaid (65). Nevertheless, these 
feeding practices became less common in the late twentieth century, when the 
community perceived these practices unfavourably due to concerns regarding risk of 
transmitting infections (65, 66). In the 1920s, Nestle’s Lactogen® was first 
introduced along with heavy marketing to promote the sales and use of infant 
formulas (67). Although it was reported that the breastfeeding rate was at its lowest 
in the 1960s, there were gradual improvements in the rates of breastfeeding during 
the 1970s when the advantages of breastfeeding became apparent amongst the 
Australian community (65-67). Lund-Adams and Heywood (68) analysed the results 
of the first 1989-1990 National Health Survey conducted by the Australian Bureau of 
Statistics (ABS) and reported that up to 48% of the infants were receiving breast 
milk at the age of one month. The authors commented that the data collected from 
this survey were less useful than expected and had suggested improvements for 
future surveys investigating the breastfeeding rates in Australia (68). Further health 
surveys on a national scale were in place to continually assess and monitor 
Australian breastfeeding rates.   
 
2.2.1 Breastfeeding Rates in Australia  
 
Many national surveys have been undertaken to monitor the rates of breastfeeding in 
Australia. Following the first National Health Survey in 1990, another Australian 
National Health Survey was conducted in 1995 and found that 81.8% of the 
respondents who had a child between the ages of zero and three, initiated 
breastfeeding, 57.1% continued predominant or full breastfeeding at three months, 
and 18.6% at six months postpartum (69). It was also reported that demographic 
factors and socio-economic status were influential in determining the rates of 
breastfeeding and had to be taken into account when implementing strategies to 
improve the rates of breastfeeding and to reach the national target of having at least 
80% of babies receiving any breast milk at the age of six months, by the year 2000 
(69, 70). The 1995 and 2001 National Health Surveys showed similar rates of 
breastfeeding where 86% and 87% of infants between the age of zero to three years 
had received breast milk at some stage of their lives, respectively (70). The initiation 
and breastfeeding rates at discharge reported by the two health surveys were also 
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comparable (70). Although a decline was observed in breastfeeding rates with the 
number of months postpartum, there seemed to be a slight improvement in the 
duration of breastfeeding in 2001 when 48% of babies were still receiving any breast 
milk by the age of six months (70).  
 
In 2004 the Australian Government funded Longitudinal Study of Australian 
Children showed an outstanding 92% breastfeeding initiation rate, however the rates 
declined sharply each month postpartum. It was reported that 71% of infants were 
receiving full breastfeeding at the age of one month, 56% at three months, 46% at 
four months, and only 14% at six months (1, 2, 71). The breastfeeding initiation rate 
continued to rise so that by 2011, 96% of infants were reported as being breastfed 
immediately after birth. At two, four and six months old, 57.8%, 38.6% and 17.6% of 
infants were exclusively breastfed, respectively, with breast milk the only source of 
nutrition (72). Nevertheless, it is important to note that a review of the available 
statistics and surveys showed that interpretation and direct comparison of the 
breastfeeding rates in Australia throughout the years are challenging due to 
inconsistent survey methodologies and definitions of breastfeeding used in these 
studies (1, 72).   
 
2.2.2 Australian Dietary Guidelines 
 
The Australian Dietary Guidelines published by the Australian Government provide 
dietary and nutritional recommendations to promote the overall well-being and 
health of the Australian population (35). The Eat for Health: Infant Feeding 
Guidelines, Information for Health Workers was published by the NHMRC in 2012, 
providing advice on the recommended infant feeding practices (35, 73).    
 
The NHMRC acknowledges the advantages of breastfeeding and the need for on-
going strategies to promote, support and monitor breastfeeding in the Australian 
community (1, 73). It has been recommended that all infants should be exclusively 
breastfed until the age of six months, with breast milk being the only source of 
nutrition for the infant (73). After this time, solids may be introduced to an infant’s 
diet, however mothers are encouraged to continue breastfeeding their babies until 
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twelve months of age. If preferred, mothers may also choose to continue 
breastfeeding in addition to complementary foods beyond this age (73). The 
recommendation by the NHMRC is in line with advice provided by the Australian 
Breastfeeding Association, American Academy of Paediatrics and World Health 
Organization (WHO) (36, 61). 
 
2.2.3 Breastfeeding Strategies in Australia 
 
In addition to clear guidelines and recommendations on best infant feeding practices, 
many strategies have been implemented in the last twenty years at both government 
and non-governmental levels to promote breastfeeding in Australia (1, 32). Some 
examples of these strategies include the Queensland’s Optimal  Infant Nutrition: 
Evidence-based Guidelines 2003-2008, Breastfeeding in New South Wales: 
Promotion, Protection and Support (2006-2012), South Australia’s Breastfeeding 
Program Strategic and Action Plan 2007-2012, Australian Breastfeeding 
Association’s Strategic Directions Plan for 2009-2012, the National Breastfeeding 
Strategy (1996-2001) and the currently running Australian National Breastfeeding 
Strategy 2010-2015 (1, 32).  The objectives and goals of these state-based and 
national breastfeeding strategies were very similar. These included promoting and 
supporting breastfeeding as well as raising the Australian community’s awareness of 
the advantages of breastfeeding. Despite adopting the national strategy, it is worth 
noting that there has been no specific state-based strategy in WA. 
 
The National Breastfeeding Strategy (1996-2001) was an Australian Government 
funded program aimed to promote breastfeeding in Australia (32). As a result of this 
strategy, many resources have been created to assist the community in promoting 
breastfeeding, targeting all relevant stakeholders, from health professionals and 
hospitals to families (1, 32). Efforts of this strategy included the provision of relevant 
breastfeeding support training to health professionals involved in the care of 
Indigenous women and Aboriginal and Torres Strait Islander healthcare workers (1). 
Continuing education kits were produced and distributed to paediatricians, general 
practitioners, pharmacists and child health nurses, to assist these health professionals 
in providing practical and consistent advice to breastfeeding women and their 
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families in the community (1). A total of 3,500 obstetricians and antenatal educators 
were sent an education package consisting of a poster, video and an educator’s 
manual, whilst about 50,000 employers in Australia were provided with booklets, 
flyers and posters with regards to balancing work and breastfeeding at workplaces 
(1). Efforts were also made to produce and distribute resources targeting families, 
such as posters, tip cards in different languages, comic booklets and booklets for 
individuals with low health literacy (1, 32). These resources served to increase the 
public’s awareness of the benefits of breastfeeding, thereby increasing the chances of 
successful breastfeeding. Despite the above mentioned efforts and actions, this 
strategy was conducted without a nationally agreed framework, and information on 
the extent and impact of this strategy on local practices in the different states of 
Australia were also not available (1).  
 
2.2.4 The Australian National Breastfeeding Strategy 2010-2015 
 
The Australian National Breastfeeding Strategy 2010-2015 that succeeded the 
National Breastfeeding Strategy (1996-2001) was endorsed by the Australian Health 
Ministers in March 2009 (1), and states “The Australian National Breastfeeding 
Strategy provides a framework for priorities and action for all governments to 
address the protection, promotion, support and monitoring of breastfeeding 
throughout Australia.”(1) 
 
The objective of this strategy is to increase the rates of exclusive breastfeeding in 
Australia from birth until six months, followed by complementary foods and 
continued breastfeeding the infant until twelve months of age and beyond (1). The 
three visions of this national breastfeeding strategy are: 
 
 “Australia is a nation in which breastfeeding is protected, promoted, 
supported and valued by the whole of society.”(1) 
 “Breastfeeding is viewed as the biological and social norm for infant and 
young child feeding.”(1) 
 “Mothers, families, health professionals and other caregivers are fully 




The principles of the current strategy are categorised as: i) “mother and child”, ii) 
“ecological context”, iii) “access”, iv) “diversity”, v) “collaborative care”, vi) 
“continuity of care”, vii) “evidence-based” and viii) “effective governance” (1). Of 
these eight principles, ‘collaborative care’ and ‘continuity of care’ are most relevant 
to the research objectives of this thesis. As suggested by the strategy, health 
professionals should work collaboratively in the provision of holistic care to women 
who are breastfeeding and their families. Since the endorsement of this strategy, 
there have been limited studies investigating the role of pharmacists in this context 
(74). Pharmacists should work collaboratively with other health professionals such as 
general practitioners, child health nurses and lactation consultants, to meet the 
healthcare needs of breastfeeding women. Furthermore, it is stated in the strategy 
that ‘continuity of support at key transition points between birthing and community 
services and into the broader community is seamless from the perspective of mothers 
and their families’ (1). The key research question here is what efforts could be made 
to ensure continuity of care for women during this transition period. Being at the 
front line of primary healthcare, community pharmacists are easily accessible and 
have been involved in the provision of continuing care and monitoring of patients 
living the Australian community (4). Pharmacists are also included in the current 
national breastfeeding strategy as one of the support staff (1). To date, no study has 
explored an expanded role for community pharmacists in providing breastfeeding 
support and continuity of care to women and their families during the postnatal 
period in the Australian context. Furthermore, there is no clear description of the 
roles and expectations of pharmacists as breastfeeding support staff in the 
community in the national documents. 
 
 
2.3 Factors Affecting Breastfeeding 
 
Despite the rise in breastfeeding initiation rates in the last decades, duration of 
breastfeeding remains an area to be improved in Australia (1, 72). Many studies have 
been conducted to investigate the factors affecting breastfeeding practices and 
reasons of early cessation of breastfeeding (2, 28). With an understanding of the 
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various factors affecting breastfeeding practices in Australia, the reasons and issues 
could be addressed to improve the duration of breastfeeding. Hector et al. (28) 
proposed a conceptual framework summarising the factors affecting breastfeeding 
practices. As shown in Figure 2.1, these factors may be classified as individual, 
group or society level factors. This framework may be used in generating hypotheses 
regarding the factors which affect breastfeeding practice and the interventions 
necessary to address these factors.  
 
Factors at the individual level consist of attributes of the woman, her infant and the 
mother-infant relationship. A woman’s awareness, experience, knowledge, skills, 
demographic and social variables can all directly influence her decision to initiate 
and to continue breastfeeding (3, 28, 66). On the other hand, the group level factors 
are associated with environmental factors, such as the hospital, community, work and 
home or family environment, as well as the availability of related health services or 
public policies (28). Creating a breastfeeding friendly environment for the mother 
and infant will encourage mothers to breastfeed their infants, provide reassurance 
and facilitate successful breastfeeding practices. Finally, attributes of the economy, 
cultural issues, and expectations as well as the perspectives of the society as a whole 
towards breastfeeding may also be influential towards breastfeeding practices in 
Australia (28). These factors are acknowledged by the Australian National 
Breastfeeding Strategy 2010-2015, which will inform subsequent interventions and 






Figure 2.1: Factors affecting breastfeeding practices 
 
2.3.1 Barriers to Successful Breastfeeding 
 
There are many factors which could contribute to a new mother not initiating 
breastfeeding or early cessation of breastfeeding. Several studies have been 
conducted in Australia to identify women’s reasons for not initiating breastfeeding or 
ceasing breastfeeding earlier than when is recommended by the Australian Dietary 
Guidelines (1, 73). The most common reported reason for unsuccessful breastfeeding 
and early weaning is milk supply that is perceived to be low or insufficient to meet 
the needs of nursing infants (30, 31, 61, 75-77). The National Health Survey 
conducted in 2001 by the Australian Bureau of Statistics (70) revealed that the most 
commonly self-reported reason for discontinuation of breastfeeding was inadequate 
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breastfeeding-related problems, such as cracked nipples (10%), and having to return 
to work (8%). Women’s socioeconomic backgrounds may also influence their 
breastfeeding practices. Results of a recent study in Chicago, USA, supported the 
literature in that women from a lower income or socioeconomic group were more 
likely to discontinue breastfeeding earlier and that the most common reported 
reasons for discontinuing breastfeeding included: the perception of insufficient milk 
supply (46%), maternal medical problems (13%), and having to return to school or 
work (13%) (78). While deficient mammary gland tissue, maternal hormone 
imbalance, poor breastfeeding technique or latching leading to ineffectual milk 
removal can all contribute to low supply of milk (30, 61), women’s inaccurate 
perception of insufficient milk supply and the lack of confidence or reassurance have 
also been shown to affect the duration and success of breastfeeding (58).  
 
According to the Queensland Health Optimal Infant Nutrition: Evidence-based 
Guidelines 2003-2008 (79), breastfeeding initiation or duration may be hindered by 
demographic, physical, psychological, social, clinical and environmental factors. 
Mothers of younger age or being adolescent, of a low income or socio-economic 
group, having lower education background, high parity, and women with a 
linguistically and culturally diverse background are less likely to initiate and/or 
continue breastfeeding (3, 66, 70, 79). According to the 2001 National Health 
Survey, the percentage of women aged over 30 years who were breastfeeding their 
infants at six months old was higher (54%) than women between the ages of 18 and 
29 (38%). The same survey also showed that 28% of women aged over 30 years 
were breastfeeding their babies at 12 months of age, compared with only 14% of 
those between the age of 18 and 29 years old (70). Women with higher education 
levels were also more likely to initiate breastfeeding and reported longer duration of 
breastfeeding compared to women with no higher qualifications since leaving school. 
This trend seems in line with other developed countries, for example the USA (80-
82): a qualitative study was conducted with 17 teenage mothers living in the USA to 
explore factors contributing to adolescent mothers’ breastfeeding practices and 
decisions (80). The study reported that adolescents’ breastfeeding practices were 
influenced by their skills and knowledge, as well as experience with any previous 




Physical factors which act as barriers to breastfeeding include sore or cracked 
nipples, multiple births, maternal obesity and diabetes, infant physical or medical 
issues, and infant prematurity (79). Besides these physical factors, maternal 
psychological factors such as lack of confidence, maternal depression, and inaccurate 
perception of inadequate milk supply, as well as negative perspectives and attitudes 
towards breastfeeding have all been demonstrated to have an unfavourable impact on 
the success of breastfeeding (79). Mastitis has been reported as a common form of 
infection experienced by breastfeeding women, which may present a challenge to 
successful breastfeeding (83). Besides attributes of the mother and infant, healthcare 
workers’ attitudes and knowledge may also affect women’s experience and 
breastfeeding practices. These include the lack of support and adequate discharge 
plans, as well as poor or wrong diagnosis or management of breastfeeding-related 
health issues (79). Other reasons reported in studies include inconsistent advice 
provided by healthcare workers and the lack of community support (84). In order to 
address the issue of inconsistency and to ensure accurate advice is provided to 
women, it is important to understand the perspectives, attitudes, knowledge and 
competence levels of the relevant healthcare workers to identify areas requiring 
interventions. Western Australia (WA) is one of the Australian states where currently 
women are discharged from hospitals after giving birth before breastfeeding is 
established (3). The issue of inadequate community support should also be looked 
into to provide continuity of care to women, especially during the immediate 
postpartum period and specifically also if it is the first child.  
 
Other cited barriers to successful breastfeeding include medical issues of the mother 
or infant, and the need to use medication whilst breastfeeding (43, 62). Several 
studies have described the risks and potential risks, as well as women’s concerns 
over the use of medications in breastfeeding (85-87). Concerns over infants’ safety 
may lead to unnecessary cessation of breastfeeding or may compromise women’s 
ability to receive appropriate pharmacotherapy in the management of health 
conditions. Therefore, appropriate resources and education should be available to and 
be provided to women to increase their awareness of this issue and prompt them to 
seek the advice of a health professional such as general practitioners or pharmacists 
in order to make informed decisions. On-going training and continuing professional 
education are also indispensable to ensure that health professionals, especially those 
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who have regular contacts with breastfeeding women, are up-to-date with their 
professional knowledge and latest evidence-based resources.  
 
 
2.4 Clinical Implication of Medicine Use in Breastfeeding: 
The dilemma 
 
Considering the recommended duration of breastfeeding, it is likely that women may 
require medical treatment at some stage whilst breastfeeding for minor ailments, 
acute conditions or chronic diseases (73). Therefore, the dilemma of medication 
administration whilst breastfeeding, including medications for breastfeeding-related 
problems such as mastitis, is not uncommon in clinical practice (88).  
 
Stultz et al. (27) conducted a survey in Pennsylvania, USA, investigating the extent 
and types of medications used by women during breastfeeding and found that 96% of 
the survey respondents had used at least one medicine during breastfeeding, either 
for chronic medical conditions or incidental and acute illnesses. The study also 
showed that women were significantly more likely to use prescription and non-
prescription medicines during breastfeeding as compared to while they were 
pregnant (27). The Pharmaceutical Society of Australia (PSA) Professional Practice 
Standard clearly defines non-prescription medicines as “all medicines available for 
purchase by the public that do not require a prescription. Non-prescription 
medicines include, but are not limited to, Pharmacist Only Medicines (S3), 
Pharmacy Medicines (S2), unscheduled medicines, complementary medicines, and 
nutritional supplements” (89). The most commonly used medicines reported by the 
respondents were multivitamins, paracetamol, non-steroidal anti-inflammatory drugs, 
nasal decongestants, cough suppressants, antihistamines, progestogens and 
antibiotics (27). Most of these medicines are available OTC (without a prescription) 
in Australia except progestogens and antibiotics. These medicines are classified as 
either non-scheduled (available in pharmacies and supermarkets), Pharmacy 
Medicines (Schedule 2, available in pharmacies only) or Pharmacist Only Medicines 
(Schedule 3, available in pharmacies only under supervision of the pharmacist) 
where pharmacists working in the community pharmacies are responsible and 
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expected to ensure the safe and effective use of these medicines (34). Nevertheless, 
the authors suggested that many of the medicines reported by the participants had 
unknown safety profiles when used in breastfeeding (27).  
 
A study was conducted in Brazil to investigate the effect of drug administration 
during the postnatal period on breastfeeding recommendations (90). Of the 2,161 
participants who provided breastfeeding-related information, the majority (96.2%) 
reported using medicines during the immediate postpartum period. However, most of 
these medicines were considered safe and compatible with breastfeeding and did not 
seem to pose a negative influence on a woman’s decision to breastfeed (90). The 
study concluded that whilst the use of medicines during the postpartum period is 
common, on-going efforts should be made to review these practices to ensure women 
are only prescribed and recommended the essential and safe medicines. 
 
Another survey conducted in the Netherlands found that 65.9% of the 549 
breastfeeding women who participated in the survey had used medicines. In contrast 
to the Brazilian study, the need to take medicines appeared to play a vital role in 
affecting women’s perspectives and decisions to initiate or continue breastfeeding. 
As stated by Schirm et al. (91), “women frequently hesitated to use drugs during 
breastfeeding, stopped either breastfeeding or drug use to avoid combining the two, 
took a measure to minimise exposure to the child, did not use any drug because of 
breastfeeding, or did not breastfeed because of drug use”, which may be summarised 
as the dilemma associated with the use of medicines during breastfeeding. The 
authors concluded that although using medicines during breastfeeding seemed to be a 
common practice, many women may be reluctant to do so (91).  
 
Breastfeeding woman with a health issue requiring medical treatment often presents 
a conundrum for health professionals. Despite the increasing popularity of herbal 
medicines amongst the general population, a review of the available literature 
identified that only limited research studies have been conducted to determine the 
clinical efficacy and safety of herbal medicines and their constituents when used 
specifically during breastfeeding. Further studies to explore women’s attitudes and 
perspectives towards the use of medicines during breastfeeding are also required to 
enhance our understanding of women’s concerns and the factors affecting their 
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decision-making process. This will subsequently enable appropriate and practical 
interventions or strategies to be implemented to promote the safe and effective use of 
medicines including CMs in breastfeeding, whilst allowing mothers to continue 
breastfeeding.  
 
2.4.1 Exposure of Breastfed Infants to Medicines via Breast Milk 
 
The main concern for lactating women on medications is the transfer of medicines 
into breast milk. Medicines circulated in the maternal bloodstream can potentially be 
transferred into human breast milk, exposing breastfed infants to medicines that may 
be harmful. The mechanisms which govern the transfer of medicines into human 
milk include passive diffusion, exocytosis, transcytosis, secretion of milk fat, 
vesicular transport and via various active drug transporters (39, 92-99). Previous 
studies have shown that passive diffusion accounts for the transfer of most medicines 
into human milk, by means of either paracellular or transcellular diffusion (92, 100).  
 
Lactation stage, physicochemical properties of medicines (size, lipophilicity, acid 
dissociation constant or pKa and ionization), pharmacokinetics of the drug or 
medicine in the mother and infant (absorption, plasma drug concentration, 
bioavailability, distribution, metabolism, protein binding, and excretion rates) and 
characteristics of milk can all influence the extent and rate of medicine transfer (92, 
94, 101-103). Furthermore, the dosage forms and routes of administration of 
medicines may have substantial implications on the pharmacokinetics of the 
medicine and hence their safety in breastfeeding.  Determining risk and extent of 
exposure as well as predicting effects in infants usually form the basis when 
considering safety of medicines use by mothers during breastfeeding, which involve 
consideration of all the above mentioned factors so that the milk-to-plasma ratio 
(M/P), and absolute and relative infant dose can be calculated (104-106). A summary 
























There have been many studies undertaken to determine the transfer and safety of 
conventional medication use during breastfeeding, as documented in Medications 
and Mothers’ Milk by Thomas Hale (62) and Drugs in Pregnancy and Lactation by 
Briggs et al. (107). The USA Food and Drug Administration (FDA) has classified 
commonly used medicines into Lactation Categories (L1, L2, L3, L4 and L5) based 
on their safety in breastfed infants, with L1 representing the safest options (62). 
Nevertheless, only limited numbers of conventional medicines which are commonly 
used are assigned a Lactation Category (62). Although most medicines are 
considered safe during breastfeeding (in L1 and L2 categories), there have been 
incidents and reports of adverse events in infants after exposure to medicines or 
substances via breast milk (61, 62). Besides conventional medicines, alcohol, 
nicotine and caffeine have all been reported to adversely affect the infant’s nervous 
system and mental alertness following maternal consumption (108-112). Certain 
food components present in human milk have also been reported to cause allergic 
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Figure 2.2: Factors influencing drug transfer from the mother to her infant
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In contrast to potentially causing harmful effects, infant exposure to xenobiotics via 
breast milk may sometimes confer therapeutic benefits and positive clinical sequelae 
in breastfed infants. For instance, studies have demonstrated the transfer and 
presence of antiviral agents including acyclovir, ganciclovir and zidovudine in the 
milk following maternal administration (97, 115, 116). Breastfed infants are exposed 
to viral infections through vertical transmission via breast milk if lactating mothers 
are infected (97, 117, 118). It has been suggested that maternal administration of 
aciclovir, ganciclovir or zidovudine reduce viral load in the maternal plasma and lead 
to the accumulation of these antivirals in the milk, thereby potentially lowering viral 
transmission rates by decreasing viral titers in the breast milk (97).  
 
As previously mentioned, an authorised prescriber is not required to be involved in 
the sale and use of CMs, including herbal medicines, in breastfeeding, and their use 
is not recorded or monitored through the Pharmaceutical Benefits Scheme (PBS) or 
dispensing software in Australia. These products are often available from stores and 
supermarkets. Unlike conventional medicines, herbal medicines are mixtures that are 
chemically rich and complex, often comprising hundreds or more herbal constituents 
(20, 119). The full profile of chemical constituents in many herbal medicines and 
their pharmacological actions in the human body remain uncertain, and in some 
cases, unknown. Furthermore, the profile and distribution of constituents may vary 
throughout a plant or plant parts. As with all crude natural substances, the profiles of 
their constituents may vary not just in terms of quantity, but also their quality (20). 
As a result of this, it is not surprising that the therapeutic effects of herbal medicines 
may vary between different manufacturers or different batches of materials within 
the same manufacturer. This explains why herbal medicines, even those with well-
evidenced efficacy, may not always demonstrate consistent therapeutic effects. In 
addition, the types of extraction and other methods of processing the herbal materials 
adopted by the manufacturers can impact on the herbal medicinal products’ chemical 
composition and subsequent quality of their products. Many herbal medicinal 
products contain more than one herbal ingredient, and there is not always 
standardisation of herbal ingredients across the different brands of herbal medicinal 
products. Hence when considering the safety of a herbal medicine or products 
containing a combination of herbal ingredients in the context of breastfeeding, one 
has to consider not just a single, but rather many, components, mostly with limited or 
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unknown pharmacokinetics, pharmacodynamics and pharmacological information. 
To add to the complexity of the issue surrounding the use of herbal medicines in 
breastfeeding, many of these medicines are used traditionally in diverse cultures and 
are known in varying names in different countries, making direct comparison of 
herbal medical products challenging (120). As with conventional medicines, the 
packaging and labelling of all CMs, including the labels of herbal medicinal 
products, should have accurate and detailed information including a batch number, 
complete identification of the contents, dosage information and contact number of 
the manufacturer. Another concern with regard to using herbal medicinal products in 
breastfeeding is the risk of adulteration and contamination with potentially toxic 
substances, accidental or intentional species substitution, and there may be 
differences between the actual and labelled contents (20, 121, 122). Further 
information on the regulation of CMs in Australia is provided in Section 2.5.3.      
 
The aforementioned factors and the characteristics of herbal medicines present 
challenges and issues for pharmacovigilance of herbal medicines in the general 
population, and more so in women who are breastfeeding. The potential and extent of 
transfer of all or any constituents of a herbal medicine to the infant, as well as its 
effects on quantity and quality of breast milk, should be taken into account when 
evaluating the safety and suitability of these medicines in breastfeeding. The health 
of an infant may be compromised if the infant is exposed to breast milk with 
potentially harmful or toxic components transferred from the maternal plasma to the 
breast milk. Hence, it makes sense that when determining the extent and rate of 
transfer of any medicine including herbal medicines into the breast milk, the 
physicochemical properties and pharmacokinetics of all the herbal constituents of a 
particular herbal medicine have to be given thorough consideration. The chemical 
complexity of herbal medicines makes the process of determining their clinical 
pharmacokinetics, pharmacodynamics and pharmacology extremely challenging and 
at times problematic, especially when they are used during breastfeeding.   
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2.4.2 Effect on Quantity of Human Breast Milk 
 
Another concern is the effect of medication administration on the quantity and 
quality of breast milk produced, which may then impact on the exclusivity, duration 
and hence success of breastfeeding. Drugs that have been reported to compromise 
production of milk include cabergoline (123), bromocriptine (124), ergotamine (62), 
pseudoephedrine (125) and oestrogens (62, 126).   
 
Cabergoline, bromocriptine and ergotamine have all been used in the management of 
hyperprolactinaemia due to their effects in terms of suppressing lactation (127). 
Interference with blood flow to the breasts and inhibition of prolactin secretion are 
two common mechanisms contributing to the decrease in breast milk production 
(127). Many studies have investigated the effects of pseudoephedrine use in 
breastfeeding (125, 128, 129). Aljazaf et al. (125) studied the effects of 
pseudoephedrine on human breast milk production (by test weighing the infants 
before and after each feed) in eight women and found that a single dose of 60 mg 
pseudoephedrine significantly decreased milk production by 24% from 784 to 623 
mL per day and that there was a moderate reduction in the mean plasma prolactin 
level of 13.5% (125). In the same study, the calculated infant dose via exposure of 
the drug in the breast milk based on four-time dosing schedule of 60mg 
pseudoephedrine was less than 10% (4.3%), suggesting untoward effects on the 
infants’ safety were unlikely (125). Despite the absence of evidence to indicate safety 
concerns in the infants, the results suggest that pseudoephedrine should be used with 
caution in lactating women to avoid unfavourable effects on their breastfeeding 
performance. Oral contraceptives containing oestrogen should also be avoided 
especially during the immediate postpartum period due to the risk of suppressing 
breast milk production (126, 127). There has also been speculation about diuretics 
decreasing breast milk supply (130). Isolated case reports published in the late 1900s 
suggested possible suppression of milk supply by oral diuretics such as 
spironolactone and hydrochlorothiazide, however no further research has been 
conducted to confirm these effects (131, 132). 
 
Besides conventional medications, some CMs have also been associated with 
reduction of milk supply. It has been suggested that pyridoxine (vitamin B6),  when 
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taken in excessive amounts, may suppress milk production (133). However, Andon 
et al. (134) demonstrated that neither nutritionally relevant nor therapeutic doses of 
pyridoxine suppressed plasma prolactin levels and did not appear to adversely affect 
lactation. Peppermint, sage, camphor, bilberry, and parsley have been used 
traditionally for weaning, however no studies have been published to support their 
clinical use (61, 133). Nevertheless, until more data are available, use of these herbal 
materials in large quantities should be avoided in lactating women who wish to 
continue breastfeeding or increase their milk supply.  
 
2.4.3 Effect on Quality of Human Breast Milk 
 
Maternal diet may affect the quality of milk by altering its taste, and hence may 
affect infant-feeding behaviour in breastfeeding (135). Infants may be sensitive to 
changes in the taste of breast milk (127, 136). For example, the use of aromatic 
substances like garlic during breastfeeding and its effect on the taste of milk remains 
controversial. While some studies suggested that maternal use of garlic may alter the 
taste of milk and render infant refusal to feed, another study has shown that garlic-
flavoured milk causes infants to nurse longer, enhancing the breastfeeding 
performance (137).  
 
2.4.4 Perspectives of Women towards Medicines Use in Breastfeeding 
 
‘Perspective’ in the context of this study is defined as “a particular attitude towards 
or way of regarding something; a point of view” (138), whereas ‘attitude’ is further 
defined as “a settled way of thinking or feeling about something” (139).   
 
A study published in 1990 conducted by Matheson et al. (140) in 885 participants 
found that women’s ‘doubts’ concerning the use of medicines in breastfeeding were 
associated with the number of medicines taken.  It was also shown in a separate 
study published in 1993 that up to one in five women who were prescribed 
antibiotics either discontinued breastfeeding unnecessarily or decided not to initiate 
antibiotic therapy at all, despite being advised and reassured by their healthcare 
providers (141). Women’s concerns over breastfed infants’ safety and the 
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compatibility of medicine use with breastfeeding were also demonstrated in a Dutch 
survey published in 2004 (91) where 30% of women hesitated over the use of 
medicines while breastfeeding: twelve percent of the 549 survey respondents were 
not breastfeeding their infants due to the need to use medicines, whilst one in ten 
either stopped using the medicines or discontinued breastfeeding (91).  
 
Despite the evidence cited above regarding antibiotic use, women who need to use 
medicines during breastfeeding often rely on their health professionals for accurate 
advice and recommendations (87). Nevertheless, a study by Jones and Brown (142) 
in 2000 which surveyed a group of 820 breastfeeding women identified that there 
was only a 28% satisfaction rate with the advice provided by their general 
practitioners and pharmacists. Six percent commented that conflicting advice was 
received and only approximately one in ten women who had purchased OTC 
medicines in the pharmacy was asked if she was breastfeeding by the pharmacy staff 
(88, 142).  
 
Studies have shown that women who suffer from postnatal depression may be 
hesitant to commence treatment with antidepressants during breastfeeding (143, 
144). In line with reasons expressed by other people who suffer from depression 
(145-147), it has been reported that women with postnatal depression, whether 
breastfeeding or not, are concerned about issues with side effects, dependency and 
stigma attached to the use of antidepressants (143). In addition to these findings, 
women who are breastfeeding have also expressed concerns over the use of 
antidepressants during breastfeeding. Women’s negative perceptions towards the use 
of antidepressants during breastfeeding may contribute to compliance issues and 
subsequently compromise women’s health outcomes (85, 143, 148). Poorly managed 
depression in a breastfeeding woman may also impact on her infant’s wellbeing. 
Nevertheless, it was demonstrated in an in-depth qualitative study by Turner et al. 
(143) that women’s perceptions of antidepressant use in breastfeeding may improve 
with appropriate counselling and advice from health professionals. Encouragement 
from their family and friends, as well as a positive experience with previous use of 





Most research has focused on exploring the perspectives of women towards the use 
of conventional medicines in breastfeeding, such as antidepressants and analgesics 
(87, 143). As discussed earlier, previous studies have shown that women may be 
reluctant to commence conventional pharmacotherapy whilst breastfeeding due to 
safety concerns and their desire to breastfeed (87, 91). As a consequence, some 
women may choose to self-medicate with OTC medicines or turn to natural remedies 
due to their perceived safety profile (7, 27, 87). However, the perspective of 
breastfeeding women towards the use of other OTC medicines and complementary 
and alternative therapies, specifically herbal medicines, during breastfeeding, is an 
area that has not been well studied. 
 
2.4.5 Perspectives and Attitudes of Health Professionals towards Use of 
Medicines during Lactation 
 
The attitudes and knowledge of health professionals often affect their decision-
making, ultimately influencing the health outcomes of their patients. Therefore, it is 
important to explore and understand the perspectives of health professionals towards 
the use of medicines, including herbal medicines, when breastfeeding. This is 
especially important for those who have regular contacts with women and their 
families during the postpartum period, to promote the safe and effective use of 
medicines during breastfeeding.  
 
Healthcare professionals and workers who have frequent contacts with breastfeeding 
women in the community include general practitioners (GPs), pharmacists, child 
health nurses and lactation consultants (87, 149). Although child health nurses play a 
valuable role in assisting women during the postpartum period, no published studies 
exist which have explored their perspectives towards the use of medicines in 
breastfeeding (87). On the other hand, many studies have been conducted over recent 
years to explore GPs’ perspectives towards prescribing for breastfeeding women (83, 
87, 88, 150-154).  
 
In a study conducted by Jayawickrama et al. (83) in Melbourne, Australia, 76% of 
the 335 GPs who participated in the survey reported on their experiences of making 
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clinical decisions about prescribing for lactating women. Approximately half of the 
breastfeeding women who presented themselves to the GPs in this study had 
infections, with mastitis being the most common form of infection (24%). Examples 
of other infections included endometritis, tonsillitis, upper respiratory tract and 
urinary tract infections. Depressive disorders and requests to use analgesics were also 
common scenarios triggering women to present themselves to GPs (83). In this 
study, “complexity of managing risk” emerged as the over-arching theme, as 
participants described the uncertainty associated with making clinical 
recommendations and prescribing for the breastfeeding woman (83). Participants 
reported having to involve other health professionals such as specialists during the 
process of decision-making for more complex medical issues, as in postnatal 
depression. The availability of reliable and consistent information resources was also 
deemed indispensable to assist them in making recommendations as to what 
medicines should be used or avoided in lactation. In this study, the issue with 
pharmacists being over-conservative was also raised by some participants (83). The 
authors concluded that GPs indicated that prescribing during lactation was a complex 
and time-consuming task, often having to do research and weigh the risk and benefit 
on a case-by-case basis. It was also reported that in the absence of evidence-based 
information, GPs sometimes suggest unnecessary discontinuation of breastfeeding 
(83).   
 
Jones and Brown (142) surveyed 590 GPs and 641 community pharmacists in the 
UK to investigate their attitudes and knowledge towards the use of medicines in 
breastfeeding, as well as their perceptions of the significance of breastfeeding. The 
majority of the participants in both groups agreed with the statement “breastfeeding 
is a health promotion issue” (142). Over 90% of the general practitioners would 
routinely ask questions to ascertain if women were breastfeeding if they were 
accompanied by a baby; however this was only the case for half of the pharmacists in 
this study. A few pharmacists (n = 9; 1.4%) expected women to initiate queries 
relating to the appropriateness of using medicines in breastfeeding. The frequency of 
queries received by pharmacists ranged from weekly to a monthly basis, with 
questions commonly concerning the safety of using medicines, such as cough and 
cold treatments, laxatives, oral contraceptives and sedatives during lactation. Both 
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groups of health professionals believed that they should provide information about 
the potential adverse effects should the woman continue to breastfeed (142).   
 
Another study conducted by Long and Montouris (152) surveyed 202 attendees of 
the American College of Physicians’ annual meeting in 2003, who were mostly 
(92%) physicians. Participants were asked their views and knowledge on the use of 
antiepileptic medications while breastfeeding. Less than half (47%) of the survey 
respondents provided the correct response (‘true’) to the statement “most women 
taking antiepileptic drugs can safely breastfeed” (152). The lack of physicians’ 
knowledge in this area may lead to unnecessary recommendations to cease 
breastfeeding. The study also demonstrated that there was a need to provide further 
training especially to those health professionals who are involved in making clinical 
decisions about medications to be used by nursing mothers.  
 
A few studies have also explored pharmacists’ knowledge and perspectives on the 
use of conventional medicines in breastfeeding. Long and Montouris (152) 
conducted a study which involved surveying 109 registered pharmacists in Ohio. Of 
these 109 participants, 79% were practising in community pharmacies. Interestingly, 
only 34% of the pharmacists who took part in the survey responded correctly to the 
statement “most women taking antiepileptic drugs can safely breastfeed” (155). In a 
separate study published in 2009, 36 community pharmacists in Rhode Island, USA, 
were supplied with a reference text published by Hale, entitled Medication and 
Mothers Milk (156) and were asked to participate in a survey. Amongst the 33 
pharmacists who responded to the survey, 45% said they received on average 
breastfeeding and medicines-related queries on a daily to weekly basis in their 
practice. Despite the majority of the participants feeling comfortable providing 
advice to nursing mothers, only 42% of them regularly asked women about the use of 
medications during breastfeeding. In line with the findings of the study previously 
conducted by Jones and Brown in the UK (142), about 60% of the pharmacists in this 
study thought that breastfeeding mothers should self-disclose to pharmacists if they 
were breastfeeding.  
 
In the most recent study published, De Ponti et al. (5) in 2013, surveyed 176 
Australian community pharmacists to investigate their perspectives on the use of 
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medicines in breastfeeding, using a structured questionnaire. The majority of the 
pharmacists (92%) agreed that they felt confident in counselling and supplying 
medicines to breastfeeding women. The participants’ knowledge was determined 
based on five medications, namely ibuprofen, paracetamol, metronidazole, lithium 
and St John’s wort (5). Ninety-four percent of the pharmacists were aware that 
paracetamol is safe to be used during breastfeeding. Only 8% and 37% of the 
participants were aware that metronidazole and ibuprofen are both compatible with 
breastfeeding, respectively. Participants were also conservative about the use of 
lithium in breastfeeding, with 43% raising concerns and 42% needing to look up 
information. The study further found that most of the participants (92%) had 
concerns or a lack of knowledge regarding the use of St John’s wort in breastfeeding, 
despite this herbal medicine being considered as “relatively compatible” with 
breastfeeding, according to the authors (5). This recommendation was based on a 
separate observational, prospective cohort study conducted by Lee et al. (157) on 33 
breastfeeding women receiving St John’s wort in Group 1, who were compared with 
101 disease-matched controls in Group 2 and 33 age- and parity-matched controls 
with no disease in Group 3. The study found no changes in breast milk production 
and infant weight gain in the first 12 months of life. There were only two cases of 
colic, two cases of drowsiness and one case of lethargy in Group 1, as compared to 
one case of colic each in Groups 2 (p < 0.01) and 3 (p = 0.20). Of the five cases 
reported from Group 1, three sought advice from their doctors but specific medical 
treatment was not needed (157). However, important information such as the details 
and descriptions of the St John’s wort products used were not provided. Another 
study which involved analysis of four breast milk samples (both fore and hind milk) 
from one woman who took 300 mg of St John’s wort extract (Jarsin®) three times 
daily found only low concentrations of hyperforin in the samples, and there was no 
reported side effects in the mother or infant (158). Although limited in numbers, the 
available studies did not identify serious adverse outcomes. Further research is 
warranted to investigate the pharmacokinetics of the constituents of this herbal 
medicine in the infants’ and mothers’ plasma and breast milk, to confirm the safety 
and justify the use of this herbal medicine in breastfeeding.  
 
In the absence of evidence-based information from Randomised Controlled Trials 
(RCT) informing the safety aspects of medicines when used during breastfeeding, 
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many health professionals face a challenge when needing to provide advice to 
women and their families. A review article published in 2011 by Hussainy and 
Dermele (87) on the practices, knowledge and attitudes of health professionals 
(endocrinologists, GPs and pharmacists),  towards the use of medications in 
breastfeeding. It was commented that despite health professionals possessing positive 
attitudes towards this topic, many showed poor knowledge in this field. To assist 
health professionals in making clinical recommendations to breastfeeding women, 
there is a need to review and update the available resources, as well as incorporating 
recent evidence and ensuring consistency between all these references.  
 
 
2.5 Use of CMs in the General Population 
 
The use of CMs is increasingly common worldwide. Over the years, much research 
has been undertaken to investigate the prevalence and pattern of use of these 
medicines in many countries (7, 159, 160). Despite the lack of evidence-based 
information confirming the efficacy of many CMs and alternative therapies in 
treating specific medical conditions, their use may potentially lead to other beneficial 
patient-centred health outcomes (161-163). Besides perceived physical health 
improvements, participants in a study conducted by Greene et al. (163) in 
Massachusetts and North Carolina, USA, described the favourable psychological 
benefits associated with the use of CAM, though the findings were related to CAM in 
the broader context, and not specific to CMs or herbal medicines. Although not 
directly related to their proposed indications, the authors reported that CAM use had 
facilitated users’ positive changes in their health behaviours, empowering them to 
lead a healthy lifestyle, including improved diets, smoking cessation and increased 
levels of daily exercise (163). Many users of CAM believed such treatments assisted 
in coping with stress and anxiety, and provided them with a sense of empowerment 
and increased hope (161, 163). Similar findings were also found specifically with the 




2.5.1 Trends in Australia 
 
Results of surveys conducted in Australia have agreed with the findings from other 
countries (7, 25, 160, 164-167), with a prevalence study conducted in 2005 by Xue et 
al. (7) showing 68.9% of the participants recorded use of one or more forms of CAM 
in the previous 12 months. In addition to herbal medicines, CAM in this context also 
referred to other forms of alternative therapies such as general clinical nutrition, 
massage therapy and meditation. The study involved a total of 1067 adult 
participants from all states and territories of Australia (7). Women between the ages 
of 18 and 34, well-educated, employed with higher income levels and were covered 
by private health insurance were more likely to use CAM (7). Forty-four percent of 
the survey respondents reported visiting CAM practitioners, and the adult Australians 
were estimated to visit CAM practitioners 69.2 million times over a one year period 
(7). The authors commented that this frequency was not only comparable, but almost 
identical to the number of times conventional medical practitioners were visited 
(69.3 million), which further confirmed the popularity of CAM amongst the general 
adult Australian population (7). Despite the common use, regular users did not 
always inform their medical practitioners of their decision to use CAM. 
Approximately 23% of the survey respondents had used Western and Chinese herbal 
medicines in the previous 12 months, with 16.3% and 7% specifically using Western 
and Chinese herbal medicines respectively. Western herbal medicine was amongst 
the top four most popular forms of CAM, after clinical nutrition, Western massage 
therapy and meditation. Amongst the users of Western and Chinese herbal 
medicines, 29.1% and 32.9% visited a practitioner of that type of CMs in the 
previous 12 months, respectively. Females were also more likely to use Western 
herbal medicines than their male counterparts (p < 0.001). 
 
A separate study investigated the prevalence and pattern of use of CAM in South 
Australia (160). This 2004 publication reported that 52.2% of the population in that 
state used CAM, with 20.6% specifically using herbal medicines. In line with the 
study mentioned above, this survey revealed that women between the ages of 25 and 
34, with higher education and income levels showed greater use of CAM (160). 
There were also some data specific to the use of herbal medicines. The use of herbal 
medicine has risen from 9.9% in 1993 to 20.6% in 2004. The prevalence of herbal 
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medicine use was higher in 2004 than in 1993 and 2000 for both men and women, 
with women’s use rising from 16.6% in 2000 to 24.9% in 2004 (p < 0.01) (160).  In 
2007, Zhang et al. (25) conducted a cross-sectional population-based survey of 2526 
participants living in Victoria, and reported that approximately one in four survey 
respondents had used one or more herbs for medicinal purposes in the previous 12 
months. The 24 most commonly used herbal medicines reported in the study were 
aloe vera, garlic, green tea, chamomile, echinacea, ginger, cranberry, peppermint, 
ginseng, ginkgo biloba, evening primrose, dandelion, valerian, liquorice, St John’s 
wort, slippery elm, milk thistle, dong quai, black cohosh, bilberry, senna, hawthorn, 
saw palmetto and chasteberry (25). The majority of the survey respondents believed 
that their herbal medicine(s) of choice was effective and helpful (25).  
 
A nationally representative cross-sectional postal survey conducted in Australia 
between June 2009 and February 2010 involving 1608 adults aged 50 years and older 
(response rate = 37.3%) found that 46.3% of respondents had used one or more 
complementary medicines in the previous 24 hours (168). The most commonly used 
complementary medicines reported in this study were omega-3 marine triglycerides 
such as fish oils (25.2%), glucosamine (16.8%), multivitamins and minerals (14.6%), 
calcium (11.6%) and vitamin D (10.8%). However, the prevalence of herbal 
medicines use specifically, was not reported. Women in this study used more 
complementary medicines in the previous 24 hours when compared to men (p < 
0.001). Pharmacies were reported to be the main source of complementary medicines 
(53.2%), followed by health food shops (20.2%), supermarkets (17.6%), and the 
internet (2.7%). The study also showed that CMs were most likely to be 
recommended by family and friends (p < 0.001) or the media (p < 0.001), when 
compared to conventional medicines (168).  
 
2.5.2 Trends in Other Countries 
 
Research undertaken in the last couple of decades in many countries including the 
USA (169, 170), Canada (171-173), Brazil (174), the UK (175, 176) and the United 
Arab Emirates (177) have all demonstrated a substantial increase in the use of CAM, 




Herbal medicines are widely used in the USA (178, 179). A nationally representative 
cross-sectional study which involved telephone surveys demonstrated that the 
prevalence of herbal medicine use amongst the USA population increased 
significantly from 3% in 1990 to over 12% in 1997 (p ≤ 0.001) (169). In 2001, a 
population-based survey was conducted in Michigan and found that the prevalence of 
herbal medicines use was 21% (180). In the 2002 National Health Interview Survey 
conducted in the USA, approximately 60% of the 31,044 adults who participated in 
the survey conducted through computer-assisted personal interviews had reported 
using some form of complementary and alternative therapies in the previous 12 
months (181), of whom, 18.9% were specifically using natural or herbal products. 
Another population-based telephone survey conducted in Michigan, USA, in 2001 
and involving 3764 adults found that 20.5% of respondents (95% CI 19.1-21.9) had 
used herbal supplements in the previous year (180).   
 
Many previous studies have demonstrated that herbal medicines use is popular 
amongst consumers or patients living in the UK (182, 183). Posadzki et al. (183) 
conducted a systematic review of studies and surveys published between 2000 and 
2011 which investigated the prevalence of herbal medicine use in the UK. The 
systematic review found that the prevalence of herbal medicines use amongst the 
general population varied, ranging from 4.8% to 92.4% (183). There was an average 
of 15.8% incidence of reported adverse effects experienced by users of herbal 
medicines. It was also reported that the majority of the herbal medicines users did not 
inform their conventional health professionals such as doctors about their decisions 
to use herbal preparations (183).   
 
A cross-sectional survey published in 2008 by AlBraik et al. (177) showed that 76% 
of the 330 survey respondents in Abu Dhabi, United Arab Emirate, had used at least 
one herbal product. The study reported a total of 65 different herbal medicines being 
used in the treatment of 48 medical conditions. Adverse effects were experienced by 
27 of the participants (8.2%), whilst the majority believed that herbal medicines were 
generally safe (177). It was also demonstrated that friends and family played an 




CAM and CMs are used by individuals worldwide, including in specific population 
types such as in the elderly, and are used for a myriad of conditions including in 
major chronic diseases. The use of herbal medicines, a type of CMs, has been 
reported to be increasingly common amongst the elderly population, with the two 
most commonly used being gingko and garlic (184). Other commonly used herbal 
medicines included chamomile, ginseng, aloe vera, spearmint and ginger (184). 
Herbal medicines have also gained their popularity amongst non-elderly patients 
with chronic diseases or conditions (185). A systematic review conducted by Liwa et 
al. (186) revealed that 25% to 65% of hypertensive patients living in the sub-Saharan 
Africa were using herbal medicines, and that herbal medicines were the most 
common form of CMs used.  
 
The use of CAM is also common amongst people with diabetes mellitus (187-193). 
For example, a recent study conducted in Malaysia showed up to 62.5% of people 
with type 2 diabetes were frequent users of CAM (193). Amongst the types of CAM 
reported in this study, biological-based therapies such as herbal medicines were the 
most commonly used. Bitter gourd (Momordica charantia) (30.4%), Misai Kucing 
(Orthosiphon stamineus benth) (24.2%), garlic (Allium sativum) (13.3%) and Sabah 
snake grass (Clinacanthus nutans lindau) (7.9%) were amongst the most commonly 
reported herbs used traditionally for their perceived medicinal benefits (193). The 
study also reported the use of other CAM therapies, including reflexology, 
Ayurveda, acupuncture, Reiki, massage bed, yoga and tai chi, albeit to a lesser extent 
than herbal medicines. Garlic, fenugreek, and bitter gourd are also frequently used in 
India to aid the management of diabetes mellitus (194). According to Nahas and 
Moher, cinnamon (Cinnamomum verum) is also used in Canada and the USA for this 
purpose (195).  
 
A review of the literature has revealed that the use of herbal medicines is likewise 
common amongst patients with other chronic health conditions, for example cancer, 
human immunodeficiency virus, rheumatological diseases, asthma and chronic renal 
disesase (159, 196, 197). It was evident that the choice of herbal medicine is heavily 
influenced by tradition in the varying cultures, and the availability of these herbal 




2.5.3 Regulation of Complementary Medicines in Australia 
 
The TGA is responsible for the regulation of all medicines including CMs, as well as 
medical devices available in Australia (198). The regulation of complementary 
medicines in Australia is similar to the approach followed by the FDA in the USA 
(199).   
 
In Australia, a two-tiered system is in place for the classification of all medicines. 
Depending on the associated risks, the TGA classifies medicines into either the 
‘higher risk’ or ‘lower risk’ categories (198). Medicines classified as ‘higher risk’ are 
registered on the Australian Register of Therapeutic Goods (ARTG) and are 
subjected to stringent assessments evaluating their efficacy, safety and quality (200). 
All registered medicines are issued with a unique AUST R code, and include all 
prescription medicines (Schedules 4 and 8) and most of the OTC conventional 
medicines available from community pharmacies (mostly Schedule 2 or Schedule 3), 
for example treatments for cold and flu or cough, some analgesics and treatment for 
other primary healthcare conditions or minor ailments (34, 200).  
 
On the other hand, medicines or products classified as ‘lower risk’ are listed on the 
ARTG by the TGA and are issued with AUST L numbers (198). These include only 
some of the OTC medicines, but the majority of the CMs including herbal medicines, 
vitamins and supplements (200). These medicines are subjected to less rigorous 
assessments as compared to registered medicines, and the products are only 
evaluated for safety and quality, but not their efficacy (200). This forms the basis of 
the argument that regulation concerning the use and marketing of herbal medicines 
should be strengthened, as these medicines may still be associated with medicine 
interactions and that adverse effects have also been reported (25, 201, 202).  
 
Although most CMs are only listed on the ARTG, it is worth noting that there have 
been significant reforms by the TGA in the last two years (203). Following 
consultations with the public and key stakeholders, the reform aims to strengthen the 
regulation of CMs in Australia (203). A series of activities has been undertaken to 
improve the confidence of the Australian community towards the quality and safety 
of CMs. Recent efforts included updates and revision of the Australian Regulatory 
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Guidelines for Complementary Medicines (ARGCM) and enhanced post-marketing 
surveillance (203). Manufacturers and sponsors of CMs have also been advised of 
their obligations to hold evidence to support the marketed indications of their 
products, along with an updated electronic or online application system for these 
medicines (203). Nevertheless, this reform is only at its early stages, hence further 
efforts and on-going monitoring are required in the regulation of CMs to benefit the 
Australian community.  
 
The marketing and supply of CMs is another aspect of the regulation of CM products 
in Australia that is relevant to the context of this research. The TGA through the 
Therapeutic Goods Advertising Code (TGAC) clearly indicates that the marketing of 
all therapeutic goods should not be against the “quality use of medicines” principles, 
and states that “the marketing and advertising of therapeutic goods, including CMs, 
is to be conducted in a manner that promotes the quality use of the product, is 
socially responsible and does not mislead or deceive the consumer” (16). Classified 
as AUST L medicines in Australia, the advertising and marketing of CMs are 
currently co-regulated between the TGAC, the Australian Self-Medication Industry 
and the Complementary Healthcare Council of Australia (CHC) (16, 204, 205).  
 
As opposed to AUST R medicines, products classified as AUST L are subjected to 
less stringent advertising control. For example, direct-to-consumer advertising of all 
medicines classified as Schedule 3 (except those listed in Appendix H of the 
SUSMP), Schedule 4 and Schedule 8 (classed as AUST R) is not permitted (16, 206). 
However, as long as they comply with the Therapeutic Goods Act 1989 and the 
Therapeutic Goods Regulations 1990 as well as the requirements specified by the 
TGAC and CHC, direct-to-consumer advertising of CM products is permitted. 
Despite the lack of efficacy data for many CMs, the widespread advertising of these 
medicines through mainstream media for example television, radio stations, 
newspapers and magazines, may have an impact on the public’s perception of the 





2.5.4 Attitudes and Perspectives of Pharmacists towards CMs 
 
In Australia, community pharmacies are one of the major suppliers of CMs including 
herbal medicines and nutritional supplements (6, 7, 207). Therefore, pharmacists 
practising in community pharmacies have regular contact with frequent users of these 
medicines. Studies have shown that the public perceive pharmacists as a reliable 
source of health and medicine-related information and most consumers in a study 
conducted by Tran et al. (208) were satisfied with pharmacists being CM providers. 
CMs stocked in pharmacies were also perceived to be superior in safety and efficacy 
compared to those sold in other places such as health food outlets and supermarkets 
(208).  
 
A study published in 2010 by Braun et al. (207) investigated the attitudes and 
perceptions of 1,121 Australian pharmacy clients towards the use of CMs and their 
expectations of community pharmacists. The majority of the survey respondents 
expected pharmacists to provide accurate information about the safety aspects of 
CMs, whilst 90% believed that pharmacists should check for any interactions or 
contraindications with the use of these products as part of their routine practice. Over 
90% of the pharmacy clients who participated in the survey expected pharmacists to 
be knowledgeable in the area of CMs (207). It is therefore important to explore 
community pharmacists’ knowledge, attitude and perspectives towards these 
medicines to improve pharmacy practice (if required) and to meet the expectations of 
the public (209, 210).  
 
In 2011 Culverhouse and Wohlmuth (201) conducted a qualitative study in 
Queensland, Australia, which involved 12 practising Australian community 
pharmacists, to explore the factors influencing their recommendation of CMs. The 
authors reported that “a desire to provide a health benefit to the customer” was the 
primary motivation of pharmacists recommending CMs (201). The pharmacists’ 
knowledge, experience, clients’ feedback and the presence of pharmacy protocols 
were also reported as factors influencing pharmacists’ recommendations. 
Pharmacists who participated in the study raised their concerns over the lack of 
information or evidence supporting the efficacy and safety of many CM products. 
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The lack of clear benefits to their clients and time constraints were also seen as 
barriers to extended recommendation of CMs. This study has demonstrated that 
pharmacists acknowledge the common use of CMs in Australia, and that education 
on these medicines should be integrated into the pharmacy curriculum (201). 
Pharmacists’ desire for greater CAM education in general, including CMs and other 
complementary therapies, was also demonstrated in previous studies published by 
Tiralongo and Wallis (211, 212) in 2008, who reported positive improvements with 
pharmacy students’ knowledge as a result of integrating CAM education and training 
into the curriculum of the pharmacy degree. Nevertheless, students who participated 
in the study demonstrated greater interest in CMs than other complementary 
therapies.  
 
Another survey was conducted in 2010 to explore the perspectives and information-
seeking behaviour of 80 pharmacists practising in community pharmacies located in 
the rural regions of Victoria, Australia (202). Despite the authors using the terms 
“CAM” or “CAMs”, the study only specifically investigated participants’ views 
towards CMs and not other complementary therapies. Despite agreeing that they 
should routinely ask clients or patients if they were taking CMs, many pharmacists 
reported a lack of confidence in doing so most likely stemming from the low self-
perceived knowledge level. It was also suggested that the lack of understanding and 
knowledge concerning CMs affected pharmacists’ attitudes and perception of 
uncertainty. Participants in this study thought that CMs most in need of information 
were co-enzyme Q10, glucosamine, fish oil, ginkgo, echinacea, probiotics and saw 
palmetto. Pharmacists used a variety of resources and references in their daily 
practice, including CM textbooks and internet websites (202). Similar to studies 
conducted in the urban areas of Australia, pharmacists working in the rural 
community pharmacies expressed their desire for more evidence-based information 
about CMs and were willing to undertake further training opportunities (202).   
 
Pharmacists practising in community pharmacies may have different exposure and 
experiences to pharmacists working in the hospital environment. In 2008 Brown et 
al. (213) investigated 81 hospital pharmacists’ knowledge, attitude and information-
seeking behaviour towards the use of CMs. The study revealed that whilst hospital 
pharmacists sought information about CMs on a monthly basis, many had limited 
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knowledge and were having difficulties accessing reliable information. A separate 
survey of 107 hospital pharmacists revealed that many were lacking in confidence 
and CAM-related knowledge, which included CMs and other alternative therapies 
(214). Eighty-seven percent of the survey respondents perceived CMs to be unsafe 
and thought that monitoring of the use of these medicines should be in place. 
Nevertheless, only 55% of pharmacists routinely asked if their patients were using 
any CMs and alternative therapies. It was identified that pharmacists were cautious 
with the use of CAM and related practices and had raised their concerns regarding 
the cost, effectiveness, safety and regulatory aspects of these products (214).  
 
Although many published studies have investigated the perspectives and attitudes of 
pharmacists towards the use of CAM, and more specifically CMs in Australia, there 
is currently limited information reported on their perspectives towards the use of 
herbal medicines specifically in women during breastfeeding.  
 
 
2.6 Use of Herbal Medicines in Lactation 
 
Many women are self-medicating with various CMs and supplements, most 
commonly as a result of recommendations by friends or family, or as prescribed by 
their healthcare professionals (26, 215-219). A study published by Nordeng et al. 
(215) in 2004 surveyed a group of 400 postpartum Norwegian women which showed 
that 36% of the survey respondents had used at least one herbal medicine during 
pregnancy, with family and friends being the most common sources of 
recommendations. Amongst the commonly reported herbal medicines were 
echinacea, ginger, cranberry, chamomile and some iron-rich herbal ingredients (215). 
An interesting trend was observed in that there was an increase in the use of these 
medicines from the first through to the third trimester (215). The authors reported 
that 39% of the users were using herbal medicines that were either considered 
potentially harmful or that there was insufficient information to indicate their safety 
in pregnancy (215). In the same study, 43.3% of the women who had breastfed in the 




Forster et al. (26) surveyed 588 pregnant women in Australia in 2003 and found that 
36% of women had used one or more herbal medicines during pregnancy. The three 
most commonly used herbal medicines were raspberry leaf, ginger and chamomile 
(26). Stultz et al. (27) suggested that women use more prescription and non-
prescription medications postpartum during lactation compared to pregnancy.  
 
Another study published in 2010 investigated the prevalence and pattern of use of 
herbal remedies in Indiana and reported that 342 (74.2%) of the 461 Hispanic women 
who participated in the survey were users of herbal remedies (219). Of the 342 
female users, 30.4% were either breastfeeding at the time of the survey or had 
breastfed in the past, with 14.8% indicating they commenced using herbal remedies 
when they initiated breastfeeding (219). The majority of the female participants were 
aware of the potential risks associated with the use of herbal medicines while 
breastfeeding and 36.6% of women who breastfed reported ceasing the use of these 
remedies when they initiated breastfeeding (219). In this study, the most commonly 
used herbal medicines for their medicinal purposes were chamomile, cinnamon, 
garlic, lemon, onion, grass syrup and oregano (219). In line with other studies, 
extended family members were the most common source of recommendation for the 
use of herbal remedies whilst breastfeeding (27, 215, 219).  
 
A study published in 2012 by Lee et al. (24) reviewed the use of nutritional 
supplements amongst breastfeeding women in Perth, Western Australia. The review 
focused on the use of nutritional supplements, particularly folic acid, iron, iodine and 
calcium. It was reported that supplementation in the form of multivitamins or 
multiminerals were most frequently used as dietary supplements during breastfeeding 
(24). Approximately three-quarters (78%) of the 587 participants reported using folic 
acid and 21% used iron supplements during pregnancy, and between 30% to 40% of 
these women continued to take these supplements during the postpartum period (24). 
Although this study aimed to investigate the use of nutritional supplements as 
previously mentioned, a few mothers self-reported the use of herbal supplements for 
example garlic and ginger whilst breastfeeding (24). However, the purposes of using 
these herbal medicines were not recorded. Nevertheless, the authors concluded that 
further studies are warranted to investigate and document the use of these 
supplements during breastfeeding in women from different countries and of different 
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cultural backgrounds (24). Current herbal reference texts often suggest avoidance of 
certain herbal products based on what is known about the toxicity of the herbal 
medicine, case reports, or when there are little or no data available to support their 
use (61, 62, 107, 220-223). Such recommendations do not take into account the 
extent of transfer of herbal constituents into human breast milk. It will be useful to 
find out whether they are transferred into the breast milk, to examine any potential 
benefits or ill effects, at the same time provide scientific evidence to ensure the 
safety of breastfed infants while allowing mothers to receive appropriate therapy of 
their choice. Despite the increasing popularity of herbal medicines, there is currently 
limited information available on the extent of use and safety of these medicines 
during breastfeeding, at least in the Australian context (24, 26, 27, 224). 
Understanding the significance of breastfeeding and possible clinical implication of 
the use of medicines during breastfeeding on infants is important, and it makes sense 
that due attention should be paid to determine the prevalence of use and identify the 
herbal medicines most popular amongst breastfeeding women.  
 
 
2.7 Use of Galactagogues in Breastfeeding 
 
Galactagogues are a group of substances or medicines either proven or believed to 
aid lactation during the initiation and maintenance stages, thereby increasing human 
breast milk supply (30, 64, 225-228). In  other words, galactagogues are substances 
which may be used by women to induce, increase or maintain milk production (228).  
As discussed in Section 2.3, the most common reported reason for unsuccessful 
breastfeeding and early weaning is milk supply that is perceived to be low or 
insufficient to meet the needs of nursing infants (30, 31, 61, 75). Besides that, 
deficient mammary gland tissue, maternal hormone imbalance, poor breastfeeding 
technique or latching, leading to ineffectual milk removal can all contribute to low 
milk supply (30, 61). Mental well-being of mothers is also an important factor to 
consider, as fatigue, emotional stress and anxiety may all inhibit milk supply (58, 
228). If problems remain after addressing the above issues with proper education of 
techniques by lactation consultants or with psychological support or relaxation 




Breast milk production is regulated by the endocrine system (230). A peptide 
hormone, prolactin, is responsible for controlling milk production (230). The 
lactotroph cells in the anterior pituitary gland release prolactin into the maternal 
blood stream in response to infant suckling on the nipple (228, 230, 231). The release 
and binding of dopamine at the dopamine D2 receptors in the tuberoinfundibular 
pathway of the brain decreases the synthesis of prolactin by the anterior pituitary 
gland, thereby inhibiting milk production (230). Therefore, it is thought that milk 
production may be increased by antagonising the effects of dopamine or inhibiting its 
binding at the dopamine D2 receptors. For example, domperidone is a dopamine D2 
receptor antagonist which is used as an antiemetic, but also used in lactation due to 
its effect in enhancing milk supply. Many dopamine D2 receptor antagonists have 
also been evaluated for their effectiveness as galactagogues, based on their 
mechanism of action (228).  
 
Although increasing prolactin secretion is thought to be the main mechanism of 
action of most galactagogues, it is speculated that some galactagogues may also act 
via a different mode of action. A review of the literature has revealed that the 
mechanisms of action, efficacy and safety aspects of many commonly used 
galactagogues have not been thoroughly studied (226, 232-236). Besides their 
clinical efficacy, Zuppa et al. (228) emphasized that any medicines or substances 
used as galactagogues should be evaluated for their safety in breastfeeding. At the 
same time, any potential adverse effects on the mother and her infant should also be 
taken into consideration when making clinical recommendations on the use of 
galactagogues in breastfeeding (233).  
 
2.7.1 Conventional and Herbal Galactagogues 
 
Galactagogues are available in Australia in the form of either conventional medicines 
or of herbal origin. Dopamine D2 receptor antagonists, metoclopramide (237-241) 
and domperidone (242, 243) are examples of conventional galactagogues that are 
most commonly used in clinical practice and best documented. These agents are 
thought to increase milk supply and production by increasing the levels of prolactin 
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in the maternal plasma (226, 239, 243). Other examples of galactagogues include 
sulpiride (244-246), chlorpromazine (247), human growth hormone (227, 248, 249) 
and thyrotrophin-releasing hormone (228, 250, 251). Many of these conventional 
medicines were initially marketed and are still currently prescribed for reasons other 
than to promote breast milk supply. For example, domperidone and metoclopramide 
are used as antiemetics, while chlorpromazine is used as an antipsychotic agent 
(252). Hence their use for this indication is off-label.  
 
Throughout the world, women have used many alternative approaches including 
following special diets and the use of herbal or natural substances in an attempt to 
increase milk production. Mothers of different cultural and ethnic backgrounds may 
choose different approaches according to their tradition or experience (253-258). 
Herbal medicines commonly believed to aid lactation include fenugreek (Trigonella 
foenum-gracum) (61, 62, 259-262), blessed thistle (Cnicus benedictus) (30, 61, 228, 
263), milk thistle (Silybum marianum) (264, 265), goat’s rue (Galega officinalis) (61, 
266, 267), marshmallow (Althaea officinalis) (61), fennel (Foeniculum vulgare) (30, 
61), torbangun (Coleus amboinicus Lour) (261), nettle (Urtica dioica) (30, 61), black 
seed (Nigella sativa) (268) and many others. Despite their long history of use, 
scientific evaluation is lacking to confirm the clinical efficacy of most of these herbal 
medicines as galactagogues. No information exists describing the transfer or 
otherwise of these medicines into the breast milk and their effects on breastfed 
infants.  
 
The Consolidated Standards of Reporting Trials (CONSORT) group develops the 
CONSORT Statement, which provides a checklist and recommendations for 
reporting of randomised trials (269). The purpose of the CONSORT Statement is to 
offer researchers and authors a standard way of preparing reports of their trial 
findings to facilitate transparent and complete reporting, as well as enabling 
interpretation and critical appraisal of their findings (269). Gagnier et al. (270, 271) 
elaborated on the CONSORT checklist and developed recommendations for 
reporting of RCTs specifically for herbal medicine interventions. Wolsko et al. (272) 
evaluated 81 RCTs published between 1st of January 2000 and 9th of February 2004, 
which involved single-herb products of five commonly used herbal medicines. The 
authors identified and reported an inadequacy in the documented characterisation of 
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herbal ingredients in these reports. This is also the case for many studies involving 
herbal galactagogues in that the recommendations provided by the CONSORT 
guidelines for reporting RCTs of herbal interventions were not followed. Detailed 
information on the herbal ingredients of the products tested, for example, the sources, 
types and concentrations of extracts and other detailed characteristics of the herbal 
products are lacking. In addition, the research methodology employed to determine 
the efficacy of herbal galactagogues, including the methods of milk volume or milk 
intake measurements, should be taken into consideration when interpreting the 
robustness of findings of the studies.    
 
2.7.2 Milk Intake Measurements 
 
There are several established methods to measure milk volume or transfer of milk 
from mothers to breastfed infants for the purpose of determining milk intake. Many 
early studies have used methods including direct milk expression using breast pumps 
or manual expression (273), deuterium dilution (274-276), measurement of fat 
droplets flow using a Doppler ultrasonic flow meter (277-279), and test-weighing  
either mothers or infants after feeding (280-283). Despite the advantages, many of 
these methods have their limitations and the choice of method is often determined 
specifically for each circumstance. Understanding that milk ejection and removal 
influence milk intake by infants, recent studies have supported the use of ultrasound 
imaging techniques to detect milk ejections (284) and use of Showmilk (by Medela 
AG), a continuous weighing balance to measure flow rate of milk (284, 285). Test-
weighing remains the most commonly used method to date for determining the 24-
hour milk intake in evaluating lactation performance. Maternal and infant test-
weighing represent two different approaches to determine milk production (283). 
These two methods involve weighing the mother and infant using electronic balances 
separately immediately before and after a breastfeed, and the weight loss and weight 
gain calculated, respectively, represents milk intake (280-283). In both cases, the 
accuracy of this method depends on successful transfer of milk from mother to infant 
which may be influenced by infant’s appetite, regurgitation and spillage of breast 
milk (283). Besides the technical and practical issues, Arthur et al. (283) also showed 
the significance of taking into consideration and correcting for evaporative water 
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losses (EWL) to avoid overestimation of milk intake by the maternal test-weighing 
method and underestimation of milk intake by the infant test-weighing method. To 
correct for EWL, subjects are reweighed approximately 20 minutes after the feed 
(that is after the post-feed weigh), during which subjects are advised not to eat, drink, 
change clothing, defecate or urinate. The change in the second period of weight 
measurement can be used to calculate the rate of EWL, using a method described by 
Arthur et al. (283). In the context of evaluating the efficacy of galactagogues, breast 
milk production, rather than intake, should be considered. Hence, to measure breast 
milk production, the mothers’ rate of EWL should be taken into account.  
 




Domperidone (trade name in Australia: Motilium®) is a dopamine D2 receptor 
antagonist which stimulates the release of prolactin, thus increasing breast milk 
production (252). This drug is currently marketed for the treatment of nausea and 
vomiting in Australia, but also widely accepted as a galactagogue (252, 286). Despite 
its widespread use in Australia, domperidone is currently not available in the USA 
and its use in lactation has been banned by the FDA since 2004 on the basis of 
potential risks associated with its use, including cardiac arrhythmias or arrest, and 
sudden death (287). In 2003, this decision interrupted an RCT designed to recruit 44 
participants to evaluate the effect of domperidone on breast milk quality and 
composition (288).  
 
Few RCTs have been successfully conducted to evaluate the efficacy of domperidone 
as a galactagogue. Results of a double-blinded RCT was published in 1985 which 
involved a total of 32 women in Italy with issues of insufficient milk supply and 
found that those who received domperidone at a dose of 10 mg three times daily 
showed significantly higher milk production than those in the placebo group (n = 17)  
(289). The 24-hour milk production was determined by the infant test-weighing 
method (weighing infants before and after each breastfeeding session) using an 
electronic scale. No side effects were reported in either the mothers or their breastfed 
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infants. The authors concluded that domperidone may be useful to assist women who 
are experiencing difficulty breastfeeding (289).   
 
Another RCT conducted in Ontario, Canada, involving 20 mothers of premature 
infants was published in 2001 by da Silva et al. (234). All participants mechanically 
expressed breast milk using a breast pump supplied by the researchers, and fed breast 
milk to their infants via a nasogastric tube. The expressed breast milk was collected 
in sterile containers which allowed measurement of the volume of milk production. 
Participants received either domperidone 10 mg three times a day or placebo for 
seven days. From day two to seven, women in the domperidone group reported a 
mean increase in milk volume of 49.5 mL (SD: 29.4mL, mean daily milk volume 
measured was 162.2 mL), significantly higher than those in the placebo group (234). 
Comparing to the basal values, the increase in milk volume was calculated at 44.5% 
in the domperidone group and only 16.6% in the placebo group. Prolactin levels in 
the maternal serum on day five were also reported to be significantly higher in the 
domperidone group (234). Whilst small amounts of this drug were identified in the 
milk samples, no known adverse effects were experienced by either mothers or 
infants.  
 
An RCT, the “EMPOWER trial”, is currently registered to investigate the effects of 
domperidone and whether this medicine is safe and effective to be used as breast 
milk enhancer in mothers of preterm infants (286). The study involves between 20 to 
25 centres located in Canada, Chile, Israel and Qatar. To be eligible for the study, 
mothers have to be recruited during the period seven to 21 days postpartum, with 
infants born in less than or equal to 29 weeks gestation, are mechanically expressing 
breast milk and are experiencing inadequate breast milk supply. Milk production will 
be determined by measuring the volume of breast milk expressed. Based on previous 
research, the authors hypothesized that domperidone may play an important role in 
assisting mothers with preterm neonates, to increase their milk supply and thus allow 









Metoclopramide is another dopamine D2 receptor antagonist, marketed in Australia 
under the trade names, Maxolon® (252). Unlike domperidone, metoclopramide can 
cross the blood-brain-barrier and its use may be associated with side effects (230). In 
a study conducted by Kauppila et al. (238), women reported side effects with the use 
of metoclopramide, namely headache, tiredness, anxiety and intestinal problems. 
Another study also reported a similar adverse effect profile, in addition to insomnia 
and extrapyramidal or movement-related side effects (241). Information on the 
efficacy of metoclopramide in enhancing milk supply has been conflicting. Two 
RCT reported that no differences were observed between the treated and placebo 
groups (237, 290), whilst some others documented positive effects in increasing 
prolactin levels and mean milk volumes (228, 239, 241, 291, 292).  
 
2.7.3.3 Other conventional galactagogues 
 
Chlorpromazine is a dopamine D2 receptor antagonist marketed as an antipsychotic 
agent in Australia (252). One study investigated the effects of chlorpromazine in four 
women with difficulty breastfeeding (247). Whilst the exact volumes of breast milk 
were not measured, women reported the feeling of breast fullness and weight gain 
was observed in the infants. Nevertheless, the use of chlorpromazine as a 
galactagogue is limited due to its side effect profile on the central nervous system. 
Sleepiness, lethargy and altered infant behaviours have been reported with the use of 
chlorpromazine in breastfeeding (228, 293, 294). No recent studies were found to 
further evaluate the appropriateness of using antipsychotic agents as galactagogues in 
breastfeeding. There are also currently insufficient data available to support the use 
of other agents such as growth hormones, somatotropin, medroxyprogesterone and 
thyrotrophin-releasing hormone in promoting breastfeeding performance (228). 
Based on the available information and adverse effect profiles, domperidone should 





2.7.4 Effectiveness and Safety of Herbal Galactagogues 
 
2.7.4.1 Fenugreek (Trigonella foenum-gracum) 
 
Originating from northern Africa and India, fenugreek, a member of the pea family, 
represents one of the many medicinal plants with a long history of use (259). The 
FDA has classified this herbal medicine as Generally Recognised As Safe (GRAS) 
when used in moderation (295). Fenugreek has been traditionally used worldwide, 
for instance in India as a spice for cooking (296), in Egypt as incense and in bread-
making (297), in Rome to aid delivery and labour, as well as in China for oedema 
and weakness of legs (298). Other historical uses without sufficient evidence for 
benefit include the treatment of constipation, gastric ulcers, indigestion, 
inflammatory bowel disease, bronchitis, dermatitis, abscesses, cellulitis, and colic 
(259, 299). Recent studies have demonstrated some evidence of fenugreek in 
reducing plasma glucose (296, 299-302) and cholesterol concentrations (301, 303, 
304).  
 
The constituents of fenugreek seeds have been studied and it is reported to contain 
0.1 to 0.9% diosgenin as the major saponin, other saponins, for example fenugrin B, 
smiligenin, sarsasapogenin and yuccagenin, coumarin compounds, betaines or 
alkaloids like carpaine, gentianine, trigonelline, flavones like vitexin, iso-orientin and 
50% of mucilaginous fiber (220). The seeds also contain sotolone and a unique form 
of an amino acid, 4-hydroxy-isoleucine (61, 62). Several specific constituents of 
fenugreek have been studied and their effects examined. For instance, Aradhana et al. 
(305) investigated the effect of saponindiosgenin in ovariectomized mice and found 
that growth of mammary tissue was induced. Hypoglycemic and insulin-sensitizing 
properties of fenugreek are suggested to be attributed to 4-hydroxy-isoleucine (306-
310), fenugreekine (311) and trigonelline (312). 
 
Fenugreek should be used with caution in individuals with peanut allergy, asthma, 
hypoglycaemia, or patients taking warfarin (313) and who are pregnant, due to its 
possible effect on uterine stimulation (314, 315). Besides mild gastrointestinal 
adverse effects for example loose stools, stomach upset and bloating (when taken 
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orally in large doses), fenugreek is considered generally well tolerated (301, 314, 
315).  
 
Sotolone, also known as 3-hydroxy-4,5-dimethyl-2(5H)-furanone is a flavour 
compound present in fenugreek seeds. In 1975, Rijkens and Boelens (316) suggested 
sotolone to be the compound responsible for the characteristic odour of fenugreek. 
This finding was further confirmed by Girardon et al. (317) who detected the 
presence of sotolone in the aroma of fenugreek seeds using mass spectrometry (MS). 
Many studies have been undertaken to investigate this compound’s unique sensory 
properties and its role in contributing to the odour and taste of various food products. 
Besides contributing to the aroma of fenugreek seeds and lovage (Levisticum 
officinale), sotolone has been identified also in wines, aged sake and cane sugar, and 
has been used in the manufacture of artificial maple syrup. Maple syrup-like odour 
which occurs in urine, sweat, and breast milk has been reported following the 
administration of fenugreek, possibly due to the sotolone component. Podebrad et al. 
(318) demonstrated the presence of sotolone in urine samples of patients with maple 
syrup urine disease and showed that this compound was accountable for the disease’s 
characteristic odour.  Sotolone has also been found to be excreted relatively 
unchanged in the urine. 
 
Over the years, fenugreek has gained a reputation in the Western world as a 
galactagogue. Its use during breastfeeding has been listed as L3 (moderately safe) by 
Hale (62). It is the herbal remedy that is most commonly recommended for deficient 
milk supply. Many anecdotal reports suggest effectiveness of fenugreek in promoting 
lactation, including a survey of La Leche League (a breastfeeding organization) 
leaders and lactation consultants indicating positive effects in milk supply in 
approximately 75% of lactating women (319). Detailed protocols in regards to use of 
fenugreek were published by Huggins in 1998 (320) and later by Newman and 
Pitman in 2000 (321). According to the Academy of Breastfeeding Medicine’s 
protocol #9 (322), the usual recommended dosage of fenugreek for stimulating 
lactation is one to four capsules three or four times daily. As there is currently no 
standardization of fenugreek content across various brands and sources, Hale and 
Hartmann (61) suggest that calculation of a total daily dose of 1.74 g to 4.9 g may be 
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more practical and useful. The German Commission E suggests a total dose of 6 g of 
fenugreek seeds daily in divided doses (323).  
 
Despite its long history of use, objective investigation of the clinical efficacy of 
fenugreek as an effective galactagogue is limited. Hale (62) described the use of 
fenugreek as a galactagogue to be “widespread but undocumented”. A study was 
conducted by Swafford and Berens (262) who reported an increase in the average 
daily milk volumes from 207 mL to 464 mL, following two weeks’ use of six 
powdered fenugreek capsules daily. Participants used the mechanical pumping 
method to collect breast milk and the volume collected was subsequently measured. 
However, this small study was not placebo-controlled, and involved only ten women 
of whom characteristics and number of weeks post-partum were not stated (228, 
262). The effect on milk volumes was also not studied following withdrawal of the 
stimulant (61, 262). The exact dosage and detailed information on the content or 
characteristics of the herbal product used were missing. The lack of this important 
information, in particular the content and composition of the herbal product used, 
creates difficulty for accurate evaluation of the study findings.  
 
Another study was undertaken by Damanik et al. (261) who investigated the effect of 
torbangun (Coleus amboinicus Lour, a traditional Bataknese remedy for lactation) 
versus fenugreek and vitamin B12 supplements. Twenty-three participants were 
given a daily dose of soup made with 150 g/day of torbangun leaves. Subjects of the 
fenugreek group (n = 22) were given capsules supplied by Bullivant Natural Product 
in New Zealand, which contained 600 mg of powdered fenugreek seeds and were 
advised to take one capsule three times daily. Participants in the other reference 
group (n = 22) took one Moloco+B12TM tablet (available from Kenrose, Indonesia) 
three times daily, each containing 20 µg of vitamin B12 and 15 mg of a placental 
extract. Milk volume was calculated by test weighing the infants before and after 
each feed over four 24-hour periods (days 14, 28, 42 and 56), then converting the 
weights into volumes by multiplying the grams with the breast milk density (0.983 
mL/g). Despite using the test-weighing method to determine milk volume, the study 
did not take into account EWL as suggested by Arthur et al. (283). A 20% increase in 
production of milk was reported in the fenugreek group after two weeks compared to 
only 10% in the vitamin group (261). The authors also reported a 65% increase in 
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milk production in participants receiving torbangun supplementations, without 
affecting the mineral and macronutrient contents of the mothers’ milk. Although the 
researchers conducted an analysis on the nutrient composition of the torbangun soup, 
the source and process involved in choosing and preparing the torbangun leaves were 
not mentioned.  
 
The effects of fenugreek on milk production and its short term effects on infants’ 
birth weight were investigated in a study by Turkyilmaz et al. (324). The study 
involved 66 mother-infant dyads who were randomly assigned to either the test (Still 
tea, Humana®), placebo (herbal tea containing apple) or control group (no herbal 
tea). It was reported that infants of mothers who received fenugreek-containing 
herbal teas showed significantly less weight loss immediately postpartum (p < 0.05) 
and had regained birth weight before the others (p < 0.05) (324). Breast milk was 
expressed by participants using electric breast pumps and milk volume was 
measured. The mean milk volume measured in women who were receiving 
galactagogue teas containing fenugreek was 73.2 mL ± 53.5 mL, which was 
significantly higher when compared to those in the placebo or control groups (p < 
0.05) (324). Despite the findings suggesting promising effects of fenugreek, it was 
possible the galactagogue teas used in this study contained other herbal ingredients 
that could have influenced the findings. The presence of other herbal ingredients in 
galactagogue teas makes it difficult to conclude if the effects seen were solely due to 
fenugreek or the additive or synergistic effects from a combination of herbal 
ingredients.  
 
The effects of fenugreek were also reported in a qualitative study conducted by 
Westfall (30). Of the 23 women interviewed, eleven used at least one herbal 
galactagogue and four specifically used fenugreek. All four women perceived 
fenugreek to be effective in increasing milk supply (method of milk volume 
measurement was not stated), however one was advised by a health nurse to stop 
using this herbal medicine due to it being contraindicated in breastfeeding (30). 
Better designed studies, for example, randomized placebo-controlled trials involving 
a larger sample size and the use of standardised products with fenugreek as the sole 
ingredient, are warranted to confirm the clinical efficacy of fenugreek as a herbal 
galactagogue. The transfer of fenugreek and its constituents into human breast milk 
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is currently unknown (62, 228). Considering its widespread use, the transfer of 
fenugreek and/or its constituents into the breast milk should be investigated to 
evaluate its safety and potential benefits to the breastfed infants.  
 
2.7.4.2 Milk thistle (Silybum marianum) 
 
In the recent decade, milk thistle has gained a reputation as a herbal galactagogue 
amongst breastfeeding women (30, 228, 265). Nonetheless, its efficacy as a 
galactagogue and its mechanism of action have not been established (133). This 
herbal medicine is considered as generally well tolerated, with very rare occurrences 
of gastrointestinal side effects like nausea, diarrhoea and flatulence (133). Silymarin, 
an extract from the seeds of milk thistle may be involved in drug interactions due to 
its inhibitory effects on the P-glycoprotein and cytochrome P450 liver enzymes, 
specifically CYP 3A4 and 2C9 enzymes (133).  
 
To date, only one RCT has been conducted to evaluate the clinical efficacy and 
safety profile of this herbal medicine in enhancing milk production. Di Pierro et al. 
(265) in Peru evaluated the safety and efficacy of milk thistle in a group of 50 
women and found that there was an 85.9% increase in daily volume of milk 
produced, compared to only 32.1% in the placebo group when milk volumes were 
measured on the last day of the trial (day 63). Breastfeeding women in the test group 
were given 600 mg of milk thistle orally three times daily in the form of micronized 
Silymarin (265). The length of the trial was 63 days and total daily milk volumes 
were measured at three time points (day 0, 30 and 63). The milk volume was 
determined by test-weighing the infants before and after each breastfeeding session, 
then adding this to the volume of milk expressed by a breast pump after each feeding 
session to empty the glands. The authors reported no adverse effects experienced in 
both the test and placebo groups and that silymarin was not detected in the expressed 
milk samples. The chemical composition and quality of milk was also not altered, 
suggesting its safety in breastfeeding (265). Nevertheless, this study was not double-
blinded and detailed information about the mother-infant dyads’ characteristics was 
not provided (228). Larger scale double-blinded RCTs are recommended to confirm 
the findings of this study and validate the clinical efficacy and safety of silymarin in 




2.7.4.3 Shatavari (Asparagus racemosus) 
 
For many years, Asparagus racemosus or shatavari has been used in Ayurveda, the 
traditional medicine of India, as a galactagogue (133, 236). Sharma et al. (325) 
conducted a double-blinded, placebo-controlled RCT in 64 women with poor 
lactation to evaluate the effects of shatavari. Half of the participants were in the test 
group and received two teaspoons of mixture containing 15% by weight of shatavari 
twice a day for four weeks, however the actual dose of this herbal medicine was not 
stated. Detailed information on the characteristics of this herbal ingredient was also 
lacking. In this study, prolactin concentrations in the maternal serum, weight gain of 
the breastfed infants, and the use of other forms of milk as supplement feeds were 
used to assess the effects of shatavari. Nevertheless, this study did not use any 
specific methods to measure actual breast milk volumes. Whilst no adverse effect 
was recorded, the authors concluded that there were no significant changes on the 
above outcome measures between the two groups (325).  
 
A separate double-blinded, placebo-controlled RCT was conducted in India to 
evaluate the effectiveness of shatavari in promoting breastfeeding performance 
(326). The study involved 60 breastfeeding women with infants younger than six 
months old. Participants had to be experiencing some symptoms of difficulty in 
lactation to be eligible for the trial. Similar to the study mentioned previously, 
prolactin concentrations in the maternal serum and weight gain of the infants were 
measured. Prolactin concentrations were significantly increased in the test group 
receiving powdered shatavari at a dose of 60mg/kg/day given three times daily for 30 
days (33% versus 10% in the placebo group) (326). Infants’ weights were also 
significantly increased by 16% and 6% in the test and placebo groups, respectively 
(326). Findings from the two RCTs which evaluated the galactogenic effects of 
shatavari were conflicting. Direct comparison between these two studies was also 
impossible as the actual dose of shatavari used in the first RCT was not provided. 
Further controlled studies are needed to confirm the clinical efficacy and safety of 





2.7.4.4 Other herbal galactagogues 
 
Another common herbal medicine used as a galactagogue to promote breastfeeding 
performance is Galega officinalis, also known as goat’s rue (133, 327). Other herbal 
galactagogues with anecdotal evidence include fennel (Foeniculum vulgare), 
chasteberry (Vitex agnus-castus), blessed thistle (Cnicus benedictus), stinging nettle 
(Urtica dioica) and raspberry leaf (Rubus idaeus) (30, 133, 236). To date, no clinical 
trials exist to evaluate the use, safety and the galactogenic efficacy of these herbal 
medicines in breastfeeding. Westfall (30)  conducted a qualitative study of herbal 
galactagogues use in British Columbia to explore breastfeeding women’s experiences 
and perceived effectiveness of five herbal medicines: fenugreek, blessed thistle, 
fennel, stinging nettle and raspberry leaf. Despite the absence of actual milk volume 
measurements, participants of this study appreciated the psychological benefits and 
reassurance that these herbal medicines had provided throughout their breastfeeding 
journey. There is also the possibility of the “Hawthorn effect”. Despite the long 
history and widespread use of herbal galactagogues, studies are still lacking to 
confirm their safety and effectiveness in enhancing breast milk production. It appears 
that there is a lack of a standardized approach or method in determining breast milk 
production. In the available studies, researchers have employed various methods to 
measure milk volumes and evaluate breastfeeding performance. The different 
methodologies used in these studies may have contributed to variation in the results. 
Although test-weighing infants before and after each breastfeeding session was 
considered most appropriate to avoid interruption to normal feeding practices, many 
studies did not take into account the potential of EWL as described by Arthur et al. 
(283). Further double-blinded RCT with carefully planned methodologies are 
required to confirm their clinical efficacy and toxicological studies to evaluate safety 
of these galactagogues in breastfeeding mothers and their infants.  
 
 
2.8 Role of the Pharmacists 
 
Breastfeeding women need up-to-date and accurate information on the benefits and 
risks of taking medicines during breastfeeding (328). In Australia, this pivotal role is 
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generally undertaken by GPs and pharmacists (87, 154). Due to their accessibility, 
community pharmacists are likely to have regular contact with nursing mothers 
living in the community who may require advice and assistance.  Breastfeeding 
women and the public in general also regard pharmacists as medication advisors and 
expect pharmacists to provide advice and recommendations regarding queries 
relating to all medications, including CMs (87, 201, 207, 328). 
 
2.8.1 Over-the-counter and Non-prescription Medicines 
 
In Australia, the TGA administers the Therapeutic Goods Act and Regulations and 
controls the availability of all medicines and poisons to the Australian public using a 
‘scheduling’ or classification system (329). In the context of pharmacy practice, 
medicines are either not subjected to scheduling (those considered having minimal 
harm or risk) or classified as Schedule 2 (Pharmacy Medicine), Schedule 3 
(Pharmacist Only Medicine), Schedule 4 (Prescription Only Medicine) or Schedule 8 
(Controlled Drug). Besides Schedule 4 and Schedule 8 medicines, all medicines or 
products classified as Schedule 2, Schedule 3 or non-scheduled are available in the 
community pharmacy OTC, without prescriptions from authorised prescribers (206, 
329, 330). Furthermore, pharmacists must be responsible and be involved in the sale 
of all Schedule 3 products, whilst adequate advice should also be provided by either 
pharmacists or trained pharmacy assistants when a Schedule 2 medicine is requested 
(329, 330). Some common examples of OTC medicines include cough and cold 
remedies, some analgesics, antifungals, herbal medicines and nutritional 
supplements.  
 
2.8.2 Public Health Services in the Australian Community Pharmacies 
 
According to the Pharmaceutical Society of Australia (PSA), promotion of the 
community’s health awareness is considered one of the roles of pharmacists (331). 
Besides the supply of medicines and provision of medicine-related advice, 
pharmacists are also encouraged and expected to be involved in the provision of 
general healthcare advice as well as providing health promotion education to the 
public. In the PSA’s Position Statement on ‘Pharmacist Involvement in Preventative 
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Health Care Services’, it is stated that “PSA regards pharmacists as a key, but 
underutilised, member of the primary care team and strongly supports an expanded 
and appropriately funded role for pharmacists” (332). The public also perceive 
pharmacists as relevant public health providers, with those who had previously 
received public health services or advice from a pharmacy reporting high satisfaction 
(4). 
 
Over the years, the roles of pharmacists have greatly expanded. Community 
pharmacy facilitated public health promotion or services have been increasingly 
common worldwide (4). Many community pharmacies in Australia have extended 
trading hours and the no appointment policy makes pharmacists one of the most 
accessible healthcare professionals. Public health and professional services available 
in community pharmacies range from bone mineral density checks, weight loss and 
smoking cessation programs, to monitoring of chronic medical conditions such as 
hypertension and diabetes. To enhance the consumers’ experience and satisfaction in 
the pharmacy, some have employed Western herbal medicine practitioners and 
naturopaths, as one of the efforts to expand the range of services available within the 
community pharmacy (333). To the proprietors, it also makes sense that these efforts 
may play a role in improving the sales and business of the pharmacy.  
 
A systematic review conducted by Eades et al. (4) published in 2011 identified that 
most pharmacists included in the studies perceived public health services an integral 
part of their professional role. Nevertheless, pharmacists’ confidence in the provision 
of public health services was considered only low to average. Common barriers 
included time constraints, lack of adequate space within the pharmacy, lack of 
consumer demand and their perception of potential negative reaction from pharmacy 
clients. Further training was identified to enhance the knowledge and skills of 
pharmacists in the specific types of professional services (4).   
 
In Australia, some pharmacies also employ nurses on private contracts to provide 
postnatal child and maternal healthcare within the community pharmacy setting (74). 
Zadoroznyj et al. (74) conducted a qualitative study in Queensland to investigate the 
practice of a pharmacy-based child health nurse in the provision of postnatal care. It 
was acknowledged that the practice of pharmacy based postnatal or child health 
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clinics was a response driven by the market and demand in filling the gaps in the 
public health system. No study has been conducted to explore the potential role of 
pharmacists in promoting breastfeeding and their perspectives on providing 
breastfeeding-related health services within the community pharmacy. Taking into 
consideration the available information on the perspectives of pharmacists and 
consumers on pharmacy-based public health services, expanding the professional 
roles of pharmacists in the provision of high quality breastfeeding and postnatal-
related healthcare services within the Australian community pharmacy setting seems 
relevant and justifiable. Nevertheless, the need for training and continuing education 
is essential to ensure this health professional is capable of meeting the needs and 
thereby promoting the overall health outcomes of their clients. Appropriate training 
in the area of medicines use in breastfeeding will also enhance pharmacists’ 
confidence in providing advice to breastfeeding women and their families (334).  
 
 
2.9 Overall Aims of this Thesis 
 
The review of the literature has highlighted a gap in current research, in particular a 
paucity of data with regard to the use of herbal and other non-prescription medicines 
during breastfeeding and the potential role of community pharmacists in the support 
of breastfeeding women. This research therefore aimed to evaluate the perspectives 
of breastfeeding women with respect to the use of herbal medicines and factors that 
influenced their decision to use non-prescription medicines, with particular emphasis 
on herbal medicines including herbal galactagogues. In addition, the study aimed to 
investigate the role of Australian community pharmacists in supporting breastfeeding 
women in the community, including the provision of advice and information on 
herbal and other non-prescription medicines.  
 
Specific objectives of each of the three stages are presented in separate chapter 
sections: the objectives of Stage 1 are located in Section 3.2, while the objectives of 
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Sections of this chapter were published in:  Sim TF, Sherriff J, Hattingh HL, Parsons 
R, Tee LBG. The use of herbal medicines during breastfeeding: a population-based 
survey in Western Australia. BMC Complement Altern Med. 2013; 13:317. *Highly 
Accessed* (335). A copy of the published paper is attached in Appendix A.  
 
This Chapter reports on Stage 1 of the research. This stage involved a population-
based survey of women living in Western Australia on the use of herbal medicines 
during breastfeeding. This stage explored the prevalence and pattern of use of herbal 
medicines during breastfeeding, the women’s sources of recommendation, supply 
and information-seeking behaviour, as well as their attitudes and beliefs. In this 
chapter, an introduction specific to the study is provided, followed by the study 
objectives and research methods including study design, questionnaire, data 
collection and analysis procedure. Data collected from the Stage 1 study are 





Literature data have highlighted findings that lactating women who are taking 
medications are often concerned about the transfer of medicines into breast milk. 
Medicines circulating in the maternal bloodstream can potentially partition into 
human breast milk, exposing breastfed infants to medicines that may be harmful. 
Another concern is the effect of medication on the quantity and quality of breast milk 
produced, which may impact on the exclusivity, duration and success of 
breastfeeding. While medicines include conventional and complementary medicines, 
most studies to date have focused on evaluating the safety aspects of conventional 
medicines. Despite the increasing popularity of herbal medicines, there are currently 
limited data available on the pattern of use and safety of these medicines during 
breastfeeding. 
 
As previously discussed in Chapter 2, the use of CAM is increasingly common 
worldwide. Research undertaken in the last couple of decades in many countries 
including the USA (169, 170), Canada (171), the UK (175, 176), and the United 
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Arab Emirates (177) has demonstrated a substantial increase in the use of CAM, 
including CMs and other alternative therapies, amongst the general population. 
Research conducted in Australia has shown results consistent with the above findings 
(7, 24, 25, 160, 164-166). A prevalence study conducted in 2005 by Xue et al. (7) 
showed that 68.9% of the participants recorded use of one or more forms of CAM in 
the previous 12 months, with 16.3% and 7% specifically using Western and Chinese 
herbal medicines, respectively. Western herbal medicine was amongst the top four 
most popular forms of CAM, after clinical nutrition, Western massage therapy and 
meditation. Amongst the users of Western and Chinese herbal medicines, 29.1% and 
32.9% visited a practitioner of that type of CMs in the previous 12 months, 
respectively. Females were also more likely to use Western herbal medicines than 
their male counterparts (p < 0.001) (7).  Zhang et al. in 2008 (25) further reported the 
prevalence and pattern of use by the general population of Victoria, Australia, of the 
top 24 most commonly used herbal medicines. These were aloe vera, garlic, green 
tea, chamomile, echinacea, ginger, cranberry, peppermint, ginseng, ginkgo biloba, 
evening primrose, dandelion, valerian, liquorice, St John’s wort, slippery elm, milk 
thistle, dong quai, black cohosh, bilberry, senna, hawthorn, saw palmetto and 
chasteberry, in decreasing order of popularity amongst the survey respondents (25).  
 
Many women have self-medicated with complementary medicines and supplements, 
most commonly on the recommendation of friends or family, or as prescribed by 
their healthcare professionals (26, 215-219, 336). Studies conducted by Nordeng et 
al. (215) in a group of 400 Norwegian women and by Forster et al. (26) among 588 
Australian women both showed that 36% of subjects had taken one or more herbal 
medicines during pregnancy. We anticipated that some use of herbal medicines was 
likely to occur during breastfeeding as Stultz et al. (27) suggested that women 
generally use more medications post-partum compared to during pregnancy. Despite 
the increasing popularity of herbal medicines, there is currently limited information 
available on the extent of use and safety of these medicines amongst breastfeeding 





The objectives of Stage 1 were guided by the initial literature review which identified 
gaps in the research. This study aimed to provide current information on the 
prevalence and pattern of herbal medicines used by women whilst breastfeeding in 
Western Australia, and to identify commonly used herbal medicines.  
 
This information will inform and direct Stages 2 and 3 of the research. The study 
also explored the attitudes of breastfeeding women towards herbal medicines and the 
perceptions of breastfeeding women regarding safety and effectiveness of herbal 
medicines used during breastfeeding, and their information-seeking behaviour. The 
specific objectives were to: 
 
i) Estimate the percentage of women who have used one or more herbal 
medicines during breastfeeding. 
 
ii) Identify the types of herbal medicines commonly used by breastfeeding 
women. 
 
iii) Explore reasons for use, sources of the recommendation, their sources of 
supply and information for use of herbal medicines. 
 
iv) Investigate factors that may affect the decision and choice of herbal 
medicines use during breastfeeding, including demographic factors such 
as age, parity, ethnic background, occupation, level of education and 
other socioeconomic contributors. 
 
v) Determine the attitudes and perceptions of breastfeeding women 






3.3 Research Methods  
 
This section describes the methodology used for Stage 1 of the study. An overview 
of the study design is presented, followed by the procedures employed for participant 
recruitment, the study questionnaire and finally the analysis of data. Data were 
collected between February and December 2012. 
 
3.3.1 Study Design 
 
This study was conducted using a self-administered structured questionnaire. The 
questionnaire was constructed based on information from the literature search and 
other published surveys (7, 25, 26, 183, 215, 219, 337). The questionnaire was 
validated following the steps described by Portney and Watkins (338). Firstly, the 
questionnaire was circulated for face validation amongst five academic colleagues, 
three lactation consultants and two pharmacists employed at a large maternity 
hospital, seeking feedback on questions and format and suggestions for 
improvement. Secondly, the questionnaire was then construct validated by 
administering face-to-face to a group of 16 breastfeeding women recruited through 
two mothers’ groups, to seek feedback on the language, comprehension and the types 
of questions asked, as well as their views on the overall format of the questionnaire. 
The questionnaire was subsequently amended following an evaluation of the 
responses and a discussion with the research team. Minor changes were made to the 
questionnaire, including the removal of ‘prompts’ of which herbal medicines were 
used to avoid bias, and some formatting changes to improve the overall presentation 
of the questionnaire. No issue with understanding of the questionnaire and the 
participant information sheet was identified during the validation process. These 
responses were not used further in the analysis. The study was approved by the 
Human Research Ethics Committee of Curtin University (Approval number: PH-03-
11, see Appendix B). A Participant Information Sheet was developed according to 




3.3.2 Study Population and Recruitment Strategies 
 
The target population was women who were 18 years or older, currently 
breastfeeding or who had breastfed in the 12 months prior to the time of the survey. 
To achieve the study objectives, there were no restrictions as to whether the 
participant was on any medications or had any medical conditions. Women from all 
cultural or ethnic backgrounds were eligible for the study.  Balancing the need to 
minimise selection bias and maximise response rate, the decision was made to recruit 
participants through four main avenues to enable a wide range of participant 
characteristic types to be recruited: 
 
i) Mothers and parenting groups. With written approval from the Australian 
Breastfeeding Association (ABA), breastfeeding women were recruited from 
local mothers and parenting groups where the primary investigator (TFS) 
attended the group meetings.  
 
ii) Community pharmacies. A list of 557 WA community pharmacies was 
provided by the Pharmacy Registration Board of Western Australia (339). A 
stratified sampling technique was used to obtain sets of pharmacies within 
three defined geographical areas: North metropolitan, South metropolitan or 
regionally based according to postcodes. The lists of pharmacies were arranged 
in a random order by attaching a computer generated random number to each 
record and sorting each list by the number. Permission was sought from a total 
of 30 randomly selected pharmacies, 10 from each region, to place 10 sets of 
recruitment forms in each pharmacy (an example of the cover letter is provided 
in Appendix D). The pharmacists in-charge were requested to hand out the sets 
of forms to any women who visited their pharmacy whom they believed could 
have been eligible for the study, regardless of whether they were using any 
medicines. 
 
iii) Immunisation clinics and child health centres. Written site authorisation was 
obtained from the Child and Adolescent Community Health Executive 
(CACH), Health Department of Western Australia, to display posters 
advertising the study at all immunisation clinics and child health centres 
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registered with the CACH in the Perth metropolitan area. Examples of the 
cover letter to CACH and poster are provided in Appendices E and F, 
respectively.  
 
iv) Advertisement in newspapers and local parenting papers. This strategy was 
implemented to advertise the study to the general public.  
 
3.3.3 Data Collection 
 
All participants who had expressed interest in participating in the study were 
provided, either face-to-face or via postal mail, a set of forms consisting of the 
participant information sheet (Appendix C), the survey questionnaire (Appendix G) 
and a reply paid envelope (Appendix H). The participant information sheet explained 
that responses would be treated in confidence. Consent was assumed upon return of 
the completed questionnaire. 
 
3.3.4 Study Questionnaire 
 
The questionnaire comprised four sections (see Appendix G). Sections 1 and 2 
collected participants’ demographic profile and their family background 
characteristics including their country of origin and ethnicity. This information was 
collected to explore the association between these factors and the pattern of use of 
herbal medicines during breastfeeding.  
 
Section 3 requested information on the prevalence and pattern of use of herbal 
medicines during breastfeeding. This section explored the reasons for use, sources of 
recommendation, users’ perceived effectiveness and side effects experienced. 
Section 4 explored the participants’ information-seeking behaviour as well as their 
attitudes and beliefs towards the use of herbal medicines during breastfeeding. The 
types of questions in the questionnaire determined the response options, which were 




3.3.5 Data Analysis 
 
The survey responses were analysed using the Statistical Package for Social Sciences 
(SPSS®) version 20 software for Windows. Responses obtained from close-ended 
questions and questions using Likert-style scaled responses were coded numerically 
and entered into SPSS® under ‘Value Labels’ (for example: 1 = Yes, 2 = No). 
Qualitative responses obtained from open-ended questions were identified and 
coded. Reasons for use were categorised and coded concurrently with data entry. 
Upon completion of data entry, all categories were reviewed, checked and 
reclassified if necessary to ensure consistency in coding and that there was no 
duplication. These coded responses were then analysed in the same manner as the 
quantitative responses. Data were summarised using standard descriptive statistics 
(frequencies and percentages for categorical variables; means and standard 
deviations for variables measured on a continuous scale). The prevalence of use of 
herbal medicines during breastfeeding was calculated, along with its 95% confidence 
interval. Univariate associations between demographic data and use of herbal 
medicines were assessed using Chi-square statistics or t-tests, as appropriate.   
Logistic regression model and cross-tabulation were used to identify any association 
between the prevalence of use and any of the demographic data collected. The 
optimal model was obtained using a ‘backwards elimination’ strategy, whereby all 
demographic variables were initially included in the model, and then excluded, one 
at a time, until all variables remaining in the model were significantly associated 
with the use of herbal medicines. Respondents were classed as ‘users’ or ‘non-users’ 
for the purpose of analysis depending on whether or not they had reported the use of 
any herbal medicines during breastfeeding.  Participants were classified as ‘users’ if 
they had specified the use of any herbal medicines for the purpose or intention of 
treating or managing any medical condition or to improve their health, whereas 
participants were treated as ‘non-users’ if they had used the herbs for non-medicinal 
purposes, such as in cooking or as a beverage. Responses that included non-herbal 
complementary medicines or other products not classified as herbal medicines, such 
as fish oils and multivitamins, were initially entered into SPSS®. During analysis of 
the data, a separate SPSS® file was created and labelled ‘only herbs’ which excluded 





Data collected from the Stage 1 study were divided into five parts and presented in 
this section: i) respondents, ii) prevalence and pattern of use, iii) sources of 
recommendation, supply and information-seeking behaviour, iv) alternative methods 
to increase milk supply, and v) attitudes and beliefs of women towards the use of 




A total of 1118 questionnaires were distributed: 560 were distributed to prospective 
participants during mothers and parenting group meetings, 300 distributed through 
community pharmacies, and the remainder distributed to prospective participants 
who expressed interests in response to posters at immunisation clinics and child 
health centres or advertisement in newspapers and local parenting papers.  No unused 
questionnaires were returned, despite a request to the distribution centres to do so. A 
total of 304 questionnaires from eligible participants were returned, with an 
estimated response rate of 27%. The mean (SD) age of respondents was 32.8 ± 4.2 
years for ‘users’ and 32.3 ± 5.0 years for ‘non-users’ (p = 0.300). The majority of 
respondents resided in the Perth metropolitan area, were born in Australia or New 
Zealand, had completed secondary school education, had a relatively high total 
annual household income (≥ AUD$ 80, 000), had only one child and were not living 
with their parents. The characteristics of respondents related to breastfeeding are 
summarised in Table 3.1. A comparison of the characteristics of the Stage 1 
respondents and the respondents of the 2010 Australian National Infant Feeding 







Table 3.1: Demographic profile of respondents  
Variable Proportion of 
users (n/N, %) 
p-value 
   
Total number of participants 304  
Proportion of respondents using herbal medicines 
Age, years (mean, SD) 
182/304 (59.9)  
0.300
     Users 32.8 (SD 4.2)  
     Non-users 32.3 (SD 5.0)  
Residential area, determined by postcode (n = 303)  0.51
     Perth metropolitan  171/284 (60.2)  
     Other WA region 10/19 (52.6)  
Country of birth (n = 304)   
     Australia/New Zealand 97/180 (53.9) 0.0180
     Asia/Africa 58/80 (72.5)  
     Europe/USA/Canada 27/44 (61.4)  
If not born in Australia, years residing in Australia 
(mean, SD) 
 0.39
     Users 14.1 (SD 8.9)   
     Non-users 15.7 (SD 10.8)  
Ethnic background (n = 301)  0.0328
     Caucasian 55/105 (52.4)  
     Asian 57/80 (71.3)  
     Others 68/116 (58.6)  
Level of education (n = 302)  0.56
     Secondary education 12/24 (50.0)   
     Secondary school certificate of education 13/24 (54.2)  
     Diploma or advanced diploma 12/16 (75.0)  
     Trade certificates I, II, III or IV 15/27 (55.6)  
     Bachelor degree 88/137 (64.2)  
     Graduate diploma or graduate certificate 19/33 (57.6)  
     Master degree 19/31 (61.3)  
     Doctoral degree 4/10 (40.0)  
Total annual household income last year (n = 302)  0.0219
     Low (< AUD$ 37K) 7/17 (41.2)  
     Middle (AUD$ 37K – AUD$ 80K) 61/86 (70.9)  
     High (AUD$ 80K+) 113/199 (56.8)  
Parity (n = 304)  0.54
     1 child 102/176 (58.0)  
     2 children 58/94 (61.7)  
     3 children 16/27 (59.3)  
     4 children 6/7 (85.7)  
Living with parents (n = 304)  0.68
     Yes 19/30 (63.3)  




Table 3.2 Comparison of Stage 1 respondent characteristics with respondents of 
the 2010 Australian National Infant Feeding Survey (340) 
Characteristics 
Percentage (%) of 
respondents in the 2010 
Australian National 
Infant Feeding Survey 
(N = 28, 759) (340) 
Percentage (%) of 
respondents in Stage 1 
(N = 304) 
   
   
Age   
     24 or younger 8.8 3.9 
     25 – 29  23.9 22.4 
     30 – 34  35.6 35.5 
     35 – older  30.7 38.2 
     Missing 1.1 0.0 
Parity   
     Primiparous 41.0 57.9 
     Multiparous 55.3 42.1 
     Missing 3.7 0.0 
Education   
     Bachelor degree or higher 41.2 69.4 
     Diploma/certificate 35.9 14.1 
     Year 12 or equivalent 13.5 7.9 
     Year 11 or below 9.2 7.9 
     Missing 0.2 0.7 
Country of birth   
     Australia 73.2 55.9 
     Overseas 26.8 44.1 
   
 
 
As shown in Table 3.2, the characteristics of the respondents of Stage 1 were similar 
to respondents of the 2010 Australian National Infant Feeding Survey (340) in that 
the majority of the respondents were women over the age of 30. In addition, the 
majority of the respondents in these two surveys were women with post-secondary 
educational qualifications and were born in Australia. Nevertheless, there was a 
higher proportion of respondents from the Stage 1 group with tertiary education 
(Bachelor degree or higher) than those of the national survey. The Stage 1 study also 
involved a larger proportion of women born overseas (44.1%) than respondents of 
the national survey (26.8%). However, no sampling frame is available for Western 




3.4.2 Prevalence and Pattern of Use 
 
Amongst the 304 respondents, 182 (59.9%) indicated that they had used one or more 
herbal preparations for various medicinal purposes during breastfeeding (CI 54.4-
65.4%).  The number of herbal products used by respondents ranged from zero to six, 
with a median value of one product per respondent. Of the 182 respondents who took 
at least one herbal medicine during breastfeeding, 70 (38.5%) reported the use of 
only one herbal medicine, 51 (28.0%) used two herbal medicines, 37 (20.3%) used 
three herbal medicines, 16 (8.8%) used four herbal medicines, five (2.7%) used five 
herbal medicines, and three (1.6%) used six herbal medicines. Over half (60.4%) of 
users indicated that the reasons for use of these herbal medicines were breastfeeding-
related. Approximately one in four of all the respondents (74/304; 24.3%; 95% CI: 
19.5% - 29.1%) took one or more herbal medicines specifically to help increase milk 
production or supply during breastfeeding. A logistic regression model was used to 
investigate if any respondent characteristics or demographic factors were associated 
with the decision to use herbal medicines during breastfeeding, with the results 
shown in Table 3.3. The multivariate model showed that respondents with an Asian 
birthplace were significantly more likely to use herbal medicines, as well as were 
those from middle income families (total annual household income of AUD$ 37, 000 
– AUD$ 80, 000).  These factors were the only two that remained after the 
backwards-elimination model-fitting strategy. Other variables which were initially 
included in the model were excluded since they appeared to be not significantly 
associated with the outcome.  
 
Table 3.3: Logistic regression model: Factors associated with the use of herbal 
medicines during breastfeeding using a multivariate model 
Variable Odds Ratio 95% Confidence 
Interval 
     p-value 
Country of Birth    
 Asia 2.20 1.25 to 3.88 0.0061
 Other 1 (reference)   
    
Family income    
 Low (<AUD$ 37K) 0.29 0.10 to 0.84 0.0234
 Mod (AUD$ 37K to 80K) 1 (reference)   





A total of 51 different herbal medicines was named by respondents. Amongst the 
survey respondents, the top ten most commonly used herbal medicines during 
breastfeeding in the descending order of popularity, along with the percentages of 
respondents who have used the herbal medicines, were fenugreek (18.4%), ginger 
(11.8%), dong quai (7.9%), chamomile (7.2%), garlic (6.6%), blessed thistle (5.9%), 
cranberry (4.9%), fennel (4.9%), aloe vera (3.3%) and peppermint (3.3%). It was 
possible that some respondents may have not recollected every herbal medicinal 
component giving rise to the possibility of under-reporting. Women were asked to 
indicate the reasons for use, who recommended the use, and their perceived 
effectiveness of whether the herbal medicine was helpful to address their intended 
indication. Of the users of the top ten herbal medicines, the proportion of women 
who perceived the herbal medicine as helpful varied from 20.0% to 83.3%. These 
findings along with their prevalence are shown in Table 3.4. There were 18 different 
herbal medicines or ingredients indicated by the respondents specifically as 
galactagogues, used to increase breast milk supply and breastfeeding performance. 
Table 3.5 reports on the top seven most commonly used herbal galactagogues along 




Table 3.4: Top ten most commonly used herbal medicines during breastfeeding 












use of this 
herbal 
medicine 







Reported indications (% of specific 





56 (18.4) 44 (78.6) Increase breast milk supply (98.2) 





36 (11.8) 17 (47.2) General health enhancement, tradition 
(65.7) 
Relief of “wind” and “air” (22.9), 
Others (11.4) 
 
Dong quai Angelica 
sinensis 










20 (6.6) 7 (35.0) Boost immune system during a cold 
(38.9) 
General health enhancement, tradition 
(50.0) 
Antifungal (5.6) 







18 (5.9) 15 (83.3) Increase breast milk supply (100.0) 
Cranberry Vaccinium 
macrocarpon 






15 (4.9) 10 (66.7) Increase breast milk supply (80.0) 
Relieve colic (13.3) 
Energy, restore iron levels from blood 
loss (6.7) 
 
Aloe vera Aloe vera 10 (3.3) 2 (20.0) Detox (62.5) 
Aids digestion, intestinal health 
(12.5) 
General health enhancement (12.5) 
Sunburn, cooling effect (12.5) 
 
Peppermint  Mentha 
piperita 
10 (3.3) 7 (70.0) Calming and relaxation (60.0) 








Table 3.5: Top seven most commonly reported herbal galactagogues (in 
descending order of popularity) 
 
Common name of 
herbal galactagogue 
Binomial/ Scientific name  n (%) 
reporting 
use of this 
herbal 
medicine 







Fenugreek Trigonella foenum-graecum 56 (18.4) 44 (78.6) 
Blessed thistle Cnicus benedictus 18 (5.9) 15 (83.3) 
Fennel Foeniculum vulgare 15 (4.9) 10 (66.7) 
Goat’s rue Galega officinalis 7 (2.3) 7 (100.0) 
Nettle/ Stinging nettle Urtica dioica 5 (1.6) 4 (80.0) 
Blackthorn berry Prunus spinosa 5 (1.6) 4 (80.0) 
Shatavari Asparagus racemosus 4 (1.3) 4 (100.0) 
 
3.4.3 Recommendation, Supply and Information-Seeking Behaviour 
 
Participants were asked to state who had recommended the use of each of the 
specified herbal medicines. Responses were tabulated separately, and grouped into 
seven main categories as presented in Table 3.6. Approximately two-thirds of the 
users (n = 112, 61.5% of herbal medicines users) had chosen to use herbal medicines 
during breastfeeding based on recommendations from their family members. 
Prescribers and specialists, including general practitioners, gynaecologists and 
obstetricians were least likely to recommend the use of herbal medicines during 
breastfeeding, as the results have shown that only four participants (2.2% of herbal 
medicines users) were recommended to use herbal medicines by this group of health 
professionals. Table 3.6 also summarises the sources of supply based on the users’ 
responses. The majority of the users (n = 105, 57.7%) had obtained or purchased 
their herbal medicines or products from community pharmacies. Health food stores 
and supermarkets were two other common sources of supply, followed by 





Table 3.6: Sources of recommendation, supply and information 
Survey Questions  n (% of user/ 
respondents)* 
 
Who has recommended the use of herbal medicines? (n = 182 
number of users) 
 
     Family members 112 (61.5) 
      Naturopaths, herbal or health food stores 86 (47.3) 
     Friends 57 (31.3) 
     Self (including self-reading of magazine, internet) 56 (30.8) 
      Health professionals (including clinic/ child health   nurses,    
      midwives, lactation consultants) 
26 (14.3) 
     Pharmacists and pharmacy staff 24 (13.2) 
      Prescribers and specialists (including doctors/ general              
      practitioners, gynaecologists, obstetricians) 
4 (2.2) 
  
Sources of supply: Where have they obtained or purchased
their herbal medicines? (n = 182 number of users) 
 
     Community pharmacies 105 (57.7) 
     Herbal or health food stores 88 (48.4) 
     Supermarkets 73 (40.1) 
     Naturopathic clinics 27 (14.8) 
     Family or friends 26 (14.3) 
     Internet 4 (2.2) 
  
Sources of information: Where to seek information concerning
use of herbal medicines during breastfeeding? (N = 303) 
 
     Pharmacists 154 (50.8) 
     Doctors 146 (48.2) 
     Family or friends 139 (45.9) 
     Internet 133 (43.9) 
     Lactation consultants 89 (29.4) 
     Naturopaths or homeopathic practitioners 87 (28.7) 
     Child health nurses 83 (27.4) 
     Herbal or health food stores 71 (23.4) 
     Books, literature or journal articles 59 (19.5) 








All respondents to the survey (users and non-users) were asked where they did get 
information or could get information concerning the use of herbal medicines during 
breastfeeding. The results indicated that respondents were most likely to seek 
information and advice from pharmacists and doctors. Of the 105 respondents who 
had purchased herbal medicines from community pharmacies, 76 respondents 
(72.4%) indicated that they would seek information from a pharmacist if necessary. 
Family and friends as well as internet resources were also common reported sources 
of information, followed by lactation consultants, naturopaths or homeopathic 
practitioners, child health nurses, health food stores, and books, literature or journal 
articles. Despite doctors being identified as one of the common sources of 
information, only 52 (28.6%) of the users in this study had made their doctors aware 
of their decision to use herbal medicines whilst breastfeeding.  
 
3.4.4 Alternative Methods to Increase Milk Supply 
 
Approximately one-third of the participants (n = 100) had indicated the use of other 
products or alternative methods including special diets or techniques to increase 
breast milk supply during breastfeeding. The most commonly used method reported 
from this study was frequent milk expression with the use of an electric breast pump, 
followed by the use of domperidone (Motilium®) and increased fluid intake. Table 
3.7 presents the list of products or alternative methods indicated by the participants.  
 
3.4.5 Attitudes and Beliefs towards the Use of Herbal Medicines 
 
Over 70% of respondents (n = 211) strongly agreed or agreed that there was a lack of 
information resources available to them regarding the use of herbal medicines during 
breastfeeding, whilst 23.6% selected the option “no idea” and 6.3% strongly 
disagreed or disagreed.  
 
Many of the respondents (43.4%) believed that herbal medicines are generally safer 
when compared to conventional medicines used during breastfeeding. Most (71.6%) 
had indicated a previous refusal or avoidance of medicine treatments during 
breastfeeding due to concerns regarding the safety of their breastfed infants. When 
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given a choice, the majority of the women (75.9% of respondents) preferred more 
information to be available regarding the safety and efficacy of herbal medicines 
specifically when used during breastfeeding. 
 
 
Table 3.7: Other products or alternative methods used by participants to 
increase breast milk supply 
 
Methods of increasing milk supply  
(other than the use of herbal medicines) 
n (% of 
respondents) 
Frequent milk expression with electric breast pump 23 (7.6) 
Use of domperidone (Motilium®) 22 (7.2) 
Increased fluid intake 21 (6.9) 
Eating rolled oats/ oat milk 12 (3.9) 
Fish soup boiled with green papaya 8 (2.6) 
Multivitamin/ iron/ folic acid 5 (1.6) 
Seafood diet 2 (0.7) 
Increase intake of brewer’s yeast 2 (0.7) 
Peanuts 2 (0.7) 
Low fat diet 1 (0.3) 
Limited caffeine and alcohol intake 1 (0.3) 
Increased protein in diet 1 (0.3) 









In this section, the results of Stage 1 study presented above are discussed in relation 
to the objectives as described in Section 3.2. The findings are discussed in five parts: 
i) prevalence and pattern of use, ii) recommendation, supply and information-seeking 
behaviour, iii) attitudes and beliefs, iv) limitations of the Stage 1 study and v) the 
next stage linking to Stages 2 and 3 of this research.  
 
3.5.1 Prevalence and Pattern of Use 
 
As previously presented in Table 3.2, the characteristics of the Stage 1 respondents 
were compared with the characteristics of the 2010 Australian National Infant 
Feeding Survey respondents. The 2010 Australian National Infant Feeding Survey 
was funded by the Australian Government Department of Health and Ageing and 
executed by members of the Australian Institute of Health and Welfare (340). The 
project was the first specialised, large-scale, nationally representative survey of 
Australian infant feeding practices, attitudes and behaviours (340). According to the 
findings of the 2010 Australian National Infant Feeding Survey, women aged 35 and 
over and those with tertiary education were associated with higher rates of initiating 
breastfeeding and were more likely to breastfeed for longer periods at higher 
intensity (340). The characteristics of the respondents of Stage 1 were similar to 
respondents of the 2010 Australian National Infant Feeding Survey in that the 
majority of the respondents were women over the age of 30. Specifically, a larger 
proportion of the Stage 1 respondents were women aged 35 and older. The majority 
of the Stage 1 respondents were also women with tertiary education.  These findings 
is of relevance to this study as women who breastfeed for longer may be likely to 
have experienced an incidental illness and to face the dilemma of needing to use a 
medicine whilst breastfeeding. The fact that Stage 1 involved a larger proportion of 
women born overseas having a higher level of herbal medicines use reflects cultural 
differences in the sample used in the study.   
 
Although many studies have been conducted to investigate the prevalence and 
pattern of use of CMs in Australia in the general population, few have focused 
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specifically on the use of herbal medicines by women during breastfeeding. In this 
study, 59.9% of the women used at least one herbal medicine during breastfeeding 
for various medicinal purposes. This estimated prevalence (59.9%) appeared to be 
higher than results from a similar study conducted in a group of Australian women 
(588 participants; median age 32; 57% born in Australia/New Zealand; 17% born in 
Asia; 26% born in other countries) published in 2006, which found that 36% of 
participants took one or more herbal medicines during pregnancy (26). The 
demographic profiles of respondents of the study mentioned previously differ 
slightly in that the Stage 1 study involved a higher percentage of women born in 
Asian countries. Many studies conducted in Australia and other countries have 
demonstrated the popularity of herbal medicines in the general population (7, 169, 
177)  and also amongst pregnant (26, 215) and breastfeeding women (24, 336, 341), 
most likely due to the increased awareness and availability or accessibility of herbal 
products. The 2011 Census indicated that 27% of the Australian population were 
born overseas, with the majority of migrants from European and Asian countries 
(342). An association was identified between the respondents’ birthplace or their 
ethnic background and the decision to use herbal medicines. Women with an Asian 
background in this study were significantly more likely to use herbal medicines 
during breastfeeding. A study conducted in Taiwan explored the use of Chinese 
herbal medicines by women during both pregnancy and the postpartum period (341). 
The authors not only reported a relatively high prevalence of herbal medicines use in 
the cohort, but also demonstrated a marked escalation of prevalence from 33.6% 
during pregnancy to 87.7% during the postpartum period. Our results suggested a 
higher prevalence of herbal medicine use by women from the middle-income 
families, supporting the argument that cost and affordability may be a factor to 
consider when selecting the type of therapy (7, 160, 165). The relationship between 
women from the middle-income families and the higher prevalence of herbal 
medicine use should be further explored.     
 
The most commonly used herbal medicines found in this study were consistent with 
previously published reports. Herbal medicines which were not used specifically as 
galactagogues including ginger, dong quai, chamomile, garlic, cranberry, aloe vera 
and peppermint, were all included in the 24 common medicinal herbs used by the 
general Victorian population as reported by Zhang et al. (25). Furthermore, the 
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reported indications for use of these herbal ingredients were consistent with the 
traditional uses in many of the previous studies (7, 25, 26, 215).  
 
Over 24% of respondents took at least one herbal medicine for the purpose of 
increasing breast milk supply or promoting breastfeeding performance. Amongst the 
top ten herbal medicines used by the women in this study, fenugreek, blessed thistle 
and fennel emerged as the top three herbal medicines used as galactagogues. Other 
herbal galactagogues included goat’s rue, nettle, blackthorn berry and shatavari. The 
ABM Clinical Protocol #9: Use of Galactagogues in Initiating or Augmenting the 
Rate of Maternal Milk Secretion published by The Academy of Breastfeeding 
Medicine Protocol Committee in 2011 (343) recognised the widespread use of herbal 
remedies including fenugreek, blessed thistle, fennel seeds, goat’s rue, milk thistle, 
oats, dandelion and other herbal ingredients as galactagogues to enhance breast milk 
supply. Reviews conducted in the area of herbal galactagogues by Abascal and 
Yarnell in 2008 (327) and Zapantis et al. (133) in 2012 both identified fenugreek, 
blessed thistle and fennel seeds as commonly used herbal galactagogues. All these 
herbal medicines have gained their reputation as galactagogues over the years, 
however mostly based on anecdotal evidence (133, 334, 336). Limited clinical trials 
or large-scale studies are available to ascertain their efficacy as galactagogues. 
Nevertheless, the present study identified the common herbal galactagogues used by 
women living in WA and that the users’ perceptions of the effectiveness of these 
herbal galactagogues were in general favourable. The above mentioned factors and 
the findings of this study have highlighted the need to conduct clinical research to 
confirm their efficacy and safety in breastfeeding. A qualitative study conducted 
through interviews exploring herbal galactagogue users’ perspectives would also 
enhance our depth of knowledge on this topic of interest.   
 
Identification of the recruitment avenues or location of surveys that were returned 
was not possible. As the survey involved a range of recruitment strategies, it should 
be noted that the source of recruitment may have had an impact on the responses of 
survey respondents. For example, participants recruited through community 
pharmacies may have been more likely to have purchased their herbal medicines or 
products from a pharmacy and may have been more likely to have sought advice 
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from a pharmacist. However, only 300 of the 1118 forms (26.8%) were distributed 
through this avenue. 
 
3.5.2 Recommendation, Supply and Information-Seeking Behaviour 
 
This study investigated the sources of recommendation and supply, and explored 
breastfeeding women’s information-seeking behaviour. Family and friends were the 
most common source of recommendation, yet approximately half of this cohort of 
breastfeeding women (57.7% of reported users) obtained or purchased their herbal 
medicines from a community pharmacy. A similar trend was reported in an 
Australian study conducted by Morgan et al. (168) which found that family and 
friends were the most common source of recommendation for the use of CMs, and 
that pharmacies were the most common source of supply of CM products. This 
finding indicates a potential role for community pharmacists and pharmacy staff in 
influencing breastfeeding women’s decisions regarding the use herbal medicines 
during breastfeeding.  
 
When given a choice, breastfeeding women were most likely to recognise 
pharmacists and doctors as sources of information and advice regarding the use of 
herbal medicines. As previously stated, over 70% of the respondents who had 
previously purchased herbal medicines from pharmacies indicated that they would 
seek information from a pharmacist if necessary. Internet resources, family and 
friends were also commonly reported sources of information. Interestingly, only 52 
(28.6%) of the 182 users of herbal medicines in this study had made their doctor 
aware of their decision and choice of therapy. Other studies have also revealed a lack 
of communication between users of CAM in general and their doctors in terms of 
their use of herbal medicines and other alternative therapies (219, 344). This finding 
contradicts the previous results which found that participants were most likely to 
seek advice from pharmacists and doctors, indicating that participants’ perceptions or 
views may not necessarily reflect their actions. Although it may be possible that 
participants could have perceived that herbal medicines were safe and hence did not 
feel the need to consult their doctors, further investigation into the reasons and 
breastfeeding women’s behaviour would provide more insight into this issue. 
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Nevertheless, all healthcare professionals, including doctors and pharmacists should 
take the initiative to ask and provide evidence-based advice, if available, regarding 
the appropriateness of using herbal medicines during breastfeeding. Considering the 
high prevalence of herbal medicines used during breastfeeding and the risk of 
potential interactions and adverse outcomes, all healthcare providers, including 
community pharmacists and pharmacy staff, should routinely ask appropriate female 
clients if they are breastfeeding and if they are using any medicines including CMs. 
Although other studies have investigated the role of community pharmacists in 
providing advice regarding the use of CMs in the general population (201, 202, 345-
348) and the role of community pharmacists in counselling breastfeeding women 
(87, 156), there is a paucity of studies that have examined the role of community 
pharmacists in providing advice regarding the use of herbal medicines specifically to 
breastfeeding women and their families.  
 
3.5.3 Attitudes and Beliefs 
 
Forster et al. (26) have suggested the reason for the high prevalence of women not 
informing their doctors regarding their decision to use herbal medicines during 
pregnancy was the assumption that herbal medicines are ‘natural’ and hence safety 
would not be an issue. It is likely that this factor may also be contributing to the high 
prevalence of use identified in this study as the majority of the women who 
participated (43.4%) perceived herbal medicines as safer options compared to 
conventional medicines during breastfeeding. Although most herbal medicines are 
readily available without a prescription, it is important to take into consideration the 
potential risk of drug-disease interactions and interactions between herbal medicines 
of their choice and medicines prescribed by doctors or available OTC. 
Approximately 70% of the 304 respondents indicated that they either strongly agree 
or agree that there was a lack of resources available to them regarding the use of 
herbal medicines during breastfeeding. Nevertheless, some women continued to use 
their herbal medicines of choice based on limited readily available evidence-based 
information. Over 70% of respondents indicated that they had previously refused or 
avoided medicine treatments during breastfeeding due to concerns regarding safety 
of their breastfed infants. The study has demonstrated the urgent need for further 
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research into this area as both untimely cessation of breastfeeding and mother denial 





This study has some limitations. As the research involved a voluntary self-
administered questionnaire, this study may overestimate the use of herbal medicines 
during breastfeeding as a result of voluntary response bias (202, 338). Women who 
had a personal interest or were taking herbal medicines may have been more likely to 
participate in the study. According to the Australian Bureau of Statistics (ABS), a 
total of 31, 820 babies were born in Western Australia in 2011 (349). Assuming 
approximately 90% of women initiated breastfeeding (3), the sample size of this 
study is small relative to this population. However, sample size calculation showed 
that the sample size of 304 breastfeeding women was adequate and provided an 
estimation of an absolute precision of 5.5%. There was also a low response from 
women from lower income families and thus the views expressed by the study 
participants may not accurately reflect those of the entire breastfeeding population. 
Although the study suggested an association between the use of herbal medicines and 
users’ country of birth and ethnic background, all questionnaires were administered 
in English. Further studies conducted in other languages could provide a broader 
representation. As the surveys were self-administered, participants may not have had 
the opportunity to seek clarification if they were confused with the questions or 
terminologies used in the questionnaire. Nevertheless, the research team validated 
the questionnaire and the participant information sheet was in plain English. 
Feedback from colleagues and validation of the questionnaire did not identify any 
issues with participants’ understanding of the questionnaire and the participant 
information sheet. When analysing the results of a survey, it is important to consider 
the style of questions and how the questions were worded in the questionnaire. On 
reflection, questions 4.3 and 4.4 were potentially leading questions, which could 
have influenced the responses of participants. While the majority of the participants 
indicated agreement to these two questions, it is unclear whether this was an artefact 
of the questions as worded. The study also collected information on other products or 
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alternative methods women had followed during breastfeeding to increase their 
breast milk supply. Future studies involving a larger sample size will be useful to 
further explore this aspect and their effects during breastfeeding.  
 
3.5.5 The Next Stage 
 
The use of herbal medicines, including herbal galactagogues is likely to be common 
amongst women during breastfeeding, at least amongst the survey respondents in this 
study. It was clear from Stage 1 that breastfeeding women indicated high levels of 
confidence in the safety of herbal medicines, compared to conventional medicines. 
This important presumption requires in-depth investigation to elicit the reasons that 
are informing the confidence and behaviour of breastfeeding women towards the use 
of herbal medicines. The Stage 1 study did not collect information on dosage forms, 
routes of administration and doses of herbal medicines used by participants. 
Although these factors may have substantial effects on the pharmacokinetics of these 
medicines and hence their safety in breastfeeding, they were beyond the scope of the 
Stage 1 study. Future studies investigating the doses and dosage forms of commonly 
used herbal medicines would provide useful information when determining the safety 
of herbal medicines in breastfeeding. These findings have therefore informed the 
objectives of the Stage 2 study, investigating breastfeeding women’s experience of 
using herbal medicines, especially herbal galactagogues and documenting their 
perceived effectiveness and safety of these medicines. Stage 1 of the study has also 
identified the potential role expansion of community pharmacists and pharmacy staff, 
however did not explore the women’s perspectives and reasons for their choice to 
utilise community pharmacies. The next stage of the research study, Stage 2 (Chapter 
4), involved qualitative interviews which enabled in-depth investigation of women’s 
perspectives and expectations and whether their needs were met, at the same time 
identifying areas for improvement in the healthcare system. 
 
Health professionals and healthcare providers should be aware of the latest 
information regarding safety and efficacy of the commonly used herbal medicines in 
lactation and provide appropriate advice to breastfeeding women. Hence, the 
research questions proceeding from the Stage 1 study included whether there is 
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sufficient and reliable information and resources available to health professionals, 
and if they are confident in advising women on the use of herbal medicines during 
breastfeeding. Stage 1 of the study identified community pharmacies as the most 
common source of herbal medicines in Western Australia amongst the survey 
respondents, thus demonstrating the potential for increasing the involvement of 
community pharmacists. Stage 3 (Chapter 5) of this study was designed to address 
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This chapter reports on Stage 2 of the research. This stage involved an exploratory 
study of breastfeeding women’s perspectives on the use of herbal galactagogues 
during breastfeeding and their views on the role of community pharmacists in 
meeting their breastfeeding needs. Both descriptive and qualitative approaches were 
used to obtain and analyse the data. An introduction specific to the Stage 2 study is 
provided, followed by the significance and rationale of the study, specific objectives, 
the research methodology including the study design, the data collection and analysis 





Guideline 4 of the Australian Dietary Guidelines 2013 published by the National 
Health and Medical Research Council entitled “Encourage, support and promote 
breastfeeding”(35) acknowledges the physical and mental health outcomes of 
breastfeeding for both infants and mothers. According to the guidelines, exclusive 
breastfeeding is recommended for infants until the age of six months. When solid 
foods are introduced to the infants’ diet at approximately six months of age, 
breastfeeding should be continued in conjunction with solid foods until 12 months of 
age and beyond as complementary feeding if desired. Many efforts, including the 
initial development of the National Breastfeeding Strategy (1996-2001) (32) and 
subsequently the Australian National Breastfeeding Strategy 2010-2015 (1), have 
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been initiated to support and promote successful breastfeeding in Australia. Despite 
the many efforts to promote breastfeeding, some women may still experience 
difficulty breastfeeding due to numerous factors. One of the commonly reported 
reasons for unsuccessful breastfeeding and early weaning is perceived low or 
insufficient breast milk supply (75). Deficient mammary gland tissue, maternal 
hormonal imbalances, poor breastfeeding technique or latching leading to ineffectual 
milk removal can all contribute to insufficient supply of milk (30, 61). If these issues 
have been addressed and other strategies followed such as education about 
techniques by lactation consultants and milk flow is still insufficient, galactagogues 
may be trialled by some mothers (229). 
 
Many herbal medicines have gained recognition and positive reputation by the public 
and health professionals as alternative approaches to enhancing breastfeeding 
performance (133, 226, 259). Herbal galactagogues are available in Australia in 
various dosage forms, from capsules and tablets to liquid tinctures (25). Considering 
that the choice of dosage forms may directly affect their safety and efficacy, efforts 
should be made to investigate and document the dosage forms and usage directions 
that breastfeeding women have followed. However, despite the increasing popularity 
of herbal galactagogues, very little is currently known about the pattern of use in 
Australia, as well as the safety and efficacy of these medicines during breastfeeding. 
Results from Stage 1 of the research study show that approximately one in four of the 
respondents in that study (74/304 = 24.3%; 95% CI: 19.5% - 29.1%) had used one or 
more herbal medicines during breastfeeding to help increase milk production or 
supply, regardless of whether they had been diagnosed with insufficient milk supply. 
Fenugreek (Trigonella foenum-graecum) was the most commonly used herbal 
galactagogue during breastfeeding amongst the survey respondents. Other commonly 
reported herbal galactagogues included blessed thistle (Cnicus benedictus), fennel 
(Foeniculum vulgare), goat’s rue (Galega officinalis), nettle (Urtica dioica), 
blackthorn berry (Prunus spinosa), and shatavari (Asparagus racemosus).  
 
In spite of their long history of use, there is a lack of scientific evaluation to verify 
the safety and clinical efficacy of most of these herbs as a galactagogue (133). 
However, many women continue to use herbal galactagogues based on anecdotal 
evidence (133, 226). In line with data presented in the literature review, an 
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interesting trend was observed through Stage 1 of the study in that many 
breastfeeding women had decided to use herbal galactagogues despite agreeing that 
there was a lack of information and resources available to them regarding the quality, 
safety and efficacy of these herbal medicines (87, 133). Research into the impact on 
successful breastfeeding and potential effectiveness or psychological benefits of 
herbal galactagogues would provide insights into the perceived clinical effectiveness 
of these galactagogues as alternative options for breastfeeding women who wish to 
increase their breast milk supply.  
 
Besides evaluating the perceived benefit, use of any medicine or substance during 
breastfeeding may have safety risks for breastfed infants (334). Limited published 
research was found with regards to the transfer of herbal galactagogues or their 
derivatives into breast milk and their potential effects on breastfed infants. Current 
herbal reference texts often suggest avoidance of certain herbal products based on 
what is known about the toxicity of the herbal ingredients, from case reports, and 
when there are little or no data available to support their use (61, 62, 107, 220-223). 
These recommendations may not have taken into account the extent of transfer of 
herbal constituents into human breast milk or the impact on infant feeding behaviour. 
In a review by Bingel and Farnsworth (263), over 400 plants have been recorded as 
galactagogues in the literature. Scientific evidence is lacking for the vast majority of 
these plants in terms of their mechanisms, effectiveness as galactagogues and safety 
when taken during breastfeeding. Whilst herbal medicines may be considered by the 
public as ‘natural’ and ‘safe’ when compared to conventional medicines, it needs to 
be pointed out that there are currently limited toxicological data available to support 
their use in breastfeeding. Some herbal medicines may contain constituents which 
are intrinsically toxic, even when present in low concentrations. Some examples of 
intrinsically toxic constituents may include, but are not limited to: aristolochic acids, 
which have been associated with nephrotoxic and carcinogenic effects (351, 352); 
and pyrrolizidine alkaloids, which have been shown to be hepatotoxic and 
photogenotoxic (353, 354). Despite limited information on the transfer of 
constituents of herbal medicines into the breast milk, it should be noted that some 
herbal constituents may still pose a risk, especially when transferred in 
toxicologically significant amounts into the breast milk. Investigation on the 
chemical constituents of commonly used herbal medicines, and whether they are 
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transferred into the breast milk, would allow examination of the potential benefits or 
ill effects and at the same time provide evidence to ensure the safety of breastfed 
infants while allowing mothers to receive therapy of their choice.  
 
The Stage 2 study endeavoured to document the pattern of use, safety and 
effectiveness of herbal galactagogues during breastfeeding based on breastfeeding 
women’s personal experience and observations. Gaining an understanding of their 
perspectives, why and how they have chosen to use herbal galactagogues over 
conventional options, their experiences and the factors or indicators that influenced 
their breastfeeding performance, will provide insight into the potential value of 
herbal galactagogues and identify research gaps to inform direction of future studies.  
 
The initial focus of Stage 2, to investigate the use of herbal galactagogues during 
breastfeeding based on breastfeeding women’s perspectives and experiences, was 
expanded to include the role of community pharmacists in meeting the breastfeeding 
needs of breastfeeding women in a community pharmacy setting. This decision was 
informed by findings from Stage 1 of the research which demonstrated that 
approximately half of the participating breastfeeding women had obtained or 
purchased their herbal medicines from a community pharmacy. Data from Stage 1 
also show that breastfeeding women were most likely to seek information and advice 
regarding the use of herbal medicines during breastfeeding from pharmacists and 
doctors, with more than half of the respondents indicating that they would seek 
advice from a pharmacist. This finding indicated a potential role community 
pharmacists and pharmacy staff could play in influencing breastfeeding women’s 
decisions to use herbal medicines during breastfeeding, and subsequently the impact 
on breastfeeding performance. There is limited information on the perceived role of 
community pharmacists from the perspective of breastfeeding women. 
Understanding the perspectives of breastfeeding women, their views and experiences 
with community pharmacists and whether they believe there is a role for community 
pharmacists to play in this area will provide valuable insight into the current and 
future potential role of pharmacists. At the same time, this may also facilitate 
positive breastfeeding outcomes in the community by evaluating how pharmacists 
can better assist breastfeeding women with their needs. Identifying the facilitators 
and barriers of breastfeeding women in utilising the expertise of community 
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pharmacists in providing high quality breastfeeding-related healthcare in a 
community pharmacy setting will also assist with identification of the areas of 
pharmacy practice which need to be improved. A better understanding of their 
unique needs and perspectives will enrich our knowledge in the area of CMs and 






The objectives of Stage 2 were guided by the initial literature review which identified 
research gaps, and was later directed by the findings from Stage 1 of the study in 
accordance with exploratory research processes. 
 
The aim of Stage 2 was to obtain an in-depth understanding of the perspectives and 
experiences of women who have used herbal galactagogues during breastfeeding. 
The specific objectives were to: 
 
i) Evaluate the use and perceived benefits, effectiveness and safety of herbal 
galactagogues during breastfeeding based on participants’ personal 
experience and observations. 
 
ii) Investigate the types of herbal galactagogues used, the dosage forms, their 
administration (whether they were tablets or capsules, tea, seed or other 
dosage forms), the dosages or amount and frequency of consumption, as 
well as the period and duration of administration since immediately post-
partum. 
 
iii) Explore the perspectives and attitudes towards the use of herbal 
medicines whilst breastfeeding. 
 
iv) Explore the perceptions with regards to the role of community 
pharmacists in meeting women’s breastfeeding-related healthcare needs 
in community pharmacies. 
 
v) Identify facilitators and barriers in utilising community pharmacists to 
provide breastfeeding-related healthcare in the community pharmacy 






4.3 Research Methods 
 
This section describes the research methods employed for Stage 2 of the study. It 
begins with an overview of the study design, followed by ethical considerations 
related to the study, eligibility criteria of participants, recruitment strategies, the 
development of the interview guide and procedure, and methods for analysis of data. 
The interviews were conducted between October 2012 and April 2013. 
 
 
4.3.1 Study Design 
 
Exploratory research was conducted through in-depth semi-structured interviews 
with breastfeeding women who were using one or more herbal medicines during 
breastfeeding to increase breast milk supply. An interview guide was developed with 
a mix of closed and open-ended questions to gather information about the use of 
herbal galactagogues, participants’ perspectives and attitudes and their perceptions 
towards the role of community pharmacists in meeting their breastfeeding-related 
healthcare needs.  
 
 
4.3.2 Ethics Approval 
 
Human research ethics approval was obtained from the Curtin University Human 
Research Ethics Committee (HREC) on 6th September 2012 (Approval number: 
HR85/2012, see Appendix K). A participant information sheet (Appendix L) and 
consent form (Appendix M) were developed according to the guidelines provided by 
the Curtin University HREC, which clearly stated the rights of participants and the 
procedure of the study.  
 
As the nature of the study could potentially have involved issues with cultural 
sensitivities, the National Health and Medical Research Council (NHMRC) National 
Statement on Ethical Conduct in Human Research (355) was consulted. Throughout 
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the study, the researcher and supervisors respected all rights, welfare, perceptions, 
customs and beliefs of participants. The researcher rigorously adhered to an open 
style of communication. To avoid distress to participants, all participants were 
reassured at the start of the interviews that the study was not to advocate or 
discourage the use of any medicines or choice of therapy, but rather to obtain insight 
into the participants’ experiences and perception. The researcher did not make any 
comments on the participants’ choice of therapy. Participants were reassured that 
their participation was completely voluntary and anonymous and they could 
withdraw at any time during the interview.  
 
No ethical issue was raised throughout the study period. Audio-recordings of the 




Eligibility and Inclusion Criteria 
 
Breastfeeding women living in the Perth Metropolitan area, who expressed interest, 
were invited to participate. All participants had to be: i) 18 years or older, ii) 
breastfeeding or have breastfed in the previous 12 months at the time of interview, 
and iii) have used or were using one or more herbal medicines as a galactagogue 
during breastfeeding to increase breast milk supply or to improve breastfeeding 
performance at the time of interview. Participants were not required to have been 
diagnosed with insufficient milk supply, nor had to be from a certain cultural or 




To achieve the study objectives, purposeful sampling was used to recruit participants 
for the study, targeting breastfeeding women who visited naturopaths or who had an 
interest in herbal medicines. According to Patton (356), “The logic and power of 
purposeful sampling lies in selecting information-rich cases for study in depth.” 
Hence, careful selection of participants with a specific interest in the topic was 
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considered appropriate to enable relevant and quality data to be collected, which in 
turn improves reliability and credibility of the findings. There are various purposeful 
sampling methods as described by Patton (356), and of these, the chain or snowball 
sampling method was considered most appropriate for this study and thus adopted. 
This process involved asking a participant recruited from a naturopathic clinic or 
community pharmacy to provide details of the study and contact details of the 
researcher to her friends or family members who were eligible for this study, and this 
chain was continued. Unlike other studies where a specific participant type may be 
identified or recruited from an organisation or setting, the use or purchase of herbal 
medicines in Australia are not required to be reported nor recorded, hence there was 
not a specific setting or location to recruit participants. Therefore, the purposeful 
chain sampling method fitted the scope of this study. 
 
To reduce bias due to the sampling method, the study was advertised to the wider 
public through a media release prepared by the Public Relations Consultant from 
Curtin University Corporate Relations and Development. The study was advertised 
in the Curtin Health Innovation Research Institute (CHIRI) newsletter, The Parent’s 
Paper, Western Nurse Magazine, the Southern Gazette, and was also announced via 
the Curtin FM 100.1 Perth radio station, where contact details of the researcher were 
provided if women were interested to participate in the study.   
 
As the main objective of the study revolved around the use of herbal galactagogues 
during breastfeeding, a decision was made to also advertise the study at naturopathic 
clinics and community pharmacies with a focus on breastfeeding and CMs use. 
Posters with details of the study (Appendix N) were placed at a health centre whose 
Clinical Director had agreed to collaborate in the recruitment of participants. This 
health centre was located in the metropolitan area of Western Australia and had a 
strong focus on naturopathy and supported the registration of Western herbal 
medicine for public safety through the TGA.  
 
Through the snowballing effect, participants suggested community pharmacies where 
more participants were likely to be recruited. Two community pharmacies were 
subsequently identified for the recruitment of participants. Both of these community 
pharmacies had a strong focus on customer service, naturopathy and provided a 
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range of breastfeeding-related services. Participants were then recruited from these 
pharmacies through expression of interest in response to the participant information 
sheets (Appendix L) and posters (Appendix N).  
 
Justification of Sample Size 
 
Portney and Watkins (338) commented that sample size determination in qualitative 
research is based on experience, judgment and the research purpose. According to 
these authors (338), ‘samples that are too small will not support claims of having 
reached a point of data saturation. Samples that are too large will not permit the in-
depth analysis that is the essence of qualitative inquiry.’ Based on a similar 
galactagogue study conducted in British Columbia (30) which involved 23 
participants, a decision was made to initially recruit up to 20 women for this part of 
the study and through the data analysis determine whether a point of saturation had 
been reached, when there was no emergence of new themes. According to a study 
published in 2005 by Guest et al. (357) on “How many interviews are enough”?: an 
experiment with data saturation and variability which studied the variability and data 
saturation degree, researchers have found that data saturation was present within the 
first twelve in-depth interviews. An initial number of 20 participants was therefore 
considered sufficient to reach data saturation whilst also enabling in-depth analysis. 
 
4.3.4 Interview Guide 
 
The initial literature review identified a need for more research in the area of herbal 
galactagogue use during breastfeeding, in particularly the perceptions of the 
effectiveness and safety in the Australian context. Taking into account findings of 
Stage 1 and the available literature, the interview guide was therefore developed to 
explore the perspectives and experiences of breastfeeding women towards the use of 
herbal galactagogues. To confirm and further evaluate the findings from Stage 1 of 
the research with regards to community pharmacy, the guide also included questions 
to explore the views of breastfeeding women on the role of community pharmacists 
in meeting their breastfeeding needs in the Australian healthcare system. The first 
step involved in developing the interview guide was emanated from the aims and 
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objectives of the study, and to identify exactly what information was needed to 
answer the research objectives. The research team then developed the interview 
questions required to obtain the relevant information. For example: one of the 
objectives of the study was to evaluate the use of herbal galactagogues and that it 
was considered useful to explore participants’ reasons for use of these medicines, 
hence the interview question was developed: “Can you tell me why you have 
used/are using a herbal galactagogue?”.  
 
To address the study objectives, a semi-structured interview guide (Appendix O) 
consisting of a mix of closed-ended and open-ended trigger questions was developed. 
This interview guide was pilot tested on two breastfeeding women to ensure that the 
research objectives were addressed and the questions were clear. As part of the 
validation process, subsequent amendments were made following suggestions made 
by the two participants and discussions amongst members of the research team. 
Amendments to the interview guide included the addition of ‘probes’ when 
considered necessary to allow more in-depth information to be elicited around a 
particular issue, for example, “Can you tell me more about that?” Another 
amendment made following pilot testing was the inclusion of sub-questions for 
Question 9, when exploring participants’ experiences and perceived effectiveness of 
herbal galactagogue(s) of their choice. The interview guide was used to provide 
guidance to the interview sessions. An overview of the interview guide is as follows: 
 
 Questions 1 to 12 (including sub-questions) involved closed-ended and open-
ended questions to provide both descriptive and qualitative data related to the 
pattern of use, effectiveness and safety of the particular type(s) of herbal 
galactagogue(s) used based on personal experiences and perceptions of the 
participants.  
 
 Questions 13 and 14 (including sub-questions) consisted of open-ended 
questions that explored the perspectives and attitudes of breastfeeding 
women, their experiences and perceptions of the available resources and 







Prior to conducting all face-to-face interviews, the purpose of the research and what 
the interview would cover were explained to participants verbally as well as with the 
provision of a participant information sheet. For the face-to-face interviews, copies 
of the participant information sheets (Appendix L) were provided and all participants 
were requested to sign a consent form (Appendix M) prior to conducting the 
interviews. An electronic copy of the participant information sheet was sent via email 
to participants who had provided their email contact and requested a telephone 
interview. In cases where email contact was not available, the content of the 
participant information sheet was read to the participant over the telephone and 
verbal consent was obtained before the interview. Participants were given ample 
opportunity to ask questions and were reminded that the study was completely 
voluntary and that they could withdraw at any stage without prejudice. Taking into 
consideration the variability between participants and at the same time ensuring that 
the topic of discussion could be thoroughly covered, the interviewer (TFS) adhered 
to a discrete and flexible approach throughout the interview process. Deviation from 
the interview guide was necessary in some instances, for example, when the 
interviewee mentioned an issue not necessarily addressing the questions in the guide, 
but still considered relevant to the topic. The use of ‘probes’ was also slightly 
different for each participant depending on their responses. The interviewer followed 
the same interview schedule to guide all interviews, however was flexible in the 
conduct of the interviews, in keeping with the flexible and emergent nature of 
qualitative research design (358, 359). All interviews were audio-recorded, rather 
than videotaping to maintain anonymity of participants, and subsequently manually 
transcribed verbatim. 
 
4.3.5 Data analysis 
 
The transcripts were analysed using descriptive and qualitative approaches. 
Participants were de-identified and codes were used in the analysis. For example: the 
first interviewee was given a code “BW1”, indicating “Breastfeeding Woman 1”, and 






Participants’ responses to closed-ended questions in the interview guide were 
analysed using descriptive analysis to summarise the findings. Data collected on the 
type(s) of herbal galactagogue(s) used, reasons for use, recommendations and 
information resources, methods, routes and dosage administered, commencement and 
duration of administration were summarised. Data were systematically separated into 




The opened-ended questions in the interview guide that explored the experiences and 
perspectives of participants were analysed using thematic analysis as described by 
Boyatzis (360). The transcription process was undertaken by the candidate and 
provided an opportunity for the candidate to become immersed in the interview data 
(361). Firstly, contents of the transcripts were read repeatedly to attain a thorough 
understanding of topics that emerged from the interviews, at the same time paying 
attention to the ‘patterns’ that occurred throughout the interviews. After 
familiarisation, the candidate then carefully read the transcripts line-by-line, while 
highlighting phrases or sentences and generating initial ‘codes’. At this stage, the 
candidate then collapsed the data to create categories to aid analysis. Notes were 
made alongside the codes to describe the meaning of the codes where relevant. These 
codes were then grouped into categories, to form a working analytical framework. 
The codes were reviewed and emerged “ideas” or themes were recorded and 
supporting quotations documented under each theme category. Different “units of 
ideas” were then reclassified as subthemes under a specific “collective idea” or 
theme. These themes were then regrouped under distinctive headings addressing the 
research questions. The analytical framework was finalised when no new codes 
emerged after coding of the last transcript. The candidate subsequently again 
reviewed all transcripts, to ensure accurate coding and that no new “ideas” had 
emerged in addition to the existing codes and categories. To ensure reliability of the 
process of analysis, project supervisors (LH, LT) reviewed the analysis throughout 





Results from the interviews are reported using descriptive analysis for closed-ended 
questions and qualitative thematic analysis for open-ended questions. Supporting 
quotations which reflected each key theme are provided to illustrate the dimensions 
of each theme.  
 
A total of 20 in-depth semi-structured interviews were undertaken with breastfeeding 
women living in the Perth Metropolitan area. Saturation of data was reached after 
approximately 15 interviews but a decision was made to continue until all 20 
participants were interviewed. After 20 interviews, the research team was confident 
that no new themes were emerged. 
 
All prospective participants who expressed interest were contacted and invited to 
participate in an interview if they met the inclusion criteria. All interviews were 
conducted on a one-to-one basis to ensure privacy and confidentiality of participants. 
Ten interviews were conducted face-to-face at a place convenient to the participant 
and 10 were conducted via telephone. Of the 20 participants, 17 were of Caucasian 
descent, two were of Asian descent and one of Middle-Eastern descent.  
 
The interviews lasted between 18 and 78 minutes. As participants were mothers with 
a young child, all participants were reassured that priority would be given to their 
infant or child if they needed to be attended to, and interviews were stopped and 
resumed at another time convenient for the participant. Qualitative narrative data 
were collected through recordings of the dialogues between the researcher and the 
individual participant.  
 
Sections 4.4.1 to 4.4.3 report on findings of the descriptive analysis; while sections 






4.4.1 Pattern of Use 
 
Data about herbal medicines used were categorised based on the name or type of the 
herbal galactagogue(s) discussed: i) fenugreek as a sole ingredient, ii) fenugreek and 
blessed thistle as a combination product, and iii) naturopaths’ own “lactation 
tincture” with a combination of herbal ingredients. Summaries of the pattern of use 
are provided in Table 4.1, Table 4.2 and Table 4.3, respectively. All 20 participants 
had used fenugreek either as a sole ingredient or in combination with other herbal 
ingredients. This finding correlates with the Stage 1 results, which indicated that 
fenugreek was the most popular herbal galactagogue amongst breastfeeding women. 
Ten participants had used fenugreek as a sole ingredient to promote breastfeeding 
(Table 4.1), whilst three had used fenugreek and blessed thistle as a combination 
product (Table 4.2), and seven used a naturopath’s own ‘lactation tincture’ with a 
combination of herbal ingredients (Table 4.3), respectively. The most popular 
formulation or brand of fenugreek was Nature’s Own® Fenugreek 1000mg, which 
nine participants had used. Participants commenced herbal galactagogue therapy at 
various times since delivery of the baby, with one participant commencing as early 
as three days and one as late as seven months postpartum. Duration of administration 
also varied from one week to nine months.  
 
4.4.2 Reasons for Use of Herbal Galactagogue 
 
Participants were using herbal galactagogues during breastfeeding for various 
reasons, including perceived insufficient milk supply (n = 9), diagnosed insufficient 
milk supply (n = 8), as a supplement in the absence of perceived or diagnosed 
insufficient milk supply (n = 2), or as part of tradition (n = 1). Participants classified 
as “perceived insufficient milk supply” were women who had not previously been 
diagnosed with breastfeeding supply issues by a health professional, however they 
“perceived” or “considered” themselves as having low milk supply. Participants who 
had been previously diagnosed with clinical insufficient milk supply by a health 
professional were classified under “diagnosed insufficient milk supply”. 
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Table 4.1: Summary of the pattern of use: fenugreek as a sole ingredient (n = 10) 
Participants Product/ dosage form Dosage of administration Commencement of therapy Duration of therapy 
BW 1 Crude seeds cooked with rice as a sweet dessert Approximately 60g of seeds cooked with 
one cup of rice and sugar in pressure cooker, 
taken twice daily 
2 weeks postpartum 5.5 months (since 2 weeks 
postpartum till 6 months – still 
using) 
BW 3 Nature’s Own® Fenugreek capsules 
(Each capsule contains 1000mg fenugreek dry seed powder) 
1 capsule twice daily, then 6 capsules when 
required as one off dose to boost supply 
3 months postpartum 9 months (since 3 months 
postpartum till one year) 
BW 6 Nature’s Own® Fenugreek capsules 
(Each capsule contains 1000mg fenugreek dry seed powder) 
Initially 1 capsule daily, then increase to 2 
capsules daily when required 
3.5 months postpartum 1 month (since 3.5 months 
postpartum till 4.5 months – still 
using) 
BW 10 Nature’s Own® Fenugreek capsules 
(Each capsule contains 1000mg fenugreek dry seed powder) 
2 capsules three times daily 2 weeks postpartum 8.5 months (since 2 weeks 
postpartum till 9 months) 
BW 12 Nature’s Own® Fenugreek capsules 
(Each capsule contains 1000mg fenugreek dry seed powder) 
2 capsules in the morning and 2 capsules at 
night, was aware of the possibility to 
increase dosage to 6g daily, however 2 
capsules twice daily was sufficient to 
product an effect.  
6 weeks postpartum 3.5 months (since 6 weeks 
postpartum till 5 months – still 
using) 
BW 13 Nature’s Own® Fenugreek capsules 
(Each capsule contains 1000mg fenugreek dry seed powder) 
2 capsules three times daily  10 weeks postpartum 8 weeks (since 10 weeks 
postpartum till 18 weeks – still 
using) 
BW 14 Nature’s Own® Fenugreek capsules 
(Each capsule contains 1000mg fenugreek dry seed powder) 
Initially 1 capsule daily, then increase to 5 to 
6 capsules daily 
2 weeks postpartum 4.5 months (since 2 weeks 
postpartum till 5 months – still 
using) 
BW 15 Nature’s Own® Fenugreek capsules 
(Each capsule contains 1000mg fenugreek dry seed powder) 
1 capsule three times daily 12 weeks postpartum 3 months continuously (since 12 
weeks to 6 months), then use when 
required 
BW 18 Nature’s Own® Fenugreek capsules 
(Each capsule contains 1000mg fenugreek dry seed powder) 
Initially 1 capsule three times a day for one 
week, then 2 capsules three times a day 
2 months postpartum 1 week (ceased therapy due to 
adverse effect –diarrhoea) 
BW 19 Nature’s Own® Fenugreek capsules 
(Each capsule contains 1000mg fenugreek dry seed powder) 
2 capsules three times a day 3 months postpartum 3 months (since 3 months 






Table 4.2: Summary of the pattern of use: fenugreek and blessed thistle combination products (n = 3) 
Participants Product/ dosage form Dosage of administration 
Commencement of 
therapy 
Duration of therapy 
BW 2 Nature’s Sunshine® Breast Feeding 
Support  
(Each capsule contains 300mg 
fenugreek seed powder and 150mg 
blessed thistle herb powder) 
2 capsules twice daily 3 days postpartum 8 months (ceased 
therapy when stopped 
breastfeeding) 
BW 7 Herbs of Gold® Breast-feeding 
Support 
(Each tablet contains 1.5g 
fenugreek seed extract and 500mg 
blessed thistle herb) 
1 tablet twice daily 7 months 
postpartum 
3.5 months (since 7 
months postpartum till 
10.5 months – still 
using) 
BW 11 Herbs of Gold® Breast-feeding 
Support 
(Each tablet contains 1.5g 
fenugreek seed extract and 500mg 
blessed thistle herb) 
Initially 5 to 6 tablets 




18 months (since 3-4 







Table 4.3: Summary of the pattern of use: naturopaths’ own ‘lactation tincture’ with a combination of herbal ingredients (n = 7) 
Participants Product/ dosage form Dosage of administration Commencement of 
therapy 
Duration of therapy 
BW 4 “Lactation tincture” from naturopath, containing 
fenugreek and other herbal ingredients which were 
unknown to participant 
1 cup tincture taken four 
times a day everyday 
5 weeks postpartum 5 months (since 5 weeks postpartum till 6 
months – still using) 
BW 5 “Lactation tincture” from naturopath, containing 
fenugreek and other herbal ingredients which were 
unknown to participant 
5mL tincture taken six 
times daily (up to a total 
daily dose of 30mL) 
9 weeks postpartum 7 months (since 9 weeks postpartum till 9 
months – still using) 
BW 8 “Lactation tincture” from naturopath, containing 
fenugreek and other herbal ingredients which were 
unknown to participant 
5mL tincture taken three 
times daily alternating with 
twice daily 
7 weeks postpartum 3 weeks (since 7 weeks postpartum, then 
ceased, then restarted at 4 months for 1 
week) 
BW 9 Weleda® Nursing Tea  
(Each tea bag contains dry powder of fenugreek seed 
500mg, fennel bitter seed 400mg, anise seed 400mg, 
caraway seed 400mg and lemon verbena leaves 300mg) 
1 tea bag steep in hot water, 
taken once or twice daily 
10 weeks postpartum 3 months (since 10 weeks till 22 weeks) 
BW 16 “Lactation tincture” from naturopath, containing 
fenugreek and other herbal ingredients which were 
unknown to participant 
5mL tincture taken once in 
the morning 
3 weeks postpartum 14 weeks (since 3 weeks till 17 weeks – 
still using) 
BW 17 “Lactation tincture” from naturopath, containing 
fenugreek and other herbal ingredients which were 
unknown to participant 
5mL tincture taken three 
times daily when required 
when breast milk supply 
was low 
3 months postpartum 1 month continuously, then use when 
required until the time of interview 
BW 20 “Lactation tincture” from naturopath, containing 
fenugreek and other herbal ingredients which were 
unknown to participant 
5mL tincture taken three 
times daily or twice daily if 
missed a dose 
6 weeks postpartum 2.5 months (since 6 weeks postpartum till 




4.4.3 Sources of Recommendation and Supply 
 
Many of the participants had chosen to use herbal galactagogues based on a 
recommendation, and in most cases more than one resource was utilised to reinforce 
the decision. These included advice obtained from friends, family members or other 
mothers with breastfeeding experience (n=11), midwives (n=5), lactation consultants 
(n=4), naturopaths (n=4), self-reading and researching (n=4), a child health nurse 
(n=1), and the Ngala helpline* (n=1).  
 
Participants were more likely to believe and seek advice from their peers, who were 
mothers with breastfeeding experience, as illustrated by the following comment:  
 
“…talking to people on the mothers group page and the breastfeeding 
support groups, they have all walked through the journey, they understand, 
and tried different things and suggested different options.” (BW 4) 
 
Although friends and family being the most common source recommending the use 
of herbal galactagogues, the majority of women (n = 17) obtained their herbal 
galactagogues from local community pharmacies. Other sources included health food 
stores (n = 6), naturopathic clinics (n = 4) and the local grocery store (n = 1), as 
summarised in Table 4.4. This finding indicates a potential vital role community 
pharmacists and pharmacy staff could play in influencing breastfeeding women’s 
decisions regarding use of herbal medicines during breastfeeding. This potential role 
and involvement of community pharmacists from breastfeeding women’s 





                                                 
* Ngala is a not-for-profit organisation based in Western Australia that provides Early Parenting and 
Early Childhood services to support and guide families with young children. 
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Table 4.4: Sources of recommendation and supply 
 Number of participants (n)* 
Who recommended the use?  
          Friends and family members 11 
          Midwives 5 
          Lactation consultants 4 
          Naturopaths 4 
          Self-reading and researching 4 
          Child health nurse 1 
          Ngala helpline 1 
  
Where did they obtain the herbal galactagogues?  
          Community pharmacies 17 
          Health food stores 6 
          Naturopathic clinics 4 
          Local grocery store 1 
 
























4.4.4 Perceived Effectiveness and Safety of Herbal Galactagogue 
 
Summaries of the perceived effectiveness and safety of herbal galactagogues based 
on the participants’ personal experience and observation are provided in Tables 4.5, 
4.6 and 4.7. Most of the participants (n = 16) had “perceived” or “observed” that 
these herbal galactagogues were effective in promoting breastfeeding performance. 
Some participants commented that they were unable to judge (n = 4) due to the 
simultaneous use of other approaches to increase breast milk supply including use of 
Motilium® (domperidone) and the “pumping method” by using electronic breast 
pumps. Overall, most participants reported a positive experience on milk supply with 
the use of herbal galactagogues during breastfeeding. Several breastfeeding 
performance indicators were mentioned as participants were asked to describe their 
experience with the use of herbal galactagogues. These included breast engorgement 
(feeling of “fullness”) and increased milk supply. The most commonly reported side 
effects were body odour from the use of fenugreek (n = 9), followed by headache (n 
= 2), diarrhoea (n = 2), delayed return of menstrual cycle (n = 1) and an increase in 
the number of wet nappies in the infant (n = 1), while the other eight participants 
stated that no side effect or adverse outcome was observed. The most common 
indicator which participants used to evaluate their breastfeeding performance and 
whether there was an increase in milk supply was the physical engorgement of the 
breasts, some described this as the feeling of “fullness”. Other indicators mentioned 
by participants included changes to the duration of feeding sessions, changes in the 
infant’s perceived satisfaction and feeding behaviour, the infant’s growth rate and 
changes in body weight, as well as an increase in the volume of expressed milk. 
When participants described their positive experiences with the use of herbal 
galactagogues using descriptions of breastfeeding performance indicators, 
confidence and self-empowerment emerged as an over-arching theme. Despite the 
lack of clinical trial data on the actual increase in volume of breast milk production, 
the breastfeeding performance indicators boosted participants’ confidence level and 
aided in the delivery of psychological benefits. This enabled participants to 
experience self-empowerment, which in turn may facilitate exclusive and successful 
breastfeeding. Further information on this is presented in Section 4.4.5, along with 
the relevant supporting quotes. 
116 
 
Table 4.5: Perceived effectiveness and safety: fenugreek as a sole ingredient (n = 10) 
Participants Perceived effectiveness by user Adverse effects observed 
BW 1 Effective 
Onset of effect: Within one day 
Indicator: Breast engorgement 
“So if I have fenugreek tonight, tomorrow morning then I will have very very , what’s the term, engorged breast, a lot of milk, and I found that it 
was quite instantaneous. Sometimes I even had to express the milk to relieve [the engorgement].The effect was that obvious and instantaneous.” 
Body odour in mother and 
infant 
BW 3 Effective 
Onset of effect: Within 4 – 6 hours 
Indicator: Breast engorgement, infant’s perceived satisfaction, increased volume of expressed milk  
“…I can feel I am full and uncomfortable which normally doesn’t happen till 6am in the morning. Even before feeding, I could feel my breasts so 
full…it’s just fuller and just quicker feed, the let down is just quicker, there’s more there… I will express 240mL [before using fenugreek], after 
using the herb, it will be around 270mL. At night normally would be 40mL, but I can express 80 to 90mL at night after using fenugreek.” “…the 
duration was shorter, quicker, because at night, it will be 15 minutes each breast for newborn. Otherwise, it will take 30 minutes each breast…. 
When I had it [fenugreek] will just be 15 minutes each side and she will be quite happy, obviously shorter feeding made her less grumpy. It’s just 
easier feeding, I think she is fulfilled quicker, the flow was obviously quicker, so it was just like drink, drink, drink, bang!” 
Sweet-smelling body odour 
which seemed to be dose-
dependent. Odour was 
absent at 1 or 2 capsules (1-
2g) daily, but present at 6 
capsules (6g) daily. 
BW 6 Effective,          Onset of effect: Within one day or less than 24 hours 
Indicator: Breast engorgement, infant’s perceived satisfaction and feeding behaviour, infant is putting on weight 
“When my milk comes down, I can see he is really swallowing like a lot, and it will come down more quickly, so it will take less time for all to 
happen, he feed probably a bit longer sometimes, and that really gulping sort of feeling, seems like a large volume he is getting, compared to 
before.” 
None observed 
BW 10 Unable to judge, was using Motilium®, and top-up with infant’s formula 
“I have no idea. Only because I have limited supply to start with, so I don’t know if it is better or worse since being on it. Same as for Motilium, I 





BW 12 Effective 
Onset of effect: 6-8 hours 
Indicator: Breast engorgement, quicker and more active feeding session, infant’s perceived satisfaction and feeding behaviour, longer interval 
between each feed 
“I could feel that my breasts were very full, and I had to feed her immediately to relief the swelling.” 
“Like if she has had a feed around 4pm, before that she would cry for a feed about 3 hours later, but after taking the tablet, sometimes she can 
wait till around 8 or 9 before needing to have another feed. I suppose that could be related to her growing up too, you know, when little they tend 
to feed more, every 2 or 3 hours, then slowly become 3 or 4 hours.” 






BW 13 Effective,          Onset of effect: 12 hours 
Indicator: Breast engorgement, decreased number of feeds per day 
“I have found that since using it myself, that I do feel like my milk supply has been kept quite high because of that.”  
“It has decreased the number of times I feed a day, probably initially because he was getting as much as what was there but it wasn’t enough, so 
he would be hungry after one or two hours. Whereas now, because he might be getting more at the first feed, he might not feed to feed again after 
3 or 4 hours.” 
None observed 
BW 14 Effective (with higher dose of 6g daily) 
Onset of effect: 4-5 hours 
Indicator: Breast engorgement, ability to express further 50mL after feeding, quicker and smoother feeding session 
“I remember increasing the dosage in the afternoon after lunch and immediately that night I felt that my breasts were so full, they were about to 
leak I think.” 
None at low dose 
 (1 capsule daily), body 








BW 15 Effective 
Onset of effect: 2-3 days 
Indicator: Breast engorgement, increased in volume of expressed milk by 50-100mL, leaking milk 
“I was leaking milk during the night. I would wake up with a wet bra in the morning.” 
 
None observed 
BW 18 Slightly Effective at low dosage (1 tds), however unable to judge for high dosage (6 d) due to adverse effect 
Onset of effect: One day 
Indicator: Breast engorgement 
“Initially with taking three a day, I think it did make some difference, but I would say it still wasn’t enough or ideal.  I decided to increase the 
dosage to six a day. I can’t really tell if taking six a day made any difference because I stopped using it immediately after a day because of 
diarrhoea and I was too scared to go back to it because now I know that my body doesn’t agree with it. Maybe if my body could tolerate the high 
dose, it would have helped.” 
 
Persistent diarrhoea, 
therefore ceased usage 
BW 19 Effective 
Onset of effect: 1-2 days 
Indicator: Breast engorgement, infant’s perceived satisfaction and feeding behaviour 
“I just felt that my breasts were a lot fuller and feeding was quicker and smooth because she isn’t crying. That’s why I am thinking, maybe it is 





Table 4.6: Perceived effectiveness and safety: fenugreek and blessed thistle combination products (n = 3) 
Participants Perceived effectiveness by user Adverse effects observed 
BW 2 Effective (in maintaining milk supply, not really increasing) 
Onset of effect: 1 day 
Indicator: Breast engorgement, infant’s perceived satisfaction 
“You could really tell when your breasts are full. Before I kind of always felt, not deflated but you know, if she were longer than usual between 
feed I wouldn’t really notice it, but then after being on fenugreek, if she went long than say 2 or 2.5 hours between feed, it was very obvious, my 
breast will look very engorged and it will start leaking, which has never happened before.” 
None observed 
BW 7 Effective 
Onset of effect: 2 hours 
Indicator: Breast engorgement, infant’s perceived satisfaction and feeding behaviour, shorter feeding session 
“I can see more effective sucking and slurping. After taking fenugreek, it was like suck, swallow, suck, swallow, so she was getting more. It was 
like proper sucking rather than just getting a bit of milk then just suck for the rest of it. Before that, she would only have proper feed for 10 
minutes then just sucking afterwards, not really swallowing. But after fenugreek, it was like 20 minutes of constant feeding and swallowing… 
she seems sort of happier and fuller after feeding. She just appeared to be getting lots of milk and I feel good about that. She appeared more 
settled.” 
Sweet-smelling body odour 
and in urine 
BW 11 Unable to Judge 
Onset of effect: 1-2 days 
Indicator: Breast engorgement,  infant’s perceived satisfaction and feeding behaviour 
“So sometimes the little one will wake up constantly all night just wanting more milk and in the morning still wants more, but whereas from 






Table 4.7: Perceived effectiveness and safety: naturopaths’ own ‘lactation tincture’ with a combination of herbal ingredients (n = 7) 
Participants Perceived effectiveness by user Adverse effects observed 
BW 4 Effective 
Onset of effect: 4-5 days 
Indicator: Infant’s perceived satisfaction and feeding behaviour, increased milk ingested based on baby-weighing method before and after each 
feed, shorter feeding session 
“I still don’t have huge milk supply, but at least I have a milk supply.” “We weighed her, initially the weight was something like 20g difference, 
and then after that it got to about 40, 50, 60g difference. The screaming stopped! She wasn’t getting enough food before, I was getting trouble 
before sleep, lots of crying and screaming before that. As soon as I started this course of action, my milk increased, she slept better, less 
screaming, she was getting enough food. Yes, so I wasn’t up until 6am in the morning trying to get her to sleep, put it that way!” 
 
Maple-syrupy smell on the 
body 
BW 5 Effective 
Onset of effect: 1-2 days 
 
Indicator: Infant’s perceived satisfaction and feeding behaviour, increased volume of milk supply through supply line 
“So for example she might be getting, you know, 5 or 10 ml from me, and 120 ml from the supplement, and then 2 weeks later when I did the 
milk studies again, she was getting 60 mL from me. Yes. 2 weeks later, and it was 60 mL and sometimes it was up to 90 mL from the breast!” 
“That definitely helped. I don’t think I would still be able to be breastfeeding if it wasn’t for the herbs. Or, actually, I probably will still be 
breastfeeding because XXX won’t take a bottle, ever, has never ever taken a bottle. But I haven’t used… I haven’t had to supplement any milk 
since she was 7 months old. And I think if I wasn’t using the herbs, I would still have to be supplementing.” 
 
Delayed return of menstrual 
cycle, woman believed that 
it is due to goat’s rue based 
on her reading 
BW 8 Effective 
Onset of effect: Within 24 hours 
 
Indicator: Breast engorgement, infant’s perceived satisfaction and feeding behaviour, shorter feeding session 
Liquorice-like smell from 




“I remember the next morning I woke up, I could just feel immediately that my breasts were really hard and full, and that was like that for a few 
days, so definitely increase very quickly. I could feel engorged. I know initially the first time I took it I was leaking milk and it was like that for a 
couple of days. I would say easily 25% increase.”“It made the feeding smoother. Definitely did have an effect on how she is feeding, she was 
feeding better. Duration of feeding would have been shorter because she was getting milk, more actively feeding throughout the whole time.” 
 
BW 9 Effectiveness observed or perceived by user: Unable to judge 
Onset of effect: Only slight effect after at least 1 week 
“To tell the truth with my supply it didn’t make a huge amount of difference, but I think it did support it slightly.” 
 
None observed 
BW 16 Effective 
Onset of effect: 1-2 days 
 
Indicator: Breast engorgement, infant’s perceived satisfaction and feeding behaviour, increased volume of milk  
“I just feel that third time round feeding, my baby is four months old and normally your breasts have settled down and you can’t tell unless it is 
right before a feed at that four hour mark or whatever, you have a very full breasts, and at the end of the day, they tend to be less full, they felt 
less full. To me, this time they feel full, there’s something always in there. So I don’t know how to explain that, just feel that there’s always got 
milk…” 
 
“Sweeter” breast milk 
BW 17 Unable to judge, believed there’s benefit, so will continue to use 
Onset of effect: 3 days 
Indicator: Breast engorgement, infant’s perceived satisfaction, modest increase in volume of milk expressed 
“I can feel my breasts are fuller first of all, and when I express I get a lot more milk. I can see that the baby, because normally before taking it, 
when I know my milk supply is a bit low, she might need both breasts on a feed. And with this, she would only take one breast for a feed. So 
there’s definitely sufficient milk in one breast. So that’s how I know my milk supply has gone up again.” “I just feel that the breasts are fuller 
before a feed…” 
 
Occasional headaches, mild 
diarrhoea, slight maple-




BW 20 Effective 
Onset of effect: Immediate effect, after 1 or 2 days 
Indicator: Breast engorgement, perceived infant’s satisfaction and feeding behaviour 
“I could tell because I could feel that they were so full, and I had to breastfeed to relieve the feeling. Also, I think baby was going through a 
growth spurt at that time, and I was surprise that I had enough milk to feed her, so I was very happy, and I think she is happy too.” 
 
Slight body odour, increase 





4.4.5 Perspectives and Attitudes towards the Use of Herbal Medicines during 
Breastfeeding 
 
Five main themes emerged from the thematic analysis of the qualitative data 
collected during interviews when participants were asked to describe their 
experiences and general perspectives towards the use of herbal medicines during 
breastfeeding: i) perseverance and determination to breastfeed, ii) confidence, self-
empowerment and reassurance, iii) concerns over breastfed infants’ safety, iv) role 
and expectations of health professionals, and v) peer and parental influence. 
Embedded within the five themes were the users’ attitudes and perspectives. 
Throughout all these themes, the views of users and why they had chosen to use 
alternative options over conventional therapies to promote breastfeeding 
performance were explored and addressed.  
 
 
4.4.5.1 Perseverance and determination to breastfeed 
 
Many participants seemed to have adopted the ‘breast is best’ philosophy. These 
women acknowledged and appreciated the health, physical and psychological 
benefits of breastfeeding to both mothers and infants.  
 
“…how much it helped my bonding with my baby and even just a general 
satisfaction from it, not only satisfaction but also I would say the benefits 
were much higher.” (BW 1) 
 
Recognition of the importance and significance of breastfeeding was identified as the 
main facilitator to develop perseverance and a determined attitude to breastfeed: 
 
“… basically I was just trying to get him back to the breasts and don’t want 
to stop breastfeeding him, so it’s to try and increase the supply because there 




“I can see a difference and it made me feel a lot better to be able to feed my 
baby in the right way. I was also less sleep deprived!” (BW 14) 
 
All women who participated in this study were aware of the Australian Dietary 
Guidelines 2013 (35) with the recommendation to breastfeed exclusively for the first 
six months of an infant’s life. Taking into consideration the advantages of 
breastfeeding along with endorsement from their health professionals, perseverance 
and determination played a vital role in promoting successful breastfeeding as 
women were prepared to take all actions required to ensure exclusivity and the 
avoidance of infants’ formula as much as possible.    
 
“I was expressing. So it [ensuring sufficient milk supply] was hard, and I 
didn’t want to use formula. I was expressing the whole year, I was always 
worried about my supply. For the whole year, it was crazy, I persevere, keep 
trying and trying.” (BW 3) 
 
“You have to try different things, until you find one that works for your body. 
I think the key thing is to let people know that you need to persevere and just 
stick with it.” (BW 4) 
 
“Yes, there was definitely some perseverance.” (BW 11) 
 
“I, myself, was very determined to breastfeed.” (BW 12) 
 
“Breastfeeding is not easy, definitely not. You need to persevere and you 
need to be absolutely patient with everything that you do. You need to have 
very high patience level and you need to feel comfortable and confident doing 
it.” (BW 20) 
 
An underlying theme was observed when women described their strong mental will 
to breastfeed. Participants were prepared and willing to attempt all options available 




“I mean honestly, if drinking snake oil would make me have more breast 
milk I would have done it, anything that helps!” (BW 3) 
 
“I would be willing to try anything if I know that it would be safe for my baby 
and that it would help keep my milk supply up.” (BW 7) 
 
“I would try anything really, anything that would help to increase my milk 
supply because the last thing I want is for my baby to not get enough milk and 
be forced to give formula.” (BW 12) 
 
“For me, I personally would try anything, anything as long as it helps to keep 
my baby on breast milk and to keep her full and healthy.” (BW 14) 
 
“I am willing to give anything a go if it works and if it helps.” (BW 15) 
 
“I certainly am not opposed to the idea of using herbs to support 
breastfeeding. Really, I don’t care what it is, as long as I can tolerate it and it 
helps, I am willing to try anything.” (BW 18) 
 
As described above, participants reported four main reasons for use of herbal 
galactagogues, including perceived insufficient milk supply, diagnosed insufficient 
milk supply, as a supplement and as part of the tradition. Besides those who had been 
diagnosed with insufficient milk supply, all other participants embraced the “just-in-
case” approach to use herbal galactagogues prophylactically in order to avoid breast 
milk supply issues. 
 
“[I use fenugreek] even though I did not have problems producing milk, but 
just to keep up the milk supply.” (BW 1) 
 
“I was just concerned that my milk was going down, because it went down 
with my first child at three or four months.” (BW 6) 
 
“My husband is 6-foot and I am only 5-foot. I know that my son has got my 
husband’s gene, he has the potential to grow quite quickly, but I was feeling 
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like he feels hungry even after he has emptied both breasts, so I thought if 
there was more milk there, it can filled him quicker and he can grow 
quicker.” (BW 13) 
“I want to make sure that I have enough supply, now having to look after two 
other children… it was just as a top up when he was eight months old, I just 
think he’s a little unsettled and a friend suggested it and I used it for a month 
or so and was just to boost the supply I guess before it gets worse.” (BW 16) 
 
“…when I expressed, I realized I didn’t have sufficient milk and my baby 
wasn’t satisfied after a feed and so I sort of better get the milk supply up 
before it is gone completely.” (BW 17) 
 
“I was under all the stress, and the fact that I was planning to go back to 
work in a couple of months’ time, I didn’t want my milk to be compromised, I 
wanted to do something and take some actions right away.” (BW 18) 
 
 
4.4.5.2 Confidence, self-empowerment and reassurance 
 
Confidence and self-empowerment was previously discussed in Section 4.4.4 when 
participants described the perceived effectiveness and safety of herbal galactagogues 
based on their personal experiences. Interestingly, these elements reappeared 
throughout the interview conversations and continued to emerge as an over-arching 
theme. There seemed to be a relationship between the women’s breastfeeding 
confidence level and duration of exclusive breastfeeding. Even in the absence of milk 
volume measurement, one participant described how the use of herbal galactagogues 
promoted her confidence and fostered self-empowerment to breastfeed. 
 
“…because this [fenugreek] works so quickly and it just gave me that 
confidence straight away. It took away that anxiety and stress.” (BW 6) 
 
Many participants also mentioned the feeling of reassurance through the use of 
herbal supplements during breastfeeding, which was especially important for first-
time mothers. Hence, the use of herbal galactagogues was thought of as one of the 
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methods of reassurance in the context of their own perceptions. These positive 
emotional impacts contributed to the success of breastfeeding practices amongst the 
participants.  
 
“I think it’s [fenugreek] worth trying. And as for me, I certainly find that 
useful and reassuring that I have found something effective to increase my 
milk supply. As a new mum, you just never know, you never know what is 
coming, what problems you will encounter and I certainly did not anticipate 
that milk supply will be an issue. I have always thought that breastfeeding is 
easy and will come naturally because everyone else does it, and I wasn’t told 
about it being an issue.” (BW 12) 
 
“I can see a difference and it made me feel a lot better to be able to feed my 
baby in the right way. I was also less sleep deprived!” (BW 14) 
 
“Breastfeeding is not easy, definitely not. You need to persevere and you 
need to be absolutely patient with everything that you do. You need to have 
very high patience level and you need to feel comfortable and confident doing 
it. To me, I think using the liquid is a good idea because I feel that at least it 
has helped, and I am doing the right thing.” (BW 20) 
 
4.4.5.3 Concerns over breastfed infants’ safety 
 
A number of participants voiced their concerns over breastfed infants’ safety 
whenever any medicine is warranted. These participants were cautious and 
apprehensive over their decision on what to take or what to avoid whilst 
breastfeeding, expressing their fear of it affecting their infants’ health.  
 
“I’ve been apprehensive about it, whenever I need to take something, I will 
always consider if that is safe for my baby or if it might affect breastfeeding.” 
(BW 6) 
 
“People need to know what is available, and what are the evidences, before 
they can make decisions, especially when you are pregnant or breastfeeding, 
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you are just always cautious about what you eat, what you can or cannot 
take.” (BW 14) 
 
“I really didn’t want to take anything harsh that could affect my baby’s 
health, so I was more cautious over what I take. I would say that because I 
was breastfeeding, I was more cautious over what I take and what I eat, and I 
think that using natural herbs would be safer than using chemicals.” (BW 18) 
 
“I don’t know a lot of herbs but I would tend to use natural remedies first 
before using other chemicals. I am more concerned about how these products 
will affect my baby and the last thing I want is to put my baby at risk.” (BW 
20) 
 
Some participants associated the use of conventional or “Western” medicines as 
dangerous or harmful to take during breastfeeding. Limited awareness of potential 
side effects and medicine knowledge had for some women led to the refusal of 
conventional recommendations for treatment of insufficient breast milk supply, for 
instance with the prescription medicine domperidone (Motilium®).  
 
“I don’t really want to take anything pharmaceutical at this stage, when she 
was only 6 weeks old at the time, she was so tiny, so definitely I was very 
reluctant to take anything. I was concerned about what was in it [Motilium®], 
and how it will affect both of us. I thought it was too harsh of a treatment.” 
(BW 8) 
 
“To me, it [herbal galactagogue] seems a lot safer, because when I was on 
Motilium®, the way how that works changes dopamine levels in the brain 
which then increases milk supply and prolactin.  That to me has always felt 
like “Frankenstein” sort of thing. It [fenugreek] just seems more natural. I 
don’t get concern about any transfer to my milk, because it’s natural and it 
has been used for hundreds or thousands of years, really, I think over time it 




An underlying theme emerged as participants described their concerns over the use 
of conventional medicine while breastfeeding. The general perception of “herbal is 
natural, and natural is safe” was identified. Many participants in this study displayed 
a tendency to use herbal alternatives during breastfeeding with the general 
assumption that herbal galactagogues were safer alternatives compared to other 
options.  
 
“It’s a herb, so it can’t be bad for you. It makes me feel happier that a herb 
can do that for me. It doesn’t have to be pharmaceutical or a drug, you know. 
I don’t take any other herbs really, but it’s amazing what it can do.” (BW 6) 
 
“I think if you can avoid taking chemical pharmaceutical drugs, then I would 
exhaust every single herbal option before I go near any pharmaceutical. 
Because the herbal options are usually much safer, they usually don’t cause 
any issues in the baby. For me, in any situation I would exhaust any 
homeopathic or herbal remedy before I went to pharmaceuticals.” (BW 11) 
 
“I would try fenugreek first. I would try the herbal options. I don’t know, but 
if he is getting it from me, then there is a chance that it can go to him, so I 
rather go with a natural option first.” (BW 15) 
 
“I guess I just thought that using a herb would be safer compared to using 
some chemicals to increase my milk supply.” (BW 18) 
 
“I don’t oppose of the idea of using herbs during breastfeeding. I think it is 
usually safer, that is usually what I choose if I am breastfeeding.” (BW 19) 
 
Nevertheless, some women commented that natural remedies may not always be safe 
and that they would still be mindful and vigilant when choosing their therapy of 
choice. As one participant commented:  
 
“Given that it comes from nature, even though you can’t quantify how much 
the active ingredient is in there, I believe that it may be enough to cause any 
problems. So in my opinion, if a herb or substance is used whilst 
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breastfeeding, as long as there is no or significant adverse effect, or it can be 
incorporated to part of your diet, then it should be okay, but I am not too 
keen on tablets and capsules, even though it may be herbal or 
complementary.” (BW 1) 
 
The decision and likelihood to use herbal options to promote breastfeeding 
performance was at times linked to women’s personal preference. Some of the 
participants appeared to have previously used herbal medicines in managing other 
health issues separate to the pregnancy and lactation phases of their lives. In 
conjunction with the perception of herbal galactagogues being “safer”, women 
preferred to use the herbal alternatives during breastfeeding.  
 
“I’ve always use herbal. I didn’t want to rely on taking a drug to get my milk 
supply up.” (BW 2) 
 
“I will try and avoid and try alternatives, my last resort will be to take the 
drug. I will try natural versions if that was available.” (BW 3) 
 
“...so definitely doesn’t matter if it was for breastfeeding, I would prefer to go 
the herbal path, as long as I understand that it will be safe for my baby. I 
think because I believe in the use of natural remedies, it was all my choice to 
walk that path first anyway.” (BW 4) 
 
“Even before I was breastfeeding, I tend to choose herbal, during pregnancy 
I tend to use herbal and that carried through till I was breastfeeding, so that 
was definitely my first choice.” (BW 8) 
 
“I do think that if there is a herbal option available, and if that is effective 
and if I know that it won’t cause any problems to me and my baby, I would 
prefer to use it.” (BW 12) 
 
“In any situation, I would exhaust any homeopathic or herbal remedy before 




4.4.5.4 Role of and expectations towards healthcare workers 
 
Breastfeeding women’s expectations of healthcare workers emerged as a prevailing 
topic of discussion in these interviews. In the context of this discussion, healthcare 
workers included doctors and specialists, midwives, child health nurses, lactation 
consultants, naturopaths and community pharmacists. Besides health information, 
expectations of participants centred on drug or product knowledge, including options 
of alternative therapies, at the same time respecting women’s decision or choice. 
Participants expected all healthcare workers to have an adequate level of awareness 
and knowledge on the availability of all different treatment options. Some of the 
participants indicated a need for healthcare workers to be more open-minded, 
supportive and prepared to provide alternative options should women wish to be able 
to choose. Participants preferred to receive suggestions or options with information 
on their effectiveness in order to make an informed decision.  
 
“I think it’s the attitude of people. So you know you go and see the lactation 
consultant, and they don’t tend to, in my experience they don’t tend to believe 
that herbs do very much. Even other health professionals like doctors and 
pharmacists should be aware or should know about the alternative options, 
so we can make our own decision, that would have been very helpful.” (BW 
5) 
 
“…or sometimes to make sure medical professionals see the benefit of 
alternative therapies. But obviously more support from them would be 
fantastic.” (BW 7) 
 
“I think that having the health professionals being more aware of it. A lot of 
doctors and even midwives and things just don’t know enough about it. So 
they would automatically go to a pharmaceutical rather than trying 
something herbal first because they don’t know enough about the safe and the 
knowledge that it is okay to do that.” (BW 11) 
 
“I think health nurses need to be informed whether they agree with it or not, 
just to, if somebody is having issues with feeding, and they don’t want to take 
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any other sort of medicines, then this [herbal galactagogue] could be an 
option for them.” (BW 16) 
 
One participant who showed preference to the use of herbal remedies described her 
experience with healthcare workers and discontentment after being diagnosed with 
milk supply issue:  
 
“It [using herbal galactagogue] is not talked about. Not to boost subject, but 
no one takes these sorts of things seriously I suppose. I think hospitals need to 
be more open-minded and willing to talk about other things other than just 
manufactured drugs.” (BW 2) 
 
It was also noticeable from the interviews that involving breastfeeding women in 
decision-making regarding their own healthcare will enable a sense of autonomy and 
therefore increase the likelihood of adherence to therapy regardless of whether it is 
conventional or alternative therapies. Many participants believed that information 
regarding herbal medicines to support breastfeeding should be provided in the 
“mother’s information pack” during visits to pre-natal clinics.  
 
There was also a perception that many healthcare workers were not supportive of the 
use of herbal medicines during breastfeeding, and were not seen as having full 
awareness of the range of herbal products available and their evidence in terms of 
safety and effectiveness. Noticeably, regular users of herbal medicines believed that 
alternative options should be made available to women by their healthcare workers 
and wished that all breastfeeding women would be counselled on the appropriate use 
of medicines and be made aware of the availability of alternative options at some 
point before lactation. Some participants further commented on the potential value of 
awareness in reducing distress and anxiety during early days postpartum.  
  
 “I think it [fenugreek] is an amazing herb. I wish I had known that with my 
first child. I think that every breastfeeding mother should know about it, 
because you get so stressed when you feel like your milk is starting to 




“I think people need to know that it does actually work, not just some crazy 
hippy thing. Because actually that was what I though, I initially thought that 
the herbs were for people who didn’t want to use conventional medicines 
because they have issues with big “pharma” or whatever, but honestly for 
me, it has worked wonders, like far better than anything that any doctors 
have ever recommended it to use. So I just wish that more women actually are 
aware of it.” (BW 7) 
 
“I just wish more people knew about it because I know, especially during the 
early days, a lot of people really worry about supply. I think there’s lot of 
misinformation about people not having enough milk and a lot of people that 
I’ve heard of said they have stopped breastfeeding because they didn’t have 
enough milk or have a very hungry baby.” (BW 8) 
 
“For me, I think it would have been a lot easier if I had known about taking 
fenugreek earlier.” (BW 12) 
 
“I think that these options should be made available to all breastfeeding 
mums out there if they do experience any trouble with breastfeeding… I think 
more people need to know about it [herbal galactagogues], and it’s not just 
about knowing that it exists, but also knowing what is the right dose and right 
way of taking it to ensure you get the effect you want.” (BW 14) 
 
“… so I just don’t think people know about it, that’s why they fear away from 
it, unless someone they trust has recommended it to them.” (BW 16) 
 
In the absence of adequate information from their health professionals regarding 
therapy of their choice, in this case herbal or alternative therapies, participants 
disclosed that internet was a common source of information. 
 
“I think more women should know about this, because no one told me until I 




Despite the criticism about the lack of information about herbal remedies by most 
healthcare providers, some of the participants reported receiving information and 
recommendations relating to the use of herbal medicines by some providers. A need 
for reassurance by healthcare providers emerged as an underlying theme as some 
participants elucidated their experiences and relationships with their trusted 
healthcare providers. Participants appeared to be more inclined to follow and feel 
comfortable with recommendations as advised by their healthcare providers.   
 
 “I was extremely grateful that NGALA mentioned it to me.” (BW 6) 
 
“I trust my naturopath in terms of what she prescribes, that it would be safe 
for myself and the baby while breastfeeding.” (BW 9) 
 
“I am certainly not opposed to the idea of using herbs during breastfeeding, 
as long as I know and have checked with my child health nurses and doctors 
or even ringing up a pharmacist.” (BW 12) 
 
“When I heard from my doctor that there were other options, I immediately 
thought that I would give it a go first.” (BW 18) 
 
“ I need to know about it, I guess be informed by someone I trust or know 
quite a lot about what I am taking and in this case, I don’t particularly know 
what’s in it, but someone that I trust [the midwife] has recommended it.” 
(BW 16) 
 
“I never even thought twice about taking it, I never had any hesitation in it, 
because of the people who have recommended it to me, like the lactation 
consultants and the naturopaths. I know a naturopath who is very cautious 
over what she prescribes when you are breastfeeding, so I never thought 
twice. I don’t know much of it or how much benefit it had, but I have no 
problems taking it, I suppose it is a natural herb.” (BW 10) 
 
The need for research and evidence-based information on the use of herbal medicines 
during breastfeeding was identified by several participants. They expected health 
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professionals to be up-to-date with the latest research data and be able to translate the 
information into their daily practice.  
 
“I guess the supplements out there just need more studies. There’s lots of 
research that goes into glucosamine and fish oil and all these that we think is 
going to help us, but not for breastfeeding, it will be nice to have that 
knowledge to know that it works and it is safe.” (BW 3) 
 
“I think more research would be needed, stuff like that to tell women what to 
expect from taking a product [whilst breastfeeding].” (BW 8) 
 
4.4.5.5 Peer and parental influence 
 
The impact of peer and parental influence on breastfeeding women’s decision and 
choice of therapy was discussed from the perspectives of sources of recommendation 
and supply.  It was evident that some participants were more likely to believe and 
follow certain recommendations if the recommendations were made by parents or 
peers whom they could relate their experience to or women who had breastfeeding 
experience.  
 
“ [The best thing is] talking to people on the mothers group page and the 
breastfeeding support groups, they have all walked thought the journey, they 
understand, and tried different thing and suggested different options.” (BW 
4) 
 
“I just heard from my other girl friends who have taken it, that it made a big 
difference to them. One of them even said that don’t take it, because it gives 
you so much milk that it gives you mastitis and all that. I mean I don’t have 
that problem, but heard lots of positive things from other people.” (BW 10) 
 
“I have now recommended it [fenugreek] to a couple of friends who have just 
had a baby, even though they are not having problems with milk supply, I 




“...because my friend who is the midwife is very cautious, but she 
recommended it, and she is a great advocate for breastfeeding, that’s why I 
thought well I’ll give it a try…” (BW 16) 
 
“The first port of call if you are a breastfeeding mum, you would probably go 
and talk to other mums.” (BW 17) 
 
“My best friend has used them in the past, so I trusted it.” (BW 18) 
 
Some participants described stress from parents and peer pressure to breastfeed as 
the drive to the trial of all methods available to ensure successful breastfeeding. In 
these instances, potential psychological or emotional benefits of using herbal 
galactagogues had further benefits in terms of confidence and reassurance as 
discussed in Section 4.4.4.  
 
  “For me, it was probably pressure from my mum to breastfeed.” (BW 3) 
 
“I was also under a lot of stress from my mother and mother-in-law to 
breastfeed… ” (BW 12) 
 
One participant further described how her family member influenced her decision to 
use herbal galactagogues: 
 
“I recommended it to my sister-in-law, but she didn’t find that useful, when I 
told her she has to take six, she found that expensive. Buying formula would 
have been much cheaper, so she didn’t bother with taking the herb any 






4.4.6 Views on Available Herbal Medicines Resources  
 
Four main themes were apparent in the interviews as participants described their 
views on the resources available to them as breastfeeding women regarding the 
effectiveness and safety of herbal medicines used during breastfeeding. These four 
themes were: i) information needs ii) credibility and reliability of information iii) 
expectations of health professionals, and iv) role of community pharmacy.  
 
4.4.6.1 Information needs 
 
Despite their decision to use herbal galactagogues during breastfeeding, the majority 
of the participants (17 of 20) commented that there was a lack of resources available 
regarding the use of herbal medicines during breastfeeding. Although these herbal 
medicines were widely available OTC in Australia, information regarding their 
efficacy and safety during breastfeeding was perceived as not being well established, 
or at least not made readily available to them.  
 
“It’s a lot of word of mouth, you cannot rely on the internet, but you can do 
some research online, but in terms of , the average woman who doesn’t have 
any contact with people who deals with herbs, they will find it difficult 
because they won’t know where to look. So there’s little out there, unless you 
know what you are looking for.” (BW 4) 
 
“There’s not much information available out there. Well, I supposed there 
might be, but most of the time I don’t know where to look for these 
information.” (BW 6) 
 
“I don’t think there is much out there, at least they weren’t easily available. 
If it wasn’t for my friend at mothers’ group, I wouldn’t have known to take 
fenugreek.” (BW 12) 
“No one mentioned it to me, I basically read it on the internet myself, online. 





Although the lack of readily available information was perceived as an 
inconvenience for most, two of the participants indicated that there was adequate 
information available provided that the source of information could be identified: 
 
“It’s probably not a lack. But you do need to know where to look for 
information.” (BW 3) 
 
“I don’t think it’s too bad, I think the resources related to herbal medicine I 
think we can do with a lot more information and make it more widely 
available so that people who are in need of it can use them.” (BW 8) 
 
Nevertheless, the majority of participants expressed a need for accessible evidence-
based information and more research to be conducted to facilitate safe and effective 
use of medicines during breastfeeding. This is vital in promoting successful 
breastfeeding and avoiding unnecessary early cessation of breastfeeding.  
 
“If it was proven medically and endorsed, more people would be able to use 
that [herbal galactagogue], instead of just giving up breastfeeding when they 
feel the supply is low or grabbing the first bottle of formula.” (BW 18) 
 
In addition to the general need for further research, a need for research specifically 
conducted locally was also identified to facilitate the application of findings to the 
Australian healthcare context. As herbal preparations exist in various brands and 
dosage formulations throughout the world, some participants found it impractical to 
relate to information or studies conducted overseas.   
 
“I think it’s better if we have our own, because obviously all countries the 
culture is different. And obviously you can’t do research in every single 
country, but I think I will be more incline to believe it if it was from Australia 
rather than from overseas. Also different countries have different brands, 
which to me in my case, different brands gave me a different effect. So like for 
example if you see a brand from an American website, but then you may not 
get it in Australia. I think it is really important to have an Australia sort of 




4.4.6.2 Credibility and reliability of information 
 
Many participants relied on the internet or their friends and family for information, 
advice and recommendations. Credibility and reliability of information accessed 
from the internet was highlighted during the interviews. Although many participants 
questioned the trustworthiness of information obtained from non-accredited sources, 
they were left with no other option but to use the internet.  
 
“Most of the stuff you get from the internet, I am just always worried about 
reliability, and the more you read, you tend to trust it more, which may not 
necessarily be a good thing sometimes.”(BW 5) 
 
“I don’t think there is a lot of information out there about the use of herbs. 
Even the one that I was taking [Nature’s Own® Fenugreek 1000mg capsules], 
on the label it only says it is for healthy gut or something along that line. 
Nothing was mentioned about breastfeeding on the label. I went online and 
people are talking about fenugreek online, but I don’t know if this 
information can be trusted.” (BW 18) 
 
Participants further cited the need for reliable information endorsed by accredited 
organisations for example the Australian Breastfeeding Association (ABA) or 
medical board. 
 
“I had to rely on [internet] forum discussions and word of mouth to make up 
my mind whether a herbal product is suitable for me or not. So if it was 
endorsed by a medical or I know the Australian Breastfeeding Association is 
not a medical, but if it was endorsed more medically in some way or another, 
it might be more helpful, people might be able to use it more.” (BW 17) 
 
Along with the general perception of the lack of easily accessible reliable 
information, one participant who was both a health professional and a mother of an 
eight-month old at the time of the interview, described her views on the information 
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resources. Inconclusive information was seen as confusing and further posed a 
dilemma: 
 
“If there is something available, I find that it is usually inconclusive. There 
is just not enough data and they [the resources] leave the ball to the mothers’ 
court to decide whether they want to take it. I feel like there is no conclusive 
information as much regarding herbal medicines during breastfeeding.” (BW 
1) 
 
From the perspective of some participants, reliance on parents or close family 
members and friends for breastfeeding-related information was considered sufficient. 
This raises questions about the credibility of information obtained from these 
sources, which will be discussed in greater detail in Section 4.5.  
  
 “I only went to where my mum told me, so I personally never looked into 
safety and efficacy of herbal medicines during breastfeeding.” (BW 1) 
 
“If it wasn’t for my friend at mothers’ group, I wouldn’t have known to take 
fenugreek. I have now recommended it to a couple of friends who have just 
had a baby, even though they are not having problems with milk supply, I 
mentioned it to them anyway, just in case they need it.” (BW 12) 
 
4.4.6.3 Expectations towards health professionals 
 
In general, health professionals were viewed as reliable sources of information. 
Besides voicing their need for additional research studies, participants also 
demonstrated a desire for written and verbal information from their healthcare 
professionals with regards to the use, safety and efficacy of herbal medicines during 
breastfeeding. It appeared that some participants perceived that there was a lack of 
health professionals’ awareness about the availability and evidence-based 
information regarding use of herbal medicines during breastfeeding. Participants 
expected information related to the use of herbal medicines to be provided in a leaflet 




“The info packs that you get from the hospitals and pamphlets from nurses 
don’t have much information about herbal remedies for use during 
breastfeeding. Like I mentioned earlier, if I had known the presence of 
fenugreek for example, I would have tried that with my first child and may 
have a better or easier time with breastfeeding.” (BW 6) 
 
Acknowledging that there is a lack of available information, participants believed 
that health professionals should endeavour to provide guidance. Information on 
herbal options during breastfeeding should be made readily available to all 
breastfeeding women as suggested by some participants.  
 
“At least on what’s available, I mean there might not be a lot of information 
available, but at least to guide us on where to look out for information.” (BW 
5) 
 
Despite expecting health professionals to have adequate levels of knowledge, 
participants had varying expectations of different health professionals. One 
participant commented on how she felt that healthcare workers working in the 
mainstream health system may have different perspectives than those from the field 
of naturopathy:  
 
“Most of the naturopaths I have spoken to are fairly comfortable 
recommending things even when I was pregnant or breastfeeding. I find 
people who are working in natural health are more comfortable than people 
who are working in mainstream health, they are more hesitant to recommend 
stuff, they have a more complex… I mean they couldn’t really say whether 
something was safe or not.” (BW 8) 
 
In the context of reliable information resources, community pharmacy was perceived 
as an easily accessible health destination and pharmacists were recognised by 
participants as overall medicine experts. The role of community pharmacy will be 




4.4.7 Perspectives on the Current Healthcare System and Level of 
Breastfeeding Support Provided 
 
Although none of the questions in the interview guide was specifically designed to 
address this topic, breastfeeding women’s perspectives on the current healthcare 
system and the level of breastfeeding support provided emerged as a common focus 
of discussion by some participants as they described their experiences before, during 
and after delivery. A mix of positive and negative feedback were noted from the 
narrative conservation during the interviews.  
 
A multidisciplinary team consisting of a diverse group of healthcare professionals 
including doctors, pharmacists, child health nurses, midwives and lactation 
consultants was seen by participants as contributors to the current healthcare system. 
Many of the healthcare workers were mentioned throughout the interviews when 
participants described their experiences and understanding with “healthcare” and 
“breastfeeding support”. Despite her perception of insufficient information available 
regarding the use of herbal medicines during breastfeeding, one participant 
acknowledged the level of assistance and support provided: 
 
“I would say there is certainly a lot of help out there, I mean a lot of 
breastfeeding help. You have the child health nurses, midwives, lactation 
consultants, chemists, doctors and all to help and ask questions if you need 
to, but I don’t think there is enough information out there about use of herbal 
medicines.” (BW 15) 
 
Despite the overall positive experiences, participants highlighted several areas for 
improvement. Immediate postpartum and early parenthood were viewed as 
challenging and may be associated with anxiety, stress and confusion in some 
women, which may impact on their ability to absorb and internalise information. 
According to some participants, in-depth practical information regarding 
breastfeeding were not provided until immediate postpartum. Although some pre-
natal classes may have touched on the subject, the level of breastfeeding-related 
information was viewed as insufficient to enable full understanding and anticipation 
of the potential breastfeeding-related issues which women may encounter. Hence, 
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participants suggested for breastfeeding and related-information to be part of the 
focus during pre-natal classes or information sessions to avoid confusion during the 
lactation stage.  
 
“Before birth, because that’s when you want to learn as much as possible 
about what’s going to happen when the baby comes because you have no 
idea. But after baby arrives, you are so consumed and you don’t pay attention 
to what’s happening around you. Especially, I didn’t really remember 
anything during the first week. So doctors and nurses could have told me 
things but I wouldn’t remember, but information should be available before 
birth.” (BW 2) 
 
All participants from this study had used one or more herbal galactagogues to 
support breastfeeding. Nonetheless, many of them were not aware of insufficient 
breast milk supply being a potential issue before the baby was born. Besides the 
provision of breastfeeding-related information during pre-natal classes, participants 
further suggested that potential issues with insufficient breast milk supply and 
information on options available to boost supply, including herbal galactagogues and 
non-pharmacological therapies should be made available prior to delivery. Pre-natal 
classes and visits to healthcare professionals were proposed as the most appropriate 
avenues. This valuable information was perceived as potentially useful and expedient 
when discussed before the birth of their infants, especially for first-time new parents.   
 
“You know breastfeeding is going to be hard, but you are not told anything 
about your milk will dry out or drop or supply issue. You are not told any of 
that, not until you go through it, then you go, “Oh okay, milk supply issue!” 
So I guess women should be warned about milk supply issues, what to do and 
what are the options including alternative therapies so women can make their 
decision.” (BW 2) 
 
“…even if there were brochures that you can pick up, or read through, as 
there wasn’t much available regarding alternative therapies or ways that you 




“I only found out that [fenugreek] after it [low milk supply] became an issue, 
but if, say maybe within the maternity ward, or during the pre-natal 
education, that could be introduced at that stage. We are told the importance 
of breastfeeding and all that, but not really about being aware that supply 
could be an issue. So, if this was discussed earlier on before delivery, we can 
prepare and start taking some supplements, rather than addressing it way 
down the track when you realized that you have a supply issue.” (BW 9) 
 
“More information on what problems you may encounter during 
breastfeeding and what you can do about it, all these information should be 
discussed and given before the baby comes. Many women would have 
attended the pre-natal classes and all that which is where you learn about 
giving birth, parenting and breastfeeding. I think that is the best time and 
place to give out information about what are the possible breastfeeding issues 
you may or may not face, for example insufficient milk supply, and what you 
can do about it.” (BW 10) 
 
“I attended several pre-natal classes and breastfeeding classes. They were 
really helpful and relevant, but nothing was mentioned about the possibility 
of supply issue and what you can do about it or how can you tell if baby is not 
getting enough. So maybe something along that line would be helpful to other 
breastfeeding mums.” (BW 12) 
 
“Most mothers will be going to prenatal classes before the baby is born. They 
do explain breastfeeding but they don’t go through the different things that 
you can do to help the situation. They sort of tell you this is how you should 
breastfeed to get the attachment right and things like that, but not really like 
the issues that could come with it. Well, I just think that if people sort of think 
that breastfeeding is given, it’s just going to come naturally, it’s just going to 
be easy. But in reality, it is not, and there are all these issues that come with 
it, so if you can kind of give everyone a heads up of things that could be 
coming your way, so at least it gives them some understanding and they can 




“Sometimes it is so, you are so sleep deprived, when the baby arrived, you 
are thinking, I am just trying to keep my head above water, so it’s great to 
have information out there before the baby arrives, or particularly with your 
first baby. I think maybe they should have given you a little bit more 
information on breastfeeding and other options out there if you have 
problems with supply, as well.” (BW 16) 
 
To avoid confusion, it is also crucial that all healthcare providers across the 
multidisciplinary team are up-to-date with recommended guidelines to ensure 
consistent and dependable information be delivered.  
 
“I don’t think that there’s, this is my opinion, there isn’t a massive amount of 
support or in hospital for my first baby. I was told different things in regards 
to breastfeeding, different ways, it was just confusing, so I had to work out 
how it would work for me, and that’s very common in first time mum. They 
are told different things and ended up feeling very confused.” (BW 16) 
 
In addition to the above, participants also put forward their thoughts on what 
information and which services would be beneficial to breastfeeding women, as 
below: 
 
i) Need for clinical studies and evidence on the use of herbal medicines during 
breastfeeding, including the safety and efficacy of herbal galactagogues: 
 
“Definitely clinical studies, about what you are doing is the right thing, if it is 
going to affect your breast milk in a positive way and that it won’t affect the 
child in a negative way.” (BW 3) 
 
“…for women who are really struggling for supply, they need to see how 
much which product can increase your milk supply. I mean for normal 





ii) Availability of information on different brands or dosage formulations of herbal 
galactagogues in Australia: 
 
“…how can you use this thing more accessible to yourself, how can you buy 
them, is fenugreek in seed or can you take tablet,  and is it going to work for 
you as well, is there a difference with different form of fenugreek. Sometimes 
it could be that you have not taken enough, so that’s interesting.” (BW 4) 
 
iii) Pamphlets or information on the different options and use of herbal and 
alternative therapies to support breastfeeding should be made available in the 
information packs prior to delivery: 
 
“I just think that in the information pack that you get in the hospital, I think 
there should be a pamphlet on the use of herbal medicines for breastfeeding. 
New mothers read the information that is in the packs, and every mother gets 
one, so it should be in there.” (BW 6) 
 
“Many women would have attended the prenatal classes and all that which is 
where you learn about giving birth, parenting and breastfeeding. I think that 
is the best time and place to give out information about what are the possible 
breastfeeding issues you may or may not face, for example insufficient milk 
supply, and what you can do about it.” (BW 10) 
 
iv) Information on monitoring breastfeeding performance, for example signs of 
insufficient milk supply and signs of a settled baby: 
 
“…signs of a settled baby, signs that maybe you don’t have enough milk , 




4.4.8 Perception on the Role of Community Pharmacists in Promoting Safe 
and Effective Use of Herbal Medicines during Breastfeeding 
 
A number of themes and subthemes emerged as the participants described their 
views and perception on the role of community pharmacists in providing 
breastfeeding support. Although their views varied widely, participants perceived 
community pharmacy in general as a convenient source of information which can be 
trusted. When asked whether they believed that there was a role for community 
pharmacists to play in the area of herbal medicines and breastfeeding, common 
facilitating themes and inhibitors or barriers were identified, as summarised in Table 
4.8. Throughout the interviews, participants identified several breastfeeding support 
services deemed to be useful and beneficial in the community pharmacy setting.  
 
Table 4.8: Facilitators and inhibitors/ barriers to an increased role of 
community pharmacist 
Facilitators Inhibitors/ Barriers 
 
 Convenience and accessibility 
  Locality 
 Availability 
 Image as a one-stop health 
destination 
 Layout  
 
 Client-pharmacist relationship 
 
 Staff knowledge and credibility 
 
 Cost factors 
 
 Lack of advertisement, publicity 
and promotions 
 
 Inconsistent approach 
 
 Breastfeeding-related 
inexperience and low awareness 
 
 Pharmacists’ pre-conceived 
perception towards herbal 
medicines 
 
 Overlap of role with other health 
professionals 
 






The facilitators including convenience and accessibility, client-pharmacist 
relationship, staff knowledge and credibility, and cost factors emerged as subthemes 
and are discussed in this section. 
 
Convenience and accessibility 
 
Participants highlighted the convenience and accessibility of community pharmacy 
as a facilitator to expand the role of community pharmacists in supporting 
breastfeeding in the community, at the same time promoting safe and effective use of 
medicines (mainly non-prescription medicines including herbal and alternative 
therapies) during breastfeeding. Participants perceived community pharmacy as a 





In the context of convenience and accessibility, locality emerged as an underlying 
theme. Community pharmacies are spread out in the Perth metropolitan area and 
were perceived as “everywhere” and “local” by participants. 
 
“I think that community pharmacies are everywhere.” (BW 1) 
 
“My local chemist is very near my house, it is literally just behind us, I can 
walk there. I think that is the case for most people as there are so many 
pharmacies around. You don’t have to make appointment, and you can ask to 
speak to a pharmacist.” (BW 18) 
 
It was noticeable from the interviews that the term “local” was commonly associated 
with “trusting relationships”. Participants often felt at ease and comfortable to 





“There is a gap for people who don’t have easy access to information. If 
there was somebody that was local who can talk to them about it, that will 
make it far easier.” (BW 4)  
 
“It is just another avenue that new mothers can use. As a new mum, we are 
so confused and so bombarded with information that we do look for 
recommendations and if there was some community pharmacists, if I knew of 
one that was close to me that is easy for me to get to, I think I would use them 
the same as how I would use my child health nurses to answer my questions 
for me. The fact that they [community pharmacies] are near and local, they 




In addition to locality, availability was recognised as a facilitator by some 
participants. The opening hours and the “no appointments required” practice of 
community pharmacies were valued, especially for those who labelled themselves as 
“busy mums”. 
 
“You do not need a booking and usually there isn’t a long wait for you to see 
a pharmacist to get some proper advice.” (BW 1) 
 
“...you don’t need to make appointment. Definitely easier to go to a 
pharmacist for advice, it’s the location and accessibility.” (BW 4) 
 
“I know I can go anytime, they are open quite late, and you can get the 
support and advice when needed. Because often when you are breastfeeding 
with the young child it is very difficult to get doctors’ appointment or another 
appointment. So it’s not easy having that accessibility.” (BW 9) 
 
Image as a one-stop health destination 
 
As participants talked about convenience and accessibility, another underlying theme 
apparent in the interviews was the image of community pharmacy as a one-stop 
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health destination. Participants labelled community pharmacy as a one-stop 
destination involved in many aspects of their health, from a source of information, to 
a source of supply and to monitoring of medical conditions in the community or an 
“alternative to doctors”. Some participants had utilised community pharmacies as the 
source of breastfeeding-related information, source of herbal galactagogues supply 
and source of advice regarding breastfeeding performance and infants’ health. This 
feature was a main contributor to the overall convenient and accessible perception of 
community pharmacies.     
 
“And this is when pharmacy can help because you don’t need to go to a 
doctor to ask a question when you have settled down at home.” (BW 2) 
 
“It would be fantastic if you could go to one place for all the information 
rather than having to go here and there, you know, one place for the medical 
information, and another place for the herbal information. It will be like a 
one-stop for busy mums to get all the information they needed.” (BW 5) 
 
“...you can almost always get quick answers and it is convenient because you 
can just buy the products or whatever they recommend at the same place, you 
don’t have to go and see someone, and then drive to another shop to buy the 
products. It’s just easier to go to one place, especially when you know you 
can get most of the things from one place when you are so busy with baby 
and other stuff.” (BW 14) 
 
“You can just get the product from the store and not have to go to a different 
place just to buy or get the product. It is easy for busy mums like me.” (BW 
18) 
 
“It will be convenient and easy. I mean I won’t want to drive all the way with 
my baby to a specific place just to get some advice or to buy something. I 








Participants experienced community pharmacy as a provider of a vast range of 
health-related products and facilities. Pharmacists were expected to play the role of 
health/medicine-related information provision and product supply. There was an 
expectation that community pharmacists should set aside their personal opinions and 
follow ethical obligations and have an adequate knowledge of all the products 
available at their workplace.   
 
“If pharmacy has them in the store, they should know about their products.” 
(BW 8) 
 
“I suppose I would ask more questions at the place where I get my products. 
For example, if I go to the chemist and get my fenugreek, I would ask the 
pharmacist or the staff questions about the product, because I would assume 
they would know best because they have it in their store. I would trust the 
information because they are trained in that area and from my past 
experience, they have always been quite helpful.” (BW 12) 
 
“Nowadays most pharmacies sell all kinds of products, including baby-
related or natural medicines, if they can provide information based on their 
knowledge and are willing to help us, I think it would be very valuable. I 
think especially with busy new mums, you really need someone you can trust 




Participants who managed to build a trusting relationship with their local community 
pharmacists were more likely to perceive community pharmacy as a valuable 
resource avenue based on their positive feedback.  
 
“Because you get to know your little pharmacy, like I mostly go to one 
pharmacy down in [a pharmacy located in the North metropolitan region of 
Perth] and they know me now. When I go in, they ask how is the baby going. 
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So if they have the information, that would be much easier to just talk to 
them.” (BW 5) 
 
“I suppose pharmacists are very trusted in the community to a lot of people. 
So if someone can go to a pharmacy, and they say we do recommend you can 
use these herbs to increase supply, people will be more incline to believe and 
try it. Whereas if it is just from word of mouth, or if you see something on TV 
or hear about it, there’s not actually any credibility behind the claim 
perhaps.” (BW 7) 
 
Staff knowledge and credibility  
 
Information attained from pharmacists or pharmacy staff were often seen as trust-
worthy and credible. Community pharmacists and their support staff were assumed 
to meet the expectations of the public by acquiring adequate levels of knowledge. As 
some participants were concerned about the reliability of information obtained from 
non-reputable sources such as the internet, participants appreciated the value of 
information given by the pharmacists.  
 
“We or the public would generally trust community pharmacists as good 
source of information.” (BW 1) 
 
“I can just walk in and ask the question and trust that answer.” (BW 2) 
 
“…the few times when I had questions about medications during 
breastfeeding, I called up the pharmacies and they were fantastic.” (BW 9) 
 
“I just notice that my local chemist is very good with all the over-the-counter 
medicines. Asking about what I am taking and you know, any 
contraindications with other medicines and things.” (BW 10)  
“It would be so much easier for new mums to just walk in [to a community 




“I think getting information or recommendation from a pharmacist would be 
more reputable than your own internet search, because you don’t know how 
reliable that website is, it may be leading you down the wrong path, so I think 
a pharmacist might have the advantage of that part, plus they know what they 
are talking about, because they are trained in that field.” (BW 13) 
 
“Services like baby-weighing services, breastfeeding information sessions 
with lactation consultants and nurses. These services are important and 
although they are available now, I think it will be more convenient for mums 
if they can get these services from their local chemists. That’s just an idea. I 
think when you are breastfeeding and when you are a new mum, you just 
need someone reputable that you can trust to tell you if you are doing things 
right, and if no, how should things be done, like if the baby is getting enough 




Cost factors were quoted as a reason for the role of community pharmacists to be 
expanded. Visits to a doctor or other health professionals were seen as costly to some 
participants, while many believed that similar information could be obtained from a 
pharmacist without a charge.  
 
“It’ll be great to have someone with medical knowledge , not having to go to 
the doctor and spend 80 dollars just for a question and not having to rely on 
the internet for basic questions to make sure I get the right information.” 
(BW 2) 
 
“I think it would be more convenient if new, or busy mums can just go in and 
get some advice, plus it would be less expensive this way, knowing that 
starting a family would cost some money, pharmacists are there all the time, 






4.4.8.2 Inhibitors/ barriers 
 
A number of inhibitors or barriers were identified by participants, which included the 
lack of advertisement, publicity and promotions, inconsistent approach, 
breastfeeding-related inexperience and low awareness, pharmacists’ pre-conceived 
perception towards herbal medicines, overlap of role with other health professionals, 
and privacy issues relating to pharmacy layout.  
 
Lack of advertisement, publicity and promotions 
 
Although many community pharmacies may be involved in expanding their services 
to the public, the lack of advertisement, publicity and promotions were identified by 
participants as a barrier. Participants from this study commented that many women 
were unaware of the available services and facilities nowadays available in 
community pharmacies. As the conventional operation of a community pharmacy 
was predominantly dispensing and the supply of medicinal products, in the absence 
of adequate publicity, breastfeeding women were not fully utilising the services and 
facilities provided by the community pharmacies.  
 
“It needs to be more advertised, or maybe mothers are told while at the 
hospital stay. A lot of women actually don’t know about the services available 
[at community pharmacies].” (BW 2) 
 
Inconsistent approach  
 
Some participants had identified an inconsistent approach from staff at various 
community pharmacies. One participant commented: 
 
“Depends if I am shopping with the kids. If I am, they will ask [if I am 
breastfeeding], if not, they won’t. Most never ask me if I don’t have kids with 
me. Just the assumption that someone is not with a child, doesn’t mean they 
are not breastfeeding. You look okay, not messy, just doing shopping in nice 
clothes, they obviously made the assumption that you are not breastfeeding. 




The lack of a consistent approach with some queries handled by pharmacy assistants 
during busy times was also seen as a hindrance to building a trusting relationship 
between the breastfeeding woman and pharmacist.  
 
Breastfeeding-related inexperience, knowledge and  low awareness 
 
A lack of some pharmacists’ personal breastfeeding-related experience, knowledge 
and awareness was identified as prohibitive in providing convincing advice to 
breastfeeding women. 
 
“I am not sure how much they know or whether they have experience with 
breastfeeding and all, but if they do, I think it would be beneficial.” (BW 18) 
 
There was a clear need for all practising community pharmacists to increase their 
awareness and knowledge in this field, which was comprehended as beneficial 
according to participants.  
 
“I think community pharmacists are accessible, except during busy times, if 
community pharmacists are better educated and have better awareness in this 
area or focus a lot more about safety and efficacy of medicines including 
herbal options during breastfeeding, that will be helpful.” (BW 3) 
 
Pharmacists’ pre-conceived perception towards herbal medicines 
 
Some participants appeared to believe that pharmacists in general as a 
pharmaceutical or medicine expert had pre-conceived negative perception towards 
herbal medicines and alternative therapies. Participants who believed that there was a 
limited role for pharmacists to be involved in natural or herbal remedies perceived 
pharmacists as “over-cautious” and their fear to recommend herbal medicines with 
little or no scientific evident to support their efficacy and safety during breastfeeding, 
which was seen by regular users of herbal remedies as a lack of willingness and 




“If they can obviously be open-minded about it. It will be better if they don’t 
just push products with medical based one, I think if you can get pharmacists 
on board I think that will be fantastic, that will help the community to make a 
difference.” (BW 7) 
 
“I think maybe checking with the pharmacist would be a good idea but I am 
not too sure how much they know about herbal medicines. I am very 
convinced that they know about their pharmaceutical products, so maybe they 
would be able to offer help regarding herbal medicines, since they sell it all 
the time.” (BW 14) 
 
“I know that there are a few people out there who just don’t believe in 
natural medicines. I know my original GP I went to said that it was a load of 
crap, don’t bother trying it.” (BW 15) 
 
“It obviously depends how much they know about alternative ways to 
increase milk supply and how much they want to be involved.” (BW 16) 
“I think if all health professionals, not just community pharmacists, if they 
can be more aware of and be more open to discussion about the use of 
alternative therapies during breastfeeding, this would definitely help 
breastfeeding women. And I am saying this not because I am being an 
advocate, it’s about giving women the choice and option that they are 
comfortable with. It is also important to understand that natural is not always 
good, but you still need to be vigilant and careful about getting the facts 
right.” (BW 18) 
 
Despite the lack of confidence in some participants, many of them continued to 
believe that it would be promising and favourable if community pharmacists could 








Overlap of role with other health professionals 
 
Some participants appeared to be concerned with the overlap of the pharmacists’ role 
with other health professionals. One participant further commented that different 
health professionals have their distinctive role in healthcare: 
 
“[If] it was about herbal stuff, maybe the naturopaths and friends who are 
naturopaths. But if it was to do with Motilium® or medical or drugs, I will be 
talking to a lactation consultant, a GP or district nurse or pharmacists.” (BW 
4) 
 
Privacy issues and pharmacy layout 
 
Participants expressed their concerns with regards to privacy when discussing 
breastfeeding-related issues with their pharmacists in the pharmacy. The layout of 
some pharmacies was not only seen as contributing to the lack of privacy issues, but 
also the amount of breastfeeding related information or products. Despite the 
availability of a vast range of products and brands across pharmacies, some 
participants expressed their frustrations in terms of purchasing herbal 
galactagoguges. 
 
“When I went to the pharmacy, there was only one bottle of fenugreek, they 
were nearly out of it, it should be stocked, and there should be a 
breastfeeding section!” (BW 6) 
 
“There wasn’t much information available to me regarding the use of herbal 
or alternative therapies. For example, there was only one brand, one bottle of 
fenugreek available on the shelf, and the product information wasn’t even in 
relation to breastfeeding or anything related. When I tried to look online, I 
could see tons of information and forums, but the thing is, whether these can 






4.4.8.3 Breastfeeding Support Services in the Community Pharmacy Setting  
 
Participants provided several suggestions and recommendations of breastfeeding 
support services in the community pharmacy setting which they believed would be 
an advantage.  
  
“These services are important and although they are available now, I think it 
will be more convenient for mums if they can get these services from their 
local chemists. That’s just an idea. I think when you are breastfeeding and 
when you are a new mum, you just need someone reputable that you can trust 
to tell you if you are doing things right, and if no, how should things be done, 
like if the baby is getting enough milk and putting on weight, signs of poor 
sleeping etc. Maybe not all of them, but I think it may benefit some mums, 
especially if transport is an issue and if they can just walk to their chemists.” 
(BW 18) 
 
In addition to providing expert advice on medicines use during breastfeeding, it was 
suggested by participants of the study that the following be implemented in 
community pharmacies: 
 
 Lactation booth;  
 Liaise with Australian Breastfeeding Association (ABA) to provide and 
distribute pamphlets and educational materials in the pharmacy; 
 Baby weigh-in service or station; 
 Breastfeeding information sessions in-store with lactation consultants and 
nurses; 
 One-on-one counselling service in a specified consultation room or corner of 










The key findings of Stage 2 of this research are presented and discussed in four 
sections: i) use of herbal medicines as galactagogues, ii) perceived effectiveness and 
safety of herbal galactagogues, iii) perspectives and attitudes of breastfeeding women 
towards the use of herbal medicines whilst breastfeeding, and iv) role of community 
pharmacists in providing medicines and breastfeeding-related advice to breastfeeding 
women. A workflow diagram illustrating the flow of Stage 2 data collection and 
thematic analysis is provided in Figure 4.1. The figure serves to aid visualisation of 
the process and discussion of Stage 2 findings.  
 
 
4.5.1 Use of Herbal Medicines as Galactagogues 
 
This section discusses the results previously presented in Sections 4.4.1, 4.4.2 and 
4.4.3. To explore their use, the initial recruitment strategy did not specify the name(s) 
or type(s) of the herbal galactagogue(s) to be used. Women were not required to be 
on a particular herbal galactagogue to be eligible for this study. Nevertheless, 
fenugreek was used by all of the 20 participants either as a sole ingredient or in 
combination with other herbal ingredients. This finding correlates with the Stage 1 
results, which indicated that fenugreek was the most popular herbal galactagogue 
amongst breastfeeding women studied in Western Australia. Herbal medicines used 
as galactagogues by participants of the Stage 2 study were fenugreek, blessed thistle, 
fennel bitter seeds, anise seeds, caraway seeds, lemon verbena leaves and possibly 
other herbal or even non-herbal ingredients used in naturopaths’ own ‘lactation 
tincture’ unknown to participants. Herbal galactagogues identified and used by 
participants of this study were consistent with findings from Stage 1 study which 
indicated that fenugreek, blessed thistle and fennel were the top three most 
commonly used herbal medicines during breastfeeding for the purpose of enhancing 
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This finding was also in keeping with the literature reports. A qualitative study 
conducted in British Columbia in 2002 which involved 23 women identified 
fenugreek, blessed thistle, fennel, stinging nettle and raspberry leaf as the five most 
reputed herbal galactagogues (30). The majority of the participants were born in 
Canada, while others were born in Germany, USA and Asia. Caucasians represented 
the majority of the participants (70%), followed by Asian, Metis, and mixed racial 
backgrounds.  In this study, 17 out of 20 participants in Stage 2 were Caucasians, 
followed by two Asians and one of Middle-eastern descent.  
 
As evident in this study, herbal galactagogues exist in various dosage forms and 
preparations. Although fenugreek was identified as the most commonly used herbal 
galactagogue in this study, the dosage forms of administration by participants varied. 
These included crude seeds, capsules containing dried seed powder, extract tincture 
and nursing tea. Potency and doses of herbal preparations across different brands 
were also not standardized, making comparison of clinical effect challenging (343). 
In addition, many participants were using relatively low doses of fenugreek, lower 
than the 6 g daily doses (in various forms or preparations of the herbal ingredient) as 
recommended by the German Commission E (323). Seven participants were also 
taking a combination of herbal ingredients as galactagogues in the form of a 
‘lactation tincture’ prepared by their naturopaths with unknown ingredients, strength 
or potency, making it impossible to compare between products in relation to the 
effects of specific herbs. Taking into consideration that dosages and length of 
treatment may influence the efficacy and adverse effect profile, all contents of the 
products including tinctures prepared extemporaneously should be clearly listed and 
made available to all users. This is important if an emergency health crisis arises.  
 
This study also indicated that fenugreek exists in many commercially available 
products in combination with other herbal ingredients in Australia, in a similar trend 
to other countries (133, 259). Many commercially available herbal products as seen 
in this study combined various herbal ingredients in an attempt to maximise 
galactagogenic effects, which further presents ambiguity when trying to identify the 
effects of a specific individual herbal galactagogue (133). Besides the variability of 
dosage of administration, there was also no consistent approach in recommendation 
in regards to the commencement and duration of therapy. As evident in this study, 
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women appeared to administer herbal galactagogues at various times since 
postpartum and for different durations. 
 
Reasons for Use 
 
There were various reasons for use of herbal galactagogues amongst the study 
population. Women were using herbal galactagogues in the presence and absence of 
milk supply issues. Only eight out of the 20 participants were diagnosed with 
insufficient milk supply by their health professionals. On the other hand, more than 
half (n = 12) of the participants were using the herbal galactagogues of choice due to 
perceived insufficient milk supply, as a supplement prophylactically and as part of 
the tradition. Although there are many physiological or medical reasons for 
insufficient milk supply, other social and psychological factors may also play an 
imperative role in affecting the mothers’ milk production (2, 133). The perception of 
inadequacy is common amongst breastfeeding women, and may lead to subsequent 
anxiety which may affect breastfeeding performance and well-being of the women 
(30). This indicates a potential psychological role of any methods or products used to 
enhance breastfeeding performance. Use of herbal galactagogues as part of the 
elements of self-care during the postpartum period was also observed for some 
women in this study. As perceived insufficient milk supply especially during early 
stages postpartum had been shown as one of the main reasons for commencing 
herbal galactagogues in this study, the importance of other non-pharmacological 
measures including education on breastfeeding techniques, encouragement and 
perseverance should not be neglected. Initiatives to increase women’s awareness of 
the possibility of various breastfeeding issues that they may encounter including 
perceived insufficiency and methods to address the issues may help to avoid early 
cessation of breastfeeding. From these data, however only a minority of these 
participants sought advice from a lactation consultant or a child health nurse. 
Increasing their awareness of the potential issues and the availability of these 
resources prior to delivery or during the perinatal period may serve to better prepare 






Sources of Recommendation and Supply 
 
This study reveals that the users of herbal galactagogues were likely to receive 
advice and believed their friends and family members who were mothers with 
previous breastfeeding experience. Women could relate their personal experience 
and emotion to other mothers, hence friends and family members were the most 
common source of recommendations. Consistent with the results obtained from Stage 
1, community pharmacies remained one of the main sources of herbal medicines 
supply including herbal galactagogues for breastfeeding women. At the present time, 
community pharmacies represent one of the major provider of CMs in the Australian 
community (201). Although community pharmacists are not the main source of 
recommendation to use herbal galactagogues during breastfeeding, being the major 
provider of CMs signals opportunity for pharmacists and pharmacy staff to intervene 
and promote safe and effective use of CMs during breastfeeding. However, the 
paucity of scientific data may present a challenge for pharmacists when it comes to 
decision-making and the provision of recommendations and advice to their clients. 
The role of community pharmacists from the pharmacists’ perspectives will be 
further explored in Stage 3 of this research. This finding also further reinforces the 
results of Stage 1, which demonstrated a potential role of community pharmacists 
and pharmacy assistants in the topic of discussion. Further studies to explore the 
perspectives of community pharmacy staff will enable better understanding of the 
topic and identify any research gaps and interventions necessary to improve 
pharmacy practice.    
 
4.5.2 Perceived Effectiveness and Safety of Herbal Galactagogues 
 
This section of the discussion refers to data presented in Section 4.4.4. 
 
The study acknowledged the users’ experience and perceived effectiveness of the 
herbal galactagogues of their choice on a case-by-case basis. In addition, the safety 
aspects of herbal medicines were also documented in the form of adverse effects 
experienced or observed by the users personally and their breastfed infants. The 
majority of the participants (16 of 20) had indicated that they felt the herbal 
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galactagogues of choice were effective in terms of enhancing their breastfeeding 
performance, with fenugreek and blessed thistle being the two most commonly used 
herbal galactagogues. Consistent with published literature, fenugreek and blessed 
thistle are the two commonly used herbal galactagogues (133, 236, 343). A study 
conducted by Turkyilmaz et al. (324) demonstrated that the use of a brand of herbal 
tea (Still tea, Humana®) which contains fenugreek and other herbal ingredients 
significantly increased breast milk production when consumed during the early 
postpartum period, as discussed in Chapter 2 of this thesis. No adverse effects were 
reported (324). As the herbal product contained a combination of fenugreek and 
other herbal ingredients, it was difficult to assess if the demonstrated effectiveness 
was attributed solely to fenugreek or included the effect of other ingredients. A study 
conducted by Di Pierro et al. (265) demonstrated effectiveness of milk thistle as a 
galactagogue with no reports of adverse effects in either mothers or infants. The 
adverse effects reported by participants in the Stage 2 study included a maple syrup-
like body odour (which was dose-dependent), headache and diarrhoea, which were 
all consistent with published literature (133, 228, 235, 236). One participant reported 
delayed menstrual cycle from the use of a ‘lactation tincture’ supplied by her local 
naturopath. This ‘lactation tincture’ contained a combination of herbal ingredients 
including fenugreek and goat’s rue, which she believed to be the cause of this 
adverse effect. A search of the literature revealed that the hormonal effect 
experienced by this participant was more likely to be due to fenugreek, as this herbal 
medicine has been shown to have oestrogenic activity in an in vitro study (362).  
 
Besides the measurement of milk volume after expression, many women used 
various ways to judge or evaluate if a herbal galactagogue was effective or useful in 
the domestic environment. These were considered ‘breastfeeding performance 
indicators’ for the purpose of this study. As discussed earlier, the psychological or 
emotional impact of the use of herbal galactagogues during breastfeeding should not 
be underestimated. As evident in this study, confidence and self-empowerment 
emerged as an over-arching theme throughout the interviews, especially when 
participants described their positive experiences. This finding was also observed in 
similar study conducted by Westfall (30), who commented that the psychological 
benefits of herbal galactagogues should not be neglected. This theme was also 
mentioned in a review article published by Ayers (29) who commented, “Because the 
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most commonly cited reason for the premature discontinuation of breastfeeding is the 
mother’s perception (usually inaccurate) of insufficient milk supply, offering women 
a sense of self-efficacy and empowerment through alternative therapy may help to 
combat this sense of inadequacy”. 
 
Despite their long history of use, there are currently limited efficacy and safety data 
with regards to the use of herbal galactagogues during breastfeeding (133, 235). 
Most available studies which have examined the clinical efficacy and safety of herbal 
galactagogues appeared to have small sample sizes and a lack of consistent approach 
in terms of standardizing the protocol and process of studies (343). Although the 
qualitative nature and sample size of this Stage 2 study does not allow for a definitive 
conclusion to be made as to which type(s) of herbal galactagogue(s) were effective or 
safe, the exploratory nature of the study delivered better understanding of the topic in 
the Australian context and provided direction to subsequent research in the field. The 
findings of this study, along with a review of the relevant literature, identified a need 
for scientific evaluation of the commonly used herbal galactagogues in Australia, 
namely fenugreek and blessed thistle.  
 
4.5.3 Perspectives and Attitudes of Breastfeeding Women 
 
This section discusses the data presented in Sections 4.4.5, 4.4.6 and 4.4.7, which 
aimed to explore women’s perspectives towards the use of herbal medicines, the 
views of users as to why they had chosen to use alternative options over conventional 
therapies to promote breastfeeding performance, their views on the available herbal 
medicines resources and the current healthcare system.  
 
Although many previous studies have examined the perspectives and attitudes of 
women towards the use of medications during breastfeeding, most had focused on 
the use of conventional medications (87). As suggested by findings of Stage 1, the 
prevalence and popularity of CMs, specifically herbal medicines amongst 




All participants of this study appreciated and valued the benefits of breastfeeding. 
The perseverance and determination to breastfeed as observed in the participants 
were thought to be an outcome of the acceptance of the ‘breast is best’ philosophy. 
Participants of this study showed a positive attitude towards breastfeeding and were 
willing to take any efforts necessary to ensure the success of breastfeeding, including 
the use of herbal medicines to promote breastfeeding performance. For most 
participants, the strong will to breastfeed along with recommendation from family 
and friends had led to the use of herbal galactagogues during breastfeeding. As 
discussed previously, the potential psychological or emotional impact of using herbal 
galactagogues prophylactically during breastfeeding should not be neglected.  
 
Women who had used herbal galactagogues during breastfeeding may have accepted 
and adopted the integrative and holistic approach into their own healthcare. Previous 
studies have demonstrated the acceptance of CM integration in healthcare amongst 
the general population in Australia (207) and Canada (363). These two studies 
explored consumers’ views on CMs (in Australia) or NHPs (in Canada) and 
pharmacy practice. Some women who had used herbal galactagogues during 
breastfeeding were also users of herbal medicines prior to pregnancy and lactation. 
Consistent with previous research on perspectives of alternative healthcare users, this 
finding demonstrated that some women chose alternative options over conventional 
medicines as they offer personal autonomy and a sense of control over their own 
health, and that the decisions aligned with their values and beliefs (364-368). The 
sense of empowerment when a breastfeeding woman actively seeks out and adheres 
to an alternative regimen plays a positive role in her breastfeeding journey (30). As 
perceived insufficient milk supply is one of the major cause of premature cessation 
of breastfeeding, offering women a sense of empowerment and self-efficacy through 
herbal galactagogues may aid in contending this inadequacy (29). Nevertheless, 
qualitative studies involving interviews of herbal galactagogue users or case studies 
alone are not sufficient to provide evidence to support the clinical efficacy of these 
medicines. A double-blinded RCT will be necessary to determine the clinical 
efficacy of these herbal medicines as galactagogues. The main outcome measures of 
such studies should include measurements of daily milk volume, maternal serum 
prolactin concentrations and reported adverse effects in mother or infant, before and 
after taking the herbal galactagogues. The potential effect of herbal galactagogues in 
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providing women with a sense of self-efficacy and their subsequent effect on 
breastfeeding performance could also be assessed using the Breastfeeding Self-
Efficacy Scale (BSES). The BSES is an instrument developed to measure the 
confidence in breastfeeding women (369). As women’s breastfeeding self-efficacy 
has been shown to be a predictor of breastfeeding duration and patterns of infant 
feeding (369, 370), such a study could also assess the effects of herbal galactagogues 
on the BSES scores and their effects on breastfeeding duration.  
 
Given the fear of adverse effects and risk of harming their infants with the use of 
conventional medicines and the popularity and acceptance of integrative or holistic 
healthcare in the general population, women may be likely to opt for alternative 
options for example herbal medicines for promoting breastfeeding performance. 
Previous dissatisfied experience with conventional treatments may also encourage 
the use of alternative therapies whilst breastfeeding (364). Of the seven participants 
who had used combination products, six were using ‘lactation tinctures’ obtained 
from their naturopaths containing a combination of herbal ingredients that were 
unknown to the participants. Of these, three participants (BW 4, BW 8 and BW 20) 
also specifically raised concerns over safety of breastfed infants with regards to using 
medicines whilst breastfeeding and that they believed herbal medicines would be a 
safer option. Despite expressing concerns over safety issues, some women continued 
to use products recommended by their naturopaths, even without any knowledge of 
the ingredients. This in itself is of concern, as participants’ decision to use these 
products conflicted with their views with regard to safety. It was apparent that these 
women had inaccurately perceived all herbal medicines in the context as being 
‘natural’ and therefore will always be ‘safe’ to be used whilst breastfeeding. It is also 
possible that these women may have built rapport with their naturopaths and that 
they had trusted their advice and recommendation. It needs to be acknowledged that 
herbal medicines are not always ‘safe’ and there is a risk that some herbal medicines 
may cause side effects or potentially toxic effects in both the mothers and their 
infants if their constituents are transferred into the breast milk. Furthermore, many 
herbal medicines lack scientific information to support their efficacy and safety when 
taken in breastfeeding, as compared to conventional medicines. Some breastfeeding 
women may have limited knowledge on the risk and benefit profiles of herbal 
medicines, and the misconceptions surrounding the safety of herbal medicines are of 
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concern. This finding highlights a need for intervention to raise the level of public 
awareness and to provide available information on safety aspects of using herbal 
medicines, at least amongst breastfeeding women. The scope for improving 
information dissemination and communication with breastfeeding women on herbal 
safety issues is limited by the lack of detailed high level data on this topic.  
 
Consistent with the literature and previous findings, breastfeeding women identified 
the need for more in-depth information, including scientific evaluation of the 
efficacy and safety of herbal galactagogues and other herbal medicines during 
breastfeeding (87, 208, 365). Women expect health professionals to have adequate 
knowledge and to be willing to offer advice and discussion over alternative therapies 
to promote breastfeeding performance. An interesting finding of the study was that 
women may have varying expectations towards different healthcare workers, where 
one participant specifically commenting that naturopaths and healthcare workers 
working in the field of naturopathy were more comfortable in recommending herbal 
medicines during breastfeeding, than those working in the mainstream health system. 
It could be argued that naturopaths and those working in the field of naturopathy may 
have more knowledge or experience in the area of herbal medicines and hence may 
be more comfortable in recommending their use in breastfeeding. Nevertheless, it 
should be noted that there is limited high level information available regarding the 
safety of herbal medicines taken during breastfeeding. Healthcare workers from the 
mainstream health system, such as doctors, nurses and pharmacists, may be more 
cautious in their recommendations due to concerns regarding the lack of 
scientifically-based information to support the use of these medicines during 
breastfeeding. In the absence of evidence-based information or when the benefit to 
the mother does not clearly outweigh any potential risk to the breastfed infant, these 
health professionals may be hesitant to recommend and choose to avoid the use of 
these medicines.  
 
4.5.4 Role of Community Pharmacists  
 
Finally, this section discusses the findings as presented in Section 4.4.8, which 
explored breastfeeding women’s perspectives on the role of community pharmacists 
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in promoting safe and effective use of herbal medicines during breastfeeding and 
providing breastfeeding support.  
 
A review paper has indicated that many studies exist to examine the perspectives and 
attitudes of health professionals as well as breastfeeding women towards the use of 
medications during breastfeeding (87). Nevertheless, there have been limited studies 
that have explored the perspectives of women towards the role of community 
pharmacists in this topic. The current study has illustrated an opportunity for 
community pharmacists to expand their role in the community pharmacy setting, 
based on breastfeeding women’s perspectives. Most participants identified a role for 
pharmacists in the area of providing easily accessed, trust-worthy advice and 
information about medicines including CMs use during breastfeeding. This study has 
highlighted the role of community pharmacists in the community pharmacy setting 
through increased provision of information and advice on the efficacy and safety 
aspects of CMs during breastfeeding. Besides information on conventional medicines 
and CMs, breastfeeding women also expect pharmacists to have basic knowledge on 
breastfeeding and the various issues related to breastfeeding.  
 
In general, breastfeeding women regard pharmacists as a trusted health professional, 
a drug expert, and the first port of call for questions relating to use of medicines 
during breastfeeding. Whilst pharmacists were not actively recommending the use of 
herbal galactagogues during breastfeeding, being one of the major supplier of CMs in 
the Australian community, women expect pharmacists to play a substantial role in 
providing advice and recommendation regarding CMs use. However, the paucity of 
data specifically in the area of herbal medicines and their safety in breastfeeding may 
create a challenge for pharmacists. The advice pharmacists can provide may be 
limited due to the lack of evidence-based information, which may not fulfil the 




As evident in this study, convenience and accessibility of community pharmacies, 
client-pharmacist relationship, knowledge and credibility of pharmacists, as well as 
cost all represent important factors when women decide the source of advice. In 
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other words, the characteristics and values of both the community pharmacies and 
the staff, which include pharmacists and assistants, are factors which drive 
breastfeeding women to utilising this avenue.   
 
Women in the study appreciated the convenience and accessibility of community 
pharmacies, which had enabled them to obtain advice in a timely manner. This 
factor, in contrast to the appointment-based services provided by other health 
professionals, consolidated the role of community pharmacies in providing free 
healthcare services to breastfeeding women. Women perceived community 
pharmacies as a convenient one-stop health destination, from obtaining health and 
medicine-related advice to purchasing products. In addition, some participants from 
this study also see a role for pharmacists to play in providing monitoring services in 
the community and as an alternative to visiting their local general practitioners. This 
finding demonstrated a switch from the traditional ‘shopkeeper’ image of 
pharmacists to now the ‘healthcare provider’ image (371). Besides contributing to 
the expansion of pharmacists’ role in the community, this will also help to reduce 
burden to the healthcare system and reduce appointment waiting times for general 
practitioners.  
 
Most community pharmacies, being local, may also help develop trusting 
relationships with breastfeeding women and their family members. As observed from 
this study, client-pharmacists relationship plays an integral role in enabling 
breastfeeding women to discuss freely and comfortably regarding issues related to 
breastfeeding. Building rapport between client and pharmacist is fundamental in 
many aspects of healthcare promotion in the community pharmacy healthcare setting, 
especially in this case, building trust between breastfeeding women and community 
pharmacists will enable the former to feel comfortable in discussing any 
breastfeeding-related issues. 
 
In many previous studies, pharmacists’ knowledge and credibility were mentioned as 
one of the facilitating factors driving consumers or clients to community pharmacies 
(4, 87, 371-373). In this study, the knowledge and credibility of both pharmacists and 
pharmacy staff were cited by some participants. However, the context of discussion 
was directed more towards pharmacists’ knowledge on general health conditions and 
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the use of conventional medicines, and less so for the use of CMs including herbal 
galactagogues during breastfeeding.  
 
Ideally, pharmacists and pharmacy staff should actively enquire and identify women 
if they are breastfeeding at every occasion prior to providing advice to ensure 
appropriate recommendations can be provided to breastfeeding women. However, 
this may present as a challenge unless pharmacists and relevant pharmacy support 
staff are adequately trained, especially in terms of their knowledge in this field and 
communication skills to ensure women do not react negatively when approached. 
Unlike some conventional medicines, herbal galactagogues and other CMs are 
readily available OTC. Breastfeeding women who are buying CMs from the 
pharmacies are more likely to have regular interactions with pharmacy assistants. 
Hence, the role of pharmacy assistants in this context and their impact on building 
relationships with clients should not be neglected.   
 
This study identified the various factors which facilitated breastfeeding women to 
utilise community pharmacies. From the breastfeeding women’s perspectives, this 
study has also identified a clear need for pharmacists and pharmacy assistants to 
continuously undergo training to upgrade their knowledge and communication skills 
when dealing with breastfeeding women. Besides improving the knowledge in the 
area of CMs, training on basic knowledge of various aspects of breastfeeding will 




Several barriers to expanding the community pharmacists’ role were identified by 
participants of this study and needed to be addressed in order to improve pharmacy 
practice in the topic of discussion. These barriers were a perceived inconsistent 
approach, lack of knowledge and awareness, lack of personal or close-contact 
breastfeeding-related experience, pharmacists’ pre-conceived perception towards 
herbal medicines, concerns regarding overlap of role with other health professionals, 
privacy issues and pharmacy layout. The lack of advertisement, publicity and 




Some participants expressed their desire for community pharmacists to be more 
‘open’ to discuss various issues related to breastfeeding and to offer more discussion 
on CMs and alternative therapies during breastfeeding. Consistent with the literature, 
the consumers expected community pharmacists to be more knowledgeable in the 
area of CMs and to have a greater level of engagement and interaction with their 
pharmacists (374). However, taking into consideration the scope of practice and 
skills of pharmacists, it is vital that pharmacists are clear with their role and be able 
to identify the need to refer breastfeeding women to other health professionals for 
example child health nurses or lactation consultants for further breastfeeding-related 
advice when necessary. Increasing the awareness of pharmacists and the appropriate 
referrals would also help foster inter-professional collaboration and relationships.  
 
The perceived lack of a consistent approach as described by one participant in this 
study was considered a barrier or hindrance to building a trusting relationship 
between the breastfeeding woman and the pharmacist. These included inconsistent 
questioning to identify whether the client was breastfeeding and the lack of referral 
to pharmacists by the pharmacy staff especially during busy times in the pharmacy. 
Hence, time constraint was seen by some as one of the contributing barriers to 
appropriate pharmacists’ advice. In a study conducted by Jones and Brown (142), 
only 11% of the surveyed breastfeeding women who had purchased OTC 
medications from pharmacies were asked their breastfeeding status by the 
pharmacists and pharmacy staff. Hussainy and Dermele (87) further commented that 
this issue should be addressed to enable accurate information and advice be provided 
to breastfeeding women in the community. All pharmacists and pharmacy staff have 
an ethical obligation to provide relevant as well as accurate advice to all clients, 
including breastfeeding women. This may be facilitated by actively enquiring, as part 
of their process and competent pharmacy practice, all women of childbearing age, to 
identify whether they are breastfeeding or pregnant. Nevertheless, care needs to be 
taken in a way these questions are presented to avoid potentially embarrassing the 
patients.  
 
Taking into consideration the potential sensitivity issues related to breastfeeding, the 
lack of pharmacists’ personal breastfeeding-related experience was identified as one 
of the contributing barrier from the breastfeeding women’s point of view. It also 
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appeared that the layout or design of some pharmacies may be contributing to some 
degree of lack of privacy. Nevertheless, the gender of pharmacists was not one of the 
issues raised by participants of this study. To overcome the above barrier, all 
pharmacists and pharmacy staff are expected to have a basic knowledge about 
breastfeeding in order to communicate effectively with breastfeeding women, and 
that all pharmacy support staff should be able to identify cases which require referral 
to the pharmacist. As a primary care provider in the community, effective 
communication is essential to enable holistic care and to appreciate and recognise the 
breastfeeding women’s needs (375). Despite the lack of personal experience with 
breastfeeding, good communication skills possessed by a pharmacist may aid to 
foster a trusting relationship with any clients, and certainly in this case, with 
breastfeeding women.  
 
Some women believed that pharmacists may have a pre-conceived negative 
perception towards herbal medicines and alternative therapies, and would prefer if 
the pharmacists were more willing to discuss and recommend the use of herbal 
medicines during breastfeeding. Some saw herbal medicines and breastfeeding as 
outside the scope of pharmacy practice, which may form one of the barriers to 
obtaining pharmacists’ advice. Increasing the awareness and knowledge of 
pharmacists in this field was identified as the key to developing confidence when 
dealing with breastfeeding women. A study conducted by Bushett et al. (202) in 2010 
which investigated rural Australian community pharmacists’ perspectives towards 
CMs had found that despite the varied views on CMs, most pharmacists 
acknowledged the popularity of these medicines amongst consumers in the 
community, and that community pharmacists play an important role in promoting the 
safe and effective use of these medicines. One of the challenges to providing 
conclusive advice to consumers regarding the use of CMs is the lack of awareness or 
access to high quality resources and information (202, 348). To address this issue, 
further studies are warranted to explore the pharmacists’ perspectives regarding the 
resources and information available to them as well as further training needed in the 
form of either continuing professional development (CPD) modules or continuing 
education (CE) lectures. Stage 3 of this study will explore the community 
pharmacists’ perspectives to enhancing understanding and to identify initiatives or 
strategies required to address the above research gap. As Stage 1 of this research has 
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begun the process of estimating the prevalence in WA of herbal medicines use during 
breastfeeding, the current stage of study suggested that community pharmacists may 
have the potential to play a greater role in promoting the safe and effective use of 
herbal medicines during breastfeeding from the breastfeeding women’s perspectives. 
 
4.5.4.3 Services and Strategies 
 
Several strategies and services suggested by participants of this study such as baby 
weigh-in service or station, lactation booth and private consultation room may be 
seen as challenges to some community pharmacies. These strategies involve space 
allocation and may require considerable financial investment. Hence, demographic 
profiles of residents around the pharmacy should be considered to establish the need, 
and ensure cost effectiveness, at the same time viability of the business model. 
Nevertheless, other strategies for example distribution of breastfeeding-related 
pamphlets and educational materials from the PSA or ABA in the pharmacy may 
prove to be beneficial to women, at the same time increase awareness and 
involvement of pharmacy staff in promoting breastfeeding in the community. 
 
From the perspectives of breastfeeding women, the findings of this study have 
enhanced our understanding of the current and potential future roles of pharmacists 
and pharmacy staff in the community pharmacy setting. While many studies have 
investigated the role of other health professionals in promoting breastfeeding in the 
community, few studies and initiatives exist to examine and expand the role of 
community pharmacists (87, 376-379). Taking into account the facilitators and the 
views of breastfeeding women, this study has identified opportunities to enhance 
community pharmacists’ involvement. Nevertheless, the barriers and challenges 
should be addressed. The perspectives of breastfeeding women and community 
pharmacists will be compared and discussed in Chapter 6.     
 
The importance of breastfeeding women’s perspectives should not be neglected. The 
issues raised by breastfeeding women through the interviews in this study identified 
areas of pharmacy practice which require improvement and revealed opportunities 
for expansion of the community pharmacists’ role to better support breastfeeding 





Taking into consideration the process and method of recruitment which involved 
naturopathic clinics, there is a likelihood of selection bias which will have increased 
the likelihood of recruiting women with similar attitudes and perspectives towards 
these medicines. However, this method was considered most appropriate to identify 
and reach out to prospective participants. Women who could have been eligible for 
the study might not have fully understood the word ‘galactagogue’ in the poster, and 
hence might not have volunteered to participate in the study. Nevertheless, all 
participants of the study met the inclusion criteria and issues with understanding of 
the questions or topic were not identified during the interviews. It should also be 
noted that two questions (Question 13c and 13d) were worded in a way that could 
potentially influence participants to respond in agreement to the questions asked. 
This could explain the finding of this study that most participants agreed there was a 
lack of available resources. Open-ended questions would have provided better 
opportunity to explore participants’ views. For example: Question 13c could be 
rephrased as “What is your opinion on the information resources available to you 
regarding the use of herbal medicines during breastfeeding?”, and Question 13d as 
“What are your views on the safety of herbal medicines and conventional medicines 
when used during breastfeeding?” Although these were closed-ended questions the 
responses provided a range of insights into these issues. Participants were self-
selected through expression of interest and hence do not represent all breastfeeding 
women in Australia who are regular users of herbal medicines. A known limitation 
with all qualitative studies, however, is the challenge to attempt generalisation of 
findings to the wider population (380). The interviewer (TFS) is a pharmacist, which 
may have influenced the interviews and affected the analysis. Participants were also 
aware that the researchers were from the School of Pharmacy at Curtin University, 
and that could have led to participants aware of a pharmacy background to provide 
more emphasis in relation to their views of pharmacists and the pharmacy profession. 
Nonetheless, this study has enhanced our understanding of women’s perspectives and 
factors which may influence their choice of therapy whilst breastfeeding in the 





4.5.6 The Next Stage 
 
The Stage 2 study provided insight into the perspectives and attitudes of 
breastfeeding women towards the use of herbal galactagogues. The positive attitudes 
of these herbal galactagogue users should prompt health professionals and 
researchers to further explore this topic whilst the negative views regarding timing of 
education on breastfeeding and inconsistency of information should be taken into 
consideration to improve services for breastfeeding women. Themes that emerged in 
this study also pointed towards an opportunity for community pharmacists to expand 
their role through the provision of breastfeeding specific advice and services, based 
on the responses of a number of participants of the study. Nevertheless, further 
studies exploring the perspectives of other stakeholders are necessary to confirm the 
feasibility, practicality and usefulness of such services within the community 
pharmacy setting. Unlike some conventional medicines, herbal galactagogues and 
other CMs are readily available OTC. Pharmacists and staff should therefore enquire 
women if they are breastfeeding prior to providing advice or supply products to 
ensure appropriate recommendations can be provided. Further research into CMs use 
in breastfeeding, specifically herbal medicines, will allow health professionals like 
pharmacists and clinic nurses to provide evidence-based advice on the efficacy and 
safety of these medicines to their clients. 
 
As the themes from Stage 2 indicated an opportunity for community pharmacists to 
expand their scope of practice and provide breastfeeding support (including advice 
about herbal medicines), the logical next step was to explore the perspectives of 
pharmacists and whether pharmacists were willing and equipped to expand their 
services. The next stage of the study would also provide insight into whether there is 
an agreement or a misalignment between the perspectives of breastfeeding women 
and pharmacists in terms of the role of pharmacists and what this profession can 
offer to better support breastfeeding women. Although Stage 2 focused on the 
perceptions of herbal medicines in breastfeeding, a theme emerging from the 
responses of some participants suggested a potential greater involvement of 
pharmacists in the provision of breastfeeding-related services within the community. 
As previously mentioned in Section 2.1.4, community pharmacists are well placed to 
provide continuing care and support to breastfeeding women and their families. In 
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the 2012 Consumer Needs project funded by the Australian Government Department 
of Health and Ageing, pharmacies were identified as the primary point of access for 
consumers in the community seeking non-prescription medicines (381). Considering 
the available literature and the fundamental role of community pharmacists in 
Australia in the provision of advice and supply of medicines that do not require 
prescriptions from authorised prescribers, it is likely that they would be approached 
on a regular basis by the public including breastfeeding women and their families 
with queries in relation to not just herbal medicines, but also other non-prescription 
medicines. In contemporary pharmacy practice, there has been growing interest for 
pharmacists to provide holistic, patient-centred care and for community pharmacies 
to be health hub destinations in Australia (382, 383).  Taking into consideration the 
aforementioned points, Stage 3 of the study (Chapter 5) has taken the broader 
approach in exploring the perspectives and attitudes of community pharmacists 
towards promoting the safe and effective use of herbal medicines and other non-
prescription medicines during breastfeeding, their confidence and knowledge, the 
factors influencing the extent of their involvement, and their perception of the current 
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This chapter reports on Stage 3 of the research. This stage involved an exploratory 
study of Western Australian community pharmacists’ perspectives on their role in 
promoting safe and effective use of non-prescription medicines during breastfeeding. 
This stage also further explored the potential for role expansion and greater 
involvement of pharmacists in supporting breastfeeding in the community. The 
chapter begins with an introduction to the Stage 3 study, followed by the study 
objectives and research methods employed. The results from Stage 3 study are then 





Breastfeeding is the preferred nutritional option to ensure a good start to an infant’s 
life. Breast milk provides good nutrition tailored to their growing needs, while 
offering passive immunity and various growth hormones to breastfed infants (1, 
384). However, studies have shown that the majority of lactating women need to take 
at least one medicine whilst breastfeeding, either for acute or chronic medical 
conditions (27, 88, 91). Lamounier et al. (90) reported up to 96% of the 2,173 
women included in their cross-sectional study received some form of medication 
therapy during the period immediately postpartum. A survey conducted by Stultz et 
al. (27) reported that women who participated in the study took more prescription as 
well as non-prescription medications during breastfeeding compared to when they 
were pregnant. Furthermore, there is also evidence that women have a tendency to 
self-medicate and use OTC and/or CMs during pregnancy and lactation (26, 335, 
341). Although most CMs are available without prescriptions from authorised 
prescribers, there is still potential for their constituents to be transferred into the 
breast milk, which could pose safety concerns in the infants (385). Some herbal 
medicines may also affect breastfeeding performance by decreasing the breast milk 
supply (61, 62, 220). Breastfeeding women expect pharmacists to provide accurate 
and up-to-date information on whether a medicine should be used in breastfeeding 
(87). A study conducted by Braun et al. (374) which surveyed Australian pharmacy 
users has demonstrated a high expectation of the public for pharmacists to provide 




Considering the recommended duration of breastfeeding, it is likely that women will 
experience minor ailments at some stage during lactation, such as a cough and cold, 
headache, or musculoskeletal pain or inflammation, which are all OTC treatable 
conditions (83). With the appropriate advice from pharmacists, some non-
prescription medicines may assist in the management of these conditions, facilitating 
the well-being of the mother without unnecessary interruption to breastfeeding. 
Although there are several reference texts and numerous studies on the use and safety 
of medicines in breastfeeding, many of these references have inconclusive data on a 
large number of medicines due to the lack of studies and research (62, 87, 154). 
Furthermore, there is a lack of documented information about the safety of CMs, 
especially herbal medicines, in breastfeeding. This often places health professionals 
and breastfeeding women who request advice in a difficult situation as the decision 
on whether to use the medicine is based on the available information. This could 
compromise treatment of the mother or the infant’s health, or may lead to 
unnecessary cessation of breastfeeding.  
 
Community pharmacists are at the front line of healthcare. As primary healthcare 
professionals, pharmacists have frequent contact with breastfeeding women and their 
family. A study conducted on the Gold Coast, Australia, by Hughes et al. (149), 
showed that 78% of pharmacists reported seeing women with infants on a daily 
basis.  Being regarded as medication experts and primary care health professionals, 
the public relies on community pharmacists for reliable and accurate information on 
the safety aspects of medicines (5). In addition, pharmacists are viewed as 
appropriate providers of advice and services related to public health in the 
community (4). Previous surveys of consumers and findings from Stages 1 and 2 of 
this research have all demonstrated that the public trust community pharmacists (87, 
386).     
 
To date, limited information exists regarding Australian health professionals’ 
practices and knowledge of medicine use during breastfeeding (5, 87). In 2013, De 
Ponti et al. (5) published the first Australian study investigating the perspectives of 
176 community pharmacists on the use and safety of medicines in breastfeeding. The 
study was conducted using self-administered postal surveys and it had a greater focus 
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on prescribed and conventional medicines, with only one CM, St John’s wort, 
mentioned in the questionnaire (5). Ninety-two percent of the participants felt they 
were confident to supply and counsel breastfeeding women on the use of medicines. 
The outcome of this study suggested that despite pharmacists felt confident and 
willing to discuss medicines use with breastfeeding women, their knowledge in this 
area was variable (5). Appropriate training and continuing education is warranted to 
ensure pharmacists are well-equipped with knowledge regarding medicines use in 
breastfeeding, including non-prescription conventional medicines and CMs.  
 
There has been no published study investigating community pharmacists’ attitudes 
and perspectives towards their role in promoting safe and effective use of CMs and 
other non-prescription medicines during breastfeeding in the Australian context. 
There are also no data exploring their views regarding breastfeeding and other 
related activities in the community as part of being a public health service provider.  
 
Exploring the perspectives and attitudes of pharmacists through a qualitative 
approach using semi-structured interviews will allow for more detailed and in-depth 
understanding of their opinions about the role of pharmacists in supporting 
breastfeeding women. As Stage 1 and Stage 2 of the research study have 
demonstrated that the use of herbal medicines is common amongst women during 
breastfeeding and community pharmacies are a common source of CMs supply and 
information in Australia, it is important to expand the research in this area to 
investigate the perspectives and attitudes of community pharmacists as service 
providers. Exploring pharmacists’ opinions will also enhance our understanding of 
the factors influencing their decision-making processes and explore educational 








The objectives of the Stage 3 study were to explore community pharmacists’ 
perspectives and opinions on their role in promoting safe and effective use of non-
prescription medicines, including herbal medicines, during breastfeeding. In 
addition, the study would evaluate the potential for role expansion in the support of 
breastfeeding and provision of related services in Australian community pharmacies. 
The Stage 3 objectives were guided by a review of the literature and informed by 
findings of Stages 1 and 2. In-depth semi-structured interviews with practising 
Western Australian community pharmacists were undertaken to: 
 
 
i)  Identify and document the commonly requested medicines or products 
by breastfeeding women and the kind of information commonly 
asked. 
 
ii) Evaluate pharmacists’ views on the major findings of Stages 1 and 2. 
 
iii) Investigate pharmacists’ information-seeking behaviour, the common 
resources or references used in their practices for information related 
to the safety of non-prescription medicines (including conventional 
medicines and CMs) in breastfeeding, and information related to other 
aspects of breastfeeding. 
 
iv)  Explore pharmacists’ personal attitudes and perceptions towards the 
use of non-prescription medicines during breastfeeding, including 
conventional medicines and CMs, their confidence and self-awareness 
of knowledge level. 
 
v) Investigate the factors facilitating or inhibiting the provision of high-





vi) Explore pharmacists’ views on providing advice and support to 
breastfeeding women, and provision of breastfeeding-related services 
in the community pharmacies. 
 
vii) Identify whether there is a need for continuing professional 
development (CPD) in this area and the topics deemed to be useful 
and practical for pharmacists. 
 
viii)  Evaluate pharmacists’ views on the potential for role expansion and 






5.3 Research Methods 
 
This section describes the research methods employed for Stage 3 of the study, 
which begins with an overview of the study design, followed by participant selection 
and recruitment strategies. Information is also provided on the development of the 
interview guide used in this study, and the procedure of data collection and analysis. 
The interviews were conducted between July and September 2013. 
 
5.3.1 Study Design 
 
This exploratory study was conducted through semi-structured interviews with 
pharmacists practising in community pharmacies in Western Australia. An interview 
guide with a mix of closed and open-ended questions was used to gather information 
about pharmacists’ perspectives and attitudes towards their role in: i) promoting the 
safe and effective use of non-prescription medicines including CMs during 
breastfeeding, and ii) supporting breastfeeding in the community. In accordance to 
the exploratory nature of this research, the design of Stage 3 and the interview guide 
were informed by findings of Stages 1 and 2. Hence, a new human ethics application 
was prepared and approved for the Stage 3 study. This stage of the study had ethics 




Eligibility Criteria and Recruitment Strategies 
 
To be eligible for the study, participants had to be registered pharmacists practising 
in community pharmacies at the time of interviews. The recruitment strategy 
involved recruiting pharmacists from community pharmacies registered with the 
Pharmacy Registration Board of Western Australia (339). The 557 community 
pharmacies in Western Australia were separated into three categories with defined 
geographical areas (North metropolitan, South metropolitan and regional), based on 
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postcodes, and then sorted into random orders.  Note that this list was also utilised in 
Stage 1 of the research study.  
 
According to Patton (359), it is recommended that a “maximum variation sampling”  
approach to participant recruitment be employed in qualitative studies to enable in-
depth inquiry into the topic of discussion. Hence, attempts were made to recruit 
participants from different banner groups and a variety of practice settings to obtain 
representation of a wide variety of working environments and banner policies, which 
could have influenced the pharmacists’ practices, attitudes and perspectives. The 
pharmacies were contacted via telephone to invite the pharmacist on duty or the 
proprietor to participate in the research study. To maximise variation in the sample, 
only one pharmacist from each pharmacy was allowed to participate.  
 
Justification of Sample Size 
 
As stated in Section 4.3.3, sample size determination in qualitative studies is based 
on the research purpose, researcher’s experience and judgment (338). The number of 
participants should be sufficient for the data to reach a point of saturation, where no 
emergence of new themes is identified, whilst also enabling in-depth analysis. Guest 
et al. (357) conducted an experiment to investigate the number of interviews required 
to reach data saturation and variability and reported that 12 in-depth interviews were 
sufficient to reach a point of saturation. Taking into account similar studies in the 
area of pharmacy practice and public health which employed qualitative research 
methods, a decision was made to recruit between 25 to 30 community pharmacists 
(4, 87, 201, 212).   
 
5.3.3 Interview Guide  
 
A semi-structured interview guide was used to provide guidance to all interview 
sessions. The interview guide (Appendix Q) was developed considering the relevant 
literature and in accordance with exploratory research findings of Stages 1 and 2 of 
the research. The interview guide was initially circulated amongst colleagues within 
the School of Pharmacy to obtain feedback. Advice and suggestions from colleagues 
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were taken into consideration and the interview guide was amended following 
discussion with the research team. The amended interview guide was then pilot 
tested on three community pharmacists to ensure the questions were clear and that 
the research objectives were met.  
 
The interview guide comprised eight sections, each with a mix of closed and open-
ended questions: 
 
 Section A: Details and experience of pharmacist. Eight questions gathering 
background information and experience of the participants. 
 
 Section B: Principal place of practice. Eight questions collecting information 
about participants’ place of practice, which included location, demographics, 
type of pharmacy (independent or banner group), business model and 
pharmacy layout. 
 
 Section C: Identifying needs. Eight questions addressing needs, for example: 
how often participants get enquiries related to the topic, the types of enquiries 
and products requested by breastfeeding women, the process of dealing with 
enquiries in the pharmacy that were related to breastfeeding, and their views 
on breastfeeding women’s source of CMs supply and information.  
 
 Section D: Education and information-seeking behaviour. Seven questions 
assessing participants’ behaviour when seeking information, what resources 
or references were preferred, and their opinion on the availability and 
credibility of resources. 
 
 Section E: Attitudes and confidence level. Six questions exploring 
participants’: i) personal confidence level in providing advice to 
breastfeeding women with regards to the use of conventional medicines and 
CMs including herbal medicines, ii) perception of their roles, and iii) the 





 Section F: Knowledge. One of the three questions in this section assessed 
self-awareness of knowledge level where participants were asked to choose 
from “strongly agree”, “agree”, “neither agree nor disagree”, “disagree” and 
“strongly disagree” to six statements related to medicine use and safety while 
breastfeeding. This section also explored participants’ perspectives of the 
Australian National Breastfeeding Strategy 2010-2015. 
 
 Section G: Implementation of strategies. Three questions exploring 
participants’ attitudes towards greater involvement in national health 
strategies and their views on what strategies could or could not be 
implemented in the community pharmacies to support breastfeeding. 
 
 Section H: Continuing Professional Education (CPE). Questions one and two 
in this section explored the topics of CPE which they felt useful and practical. 
Questions three and four explored participant’s perspectives on pharmacists 
specialising in women and newborn’s health and role expansion into lactation 
consultancy.  
 
 Four of the open-ended questions in the interview guide specifically explored 
participants’ views on the major findings of Stages 1 and 2 which were 
relevant to pharmacists and pharmacy practice. Questions seven and eight of 
Section C explored participants’ views on findings of Stage 1; whereas 
question six of Section E and question three of Section G explored 
participants’ views on findings of Stage 2.  
 




The Stage 3 study employed a similar data collection approach to Stage 2, as 
described in Section 4.3. Interviews were conducted either face-to-face or via 
telephone at a mutually agreed place and time. For all face-to-face interviews, the 
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purpose and process of the interview were explained verbally and in written form to 
the participant, with the provision of a participant information sheet (Appendix R). 
Ample opportunities were given to participants to ask questions if they required 
further information about the study. All participants were requested to sign a consent 
form (Appendix S) before the commencement of the interviews. Where face-to-face 
interviews were not feasible (due to logistical difficulties or the location of 
pharmacists), interviews were conducted via telephone. With the participants’ verbal 
consent, copies of the participant information sheet and consent form were mailed to 
their postal addresses, along with a reply paid envelope to return the signed consent 
form. Upon receiving the signed consent form, arrangements were then made to 
conduct the telephone interviews. All participants were provided with an AUD$50 
Coles Group gift voucher, as a token of appreciation and reimbursement for their 
time and expenses such as travel costs (with Curtin University low risk ethics 
approval). With written consent from all participants, the dialogue between each 
participant and the student researcher were recorded to collect the narrative data for 
the purpose of analysis. All interviews of the Stage 3 study were audio-recorded, 




Participants were de-identified and identification replaced with codes, to ensure 
anonymity. For example: the first interviewee was given the code “CP1”, indicating 
“Community Pharmacist 1”.  
 
A computer software package (NVivo® Version 10.0, QSR International) was used to 
organise qualitative data and quotations to facilitate the thematic analysis. The 
transcribed data were analysed using descriptive and qualitative approaches. Data 
collected from Sections A and B of the interview guide were summarised using 
descriptive analysis, which included the details and experience of the participants, 
and information on their principal place of practice. Participants’ responses to the 
closed-ended questions were summarised, whilst a similar approach of thematic 
analysis and development of the coding framework as described for the Stage 2 study 
(see Section 4.3.5) was followed to analyse the qualitative data collected from the 





Closed-ended questions were analysed and presented using a descriptive approach, 
while data collected from the open-ended questions were subjected to qualitative 
thematic analysis. Supporting quotes are provided to explicate the themes where 
relevant.  
 
A total of 30 in-depth semi-structured interviews were conducted with pharmacists 
practising in community pharmacies in Western Australia. All participants were 
registered with AHPRA at the time the interviews were conducted. The point of 
saturation was reached after about 25 interviews however a decision was made to 
conduct five more interviews to ensure no new themes emerged from the data. After 
the completion of 30 interview sessions, the research team was confident that the 
data had reached saturation.  
 
Twenty-eight interviews were conducted face-to-face at a place and time mutually 
agreed by the interviewer and interviewee. Two interviews were conducted via 
telephone due to the location of the participants and the logistics or feasibility of 
sending an interviewer. The duration of interviews ranged between 26.2 minutes and 
70 minutes, with a mean interview duration of 39.4 minutes (n = 30).  
 
Section 5.4.1 will report on demographic characteristics of the participants and their 
pharmacies; while Sections 5.4.2 to 5.4.6 will concentrate on exploratory data and 
results of the thematic analysis.  The results are presented according to the sections in 
the interview guide. Although the section headings reflect the interview guide 
sections, subthemes that had emerged will also be reported under the respective 














Themes / Main 
Findings 
 Summarised in Table 
5.1 
 Attitudes towards CMs 
use in breastfeeding and 
pharmacy practice 
 
 Perception of roles 
 
 Self-awareness of 





 Barriers and challenges 
 Public education 
 
 Professional education 
 
 Research and 
development 
 
 Government initiatives 
 Majority of participants 
received enquiries on a 
weekly basis 
 
 Common health 
conditions and 
medicines summarised 
in Table 5.2 
 CPD topics  





































Sections in Thesis 
Figure 5.1: An overview of the Stage 3 results 
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5.4.1 Demographic Characteristics of Participants and Pharmacies 
 
Table 5.1 summarises the demographic characteristics of participants and their 
principal place of practice. Most participants received their university qualification in 
Australia, and three participants had postgraduate qualifications which included the 
Australian Association of Consultant Pharmacy (AACP) accreditation and 
Postgraduate Diploma in Clinical Pharmacy. Their experience in community 
pharmacy practice as registered pharmacists ranged from one month to 42 years. 
Participants represented a range of positions or roles in the pharmacy, which are 
reported in Table 5.1.  
 
Seven participants worked in independent pharmacies, while 23 worked in 
pharmacies of varying banner groups, which included Chemmart Pharmacy, 
Superchem Discount Pharmacy, Guardian Pharmacy, Friendlies Chemist, Soul 
Pattinson Chemist, Terry White Chemists, Optimal Pharmacy Plus, Pharmacy 777 
Chemists, Priceline Pharmacy, Pharmacist Advice and Greg’s Discount Chemist. 
Information about participants’ role in the pharmacy and business model or 
orientation was also collected, as shown in Table 5.1.  
 
Twelve male and 18 female pharmacists, aged between 23 and 63, participated in the 
study. Eight worked in pharmacies located in the North metropolitan region; seven 
from regional areas and 15 from South metropolitan regions. Nine pharmacies were 
located in areas with mostly young families; eight were in areas with mostly older 
people; while the rest reported a mix of age groups. Amongst the 30 pharmacies, 
only five had employed a child health nurse and none employed a lactation 
consultant within the practice. Most pharmacies (24 of 30) had a counselling area 
suitable for providing private counselling to breastfeeding women and two had plans 
for pharmacy refits in the near future to accommodate the growing demand for an 







Table 5.1: Demographic characteristics of participants and their pharmacies 











Pharmacy business model Breastfeeding 
experience 
         
CP1 30 Female 38 7.5 Dispensary pharmacist 
and patient care-
focused 
Banner Discount, volume and sales-
focused 
Close family and 
friends 
CP2 27 Female 44 3 Dispensary pharmacist Independent Compounding pharmacy and 
newsagency 
None 
CP3 35 Female 12 12 Dispensary pharmacist Banner Nursing home-focused Personal or 
partner 
CP4 63 Female 18.5 42 Dispensary pharmacist 
and patient care-
focused 




CP5 29 Female 34 6 Dispensary pharmacist 
and patient-care 
focused 
Banner Professional services-focused None 
CP6 29 Male 50 2.5 Pharmacy manager Banner Mixed sales and professional 
services-focused 
None 
CP7 33 Female 25 10 Professional services 
pharmacist and patient 
care-focused 
Banner Professional services-focused Close family and 
friends 




CP9 38 Female 20 17 Proprietor Banner Professional services-focused Personal or 
partner 
CP10 24 Male 45 2 Dispensary pharmacist 
and patient care-
focused 





CP11 28 Male 65 4 Pharmacy manager Independent Discount, volume and sales-
focused 
None 
CP12 31 Female 25 7 Proprietor Banner Professional services-focused Personal or 
partner 
CP13 31 Male  45 6 Proprietor Banner Professional services-focused Personal or 
partner 
CP14 28 Male 40 3 Dispensary pharmacist 
and patient care-
focused 
Banner Professional services-focused None 
CP15 27 Male 46 0.5 Pharmacy manager Banner Discount, volume and sales-
focused 
Close family and 
friends 
CP16 31 Male 55 7 Dispensary pharmacist 
and patient care-
focused 
Independent Professional services-focused None 
CP17 25 Female 40 0.5 Dispensary pharmacist Banner Professional services-focused None 
CP18 23 Female 42 2.5 Dispensary pharmacist 
and patient  care-
focused 
Banner Professional services-focused None 
CP19 28 Female 45 2 Pharmacy manager Banner Discount, volume and sales-
focused 
None 








CP22 27 Female 50 2 Pharmacy manager Independent Mixed sales and professional 
services-focused 
None 
CP23 28 Male 50 1 month Pharmacy manager Independent Mixed sales and professional 
services-focused 
None 
CP24 24 Female 45 0.5 Professional services 
pharmacist and patient 
care-focused 





CP25 33 Female 10 11 Dispensary pharmacist Banner Professional services-focused Personal or 
partner 
CP26 37 Female 60 16 Proprietor Independent Professional services-focused None 
CP27 30 Male 45 6 Pharmacy manager Banner Mixed sales and professional 
services-focused 
None 
CP28 29 Female 35 0.5 Dispensary pharmacist Banner Discount, volume and sales-
focused 
None 
CP29 29 Female 38 8 Pharmacy manager Banner Professional services-focused Close family and 
friends 
CP30 28 Male 50 4 Professional services 
pharmacist and patient 
care-focused 




5.4.2 Identifying Needs and Demand 
 
The majority of the participants received regular enquiries from the public about the 
use of various medicines during breastfeeding on a weekly basis. Most pharmacies 
had procedures in place for pharmacy assistants to refer enquiries related to the use 
of medicines while breastfeeding to a pharmacist. These enquiries were mostly 
related to the use of OTC conventional medicines, which included products classified 
as Schedule 2, Schedule 3 and other non-scheduled conventional medicines. To a 
lesser extent, participants also received requests for advice regarding the use of CMs 
and prescribed (Schedule 4) medicines. Nevertheless, most participants reported a 
growing demand for CMs. As stated by CP 7: 
 
“It is an area that is becoming more and more popular and a lot more people 
are going down the path of complementary medicines and vitamins.” (CP 7)  
 
All of the conditions or health issues presented by breastfeeding women, along with 
the requested medicines as reported by the participants of this study, are presented in 
Table 5.2. 
 
Participants indicated that women were mostly concerned over the safety of their 
breastfed infants as a result of using medicines while breastfeeding. Another concern 
was the impact of medicine on breastfeeding performance and breast milk supply. 
Other commonly sought information included directions for use and efficacy of the 
recommended medicines or products and ways to minimise the transfer of medicines 











Table 5.2: All health issues and medicines requested by breastfeeding women 
reported by participants of the study 
Ailments or health issues Medicines/products requested 
Allergies Antihistamines
Cough and cold Cough suppressant 
 Expectorant/mucolytic agent 
 Nasal decongestant 
Enhancement of breast milk supply Domperidone 
 Fenugreek 
General health using CMs Echinacea 
 Fish/krill oil 
 Peri-natal multivitamins 
 Vitamin C 
 Weight loss product 
Inflammation and pain Analgesic 
 Non-steroidal anti-inflammatory agent 
Other miscellaneous Antibiotics 
 Eye drops and ointments 
 Hypnotics for insomnia 
 Topical corticosteroid 
 Treatment for mastitis 
 Treatment for postnatal depression 
 
 
When participants were presented with one of the findings from Stage 1 which 
indicated that approximately 60% of the survey respondents had used one or more 
herbal preparations during breastfeeding, participants expressed their concerns over 
safety and the lack of stringent regulations over the sales of CM preparations and 
products: 
 
“It concerns me as well that it is saying that people are getting them from the 
pharmacy, but nearly everything that we sell in the pharmacy can be sold in 
the supermarket or health food store, so there is not going to be any 
intervention in those places.” (CP 3) 
 
Participants were also asked to present their views on another finding of the Stage 1 
study, which indicated that 48.6% of the survey respondents regarded pharmacists as 
the main source of information, with the internet, family and friends also being 
reported as common sources of information. Most participants expressed their 
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concerns over the reliability of information accessible by women from the internet; 
some indicated a need for greater pharmacists’ involvement: 
 
“I feel that pharmacists should play a larger role in this sort of area, as a 
healthcare professional providing these sorts of information, rather than 
them sort of just jumping onto google and hoping that the piece of 
information they find is legitimate.” (CP 11)  
 
“We have more access to information than what you can find from the 
internet, because you don’t know, the resources from internet, they might not 
be true all the time and they might not be evidence-based.” (CP 18) 
 
5.4.3 Information-seeking Behaviour and Use of Resources 
 
Participants reported they had acquired most of their knowledge regarding the use of 
non-prescription conventional medicines and CMs in breastfeeding from their day-
to-day work experience, self-directed continuing professional development, personal 
or close-contact breastfeeding experience, and university training as part of their 
pharmacy degree. In line with the growing demand, participants identified that 
universities should include more content and provide greater exposure to pharmacy 
students, covering: basic breastfeeding knowledge and postnatal care, the safety and 
use of medicines during breastfeeding, and reliable references or resources. One 
participant specifically commented on the need for pharmacists to show empathy and 
careful attention when communicating with women who may have decided to cease 
breastfeeding: 
 
“You just have to be really careful and really empathetic and take each case 
by a case-by-case basis, because you don’t want to offend people and make 
them feel intimidated or feel guilty because they are not breastfeeding.” (CP 
29) 
   
A few participants also raised their opinion on the need for communication and 




“I think the university should train pharmacy students or future pharmacists 
on how to deal with breastfeeding mothers… it is the empathy side, the 
emotional side that it is hard for us to gauge… university should have one or 
two lectures on how to communicate with mothers, because personally I have 
seen mothers who would get really really really emotional when they get 
diarrhoea, because they will get dehydrated and they have got no milk… they 
are already emotional… I don’t think the universities have prepared the 
students enough to handle the emotional side of things, and how mothers deal 
with babies.” (CP 1)  
 
“It was very limited in terms of herbal medicines and I had to do a lot of 
extra learning, and still continue to do a lot of extra learning in terms of 
herbal medicines and alternative medicines.” (CP 3)  
 
Participants used a variety of references and resources to assist them in their daily 
practice to advise breastfeeding women on the use of non-prescription medicines and 
CMs during breastfeeding. These included: 
 
 Australian Medicines Handbook (AMH),  
 Electronic version of the Monthly Index of Medical Specialities (MIMS),  
 Australian Pharmaceutical and Formulary Handbook (APF),  
 Royal Women’s Hospital Pregnancy and Breastfeeding Medicines Guide, 
 Therapeutic Guidelines,  
 Product companies or manufacturers,  
 Drug information centres at maternity hospitals and  
 Other internet databases or websites.  
 
Referral to other health professionals such as general practitioners, child health 
nurses and lactation consultants were at times considered necessary when 
pharmacists deemed the queries as beyond their scope of practice or expertise. There 
was also an overwhelming concern raised by all participants regarding the lack of 
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evidence-based reliable clinical studies about the use of CMs and their safety in 
breastfeeding: 
 
“We can only go by or give the information that is available to us, and a lot 
of the times there isn’t a lot of information available on breastfeeding, there 
is quite a lot on pregnant women at the moment, but not a lot in 
breastfeeding.” (CP 2) 
 
“I don’t think we have enough up-to-date and thorough information to 
provide. I think we have just sort of a limited amount of information that we 
can provide in our setting.” (CP 7)  
 
“Particularly the complementary, because that is where people get caught 
up… particularly the complementary because that is what we don’t have hard 
evidence on.” (CP 21) 
 
“I just don’t think there have been enough studies done on the herbal and 
complementary medication that provides sufficient data.” (CP 25) 
 
Only one of the participants was aware of and fully utilising the Medicines 
Information Centre, Women and Newborn Health Service in WA, as recommended 
by the APF 22 (387). Mixed responses were observed when participants were asked 
their views on the need and feasibility of setting up a lactation resource centre in 
WA, which would be a potential source of information for women and health 
professionals. From the participants’ perspective, the main issue was to consider the 
cost-effectiveness of resource centres: 
 
“I don’t know what is the cost. I guess you need to weigh out the cost and 
benefit, but I think it would definitely be beneficial, but whether or not it is 
cost effective…” (CP 26)  
 
Most participants discussed the advantages of setting up a state-based lactation 
resource centre such as local and accessible face-to-face interactions and assistance 
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to women experiencing issues with breastfeeding, and that it would serve as a 
strategy for continuation of care and support in the community during the postnatal 
period. Another benefit mentioned was provision of information to health 
professionals: 
 
“Because there’s a lot of enquiries regarding breastfeeding, in terms of 
either the technique, or how to use devices and all those things, and obviously 
that will relieve the burden of midwives.” (CP 11) 
 
“Given that breastfeeding is always promoted as being the best, and that so 
many women have trouble with it, I think it would be really useful and also 
just to have that continuation of care. Because you have your baby, and you 
go home and a lot of women struggle, and just give up breastfeeding because 
it’s too hard or they think that they don’t produce enough milk, and there is a 
lot of misinformation out there as well. So I think it would be really useful, 
and also not just for like the actual patients but also for health professionals 
as well. So we can go to them for information or refer people on, because 







5.4.4 Attitudes, Knowledge and Confidence Level 
 
Five major themes emerged regarding participants’ attitudes, knowledge and 
confidence level towards promoting the safe and effective use of non-prescription 
medicines and other OTC products during breastfeeding and their role in supporting 
breastfeeding in the community: i) attitudes towards CMs use in breastfeeding and 
pharmacy practice, ii) perception of roles, iii) self-awareness of knowledge level and 
confidence, iv) facilitators and v) barriers and challenges to achieving effective 
support for breastfeeding women in the Australian community pharmacy context.  
 
 
5.4.4.1 Attitudes towards CMs use in breastfeeding and pharmacy practice 
 
Five subthemes or issues were apparent in terms of participants’ attitudes towards the 
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5.4.4.1.1 Complexity and dilemma in making clinical recommendations 
 
A common theme was the complexities that need to be considered and the dilemma 
in making clinical recommendations involving the use of non-prescription medicines 
and other OTC products, in particular CMs, during breastfeeding due to the lack of 
studies and safety data. Many participants expressed uncertainty and frustration when 
required to provide recommendations to breastfeeding women presenting to 
pharmacies:  
 
“Sometimes we’ve been out in this dilemma. And the patient will say the 
doctor didn’t say anything or the doctor says its fine. So sometimes we do get 
that sort of dilemma. So at that stage we can only use our professional 
judgement and say, look, this is what is stated in the literature. I would just 
say if I were in your position that’s what I would do. And I think that’s the 
advice that we can offer, and it’s up to the patient…” (CP 12) 
 
“It’s frustrating and more so it’s confusing because you would like to know if 
it is or is it not [safe].” (CP 21) 
 
“I think that has impacted on a lot, it can make it quite difficult to say, you 
know, when there is not enough evidence to sort of give that information to 
the customer. So I do find that quite difficult…” (CP 28) 
 
“…you feel like you can’t give people a definite answer. So it’s like there is 
no information, so you don’t really know, so you kind of just err on the side of 
caution because of the lack of information you have got on hand.” (CP 29) 
 
The lack of conclusive, evidence-based information on the use of CMs and safety in 
breastfeeding was seen as a major dilemma when having to make clinical decisions 





“…there is no evidence and I am not comfortable recommending...” (CP 1) 
 
“I think that they are inconclusive. Often, it makes it hard for you to 
recommend anything, because the chances are they might be safe, but I 
wouldn’t like to refer them on the ‘might’, you know. I would rather refer 
them onto the drugs that we know are safe… it seems to me that there is less 
choices for breastfeeding mum than there is for pregnant mum, because we 
know more about drugs in pregnancy than drugs in breastfeeding.” (CP 3) 
 
“…because the evidence isn’t there, I don’t have the confidence to say you 
can or you can’t use this… sometimes they can be a little bit vague like with 
the insufficient evidence, or they can be a little too brief, sometimes I would 
like a little bit more information.” (CP 28) 
 
The safety of mothers and their breastfed infants was considered priority as it was 
consistently mentioned by all participants that they would not recommend any 
medicines, including CMs, in the absence of evidence demonstrating their safety in 
breastfeeding: 
 
 “I won’t take the chance, if there is a lack of information.” (CP 6) 
 
“I usually find that the case with complementary medication… when I can’t 
find it that’s when I would go on the side of caution and don’t recommend it 
and tell them there hasn’t been enough studies done about it.” (CP 10) 
 
“Usually if the reference says they don’t have enough evidence to support it, 
I wouldn’t recommend it to the patients, and the breastfeeding mums as well, 
because I wouldn’t be comfortable selling it them.” (CP 17)  
 
“I would look into it a bit more and just with peace of mind, to make sure it’s 
really really safe in breastfeeding.” (CP 27) 
 
In the absence of evidence-based information, many participants also tend to err on 




“what I feel is that it makes me more conservative in my recommendation of 
products, because everything is not recommended… essentially what I do is I 
look through all the resources to find the one that says safe to use, and unless 
I can find one that say safe to use, I won’t recommend that product. So, that 
makes me more conservative in my recommendation and that compromises 
the mum’s ability to, you know, help with whatever she is experiencing at the 
moment…” (CP 2) 
 
“I would err on the side of caution. Let the patient know and I wouldn’t 
recommend that particular product and look for an alternative.” (CP 8)  
 
Nevertheless, being over-cautious or conservative in their recommendations may 
compromise breastfeeding women’s health, as one participant commented:  
 
“I still feel like I could be helping them more, they often walk away without a 
good solution to their problems because I can’t be sure that what I 
recommend to them would be safe, so to be safe you would recommend less, 
and then probably the mum goes through a bit more suffering than she might 
need to, because we are on the side of safety.” (CP 3) 
 
5.4.4.1.2 Duty of care, legal and ethical obligation of the pharmacist 
 
From the participants’ perspectives, it was their duty of care as pharmacists to ensure 
the safe and effective use of all products and medicines, including OTC products 
sold in their pharmacies. Participants felt that they had the responsibility to ensure 
the safety of breastfeeding women and their breastfed infants: 
 
“We need to make sure that the medicines we give out needs to be safe, and 
because we stock it… we still need to ensure. This is part of our job, to make 




“I feel that it’s part of your job as pharmacist if you are to sell that in your 
store, you should be able to make recommendations on it based on whether 
the patient is breastfeeding or not breastfeeding.” (CP 10) 
 
“I think if we sell it then we are responsible for that sale.” (CP 29) 
 
It was acknowledged that pharmacists had a legal and ethical obligation to acquire 
adequate knowledge of all products sold in the pharmacy, regardless of whether they 
were conventional or CMs. Participants also felt that it was part of their professional 
role to ensure the safe and effective use of these products in lactation and be able to 
make appropriate recommendations to women who may require treatment while 
breastfeeding. 
 
“I would think that anything that we sell it in the pharmacy, if we choose to 
sell or to recommend that sort of products to the public, we need to have 
some general knowledge about the product itself…” (CP 20) 
 
 
Clients’ well-being and health were identified as the main focus of pharmacists, as 
many commented that they would be reluctant to recommend or sell a product on the 
basis of promoting the business or increasing profit in the absence of clear client 
benefits:  
 
“It is not a matter of having one less sale, it is a matter of what is good for 
the baby.” (CP 1) 
 
“I think we need to be responsible when we are selling vitamins and it’s just 
not a business that, you know, you are getting an extra sale. I think we need 
to have some responsibility on our part to make sure that it is okay and that 
we do ask appropriate questions.” (CP 9) 
 




When participants were asked their opinions on whether there was potential for 
pharmacists to expand their role and scope of practice to promote breastfeeding and 
other related professional services in community pharmacies, many showed support 
and willingness for expanding their professional roles:  
 
“I think pharmacists are well placed to help with breastfeeding support… I 
would like to see that perhaps pharmacists are promoted more, maybe 
through… like child health nurses. Maybe child health nurses need to be 
saying to the mums, make sure you are checking all your medicines with your 
pharmacist, before you start taking anything…” (CP 3) 
 
“I feel that pharmacists should play a larger role in this sort of area, as a 
healthcare professional providing these sorts of information.” (CP 11) 
 
“…as a pharmacy profession, we are highly respected in the field, in terms of 
knowledge and definitely the willingness to provide the information at a 
convenient time to customers.” (CP 20) 
 
It was also described that the pharmacists’ role should not be limited to merely 
dispensing and the supply of medicines, but to play a greater role in the provision of 
professional healthcare related services in the community: 
 
“I stand for about pharmacists being more service and healthcare-
orientated.” (CP 10) 
 
“…pharmacists can do something else other than just dispensing medicines.” 
(CP 16) 
 
One participant further commented that the provision of breastfeeding advice and 





“In the pharmacy we teach people how to use the blood pressure monitors, 
we teach people how to use the diabetes monitor, we teach people how to use 
the pedometer, why can’t we teach people how to use the breast pump?... I 
think if we have time to teach people how to use the blood pressure monitors, 
[then] I think we will have time to teach people how to use the breast 
pumps.” (CP 1) 
 
5.4.4.1.4 Provision of evidence-based recommendations 
 
In their daily practice, participants strived to provide evidence-based 
recommendations to women in relation to the use and safety of medicines in 
breastfeeding. Consultation and advice were made based on the resources and 
evidence available: 
 
“I consulted the reference. I showed the customer the information in the 
reference and explained the logic behind.” (CP 1)  
 
5.4.4.1.5 Process and approach in handling health and medicine-related queries 
 
It was evident that pharmacists followed a step-wise process and approach when 
handling health and medicine-related queries to breastfeeding women, as participants 
described the process involved in making clinical recommendations: 
 
“So I checked the little breastfeeding book we had, I checked the eMIMS to 
find the appropriate product for her and recommended a couple of things to 
her depending on which symptoms were the most severe or what she wanted 
to treat and explained to her and recommended the products.” (CP 7) 
 
“Now obviously the first thing we do is we have to check the patient, whether 
she’s on other medication, how old is the baby, and we have to go through, 




“I try to get everyone to at least ask who is it for, this type of WHAMM2 
questions to ascertain if somebody is breastfeeding, then they can refer it to 
the pharmacists and…” (CP 27) 
 
 
5.4.4.2 Perception of roles 
 
Participants’ perceptions towards accepting the role of promoting safe and effective 
use of non-prescription medicines during breastfeeding and supporting breastfeeding 
in the community were generally favourable. The majority of the participants 
perceived pharmacists’ main role as the medication experts, providing advice on 
whether to use or not to use certain medicines whilst breastfeeding. Participants also 
commented that they were responsible for medicine advice and information, in 
particular non-prescription medicines, that are available in pharmacies without 
prescriptions or consultation with doctors.  
 
“I think our role is to ask the questions and to ensure the medicine that we 
delivered to the patient or customer is safe to use and minimise the risk even 
for complementary products, we still need to make sure it is really safe to 
use.” (CP 6) 
 
“Provide advice, counselling, as well as information on the medications that 
breastfeeding mothers may be seeking…” (CP 10) 
 
“Simple questions like how do you help, what kind of medication we should 
recommend, what they can take, what they can’t take when they are 
breastfeeding.” (CP 15) 
 
“Providing information on the use of medication, safe use of medications, 
from complementary to prescription medications… I think it’s advising 
                                                 
2 WHAMM is an acronym representing a list of questions used by pharmacists and pharmacy staff to 
acquire information from their clients, including: who is the patient, what are the symptoms, how long 
has the symptoms been present, any action taken, current medications and medical conditions.  
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whether it is safe to take medicines… I think pharmacists should be doing 
that regardless.” (CP 26) 
 
“…mainly proving advice, and ensuring that the infant and the mother are 
using medications safely… we are supposed to be very knowledgeable about 
medication in general, so we will be one of the port of call for breastfeeding 
mothers.” (CP 27) 
 
Many felt that their roles and expertise were clearly defined from workers at 
supermarkets or shopping centres, as one participant stated: 
 
“That’s the difference between a pharmacy and a shopping centre like Coles. 
We try to provide our advice.” (CP 13) 
 
With knowledge of safe medicine use during breastfeeding, one participant felt that 
pharmacists could play a role in promoting breastfeeding continuation and avoiding 
unnecessary early cessation of breastfeeding: 
 
“I think that pharmacists can help mothers who might be wanting to cease 
breastfeeding. Perhaps they might want to cease breastfeeding for something 
as simple as them wanting to use a certain medication and they don’t feel 
safe in doing so, and they might find a way around it, either a different 
medication, or perhaps pumping and discarding and just do a complementary 
feed in the meantime. I think pharmacists can help with that.” (CP 3)  
 
The majority of the participants agreed that pharmacists represent a reliable source of 
medicine and health-related information for the public, at the community level.  
 
“…we get a lot of queries independent of the sales. We are the information 
givers and advice and they take it… and it’s genuinely the trust in us.” (CP 8) 
 
“I think pharmacists still play a very important role in terms of providing 




“…it’s showing that pharmacists have got the biggest role and consumers are 
recognising this, and if they want the correct information, pharmacists are 
the way to go.” (CP 26) 
 
 
Perceptions about the potential for greater involvement and role expansion of 
pharmacists in supporting breastfeeding and various related health promotions in the 
community pharmacy setting were generally positive. Many felt that they were in a 
position where unique opportunities were present to raise the awareness of the public 
with regard to the benefits of breastfeeding and related health topics.   
 
“We are there to give advice on health issues and breastfeeding is a health 
issue as well.” (CP 6)  
 
“I think being in the community setting, definitely as we are seeing mothers 
before and after their pregnancy, I think definitely pharmacists can help 
encourage women who have difficulty or are having second thoughts about 
breastfeeding, particularly about the benefits of breastfeeding.” (CP 9) 
 
“We are one of the first port of calls, when people have healthcare-related 
questions or when people are sick, so I think you do have the opportunity to 
promote breastfeeding when people do come in.” (CP 10) 
 
“I think we can help promote women to breastfeed for longer if they know 
that we are an educated resource that they can come and approach if they 
have any difficulty on top of their lactation consultants.” (CP 25) 
 
Participants also discussed their role in the provision of postnatal care and support to 
women at primary healthcare level, at the same time recognising women who could 
be at risk of postnatal depression and other aspects of women’s mental well-being: 
 
“…be able to learn how to communicate effectively with them, calm them 




“if they find that once they leave the hospital and they forget, they are sure 
that they can go somewhere where they can get information again, or just a 
reinforcement, because sometimes some mothers don’t stay in hospital for 
one or two days if you have natural birth unless you have caesarean, 
obviously you have to wait six days before your stitches come out. I mean you 
can’t always remember everything, and you are tired as well, you know, you 
haven’t had much sleep, so you are not always getting all the information 
thrown at you.” (CP 9) 
 
 
Nevertheless, some participants felt that they had a limited role in the area of 
prescribed medicines: 
 
“Very very very rare on prescription medicines because their doctor would 
have already spoken to them about it.” (CP 1) 
 
Few participants commented that the provision of advice regarding techniques and 
other physical aspects of breastfeeding, such as feeding position and issues with 
infant latching, were beyond their defined roles and capabilities: 
 
“…we do sell pumps, so we need to be able to support and recommend the 
correct use, but I think the whole actual natural feeding is probably a bit 
beyond our normal role.” (CP 21) 
 
“Maybe not in regards to difficulty with latching and insufficient milk supply, 
that’s a bit beyond our capabilities.” (CP 24) 
 
“In terms of difficulty with latching, I don’t know, I mean that is a very 
personal area, I don’t know if, I mean I don’t think it’s the pharmacist’s role 
to sit there and help them. I think that’s probably crossing boundaries. I think 
that is something that a mum is more comfortable with a lactation consultant, 




Forming an interdisciplinary collaboration with other healthcare professionals such 
as doctors, child health nurses and lactation consultants, was perceived as beneficial 
in terms of improving the overall health outcome of breastfeeding women and their 
infants: 
 
“…you could also maybe liaise and work with… a child care nurse close to 
the area, put some pamphlets there or put some pamphlets at the local 
doctor’s surgery.” (CP 7) 
 
“All of us do need to know bits and pieces of how each profession works. If 
we can drag nurse, doctor and pharmacist to a group of health professions 
that can discuss things, that will be even easier or better.” (CP 13) 
 
“[If it is] not our area then we get someone more professional on it… we 
have few other professionals working together, so we all are good at what we 
know, at the end it will be good.” (CP 19) 
 
Pharmacists could potentially also play a greater role as acting as a contact point and 
referring women to other health professionals where appropriate:  
 
“…just being an access point to say, right, yes, you need to now talk to…for a 
reference, being a first point of contact, and an easy point of contact, rather 
than actually executing a strategy.” (CP 21) 
 
“I think that the basic should be pharmacists giving free advice to the 
consumer, with a point of referral to someone who is being reimbursed by a 
government or a private industry, not by a small business.” (CP 26) 
 
Other perceived roles discussed by the participants included the provision and 
demonstration of breastfeeding-related needs or equipment for example: how to 
operate a breast pump, how to express and store breast milk and other issues related 
to infant feeding. In addition to the previously mentioned roles, participants also felt 
that it was their role to provide women with advice in relation to common conditions 
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in breastfeeding and other primary healthcare issues related to breastfeeding, such as 
mastitis, sore nipples and insufficient milk supply.  
 
5.4.4.3 Self-awareness of knowledge level and confidence  
 
To explore pharmacists’ self-awareness of knowledge level, all participants were 
asked to indicate their responses to six statements related to topics associated with 
breastfeeding and the use of medicines. Responses are summarised in Table 5.3. 
  
Table 5.3: Participants' responses to statements in relation to their knowledge 








I am confident in discussing the safety 
and efficacy of non-prescription 
medicines use with breastfeeding 
women. 
23 2 5 
I am confident in recommending non-
prescription medicines to 
breastfeeding women. 
19 7 4 
I feel comfortable in discussing any 
aspects and issues related to 
breastfeeding. 
22 4 4 
I understand how medications and 
nutrients are transferred into the breast 
milk. 
19 5 6 
I am aware of the factors determining 
infants’ exposure to medicines in the 
breast milk. 
23 3 4 
I know how to advise women who 
require to use medicines during 
breastfeeding on how to minimise the 
transfer of medicines to their infants. 






Participants were also asked to assess their confidence levels in providing advice to 
breastfeeding women on the use of both conventional medications (including 
prescribed and OTC) and CMs (including herbal medicines). All participants stated 
that they were more confident in providing advice on conventional medicines over 
CMs. It appeared that participants recognised the limited knowledge about the use of 
herbal galactagogues while breastfeeding. An over-arching theme emerged as 
participants discussed the availability of evidence and resources for CMs. The 
perceived lack of knowledge and evidence-based studies or research in the area of 
CMs use, including herbal medicines, in breastfeeding was seen to negatively impact 
on pharmacists’ confidence to recommend them.  
 
“We don’t have the data to support the use of herbal preparations in 
breastfeeding, to know if they are going to be safe.” (CP 3) 
 
“I think because we have more literature on prescribed and OTC medicine. 
Whereas with complementary is one of those areas that we don’t have a book 
that says okay or not okay.” (CP 12) 
 
“Unfortunately there isn’t much evidence behind to support whether it [CM] 
is safe, that is the drawback, it becomes like a grey area where I am not 
comfortable recommending it.” (CP 15) 
 
Many participants also reported they had greater experience and knowledge with 
regard to the use of conventional medicines over CMs in breastfeeding. “…because 
of the experience I suppose. Because of the use or practice and the study that we 
have gone through…” (CP 20) The issue with the lack of standardisation of herbal 
medicinal products was also raised by few participants, as one commented: 
 
“I think because there is more trials and research done with prescribed and 
over the counter medicines, whereas with herbal medicines, especially if they 
are not standardised as well, that, and there’s not as much evidence, so that 






A number of subthemes emerged as participants described the factors that serve to 
facilitate the promotion of breastfeeding by community pharmacists and the 
provision of professional advice to breastfeeding women regarding the use of non-
prescription medicines and other OTC products including CMs. These included: 
convenience, accessibility and affordability, respect, trust and the pharmacist-client 
relationship, knowledge and professionalism, expanding role of the profession and 
creating job opportunities, promoting better health in the community, facilitate 
complementary sales and promote business of the pharmacy, promote image of 
pharmacy and the profession in the community, ease burden on the health system. 
 
Participants felt that their profession represents a convenient, accessible and 
affordable source of health and medicine related information to the public. The 
importance of trust, professionalism and favourable pharmacist-client relationships 
were also acknowledged by the participants. It was also reported that expanding the 
professional roles of pharmacists will facilitate greater job opportunities, at the same 
time contributing to better health in the community. Expanding the role of 
pharmacists in this context will also aid in the reduction of waiting periods at general 
practitioners, overall easing the burden on the Australian healthcare system.  
 
Figure 5.3 shows a summary of the facilitators and barriers of expanding the role of 
pharmacists. The subthemes of facilitators and barriers, along with the supporting 
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Table 5.4: Facilitators identified by participants  




“I think that pharmacies are available so easily and so readily in 
every community and that it might be somewhere that the mums feel 
comfortable as well because they are in there so often, and that they 
are known, and it is somewhere that they can go into without a specific 
appointment time, because some babies are not on-time or have 
routines  necessarily, and some mums might find it hard to stick to it, 
whereas in the pharmacy, they can just drop in or out when it suits 
them.” (CP 3) 
 
“I think we are convenient because we are there, and we can provide 
advice free of charge, they don’t need to make appointment, they can 
come in and see us anytime.” (CP 7) 
 
Respect, trust and 
pharmacist-client 
relationship 
“…we already have that relationship with the customers. So 
pharmacist-client relationship, we have already known the customers 
for six seven years, and we know them by their first name.” (CP 1) 
 
“Many of the time, these women are all already clientele before they 
are even a breastfeeding mother and that makes us having a really 




“Pharmacists are knowledgeable in the area certainly in regards to 
medicines.” (CP 3) 
 
“Our professionalism… and our training and knowledge and also the 
trust that the public have in us as health professionals.” (CP 29) 
 
Expanding role of 
the profession 
and creating job 
opportunities 
“…we are trying to increase our professionalism, and to do different 
things in our profession, so why not take on something like that that 
hasn’t really been a focus for pharmacists.” (CP 7) 
 
“Nowadays we’ve got more and more pharmacists on the market and 
a lot of them can’t even look for a job. I guess if let’s say we create 




health in the 
community 
“…we are not just selling them a breast pump, but also telling them 




sales and promote 
business 
“…that would drive the sales up for any baby products because they 
know that you have these kind of services.” (CP 6) 
 
“I mean you will hope to get the follow-on, you will get the customer, 
they will become your customer, so then they would come in for 
anything else that they need.” (CP 7) 
 
“It is a good strategy for pharmacies to boost their sales and at the 
same time, it also makes them aware that the pharmacy also carries 
this service.” (CP 15) 
 
Promote image of 
pharmacy and the 
profession in the 
community 
“…it would increase the image of the pharmacy in their perception in 
their minds…” (CP 1) 
 
“Any type of service that we can offer, above and beyond is always 
good for the image of the pharmacy.” (CP 9) 
 
“It pushes pharmacy back to being more of a healthcare 
professional.” (CP 10) 
 
Easing burden on 
the health system 
“…ease the pressure on the health system, the GPs… that will ease the 
pressure on the whole health system, doctors can focus on things that 
you can’t focus on in a community pharmacy setting.” (CP 10) 
 
“…reduce the burden of GPs when we can provide them with the 






5.4.4.5 Barriers and challenges 
 
There were a number of barriers identified by the participants, as summarised in 
Table 5.5. These included: the lack of evidence-based information and resources, 
safety concerns and legal implications, time constraints, lack of training or 
knowledge and confidence, lack of funding or financial compensation, lack of needs 
or demand due to demographics, the issue with opposite gender, lack of pharmacist’s 
personal experience or interest, inappropriate pharmacy layout and the lack of 
uniform approach by all pharmacists.  
 
The majority of the participants expressed their concern in relation to the lack of 
funding or financial remuneration for providing professional services. Lack of 
financial compensation was also seen as a contributing factor to time constraints as a 
barrier and the increase in pharmacists’ workload. Interestingly, one participant 
provided an opposing opinion, and stated:  
 
“I think traditionally this should be part of our service, I don’t think it needs 
to be compensated. From my point of view, it is part of our job, it should not 
be like wanting to get some benefits from that.” (CP 6)  
 
Despite agreeing that professional services provided in pharmacies should be 
remunerated, one participant also acknowledged that providing professional services 
would assist in building of relationships, and in turn improve the sales and business 
of the pharmacy:  
 
“…you are building that rapport with them so they will come back and buy 
things from you, so you are being remunerated indirectly.” (CP 26) 
 
Breastfeeding was perceived as a potentially sensitive issue, especially for the 
opposing gender, an issue raised by some male and female participants. Interestingly, 
when male participants were asked to share their views about gender, over half of 
them felt that they were comfortable discussing breastfeeding issues, provided 
breastfeeding women were willing to discuss it with them and that they had positive 




“I can see why some people think it would be, but to me it also depends on 
how willing the breastfeeding mum is willing to talk to a male pharmacist 
about it. Me personally, I don’t have any issue with it.” (CP 10) 
 
“For myself, I don’t think so. I think it’s the trust that you have and how 
professional you are to present yourself in the area. Now I guess the trust 
doesn’t come overnight. For me, to work there for seven years, and I’ve seen 
some of the mum before that they are couple, they got married, and they come 
to me and they just tell me everything… It’s definitely not a barrier.” (CP 16) 
 
One of the male participants further commented it was considered his responsibility 
and role to provide advice and professional services to clients regardless of their 
gender, and hence opposite gender should not be seen as a barrier: 
 





Table 5.5: Barriers and challenges identified by participants  





“You really don’t have a clear decision on what is best for the patient 
as such. It would be better if we say no don’t use it or yes it’s safe use 
it. Obviously with a lot of clinical studies, there isn’t enough data or 
there aren’t enough people in the actual test study to come to a, you 





“I know people who will not do it, and that’s fair enough because they 
don’t want to put their license at risk.” (CP 6)  
 
“I suppose the litigation reasons as well, you don’t want to be stuck in 
a law suit if something happens.” (CP 9)  
 
Time constraints “I think that it is a time-consuming area. I doubt that most 
pharmacists would be able to sit down long enough to give the mums 
the time they would need…” (CP 3) 
 
“…in the pharmacy time is always an issue with everything, whether it 
is script, or counselling, doing blood pressure, or putting the order 
away,  or dealing with something that has happened in the pharmacy.” 
(CP 9) 
Lack of training, 
knowledge and 
confidence 
“…not enough knowledge in the area, not enough training, so that we 
can’t give out the information confidently.” (CP 5) 
 
“I find it is a barrier for most pharmacists because we are not trained 
and there is not enough focus for time being put in to educate 
pharmacists on how to educate breastfeeding mothers.” (CP 15) 
 
Lack of funding 
or financial 
compensation 
“My view is that the above is not possible without funding. Because 
it’s going to be a lot of, a big investment, and is certainly not viable to 
do the above investment if there’s no return. And of course there are a 
lot of factors that attribute to what are you going to do in the 
pharmacy but without government funding, it is not possible.” (CP 11) 
 
“…obviously all these exercises require spending, this becomes 
expenses for the pharmacies. Like I said the return for the money that 
you put in is very very minimal. So the only barrier that stopping this 
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to happen is because of the cost of running the program.” (CP 16) 
 
“We can’t keep providing this sort of service, and the resource, the 
staff resources, the pharmacy’s resources to care and giving advice 
for free.” (CP 20)  
 
“It’s all great, but who is going to pay. Community pharmacies are 
not in the position to pay for these services, and funds these services 
anymore, particularly with all the price reductions…” (CP 26)  
 
Lack of needs or 
demand due to 
demographics 
“…depending on where your pharmacy is. I mean not one shoe fits all. 
Each pharmacy is different, each pharmacy has different cliental so 
definitely demographics would play a role.” (CP 9) 
 
“Depends on demographics for sure. In a town with older population, 





“It is a very sensitive issue for male pharmacists to handle.”(CP 1) 
  
“…sometimes it can be an awkward situation, so the staff don’t always 
ask if you are pregnant or breastfeeding because you know, some 
people may take offence to it.” (CP 2) 
 
“It also depends on how willing the breastfeeding mum is willing to 
talk to a male pharmacist about it…” (CP 10) 
 
Lack of personal 
experience or 
interest  
“Not everyone is up to doing it…” (CP 9) 
 
“I’ve never experienced it myself. I’m afraid I would upset them 
because I don’t know what they are going through.” (CP 24) 
Inappropriate 
pharmacy layout 
“…we don’t really have quiet place, secure place or private area” 
(CP 4) 
 
“I think breastfeeding might be a sensitive issue, like more private 
issue. So a pharmacy without proper layout, I don’t think people will 
ask that much.” (CP 14) 
Lack of uniform 
approach  
“I think [there’s] actually a gap in community pharmacies. I think we 




5.4.5 Implementation of Strategies and Public Health Services in Pharmacy 
 
Participants’ perceptions about their role in providing breastfeeding-related health 
services in community pharmacies were generally favourable. They acknowledged 
the benefits of health services which could provide women with postnatal care and 
support at the community level. These included baby weigh-in stations and lactation 
clinics in the pharmacy. The employment of lactation consultants and child health 
nurses in the pharmacy was considered advantageous and feasible provided 
appropriate funding was available. The majority of the participants also considered 
the distribution of pregnancy and breastfeeding-related educational materials 
practicable within the context of pharmacy practice. This could be achieved through 
liaison with organisations such as the Australian Breastfeeding Association (ABA) 
and Pharmaceutical Society of Australia (PSA).  
 
“That is easy enough to put pamphlets and stuff in and around the baby 
section or have some behind the counter.” (CP 2) 
 
With appropriate training, some participants also felt that they would be capable of 
providing motivational counselling to breastfeeding women with health issues for 
example: insufficient breast milk supply and postnatal depression. Nevertheless, 
promotion of services should take place to advise the public should the pharmacy 
decide to implement any new services, as one participant commented: 
 
“You could have people in the area that just don’t come to you because they 
don’t know that you have the service, or don’t think you would…” (CP 7) 
 
Only one participant was fully aware of the Australian National Breastfeeding 
Strategy 2010-2015, which included pharmacists as one of the breastfeeding support 
staff. Participants commented on the need for pharmacists to be informed of national 
health strategies in order to enhance community pharmacists’ involvement, and 
ultimately improving client health outcomes. Many participants highlighted the 
importance of further training and education for pharmacists and pharmacy assistants 




One of the questions from the interview guide explored participants’ perspectives of 
what could be done to improve or promote the practice of safe and effective use of 
non-prescription medicines including CMs during breastfeeding. Strategies identified 
by participants were multifaceted and included efforts from different areas: i) public 
education, ii) professional education, iii) research and development, and iv) 
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Figure 5.4: Multifaceted efforts to promote the safe and effective use
of non-prescription medicines including CMs in breastfeeding 
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Educating and raising the awareness of the public was seen as key to promoting the 
safe and effective use of non-prescription medicines while breastfeeding. 
 
“Maybe we should have more campaigns for breastfeeding women I’d say, 
like to increase the awareness, like not every product can be used when 
breastfeeding. For instance, if they are breastfeeding, make sure they ask the 
questions or refer to the pharmacists whenever it’s possible.” (CP 23) 
 
It was consistently mentioned by participants that the public should be educated on 
the potential risks associated with the use of any medicines, including herbal 
medicines and natural products, when breastfeeding: 
 
“A lot of the times I find that mums they don’t realise that if they are 
breastfeeding they need to be careful with what medications they are taking… 
they don’t think that breastfeeding is an issue and they don’t realise that the 
medicines that they take can get transferred to the baby…” (CP 2) 
 
“A lot of people assume that they are natural products and assume that they 
are not going to do any harm.” (CP 3) 
 
“I think when it comes to complementary medicines, they didn’t seek advice 
from the pharmacists, it seems like they commonly have a concept that it is 
just a herbal product, it is very unlikely to cause harm…” (CP 6) 
 
“People just need to be careful, you know, don’t just assume that because it 
is natural, it is safe.” (CP 9) 
 
One participant further commented on the importance of women informing 
pharmacists if they were breastfeeding: 
 
“Customers also need to make us aware that they are breastfeeding, not 
withhold information from us, if that’s relevant. So if someone asked if they 
have any other medical condition, if they don’t say breastfeeding or if they 
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don’t count breastfeeding as a medical condition, then really that’s not our 
fault…” (CP 29) 
 
Some participants suggested the awareness of the public could be increased through 
promotion and during prenatal classes: 
 
“For example, the hospital should tell the mothers that when you are 
breastfeeding if you want to take any complementary supplements, you have 
to always ask pharmacists.” (CP 6) 
 
“I would say let the public know more, maybe TV advertisement, or paper 
and radios.” (CP 14) 
 
“Get people to ask the pharmacists. Push to ask the pharmacists message.” 
(CP 21) 
 
One of the common issues raised was to do with training and education. On-going 
training for pharmacists and pharmacy assistants was raised as important as well as 
training for pharmacy students at the university level. Nevertheless, focus should be 
placed on the safety aspects of medicines used in breastfeeding, especially CMs: 
 
“…we work in the community pharmacy, and there’s a big portion of vitamin 
and herbal supplements sale, and what we learn in Uni is about 90% on S2, 
S3, [and] S4 medicines, and 10% of herbal and vitamins. Whereas when you 
go out to a real community pharmacy, it’s almost fifty-fifty. So it’s definitely 
not adequate.” (CP 6) 
 
The need for greater information and research especially into the area of CMs use in 
breastfeeding was identified by many participants of this study. To that extent, the 
development of a Lactation Safety Category and the availability of clear and 
practical guidelines with evidence-based recommendations would better inform and 




Some participants also discussed their expectations of drug companies and the need 
for more stringent TGA regulations on all CMs: 
 
“I think first of all what needs to happen is from the legislation point of view. 
If the current legislation stays in place then the companies that make the 
complementary medication will not obviously spend more money on study of 
safety and efficacy of the medication in breastfeeding… If they are not 
spending anymore effort, you pretty much is going to be restricted on 
information and is not going to have more studies done. So I think if the 
government can do something to encourage the manufacturer to do more 
studies...” (CP 11) 
 
“…the government has to be quite stringent on the drug company, and the 
labelling has to be quite up-to-date.” (CP 16) 
 
It was recognised that government funding and incentives were necessary to assist 
with the implementation of the above mentioned strategies and services: 
 
“I think they could provide more funding so pharmacists can have more 
programs or provide more services to increase the awareness.” (CP 18) 
 
“Remuneration could help to motivate employers to allow the pharmacists to 
do so…” (CP 24) 
 
“…put in money for research, so funding from somewhere for more research 
so that our references can be more up-to-date…” (CP 26) 
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5.4.6 Continuing Professional Development 
 
A need for on-going CPD and training was highlighted in this study, for both 
pharmacists and pharmacy assistants. The majority of the participants agreed that 
additional training in the area of breastfeeding and medicine use should be a priority 
to increase confidence of pharmacists and to meet the growing demand and 
expectations of the public. Most participants preferred the contents to be delivered 
either face-to-face in events such as a CPD session, hardcopies in booklet format or 
CPD modules available via the internet. Participants were also asked to indicate 
topics of CPD which they thought would be practical and useful to their practice, 
which are summarised in Figure 5.5. 
 
In addition to the topics summarised, participants also cited the need for training on 
motivational and effective counselling skills to assist them with communicating and 
understanding the emotional needs of breastfeeding women experiencing health 
issues.  
 
Participants’ views on whether there was scope for pharmacists to specialise in 
women and newborns’ health and to qualify as lactation consultants were mixed. 
Whilst the majority of the participants supported the expansion of pharmacists’ roles 
into these areas, a few believed they were beyond the scope of practice and 









































Participants identified that the topics of CPD should include: 
 
1. How to look for evidence-based information with regards to use of 
medicines, especially CMs in breastfeeding, 
 
2. How medicines are transferred into the breast milk, 
 
3. How to minimise the transfer of medicines into the breast milk, 
 
4. What are the factors determining the exposure of infants to medicines in the 
breast milk,    
 
5. What are the signs of a healthy breastfed infant and breastfeeding mother, 
 
6. What are the common issues or ailments seen in lactation and how to 
manage them, for example: signs and management of insufficient milk 
supply and mastitis, 
 
7. What are the non-prescription medicines or evidence-based alternative 
options available and recommended to treat breastfeeding women requiring 
treatment for common conditions seen in the pharmacy, for example: cough 
and cold, allergies, pain and inflammation, 
 
8. Basic knowledge with regards to breastfeeding, for example: how to operate 
a breast pump, how to express and store breast milk, and 
 
9. Signs and symptoms which warrant referrals and who their clients should be 
referred to.  




The key findings of the Stage 3 study are discussed in five sections: i) attitudes and 
knowledge, ii) lack of resources for CMs use in breastfeeding iii) professional 
judgement and dilemmas, iv) ethical and legal obligations, and v) need for on-going 
professional education and training.  
 
5.5.1 Attitudes and Knowledge 
 
Limited published studies exist in the Australian context exploring community 
pharmacists’ perspectives towards their role in promoting the safe and effective use 
of non-prescription medicines in breastfeeding, and supporting breastfeeding as well 
as other related professional health services in the community pharmacy setting (4, 
5).  
 
The role of pharmacists in this context is further defined in the PSA’s Competency 
Standards Domain 6 Deliver primary and preventative healthcare (388). The only 
published study is a 2013 publication by De Ponti et al. (5) that investigated 
community pharmacists’ perspectives on the use and safety of medicines in 
breastfeeding, and highlighted a need for further research in this area. It involved 
administration of postal surveys using a questionnaire form similar to that used by 
Amir and Pirotta (150) in their study of GP’s perspectives. The study explored 
community pharmacists’ perspectives and their knowledge of using paracetamol, 
ibuprofen, lithium, metronidazole and St John’s wort in breastfeeding. The authors 
concluded that whilst pharmacists felt confident in counselling breastfeeding women, 
their knowledge was variable. This Stage 3 study differed from the former study in 
terms of the specific objectives, the overall focus, medicines investigated and the 
research methodology. With a qualitative approach using semi-structured in-depth 
interviews, the Stage 3 study has enhanced our understanding of community 
pharmacists’ perspectives of their role in promoting the safe and effective use of non-
prescription medicines, including both conventional and CMs, in breastfeeding. 
Furthermore, this study has also explored the potential for the expansion of the 
pharmacists’ role into providing women and breastfeeding-related health services in 




The most common health issues presented by breastfeeding women at the 
participating community pharmacies agreed with the results of a Melbourne, Victoria 
survey conducted in 2008. The survey results indicated that the common conditions 
breastfeeding women presented to general practitioners included mastitis and other 
infections requiring the use of antibiotics, depressive disorders, use of analgesics, 
contraception, insufficient milk supply and other atopic conditions (83, 150, 389).  
 
In this study, the overall attitudes of pharmacists towards their role in promoting safe 
and effective use of medicines in breastfeeding and promoting breastfeeding in the 
community were favourable. Throughout the interviews, pharmacists showed care 
and willingness to expand their professional roles in supporting breastfeeding 
women. The facilitators and barriers identified were in accordance with the literature 
(4, 5, 87, 201, 390, 391). Eades et al. (4) commented that community pharmacists are 
regarded as one of the most accessible health professionals due to their extended 
trading hours and that no appointment is needed to obtain their advice. Convenience 
and accessibility of community pharmacists were acknowledged as main facilitators 
by participants of this study. As stated by Hughes et al. (149), “Pharmacy-based 
personnel reported more frequent exposure to women across the perinatal life-stages 
compared with GPs and nurses”. Consistent with the literature, the Stage 3 study 
demonstrated pharmacists’ frequent and regular contact with breastfeeding women in 
the community. This presents an invaluable opportunity for pharmacists and 
pharmacy staff to provide on-going support to women during the postnatal period, at 
primary healthcare level. Pharmacy support staff form approximately two-thirds of 
the Australian pharmacy workforce (392). Considering the regular interactions 
between women and the pharmacy staff, appropriate training should also be offered 
to support staff in order to meet the needs and expectations of women, at the same 
time ensuring they are able to recognise symptoms or cases which warrant referral to 
the pharmacist.   
 
It was consistently reported by participants that pharmacists lack knowledge and 
confidence in discussing the use of CMs in breastfeeding. Despite the popularity of 
herbal galactagogues as indicated in Stages 1 and 2 of the study, pharmacists who 
participated in the Stage 3 study had limited experience and knowledge with regards 
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to their efficacy and safety in breastfeeding. Pharmacists’ lack of knowledge and 
confidence in recommending and providing advice regarding the use of CMs to the 
general population have also been reported in various published studies (201, 214, 
345, 390, 393-395). Taking into consideration the prevalence of herbal medicine use 
amongst breastfeeding women in Western Australia and to meet their expectations, 
the perceived lack of knowledge and confidence of pharmacists should be addressed 
(335, 350).  
 
Pharmacists’ attitudes in this context may be influenced by previous successful or 
positive experiences (201). Participants who had previous experience with the use of 
CMs and personal experience with breastfeeding showed great interest in supporting 
breastfeeding women. However in terms of herbal medicines, it was unclear whether 
they would choose to provide recommendations beyond the limited evidence-based 
information. Despite their interest and willingness to participate in public health 
services in the community, only one participant was fully aware of the 
implementation of the Australian National Breastfeeding Strategy 2010-2015. As 
pharmacists are listed as support professionals (1), this finding indicated that all 
stakeholders should be better informed of their roles and expectations in order to 
meet the objectives of such strategies.  
 
The majority of the participants in this study agreed with the six statements 
addressing pharmacists’ self-awareness of knowledge and confidence level. Despite 
the favourable perceived knowledge level, previous studies have demonstrated 
pharmacists’ variable and poor knowledge in the area of medicines use in 
breastfeeding (5, 87, 88, 156). Nevertheless, the current study did not assess 
participants’ knowledge of specific medicines, hence direct comparison to the 
literature is not possible. A review of the literature also suggested that a pharmacist’s 
self-perceived confidence level does not always equate to knowledge adequacy (5, 
88, 156, 396). It was suggested that raising the awareness and knowledge of 
pharmacists in regard to the commonly used medicines and their safety in 
breastfeeding would prevent health professionals from giving conservative 
recommendations unnecessarily and improve the quality use of medicines during 




5.5.2 Lack of Resources for CMs use in Breastfeeding 
 
Participants identified a lack of available resources about non-prescription 
medicines, in particular high level information on CMs use in breastfeeding. This 
finding was in line with the published literature (5, 201). Despite findings from 
Stages 1 and 2 demonstrating the popularity of herbal medicines amongst 
breastfeeding women, to date, no published study has focused on investigating 
community pharmacists’ perspectives towards CMs use in breastfeeding. Stage 3 
provides useful information on the perspectives of community pharmacists with 
regard to the available resources and references in the context of CMs (including 
herbal medicines) and other non-prescription medicines in breastfeeding. Many 
previous studies have highlighted the lack of resources available with regards to the 
use, efficacy and safety of CMs in the general population (202, 210, 348, 394, 395, 
397-399). Insufficient information and research into the use and safety of medicines 
in breastfeeding had also been identified by both women and health professionals as 
a challenge (83, 87, 142, 150, 156, 328, 396, 400, 401). As previously reported in 
Section 5.4.3, participants used a variety of references and resources to assist them 
with their daily practice in the provision of advice to breastfeeding women with 
regard to the use of non-prescription medicines, including CMs. Although these 
references and resources may provide useful information on conventional medicines, 
there is limited information on CMs, especially herbal medicines. The Pharmacy 
Board of Australia provides a list of recommended essential references and states 
“Pharmacists must be able to readily access contemporary works of professional 
reference in either conventional or electronic forms. The information is to be 
immediately available to the pharmacist during the clinical assessment, reviewing, 
dispensing and counselling processes” (402). According to the Pharmacy Board of 
Australia’s Guidelines on practice-specific issues – Guideline 1 (List of References) 
(402), current editions of “an evidence-based reference work on complementary and 
alternative medicines” (402) must be readily accessible to pharmacists. Under this 
category, pharmacies in Australia should have at least one of the following: i) Herbs 
and Natural Supplements: An evidence based guide. Braun and Cohen (220); or ii) 
Herbal Medicines. Barnes, Anderson and Phillipson (403); or iii) e-MIMS; or iv) 
AusDI Advanced. Nevertheless, the Pharmacy Board of Australia does not have 
jurisdiction over pharmacy premises. The Pharmacy Regulations 2010 (404) states 
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that it is mandatory for pharmacy premises to have specific documents and 
references, but none of them are references specific to CMs. Interestingly, in the 
interviews with Stage 3 participants, there was no mention of resources specific to 
CMs or herbal medicines, including textbooks (220, 403) and relevant CMs database 
for example Natural Medicines (formerly Natural Standard and Natural Medicines 
Comprehensive Database) (405). The fact that e-MIMS provides information on both 
conventional medicines and CMs and that it is available in electronic version and 
also contains other features such as “Drug Alert Interactions”, these factors may 
explain why some pharmacies would opt for e-MIMS as an option rather than 
textbooks. It may also be possible that participants were not aware of resources 
specific to CMs or it may be interpreted as pharmacists demonstrating their focus on 
conventional medicines. Nevertheless, this finding highlights the importance of 
ensuring that pharmacists are aware of the available resources, specifically not just 
where to find them, but also how to interpret the available information.  
 
LactMed® (406) is a peer reviewed TOXNET database which contains information 
on safety of drugs in breastfeeding, including conventional medicines and some 
herbal medicines for example fenugreek. In the study conducted by De Ponti et al. 
(5), up to 25% of the survey respondents who were pharmacists (n = 175) reported 
using the LactMed® database as one of the resources for information with regard to 
the safety of medicines in breastfeeding. However, there was no mention of the use 
of this database from participants of Stage 3. Although this database is based in the 
USA and uses North American drug names, the database does provide useful 
information which could assist Australian pharmacists in making clinical 
recommendations since there is no similar database specific for drugs use in lactation 
available in Australia.  
 
In addition to the need for further research into CMs use in breastfeeding, 
participants also raised the need for a more stringent approach by the Australian 
TGA to regulate the marketing of CMs. Currently, most CMs, including herbal 
medicines and supplements, are regulated under the specifications of ‘AUST L’ or 
‘listed’ medicines (16). Although there have been many debates over the years 
around whether CMs should be subjected to the same regulations as conventional 
medicines (16, 160, 165, 391, 407), participants were of the opinion that improved 
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Australian regulation may encourage pharmaceutical companies to undertake further 
research regarding the safety and efficacy of their products in the different 
population groups, including pregnant and lactating women. As discussed previously 
in Section 2.5.3, the marketing and supply of AUST L medicines in Australia is 
currently co-regulated between the TGA through the TGAC and the CHC’s Code of 
Practice (16, 204). As opposed to AUST R medicines, products classified as AUST L 
are subjected to less stringent advertising regulation. Despite the lack of efficacy data 
for many CMs, the advertising of these medicines through mainstream media may 
positively but inaccurately affect the public’s perception of the safety and efficacy of 
these products. Considering the purpose of marketing is to promote the sales, loose 
controls over marketing of CMs will impact on the public’s decision to purchase.   
 
A range of information sources was used by participants of this study, reflecting their 
familiarity with seeking information particularly in relation to conventional 
medicines. The common information resources and references reported were similar 
to those described by De Ponti et al. (5), who stated that 79% of their survey 
respondents thought the available information regarding use and safety of medicines 
in breastfeeding was adequate, including St John’s wort, which was the only herbal 
medicine included in the study. In a review written by Ilett and Kristensen (127) 
which was cited by De Ponti et al. (5), St John’s wort was also the only herbal 
medicine evaluated for partition into breast milk. Despite agreeing that these 
resources and references provided guidance to pharmacists when making clinical 
recommendations, most participants of the Stage 3 study indicated that information 
specifically with regards to CMs including herbal medicines and their safety in 
breastfeeding was lacking. Insufficient coverage of data related to CMs and the 
safety of medicines in breastfeeding in commonly used resources and reference texts 
was identified as a barrier in this and previous studies (87, 156, 390) This area was 
perceived by the participants as a practice gap and had a negative impact on 
pharmacists’ confidence. Participants preferred an easily accessible website or 
reference text which provides topic-based information on various OTC treatable 





In Australia, most conventional medicines have been classified under categories that 
indicate their safety in pregnancy (408). Many drugs have been assigned an 
Australian category, namely Category A (safest in pregnancy), B1, B2, B3, C, D or 
X (should be avoided in pregnancy due to high risk of permanent damage to the 
foetus), demonstrating their safety in pregnancy based on the available literature 
(252). Similar categories do not exist about the safety of medicines in lactation (83). 
The United States’ Food and Drug Administration (FDA) has previously made 
attempts to classify commonly used medicines into Lactation Categories based on 
available evidence and the safety in lactation (61, 62, 409). Nevertheless, due to the 
lack of available evidence and research, not many medicines have been assigned a 
category.  The lack of resources and research in this area had been acknowledged by 
the FDA and major revisions to the labelling of medicines in the US with regards to 
their effects in both pregnancy and in lactation were recommended (409). It should 
be highlighted that there were no comments about these lactation safety categories by 
the Stage 3 participants, suggesting that this classification has not been adopted into 
the daily practice of pharmacists in the Australian context. Until this point, the TGA 
has not introduced classification of medicines and their safety in breastfeeding. This 
in itself is of interest as there are currently no similar lactation safety categories in 
the Australian guidelines to assist health professionals in making clinical decisions 
and providing recommendations to breastfeeding women.   
 
5.5.3 Professional Judgement Dilemmas 
 
Concern over breastfed infants’ safety was regarded as one of the crucial factors 
guiding pharmacists’ decision-making process. This over-arching theme emerged as 
participants described their dilemma when making clinical recommendations with 
regards to the use of non-prescription medicines in breastfeeding. Pharmacists often 
face challenges to recommend non-prescription medicines which are safe and 
effective to breastfeeding women when they present themselves to the pharmacy 
requesting treatment for OTC treatable conditions. Based on the limited available 
information and resources, pharmacists based their recommendations on professional 
judgement and personal experience, weighing benefits of using a medicine for the 
breastfeeding mother and the potential risks to the infant’s safety. In order to 
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minimise the level of uncertainty, participants tend to adopt a conservative attitude 
and recommend a product that they were familiar with. This finding was in line with 
the literature which also demonstrated the challenges and concerns of health 
professionals, including general practitioners and pharmacists, when they were 
required to provide clinical recommendations to breastfeeding women who present 
themselves to their practice for treatment (5, 83, 150, 389). In the absence of 
available evidence-based information, health professionals in many cases were 
required to consider the “risk to baby versus benefit to mother”, as described by 
Amir and Pirotta (150). 
 
It appeared in this study that making clinical recommendations to breastfeeding 
women was regarded as a complex and potentially complicated task. A study 
conducted by Jayawickrama et al. (83) in Melbourne, Australia, explored general 
practitioners’ experience and perspectives towards prescribing for breastfeeding 
women. The researchers reported the “complexity of managing risk in prescribing for 
breastfeeding women” as the global theme of the study. Although this study was 
conducted with general practitioners, it provided insight into the challenges which all 
clinicians may face when making clinical recommendations to lactating women. 
Findings of the Stage 3 study complement the literature, by exploring pharmacists’ 
perspectives and attitudes towards promoting the safe and effective use of non-
prescription medicines in breastfeeding.  
 
5.5.4 Ethical and Legal Obligations 
 
In order to practice in Australia, it is a requirement for all pharmacists to register 
with the AHPRA (22). Health professionals registered with AHPRA need to comply 
with the Code of Conduct for Health Professionals as well as a number of practice 
standards. Pharmacists practising in Australia are guided by the PSA’s Professional 
Practice Standards and Code of Ethics, where expectations of the pharmacists and 
pharmacy profession are summarised (33, 89). Regardless of the practice setting, all 
pharmacists should be competent with the PSA’s Professional Practice Standard 1: 
Fundamental Pharmacy Practice, which states: “The pharmacist displays accepted 
professional and ethical behaviour, maintains the consumer’s right to privacy and 
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confidentiality, and aims to achieve the quality use of medicines, health and 
wellbeing” (89). 
 
The PSA’s Professional Practice Standard 12: Provision of Non-prescription 
Medicines and Therapeutic Devices states that: “The pharmacist is responsible for 
the safe and judicious provision of non-prescription medicines and therapeutic 
devices appropriate to the needs of the consumer” (89). The standard further defines 
non-prescription medicines as “all medicines available for purchase by the public 
that do not require a prescription. Non-prescription medicines include, but are not 
limited to, Pharmacist Only Medicines (S3), Pharmacy Medicines (S2), unscheduled 
medicines, complementary medicines, and nutritional supplements” (89). As non-
prescription medicines are available to the public without a prescription from a 
prescriber, pharmacists have the professional obligation over their sales, to ensure 
quality use of these medicines.  
 
Notably, aspects of the pharmacy profession’s ethical and legal obligations were 
recognised by all participants of the Stage 3 study. It was evident that those 
pharmacists constantly reflect on their ethical obligation to the public when 
providing professional advice, and that all recommendations were centred on their 
clients’ health and safety. This was in accordance to the first principle of the PSA’s 
Code of Ethics, which states: “A pharmacist recognises the health and wellbeing of 
the consumer as their first priority” (33). 
 
Participants felt responsible for ensuring the safe and effective use of all medicines 
and products sold in their pharmacies, regardless of whether they were prescription 
or OTC medicines. This finding emphasised the participants’ awareness and 
compliance with the fourth principle of the Code of Ethics, which states: “A 
pharmacist acknowledges the professional roles and responsibilities to the wider 
community: A pharmacist will ensure responsible and accountable control and 
supply of therapeutic goods and contribute to public health and enhancing the quality 
use of medicines” (33). This was also in accordance with the PSA’s Position 
Statement on ‘Complementary Medicines’, which states: “The provision of 
complementary medicines is at the discretion of individual pharmacists who must 
exercise their professional judgement. However, pharmacists involved in the supply 
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of such products have the same obligation to provide information and advice, 
consistent with consumer needs, as they do with registered prescription and 
proprietary medicines” (410).  
 
The PSA’s fifth principle of the Code of Ethics states: “A pharmacist demonstrates a 
commitment to the development and enhancement of the profession: A pharmacist 
will commit to advancing the profession through involvement in activities including 
training staff; engaging in teaching; acting as a preceptor; mentoring students, interns 
and colleagues; engaging in discussions and participating in initiatives to develop the 
profession; and showing professional leadership” (33). Furthermore, the sixth 
principle states: “A pharmacist maintains a contemporary knowledge of pharmacy 
practice and ensures health and competence to practise: A pharmacist will recognise 
the importance of lifelong learning and self-development and their impact on 
professional competence. Further, a pharmacist is responsible for ensuring personal 
health to practise and supporting health professional colleagues in this regard” (33). 
Compliance to the fifth and sixth principles of the Code of Ethics was also evident 
from participants’ commitment to CPD and desire for on-going training in the area of 
medicines use in breastfeeding and the other aspects of breastfeeding. 
 
5.5.5 Need for Continuing Professional Education and Training 
 
For on-going AHPRA registration, pharmacists in Australia are required to comply 
with the annual CPD requirements (22). For example, it is a requirement for all 
pharmacists to obtain 40 CPD credits between 1st October 2013 and 30 September 
2014 in order to be eligible for renewal of AHPRA registration. As discussed in 
Stage 1 of the study, the increasing number of women using herbal medicines whilst 
breastfeeding pose a great challenge to community pharmacists. Findings of the 
Stage 3 study were in accordance with the literature, demonstrating pharmacists’ 
desire for further education and training in the area of CMs use and breastfeeding, as 
well as the need for modification of the university pharmacy degree’s curriculum to 
incorporate a greater component on CMs and various aspects of breastfeeding to 
meet the growing demand (87, 201, 390).  Results have also showed that 
pharmacists, especially those who have regular contacts with breastfeeding clients in 
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the community need further training and education in order to provide appropriate 
guidance to the increasing number of women who are using CMs whilst 
breastfeeding and who regularly utilise community pharmacies as sources of advice 
and information. A need for continuing professional education and training for 
pharmacists was established, taking into account the demand and expectations of 
clients and the pharmacists’ interests in further learning (163, 208, 390, 411). There 
seems to be an opportunity and urgent need for professional organisations and 
universities to provide CPD on CMs and various aspects of breastfeeding to 
pharmacists and pharmacy students. There is also a need for on-going and regular 
revisions of reference texts to make sure they incorporate the latest studies and 
evidence, so that these resources assist health professionals in providing up-to-date 




Every study has its limitations. As participation was voluntary, it is likely that 
pharmacists who were more interested in the topic had participated in the interviews, 
which could potentially underestimate the challenges or barriers to the expansion of 
pharmacists’ role. Despite collecting information on pharmacists’ self-awareness of 
knowledge and confidence level, the study did not assess pharmacists’ actual 
knowledge on the commonly used medicines in breastfeeding and their approach to 
managing common OTC treatable conditions. As all participants of the study were 
community pharmacists from Western Australia, findings of the study may only be 
limited to the pharmacists group previously mentioned, and it is acknowledged that 
pharmacists working in different sectors, such as hospitals, or in other states or 
internationally, may have different experiences, perspectives and attitudes 
influencing their practices. The student researcher, who was the interviewer in this 
research study, is a practising pharmacist which may have influenced the interviews 
and affected the analysis. In an attempt to counterbalance any potential bias, the 
student had regular meetings throughout the period of data collection and analysis 
with the supervisors, all of whom have different disciplinary backgrounds and had no 
affiliations with any of the community pharmacies and pharmacists who participated 




















This chapter provides a summary and a general discussion of the significance of the 
overall findings of this research, followed by the overall conclusions from the 
research and the recommendations and directions for future studies.  
 
6.1 Summary of the Thesis 
 
This research explored breastfeeding women and community pharmacists’ 
perspectives on herbal medicines use in breastfeeding. In summary, there were three 
stages to this study: 
 
 Stage 1 investigated the prevalence and pattern of use of herbal medicines 
amongst breastfeeding women living in Western Australia using a 
population-based survey.  
 
 Stage 2 explored breastfeeding women’s experience on the use of herbal 
galactagogues and their attitudes towards the use of herbal medicines in 
general whilst breastfeeding. This stage also provided insight into women’s 
perspectives on the pharmacists’ involvement and potential roles in meeting 
their healthcare needs in the community pharmacy setting.  
 
 Stage 3 explored community pharmacists’ perspectives of their role in 
promoting the safe and effective use of non-prescription medicines, including 
CMs in breastfeeding. This stage also explored community pharmacists’ 
attitudes towards expansion of their roles in the provision of women and 
breastfeeding-related professional services in the community.  
 












































A population-based survey on the use of 
herbal medicines during breastfeeding  
Stage 2 
The use of herbal galactagogues in 
lactation: Breastfeeding women’s 
perspectives and views including the 
involvement of community pharmacists 
Stage 3 
Promoting safe and effective use of herbal and 
non-prescription medicines during breastfeeding 
and supporting breastfeeding in the community:  
The pharmacists’ perspectives 
Main findings informing Stage 2: 
 Commonly used herbal galactagogues 
 Attitudes of breastfeeding women towards herbal medicines 
 Pharmacies are common source of supply 
 Pharmacists are commonly used source of information 
Main findings informing Stage 3: 
 Pharmacies are common source 
of supply 
 
 Pharmacists are commonly used 
source of information 
 
 Conflict between the lack of high 
level information on herbal 
medicines in breastfeeding and 
breastfeeding women’s needs 
 
 The role of pharmacists when 
selling herbal medicines to 
breastfeeding women 
 
Main findings informing Stage 3: 
Women’s attitudes and perceptions of 
using herbal medicines 
Most breastfeeding women who used 
fenugreek to increase milk production 
found it effective 
 Low perception of herbal medicines 
toxicity by breastfeeding women  
 Pharmacists are perceived as readily 
accessible and trusted source of 
information 
 Identified potential for expansion of 
pharmacists’ role 
 Identified need for exploring 
pharmacists’ perspectives 
 Identified need for further research into 
the use of CMs during breastfeeding 
 




6.2 General Discussion 
 
Detailed justification of the methodology employed in this research, the limitations 
and discussion of the key findings are presented in this section. The results and 
findings of Stages 1, 2 and 3 are discussed in relation to the overall aims of the 
thesis, which were to evaluate the perspectives and influencing factors of 
breastfeeding women with respect to the use of herbal medicines (especially 
galactagogues) and to investigate the role of Australian community pharmacists in 
supporting breastfeeding women, in relation to the provision of advice and 
information on herbal and other non-prescription medicines.  
 
6.2.1 A Review on the Research Methodology of these Studies 
 
To achieve the overall aims, a mixed-methods approach was adopted to gather data, 
opinions and experiences necessary to evaluate the perspectives of breastfeeding 
women and community pharmacists. Over the last decade, mixed-methods research 
has become increasingly popular amongst researchers in the fields of healthcare, 
pharmacy practice and health services (412-414). Mixed-methods research is also 
often been regarded as the third research paradigm, after quantitative and qualitative 
research (415). According to Creswell and Plano Clark (416), 
 
Mixed methods research is a research design with philosophical assumptions as well 
as methods of inquiry. As a methodology, it involves philosophical assumptions that 
guide the direction of the collection and analysis and the mixture of qualitative and 
quantitative approaches in many phases of the research process. As a method, it 
focuses on collecting, analysing, and mixing both quantitative and qualitative data in 
a single study or series of studies. Its central premise is that the use of quantitative 
and qualitative approaches, in combination, provides a better understanding of 
research problems than either approach alone (416).   
 
The overall approach followed to achieve the research aims was to use both 
quantitative and qualitative methodology with the goal of providing an in-depth 
understanding of the research topic of interest. Hadi et al. (412) state that this 
methodology “can potentially resolve this ‘indecisive battle’ between the two types 
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of methodology as it recognizes and appreciates the strengths and weaknesses of 
both qualitative and quantitative research designs”. Mixed methodology is also 
viewed as “practical” by Creswell and Plano Clark (417) as it allows researchers to 
develop the optimum method by choosing and merging different methodologies in 
order to gather comprehensive data to address the research problems.    
 
According to Smith (414), the choice of research methodology in pharmacy practice 
and health services is “generally governed by data requirements for fulfilling 
research objectives and practical considerations in conducting research” (414). 
Considering the aforementioned points and the overall aims of this research, mixed 
methodology was considered the most suitable approach and best fitted the scope and 
purpose of the overall thesis. This research comprised three stages to collect 
comprehensive and relevant quantitative and qualitative data to evaluate the 
perspectives of breastfeeding women and community pharmacists on the use of non-
prescription medicines, in particular herbal medicines in breastfeeding. As this thesis 
was an original work in Western Australia to evaluate the perspectives of 
breastfeeding women and pharmacists in the context of herbal medicines in 
breastfeeding, the design of the research had to be exploratory in nature, in that the 
findings of the various stages would inform and shape subsequent stages of the 
research, as shown in Figure 6.1.  
 
The review of the literature identified that there was a lack of data with regards to the 
pattern of use of herbal medicines during breastfeeding and the potential role of 
community pharmacists in supporting breastfeeding women in relation to the 
appropriateness of their use. Although many studies have explored the pattern of use 
of herbal medicines amongst the general population, the use of these medicines 
specifically by breastfeeding women had not been well studied. The essential first 
step of this research was to investigate the prevalence of herbal medicines usage 
amongst breastfeeding women, the commonly used herbal medicines, women’s 
attitudes towards the use of these medicines as well as their information-seeking 
behaviour. To fulfil the research objectives of Stage 1 (as specified in Section 3.2), a 
survey of breastfeeding women living in Western Australia was considered an 
appropriate method to gather the required data. Using a quantitative approach, the 
survey was conducted using a structured questionnaire as the survey instrument, 
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designed for self-administration by respondents. This research method was chosen 
for Stage 1 as it allowed quantification of the data and enabled exploration of the 
associations, if any, between the responses of respondent subgroups and their 
patterns of herbal medicines use in breastfeeding. This quantitative approach also 
allowed the candidate to gather information on the commonly used herbal medicines 
and provided guidance to subsequent stages of the research.  
 
Findings of the Stage 1 study, along with the literature review, guided and justified 
the development of Stage 2. Although Stage 1 identified that herbal galactagogues 
were commonly used amongst the survey respondents, detailed information on the 
routes of administration and dosages were not collected. Other aspects identified 
through Stage 1 that required further exploration were presumptions of the safety of 
herbal medicines compared to conventional medicines and the role of the pharmacy 
profession as pharmacies were identified as a common source of herbal medicines 
supply and pharmacists indicated to be the most common source of information. A 
need was therefore identified to obtain an in-depth understanding of the perspectives 
and perceptions of breastfeeding women and the factors affecting their choices. 
Hence, the aforementioned points justified the need to conduct Stage 2 with a 
qualitative approach, bearing in mind the strengths and limitations of qualitative 
methodology.  
 
Qualitative research methods allow the collection of relevant, rich and in-depth 
information, enabling researchers to explore the attitudes and perspectives of 
individuals in the context of the their individual circumstances (359, 414, 418). 
Smith (414) considered qualitative studies the most appropriate for “why?” and 
“how?” questions to explore the patterns and processes in participants’ behaviour and 
thoughts.  According to Patton (359), there are three types of qualitative data: 
interviews, observations and documents. Of these, data collected through the medium 
of interviews best suited the objectives and purpose of Stage 2, which employed a 
semi-structured interview guide to assist in the evaluation of breastfeeding women’s 
perspectives and to seek in-depth understanding of the major findings of Stage 1.   
 
The value of qualitative research lies in its flexible approach and the ability to be 




Qualitative researchers, however, must remain sensitive to the respondents’ 
viewpoints and be prepared to consider new issues and ask questions throughout 
data collection and analysis. To gain insights into the respondents’ interpretations 
and perceptions of events, experiences and surroundings, qualitative researchers 
must be attentive to the perspectives of the respondents, and endeavour to leave their 
own preconceptions behind (414).        
 
In accordance with the essence of qualitative exploratory research there is 
justification for the need, at appropriate times, to deviate from an interview guide. 
For example, some participants from Stage 2 raised their thoughts on the health 
system and the potential role for expanded breastfeeding-related professional 
services within the community pharmacy setting. These topics were not specifically 
included in the interview guide. However, as the study was conducted through the 
form of interviews, the methodology allowed the interviewer to probe in order to 
elicit further information about the participants’ perspectives. This also enabled the 
participants to elaborate on their thoughts which added to the richness and quality of 
the data collected.  
 
As Stages 1 and 2 identified some common themes in that pharmacies were a 
common source of CMs supply and that breastfeeding women were likely to access 
pharmacies and seek advice from pharmacists, Stage 3 of the study was conducted to 
evaluate the perspectives of community pharmacists on the use of herbal medicines 
and other non-prescription medicines in breastfeeding, as well as their role in 
supporting breastfeeding women in the community and any associated facilitators 
and barriers emerging from the themes. Justification for gathering information in the 
broader context of non-prescription medicines has previously been provided in 
Section 4.5.6. To meet the research objectives of Stage 3 (provided in Section 5.2), 
interviews with pharmacists were considered the best form of data collection as it 
allowed the interviewer to explore pharmacists’ viewpoints towards the major 
findings of Stages 1 and 2, and enabled participants to elaborate on their thoughts 
and the factors impacting their behaviour. For example, Questions C7 and C8 of the 
interview guide were designed to collect participants’ views on the Stage 1 findings; 
whilst Questions E6 and G3 explored their views on Stage 2 findings. As this was the 
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first study in the Western Australian context to evaluate the perspectives of 
pharmacists towards providing advice on herbal and non-prescription medicines to 
breastfeeding women and supporting breastfeeding in the community, a series of 
closed and open-ended questions were incorporated to meet the study objectives. 
Semi-structured interviews with community pharmacists were used to obtain detailed 
descriptions and an understanding of their experiences and perspectives that allowed 
the development of perspectives and understanding of the current and potential future 
role of community pharmacists in supporting breastfeeding women. 
  
The number of participants and types of data collected in each stage of the study also 
strengthened the research. Stage 1 was a survey with 304 respondents, which enabled 
quantitative data collection from a large number of women. Stages 2 and 3 focused 
on smaller numbers of participants (n = 20 for Stage 2 and n = 30 for Stage 3) to 
collect more in-depth qualitative data. Interviews with breastfeeding women and 
community pharmacists ceased when the interviewer (in this case the candidate) did 
not identify new emerging concepts coming forward. The initial analysis was also 
discussed in detail with the supervisors to ensure that data saturation had been 
reached.   
    
6.2.2 Limitations  
 
Any research design has its limitations and challenges, and the limitations should be 
taken into consideration when analysing and interpreting findings of the studies. 
Stage 1 collected quantitative data through self-administered structured survey 
questionnaires. The reliability of this research method depended on the willingness 
and ability of respondents to provide accurate information or responses to the 
questions in the questionnaire, which could have presented as a challenge 
specifically if participants could not accurately recollect the information needed 
(414). As the surveys were self-administered and anonymous, the research method 
employed in Stage 1 did not allow follow-up of responses or the opportunity for the 
candidate to clarify viewpoints of the respondents. Nevertheless, this was overcome 
through Stages 2 and 3, which provided opportunity for clarification and in-depth 
understanding of the major findings of Stage 1. As with all qualitative research, the 
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background and perspectives of the researchers may have had an impact on the 
analysis of the interview findings (359). As previously stated in Section 5.5.6, the 
candidate is a registered pharmacist in Australia carrying out research through a 
School of Pharmacy, which could have impacted the interviews and analysis. 
However, to counterbalance the potential bias, regular meetings were scheduled 
throughout the period of data collection and analysis with the supervisors, who have 
different disciplinary backgrounds and had no affiliations with any community 
pharmacies. Therefore, considering the strengths and limitations of the chosen 
research methodology, it was considered appropriate in fulfilling the overall aims 
and objectives of the research. The collection of both quantitative and qualitative 
data from breastfeeding women and pharmacists allowed the researchers to obtain in-
depth insight into the topic of interest.  
 
6.2.3 Prevalence of the Use of Herbal Medicines in Breastfeeding 
 
Stage 1 showed that there was a high prevalence of breastfeeding women using 
herbal medicines amounting to approximately 60% of the study population. In 
addition, many of these were using two or three different herbal medicines. 
Approximately 25% of respondents took one or more herbal medicines specifically 
to increase breast milk supply. The major factor influencing the use of herbal 
medicines was that women born in Asian countries were 2.2 times more likely to use 
herbal medicines during breastfeeding than participants born in other countries.  
 
There is no database from which a sample of breastfeeding women living in Western 
Australia can be accessed. Hence, recruitment strategies may have impacted on the 
above findings. To maximise the sources for recruitment, four strategies were 
employed with approximately equal recruitment resources distributed through each 
strategy. It is accepted that it is possible that women who were using herbal 
medicines may have been more inclined to respond. However, the selection criteria 
were all breastfeeding women or women who had breastfed in the past 12 months 
and who were over 18 years of age. When compared with a nationally representative 
sample from the 2010 Australian National Infant Feeding Survey  (340), age and 
parity of the respondents of Stage 1 were reasonably well matched. The majority of 
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the respondents in both studies were women with university degrees and were born 
in Australia. This is a likely outcome for Stage 1 considering respondents had to 
initially volunteer to participate for the study. Nevertheless, a higher proportion of 
Stage 1 respondents were born overseas than those of the national survey.  
 
A cross-sectional study of the general population in Victoria, Australia, in 2007 
found nearly one-quarter of the sample had used at least one herbal medicine in the 
preceding 12 months (25). Other studies have shown between 20% and 30% of adult 
Australians use herbal medicines (7, 160). A 2004 South Australian study revealed 
that women between the ages of 25 and 34, with higher education and income levels 
showed greater use of CAM (in general) (160).  The South Australian study also 
demonstrated that women’s use of herbal medicines rose from 16.6% in 2000 to 
24.9% in 2004 (p < 0.01) (160). Pregnant (36%) (26) and mid-life (41%) (419) 
Australian women have shown higher rates of herbal medicines usage. Although 
60% (in Stage 1) is a high estimated prevalence of use which may have been 
influenced to an extent by respondent bias, there is clear evidence of a high 
utilization of herbal medicines by breastfeeding women. There are no comparable 
data available in Australia with regard to the prevalence of herbal medicine use 
amongst breastfeeding women, however overseas data indicated estimated 
prevalence between 15% and 88% (215, 219, 341). In a study conducted in Taiwan 
in 2006 (341), the authors reported a marked escalation of the prevalence of use of 
Chinese herbal medicines from 33.6% during pregnancy to 87.7% during the 
postpartum period. As Stage 1 involved a larger proportion of women born overseas 
compared to the 2010 Australian National Infant Feeding Survey, the above 
mentioned factor could explain the higher estimated prevalence found in Stage 1 and 
the other finding which indicated that women who were born in Asian countries were 
significantly more likely to use herbal medicines.    
 
6.2.4 Breastfeeding Women’s Perspectives 
 
Despite the widespread use of herbal medicines and herbal galactagogues, very little 
is currently known about their effectiveness and safety in breastfeeding. This in itself 
is of concern considering the chemical complexities of herbal medicines and the 
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paucity of scientific evidence to support the clinical efficacy and safety of the 
majority of these medicines in breastfeeding. Additional risk arises for those using 
multiple herbal medicines. Nevertheless, the majority of the Stage 1 survey 
respondents (70.1%) reported that there was a lack of information resources. A 
review of the literature revealed that reliable data on the use, efficacy and safety of 
many herbal medicines in breastfeeding are lacking. It could also be argued that poor 
access to the available resources or the lack of credible resources could also 
contribute to women’s perceptions of not having sufficient information. A need was 
therefore identified to address the information needs and that the available (or the 
lack of) information about the effectiveness and safety of these medicines needs to be 
disseminated to breastfeeding women in an effective manner. Health professionals 
who have regular contacts with breastfeeding women and their families are therefore 
well placed to provide support and to present as a reliable source of information. 
Despite the fact that the majority of the respondents believed there was a lack of 
information available to them, 43.4% of respondents perceived herbal medicines to 
be safer than conventional medicines. An overwhelming 71.6% of women who 
participated in the survey reported previous refusal or avoidance of conventional 
medicine treatments due to concerns regarding safety of their breastfed infants. As 
previously mentioned, there are no comparative data available in Australia in this 
context. However, a study conducted in Indiana which involved 461 Hispanic 
women found that the majority of the participants were aware of the potential risks 
associated with the use of herbal medicines in breastfeeding (219). Interestingly, the 
author revealed that 37% of the participants who breastfed reported ceasing the use 
of herbal medicines when they initiated breastfeeding (219). This finding identified a 
need to establish and implement a sustainable strategy to improve education to 
breastfeeding women in Australia in order to address the misconceptions about 
conventional and herbal medicines. It also justified the need for Stages 2 and 3 to 
explore breastfeeding women’s perspectives and their unique needs during the 
postnatal period and how to address their information needs from the pharmacists’ 
perspectives.  
 
Fenugreek was the herbal galactagogue most commonly used by women with 
perceived insufficient milk supply. Community pharmacies were one of the most 
common sources of supply. The overall satisfaction and experience of women with 
253 
 
the use of fenugreek as a herbal galactagogue was positive. Most had perceived it as 
the herbal galactagogue of choice in promoting breastfeeding performance. As 
discussed in Chapter 2, domperidone is a conventional medicine commonly 
recommended by health professionals for use in breastfeeding as a galactagogue. 
However, domperidone is not registered in Australia for the indication of increasing 
breast milk supply (252). It is therefore prescribed off-label for this indication. 
Although the study did not specifically explore the use of domperidone, one 
participant from Stage 2 reported the use of this medicine in conjunction with 
fenugreek whilst breastfeeding. Information on the prevalence of use of domperidone 
as a galactagogue amongst breastfeeding women living in Western Australia is not 
available. Nevertheless, this study highlighted a mismatch between the perspectives 
of participants (breastfeeding women in Stage 2) and what is considered as 
mainstream management. According to a review conducted by Ilett and Kristensen 
(127), domperidone is considered the preferred choice of galactagogue in Australia 
based on the available evidence for efficacy and safety in breastfeeding. Other 
studies have also demonstrated the efficacy of domperidone in increasing breast milk 
production (234, 289). This in itself is of interest as despite the fact that higher level 
evidence is available to support the use of domperidone as a galactagogue, some 
women preferred to use herbal galactagogues and considered these options “safer” 
than conventional treatment. This finding further reinforces the need to provide 
better education and improved information dissemination to breastfeeding women. 
As community pharmacists were perceived by breastfeeding women as “easy to 
access” and “convenient” sources of information and supply of medicinal products, it 
appears that there may be a potential for these health professionals to expand their 
roles to fill the gaps in providing support and advice to breastfeeding women in 
relation to both herbal and non-herbal galactagogues.  
 
In the absence of milk volume measurement, women described a range of subjective 
indicators to “measure” their breastfeeding performance. Complementing the 
findings of the Stage 1 study, women in Stage 2 described how their choice of 
therapy was influenced by their perseverance and determination to breastfeed, and 
their concerns over infants’ safety with the use of conventional treatments. An over-
arching theme that emerged was “confidence and self-empowerment”. A sense of 
autonomy and self-efficacy over their own health needs was recognised as influential 
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to their level of confidence, at the same time provided women with reassurance 
throughout the breastfeeding journey. This is an important finding considering that 
evidence is lacking to support the use, effectiveness and safety of the majority of 
herbal galactagogues in breastfeeding. As discussed in Section 2.3.1, psychological 
factors may influence the initiation and duration of breastfeeding (79). This study has 
highlighted the importance of considering the potential psychological benefits of 
using herbal galactagogues, and how this translates into breastfeeding performance. 
There appears to be an innate comfort in using herbal medicines with unknown 
toxicity profiles over a conventional medicine shown to have efficacy and low 
toxicity in breastfeeding women (420). In addition, herbal tinctures were used 
without concern of their contents or toxicity by women who expressed distrust 
arising from toxicity concerns for conventional medicines. Furthermore, the alcohol 
content of such a tincture is unknown. It further highlights the role that pharmacists 
could play in educating breastfeeding women to fully comprehend the available (or 
the lack of) information and the fact that other conventional medicines, such as 
domperidone, may have higher efficacy and known safety data to support their use in 
breastfeeding.   
 
Stage 2 also explored the perspectives of breastfeeding women on community 
pharmacists’ breastfeeding support role and whether there is potential for role 
expansion, as well as how community pharmacists can meet their healthcare-related 
needs in the community pharmacy setting. The overall perspectives of women with 
regards to the role of community pharmacists were positive. Pharmacists were 
perceived as trust-worthy, convenient and easily accessible sources of information 
and advice. Facilitating factors reported by women included pharmacists’ knowledge 
and credibility, effective client-pharmacist relationships, and that no direct costs are 
involved when consulting a pharmacist. These findings were consistent with and 
supported the available literature which explored the potential for role expansion of 
pharmacists in Australia (382, 383). Nevertheless, this thesis contributes to our 
knowledge specifically in the context of their trust in pharmacists. This is a sound 
basis for support of breastfeeding women via the provision of advice on the use of 
herbal and other medicines, through understanding the perspectives of breastfeeding 




A number of barriers or concerns were raised in the themes in Stage 2 which need to 
be addressed to provide better care and improve pharmacy practice. These included a 
lack of experience and breastfeeding-related knowledge or awareness, inappropriate 
pharmacy layout and privacy issues, and pharmacists’ inconsistent approach. A 
previous Australian study has shown that pharmacy customers expected greater level 
of interaction and engagement with pharmacists and that there was an expectation for 
community pharmacists to have adequate knowledge on CMs (207). This research 
identified that Stage 2 participants, who were users of herbal galactagogues, also had 
similar expectations for community pharmacists. In addition, it was also the 
perception of some women that pharmacists may have pre-conceived negative 
perceptions towards herbal medicines or other alternative therapies.   
 
Women also suggested several breastfeeding-related services perceived to be useful 
in the community pharmacy setting for example baby weigh-in services, lactation 
booths, in-store information sessions and distribution of pamphlets or educational 
materials in pharmacy. The pharmacists’ views on the feasibility of these services 
were then explored in Stage 3. The question of whether pharmacists should expand 
their role into women and newborns’ health in the community pharmacy setting 
should be explored in consultation with other groups working in this area, and, their 
specific roles and expertise should be clearly defined to avoid duplication of roles 
with other healthcare workers. The study also revealed opportunities for community 
pharmacists to expand their role to better support women and promote breastfeeding 
in the community, which informed the objectives of the Stage 3 study.  
 
6.2.5 Pharmacists’ Perspectives 
 
There were some similarities between the findings of this study and previously 
published research (4, 5, 83, 87, 149). Pharmacists reported regular interactions with 
breastfeeding women and their infants in the community, and the common health 
issues presented by women for management in the pharmacy were mostly regarded 
as OTC treatable conditions. These included cough and cold, allergies, pain and 
inflammation, insufficient milk supply and other general primary care health issues. 
A range of reference resources was reported by pharmacists, similar to what was 
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described in a previous study (5). Nevertheless, the overwhelming concern raised by 
all participants was the lack of evidence-based clinical studies advising the efficacy 
and safety of CMs use in breastfeeding. It was notable that LactMed®, a TOXNET 
database was one of the websites used by up to 25% of the community pharmacists 
in Australia who participated in the survey conducted by De Ponti et al. (5) in 2011. 
However, the use of this database by WA pharmacists did not arise in any of the 
Stage 3 interviews. This was despite that throughout the interviews, pharmacists 
described how the lack of information and resources influenced their confidence 
level and decision-making processes, contributing to the perception of “complexity”, 
“uncertainty” and “dilemma” when making clinical recommendations. Concern over 
infants’ safety was also regarded as one of the crucial factors affecting pharmacists’ 
decision-making, often leading to pharmacists adopting conservative approaches in 
the provision of advice to breastfeeding women in relation to CMs.  
 
Pharmacists acknowledged that promoting the safe and effective use of non-
prescription medicines in all clients, including breastfeeding women and their 
infants, were part of their professional responsibilities and duty of care. Health 
professionals have an ethical obligation to continuously improve their professional 
ability to ensure optimum health outcomes of patients. Pharmacists participating in 
the Stage 3 study expressed their desire for continuing professional development and 
on-going training to improve their knowledge in the area of medicines use in 
breastfeeding, in particular CMs, and various aspects of breastfeeding. This finding 
correlates with breastfeeding women’s desire for greater support from community 
pharmacists. By expanding their roles and services in the community, these health 
professionals may contribute to fulfilling breastfeeding women’s healthcare-related 
needs. Many aspects of the pharmacy profession’s ethical and legal obligation, as 
stated in the PSA’s Code of Ethics (33), were also recognised by all pharmacists who 
participated in the Stage 3 study.  In addition, the findings broadened the body of 
knowledge about community pharmacists’ decision-making processes when making 
clinical recommendations to breastfeeding women. The positive attitudes of 
pharmacists identified in this study as well as relevant literature findings highlighted 
the opportunity for expansion of pharmacists’ professional roles (207, 382, 383), 
whilst the barriers and challenges should be addressed and taken into consideration 




6.2.6 Comparison between Perspectives of Breastfeeding Women and 
Pharmacists 
 
The qualitative research methods employed in the Stages 2 and 3 studies facilitated 
interaction with participants and allowed in-depth investigation into the meanings of 
comments.  Several areas of overlap emerged during comparison of the perspectives 
of breastfeeding women and community pharmacists. 
 
Consistent with literature findings, breastfeeding women and pharmacists who 
participated in this research all agreed that community pharmacists were a 
convenient and accessible source of credible medicine and health-related information 
(4, 202, 386, 397). Both participant groups (from Stages 2 and 3) perceived the 
pharmacy profession as having drug knowledge or medicine expertise. The “no 
appointment” and “consultation at no cost” approach were appreciated by women 
and acknowledged by the pharmacists. Nevertheless, it was also emphasised by some 
pharmacists that despite their willingness to provide professional services and advice 
to the public, the lack of direct financial compensation or remuneration contributed 
to the challenge of maintaining the sustainability of the community pharmacy 
business model. This was also discussed in the context of “time constraints”, another 
common theme that emerged from the interviews of both participant groups. The 
issue with the current remuneration model was also identified as a barrier in an 
Australian study conducted by McMillan et al. (382) which aimed to explore new 
opportunities, roles and barriers for community pharmacists. However, the study 
focused on professional services targeting patients with chronic illnesses, whereas 
this thesis focused on how community pharmacists can better assist breastfeeding 
women with their needs, with an emphasis on herbal medicines.  
 
The formation of a trusting relationship was recognised by breastfeeding women and 
community pharmacists as a vital aspect facilitating the expansion of the profession’s 
role. Previous experiences and the pharmacist’s perceived knowledge were also 
identified as influential to the building of an effective relationship between the 
breastfeeding woman and the pharmacist. This finding was in accordance with other 
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studies which identified that pharmacists’ credibility and knowledge were one of the 
main facilitating factors enticing customers to pharmacies (4, 5). However, the 
reality of pharmacy practice is that workforce demands could make spending time 
with non-paying consumers challenging. Therefore, financial incentives need to be 
considered for pharmacists to provide professional services beyond medicine supply 
and counselling to maintain sustainability of the pharmacy business as previously 
discussed. Although some women expressed their desire for pharmacists to be more 
“open” to discussions and recommendations around the use of CMs in breastfeeding, 
many pharmacists showed disagreement to this statement. Pharmacists believed that 
it is their duty of care to provide evidence-based advice to facilitate quality use of 
medicines. However, the perceived lack of evidence and research regarding the use 
of CMs specifically in breastfeeding may have contributed to a misconception by 
breastfeeding women of the lack of support from pharmacists.  Nevertheless, both 
participant groups agreed that advice and recommendations provided by the 
pharmacists should be patient-centred and that the well-being of the breastfeeding 
woman and her infant should be the main consideration.  
 
Pharmacists in the study appeared to be aware of their legal and ethical obligations, 
as well as the expectations of their clients. With the increasing popularity of CMs 
and to meet the expectations of breastfeeding women, pharmacists acknowledged the 
need for further training and on-going CPD to improve their knowledge and 
confidence level when dealing with breastfeeding and medicine-related queries. 
Guidelines and policies should also be in place to ensure all pharmacists adopt a 
consistent approach in their daily practice.  
 
There is a misalignment between the opinions of the users of herbal galactagogues 
(breastfeeding women) and pharmacists about the use of herbal medicines whilst 
breastfeeding and the available information to support their use when compared to 
conventional treatments. The assumption that herbal medicines are “natural” and 
“safer” than conventional medicines was apparent amongst the breastfeeding women 
group but not the pharmacists group, which was expected considering that 
pharmacists are trained to utilise evidence-based resources and are experts in 
medicines. The lack of evidence-based information on the efficacy and safety of 
many herbal medicines in breastfeeding, as well as the complexity of the chemical 
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constituents of herbal medicines contributed to pharmacists’ cautious behaviour 
when it comes to recommending their use. Furthermore, the fact that the majority of 
these medicines are not registered in Australia on the ARTG (200) suggests to 
pharmacists that these products may not have efficacy data. The aforementioned 
factors could have led to women who are advocates of herbal medicines believing 
that pharmacists are “unwilling” or “not open” to discussion around the use of 
therapies other than conventional medicines. This in itself is of interest as it shows 
the difference in the level of awareness between the public and health professionals 
and identifies gaps in pharmacy practice where improvements are needed in the 
dissemination and communication with the public regarding the differences between 
conventional and non-conventional medicines, especially in this case with 
breastfeeding women.      
 
There is also a gap between what breastfeeding women expect of pharmacists and 
what services pharmacists are offering. Although some pharmacies in Western 
Australia currently do provide breastfeeding-related services, such as infant weigh-in 
stations and employing child health nurses, it does not appear to meet the demand 
and expectations of breastfeeding women based on the findings of Stage 2. It is also 
interesting in that pharmacists have raised their concerns with regard to the current 
business and remuneration model, and yet breastfeeding women perceive the fact 
that community pharmacy services are provided at no charge to be a facilitator. The 
gap or issue raised involves the source of funding, the feasibility and to what extent, 
if such services were to be implemented in pharmacies. Interviews with other 
stakeholder groups, such as representatives and policy makers of government and 
non-government organisations (including academia, leaders of the pharmacy 
profession and relevant breastfeeding associations), will provide useful insight to 
address this issue. It is notable that women have access to child health nurses free of 
charge, but paid for by the state or local authorities. This may possibly create 
women’s expectation of free services.   
 
Perspectives of breastfeeding women and pharmacists towards the potential for 
pharmacists to expand their professional roles and the provision of breastfeeding and 
other related professional public health services in the community pharmacy setting 
were favourable, provided the barriers are addressed. If community pharmacies are to 
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better support breastfeeding women especially those with breastfeeding-related 
issues, appropriate training is crucial to ensure pharmacists are well equipped with 
both the knowledge and resources to execute their expanded role and to meet the 
expectations of the public. If such services are to be implemented, there also needs to 
be improved community awareness of the scope and what pharmacists can offer. 
  
6.2.7 The Interpretation of Available Information  
 
Throughout the interviews, both participant groups expressed a clear need for further 
research into the commonly used herbal medicines to establish their efficacy and 
safety in breastfeeding, and that up-to-date, accurate and reliable information on 
CMs should be made easily accessible. This finding was in accordance to the 
recommendations made by the Expert Committee on Complementary Medicines in 
the Health System (421). The committee was commissioned in 2003 to report on the 
status of CMs in Australia and aimed to identify concerns and make 
recommendations to facilitate safe and effective use of CMs. One of the concerns 
raised by the committee was the need for health professionals and consumers to be 
able to make informed decisions about the use of CMs based on the availability of 
independent, accurate and reliable information on CMs, at the same time to acquire 
necessary skills to “interpret information” and be able to “discriminate between 
reliable and unreliable information” (421).  
 
In addition to the lack of information about the safety of medicines in breastfeeding, 
in particular herbal medicines, this research has also raised concerns over the 
dissemination of the available information and how this translates into professional 
practice and the public’s perception. In the Breastfeeding Policy adopted in 
September 2010, the Public Health Association of Australia (422) notes “Health 
professionals and consumers need accurate information about safe use of medicines 
for breastfeeding women” (422). With reference to Briggs (423) and Hale (424), the 
association further states that “there are very few medicines which are unsafe for 
breastfeeding women” (422) and “the amount of maternal medicine an infant would 
receive is less than 1% of an infant dose for the vast majority of medications” (422). 
As the target audience of such policy documents include government and non-
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government stakeholder groups as well as the Australian public, this may have a 
potential impact on women’s perspectives and interpretation of the information 
which may subsequently influence their decisions and choice of therapy. Whilst it is 
true that only very few medicines have been proven to be unsafe in breastfeeding, the 
safety profiles of the majority of medicines in breastfeeding, including herbal 
medicines, remain unknown. Nevertheless, amendments were made to the September 
2013 Breastfeeding Policy, and the Public Health Association of Australia states 
“Most prescription drugs and medicines are compatible with breastfeeding, but each 
case should be specifically assessed by a health professional” (425). The amended 
statement has therefore shown that the association has taken greater cognizance of 
the potential safety concerns or toxicity issues with the use of medicines in 
breastfeeding.  
 
As discussed in Section 2.5.3, the majority of CM products are classified as AUST L 
and are subjected to less stringent advertising control compared to medicines 
classified as AUST R (198, 204). Widespread promotion of these medicines, 
including herbal medicines, through mainstream media may potentially have an 
impact on breastfeeding women’s perception of the safety margins of these products. 
Considering the popularity of herbal medicines amongst breastfeeding women and 
the chemical complexities of these medicines as discussed in Chapter 2, the safety of 
herbal medicines in breastfeeding should not be assumed based on the absence of 
information. The lack of information on the majority of herbal medicines may be 
misinterpreted as “safe” to use whilst breastfeeding. Therefore, it is of paramount 
importance that breastfeeding women and health professionals are mindful that the 
absence of safety reporting should not be interpreted as evidence of safety.  
 
6.2.8 Contemporary Pharmacy Practice 
 
In the recent Australian government’s healthcare reform to achieve an improved 
healthcare system in Australia, there has been a call for primary healthcare to be 
provided by the community healthcare providers, thus relieving costs and pressure on 
GPs (426). It is stated in the Primary Health Care Reform in Australia: Report to 
Support Australia’s First National Primary Health Care Strategy published in 2009 
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(426) that “primary healthcare is more than the provision of services by a GP through 
Medicare, and also includes specialists, nurses, pharmacists and other allied health 
workers, providing publicly and privately funded services”. The current and potential 
future roles of pharmacists as part of the primary healthcare team have also been 
highlighted (426). As Australian community pharmacies have been recognised as 
highly accessible (4, 427), there appear to be opportunities for pharmacists to expand 
their services and contribute towards healthcare amongst Australians (426). 
According to the Pharmacy Guild of Australia (381), “A key focus for Australia’s 
healthcare reform is to create a stronger primary healthcare system through the better 
integration and coordination of care for consumers. Community pharmacy can play a 
pivotal role in this model as one of the most frequently accessed primary healthcare 
services” (381). The needs and expectations of the Australian community drive and 
form the basis of change in how the profession practises pharmacy. There is evidence 
that the role of Australian community pharmacists is expanding from being a 
conventional medication dispenser to being a provider of holistic and patient-centred 
healthcare in the form of related professional services (382, 383, 427, 428). In 
keeping with the healthcare reform agenda, integration of a range of professional 
services such as disease-specific management programs and medication reviews is 
becoming a common practice of many pharmacists in Australia (429).  
 
Through the continuously evolving practice of pharmacy in Australia, the scope of 
community pharmacy practice has expanded beyond the conventional medication 
dispenser and advisor role. There has been a shift towards holistic patient-centred 
care delivery which requires knowledge and necessary skills to conduct professional 
services that may not be directly related to medicines or drugs, for example, health 
checks, sleep apnoea programs, weight loss and healthy living programs. Whilst 
acknowledging the existing barriers, McMillan et al. (382) recognised a potential for 
Australian community pharmacy to be a “health hub destination of the future”. 
Interviews with breastfeeding women in Stage 2 identified a similar theme where 
pharmacies were imaged as a one-stop health destination. In fact, this was an 
important factor where advice and any medicines or other requirements could be 
obtained at the one location. Considering the objective and vision of the Australian 
National Breastfeeding Strategy 2010-2015 (1) and the call for a healthcare reform in 
Australia (430), this research provides first-hand insight and useful information on 
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the future potential role of pharmacists in supporting breastfeeding women in the 
Australian community, particularly in the provision of advice and supply of non-
prescription medicines including CMs and being a service provider for 
breastfeeding-related services, which is an area that has not been well explored in the 
Australian context. 
 
Nevertheless, contemporary pharmacy practice does not come without its challenge. 
Under the Fifth Community Pharmacy Agreement, the Consumer Needs project was 
funded by the Australian Government Department of Health and Ageing and 
managed by the Pharmacy Guild of Australia (381). One of the objectives of the 
project was to identify consumers’ needs, experiences and expectations of 
community pharmacy services, and the first stage involved consultations with 30 
stakeholders. In this project, the issue of privacy and pharmacy layout was raised by 
participants. It states “Without a sense of privacy consumers are often reluctant to 
engage with their pharmacist and ask questions about their health needs” (381). This 
finding is of relevance to this research as “new mothers” were specifically identified 
as consumers who “desire more privacy” (381). The issue of privacy and 
inappropriate pharmacy layout was also raised by breastfeeding women and 
pharmacists who participated in Stages 2 and 3 of this research. Unless the pharmacy 
has a private consultation area or room to overcome this barrier, pharmacists may not 
be in the optimal position to expand their services to meet the needs and expectations 
of breastfeeding women. This is a particular challenge to pharmacies which do not 
currently have this facility within their premises, considering the cost involved and 
the current pharmacy remuneration model. Without a viable remuneration model, the 
feasibility and sustainability for the provision of such services within the community 
pharmacy setting are of concern.   
 
The findings arising from the perspectives of breastfeeding women and community 
pharmacists in Stages 2 and 3 support the argument that community pharmacists are 
well placed to provide advice and support to breastfeeding women using herbal 
medicines as galactagogues, at least amongst the participants of this research, with 
due consideration of the barriers and challenges raised by the participants. As this 
research had only focused on the perspectives of breastfeeding women and 
community pharmacists, future studies evaluating the perspective of other 
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stakeholders, for example child health nurses, lactation consultants and policy 
makers, will provide further insight into this topic in particular the feasibility and 





This research has demonstrated a high utilization of herbal medicines amongst 
breastfeeding women in WA, while information supporting their safety and efficacy 
is limited. This usage includes particularly fenugreek being used as a galactagogue 
over prolonged periods of breastfeeding. An urgent need was identified for further 
research into the commonly used herbal medicines, evaluating their efficacy and 
safety in breastfeeding. Evidence-based information should be available to health 
professionals and breastfeeding women who wish to consider the use of all 
medicines, including herbal medicines, to avoid unnecessary cessation of 
breastfeeding, while allowing mothers to receive appropriate pharmacotherapy 
without compromising breastfeeding performance and the infant’s health. This study 
provides insight into the perspectives and attitudes of breastfeeding women and 
pharmacists in Australia to explore breastfeeding and postnatal-related healthcare 
needs and expectations of the community pharmacy. As evident from this study, 
most women were willing to engage in discussions about breastfeeding and the use 
of herbal medicines during breastfeeding with pharmacists. In order to facilitate this, 
pharmacists themselves must have sufficient knowledge, an interest and be available 
to interact with women or their family members in the provision of advice. This will 
promote the quality use of medicines whilst breastfeeding and support successful 
breastfeeding practices in the community, especially with community pharmacies 
being viewed as a one-stop health destination. This research has also demonstrated a 
mismatch between the perceptions of breastfeeding women and pharmacists with 
regards to the issue of safety and toxicity of herbal medicines. This is an important 
finding which requires further investigation. This study has revealed that community 
pharmacists are perceived favourably by breastfeeding women in the Western 
Australian community. Opportunities have also been identified for community 
pharmacists to expand their professional role and to potentially collaborate with other 
healthcare workers such as lactation consultants and child health nurses to provide 
breastfeeding women with support and postnatal care at the community level. 
Government and professional pharmacy bodies should consider these findings when 
promoting an expansion of community pharmacy services.   
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6.4 Future Studies and Recommendations 
 
The results from the research presented in this thesis suggest a number of future 
studies and recommendations about the use of CMs in breastfeeding women and the 
role of pharmacists. These are summarised in four categories, namely:  
 
 i) Use, safety and efficacy of CMs in breastfeeding 
 ii) Pharmacy profession and the role of pharmacists 
 iii) Role of other healthcare workers and interdisciplinary collaboration 
 iv) Resources and health promotion initiatives. 
 
 
i) Use, safety and efficacy of CMs  in breastfeeding 
 
 As the backgrounds and experiences of women and the availability of herbal 
preparations may vary in different Australian states and specific ethnic groups, a 
nationally representative study among breastfeeding women should be conducted 
to compare with the findings of the Stage 1 study. 
 
 A further study of breastfeeding women in Western Australia would be useful to 
explore their use of all medicines including prescription and non-prescription 
medicines during breastfeeding, their sources of recommendation, supply and 
information, and who they would be likely to consult for general breastfeeding 
advice. This study could be conducted using self-administered questionnaires 
with carefully planned questions. Recruiting potential participants from a 
maternity hospital is one recruitment option, where invitations to participate 
could be sent out to all women after giving birth during a defined period, and 
questionnaires to be posted at three and six-month intervals to those who have 
expressed interest in participating. As with other recruitment strategies, recruiting 
participants through the above mentioned strategy has its limitations. Hospitals in 
Australia cater for public patients (often from lower socioeconomic background) 
or private patients (higher socioeconomic background), hence some bias is likely 
unless many hospitals are used. In addition to the possibility of low response rate, 
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such a recruitment strategy could also contribute to a degree of bias in sample 
selection, in that breastfeeding women of a certain socio-economic background 
or who are living in a specific geographical area could be preferentially selected, 
which would not be representative of all breastfeeding women in Western 
Australia. Nevertheless, the findings of such a study could then be compared with 
findings of the Stage 3 study, at the same time provide an opportunity to explore 
breastfeeding women’s views on the broader role of community pharmacists in 
the provision of breastfeeding support, using a quantitative approach.  
 
 Further studies are warranted to confirm the safety of commonly used herbal 
medicines in breastfeeding, and their effects on infants’ safety and breastfeeding 
performance. These include studies investigating the transfer of herbal 
ingredients, if any, into breast milk, and whether they have any effects in terms of 
reducing breast milk supply and quality, and affecting infant feeding behaviour.  
 
 As perceived insufficient milk supply was identified in the Stage 2 study as a 
common reason for use of herbal galactagogues in breastfeeding, and that it has 
also been reported in literature as the most common reason for early weaning or 
supplementation with formula, approaches that help increase milk production 
during the early post-partum period may reassure mothers and help ensure 
exclusive breastfeeding for six months (2, 31, 75). Opportunities should also be 
given to women to discuss whether there really is a lack of milk production and 
to educate them on the signs to monitor. Double-blinded RCTs are needed to 
evaluate the clinical efficacy and safety of commonly used herbal galactagogues 
as reported in the Stage 1 study, particularly fenugreek, to increase breast milk 
production in the early post-partum period and their effects on breastfeeding 
exclusivity and success.  
 
ii) Pharmacy profession and the role of pharmacists 
 
 Interviews with the pharmacists identified a need for developing training and 
continuing professional education modules for pharmacists and pharmacy 
assistants in relation to use of medicines in breastfeeding and the various aspects 
of breastfeeding. Online CPD modules that assist pharmacists to improve their 
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awareness and knowledge could address this need. It will also be useful to 
develop a “topic-based” reference guideline or textbook, with clear and concise 
recommendations of medicines that could be used or avoided in the treatment of 
various common ailments or health issues while breastfeeding. The guidelines 
could then be used to assist health professionals in making informed clinical 
recommendations to breastfeeding women presenting for treatment.  
 
 Further qualitative studies to explore the perspectives of pharmacy students and 
teaching staff could enhance our understanding of the topic and help justify the 
need for further integration of educational materials related to various aspects of 
breastfeeding and the use of CMs in general into the formal university 
curriculum.  
 
 As pharmacy support staff may have regular contact with breastfeeding women 
in community pharmacies, further studies exploring their perspectives and 
experiences could enhance our understanding of the topic and help identify, if 
any, the need to provide training to pharmacy staff.  
 
 As part of the initiative to expand the professional roles of pharmacists, it is 
worth considering postgraduate accreditation courses at universities to allow 
pharmacists to specialise in women and newborns’ health and to encourage the 
option to be qualified as an International Board Certified Lactation Consultant. 
With the medication knowledge and educational background, pharmacists who 
are also lactation consultants will be able to provide better support to women who 
are required to use medicines while breastfeeding.  
 
 Pharmacist prescribing is an area of research that is increasingly important to 
pharmacy practice in Australia. Further studies should be undertaken to evaluate 
the potential role of pharmacists in prescribing domperidone for women 







iii) Role of other healthcare workers and interdisciplinary collaboration 
 
 As lactation consultants and child health nurses have been consistently 
mentioned by women throughout the studies, further qualitative studies could be 
undertaken to explore the perspectives and attitudes of these healthcare workers 
towards the use of herbal medicines in breastfeeding and the factors affecting 
their decision-making. A greater understanding of their role and perspectives may 
help inform opportunities for interdisciplinary collaboration with community 
pharmacists.  
 
 Based on the results of the Stages 2 and 3 studies, a pilot study should be 
conducted to facilitate and evaluate the practicality or impact of interdisciplinary 
collaboration in providing women with postnatal care and breastfeeding support 
at the community level. This could be achieved by firstly forming a joined 
network consisting of pharmacists, child health nurses and lactation consultants, 
working collaboratively to meet the needs of women in the postpartum period. 
Although current government initiatives include funding of one or two visits to 
women’s homes by child health nurses, involving pharmacists with their 
convenient accessibility and pharmacists’ medicine knowledge in the network, 
could provide women with improved continuity of care at the community level.  
 
iv) Resources and health promotion initiatives 
 
 In order to address the issue of the lack of information resources, the setting up of 
a local lactation resource centre in Western Australia for professionals and the 
public should be investigated to provide access to up-to-date information relating 
to breastfeeding. This could be done in collaboration with the Australian 
Breastfeeding Association. Nevertheless, further research into the perspectives of 
key stakeholders would be necessary to assess the need and feasibility of such 
centres.  
 
 Lastly, health promotion campaigns could be a practical and effective 
intervention to increase public’s awareness of the potential risks associated with 
270 
 
the use of all medicines in breastfeeding, and that women should always consult 
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Appendix C: Stage 1 Participant Information Sheet 
 
Breastfeeding is widely recommended as the best feeding choice for most infants and their mothers. 
One of the main concerns for breastfeeding mothers using medication is the entry of medication into 
breast milk. This could happen when the drug pass from the mothers’ blood circulation into the breast 
milk, then being fed to the infants. Another concern is how these drugs will affect the quality 
and quantity of the breast milk, which may then impact on breastfeeding performance. 
 
In Australia, the use of herbal medicines has increased over the years.1-3. Many women are now taking 
these herbal medicines with or without recommendation from health care professionals. Currently very 
little is known about the use and safety of these medicines during breastfeeding. Although most 
of these herbal ingredients are deemed to be “weak” or “mild” in effects, it will be important to 
investigate the effects of these herbal medicines on the quality of the breast milk and to ensure the 
safety of the breastfed infants. 
 
We have designed this survey in order to identify the most popular herbal medicines among 
breastfeeding women in Australia. This survey is aimed at finding out the percentage of women who is 
currently using or have previously used herbal medicines during breastfeeding, the types of herbal 
medicines, reasons for use, their believes and where they are exposed to such use. This survey will 
provide us with a better understanding on the use of herbal medicines during breastfeeding. 
 
We are seeking for women who are 18 years or older, currently breastfeeding or have breastfed in the 
past 12 months to participate in this survey. This survey will take approximately twelve minutes 
to complete. 
 
This survey is entirely voluntary and you may withdraw at any time. This survey will most likely 
not benefit you immediately, but the information gained from this study may help us to understand 
more on the effects and safety on the use of herbal medicines in breastfeeding mothers and to their 
infants. Only staff and students who are directly involved in this study will have access to the data 
collected. The results of this survey and the following studies may be published, however, any 
information which may potentially identify you will not be used in any publication. No personal contact 
details of participants will be recorded to ensure anonymity. 
Further information on the study can be obtained from Miss Tin Fei Sim at the Curtin University 
(phone: 9266 1875 or mobile: 0401 649 800) or supervisor Dr Lisa Tee (phone: 9266 2526). This 
study has been approved by Curtin University Human Research Ethics Committee (Approval number: 
PH-03-11). The Committee is comprised of members of the public, academics,  lawyers,  doctors  and  
pastoral carers. Its main role is to protect participants. If needed, verification of approval can be 
obtained either by writing to the Curtin University HREC, C/- Office of Research and Development, 
Curtin University of Technology, GPO Box U1987, Perth WA 6845, or phone 08-9266 2784 or email 
hrec@curtin.edu.au. 
 
References: 1. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine 
in Australia. The Lancet. 1996; 347(9001):569-573. 2. MacLennan AH, Wilson DH, Taylor AW. The 
Escalating Cost and Prevalence of Alternative Medicine. Preventive Medicine. 2002; 35(2):166-173. 3. 
Xue CCL, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and Alternative Medicine Use in 
Australia: A National Population-Based Survey. The Journal of Alternative and Complementary Medicine. 
2007; 13(6):643-650.  
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Community pharmacies remain one of the main sources of herbal medicines in the Australian 
community. Information from pharmacists may affect breastfeeding women’s decision and 
choice of herbal therapy. This study aimed to explore experiences and perspectives of 
breastfeeding women on community pharmacists’ role and whether there is potential for 
role expansion as well as the facilitators and barriers in meeting their health care related 




Semi-structured interviews were conducted with breastfeeding women who were using one 
or more herbal galactagogues while breastfeeding. Interviews were audio-recorded and 
transcribed verbatim. Transcripts were analysed using qualitative approaches. Extracts 




Twenty breastfeeding women from Western Australia were interviewed between October 
2012–April 2013. Views of participants were classified into three major themes: i) facilitators 
and ii) barriers to an increased role of community pharmacists related to breastfeeding, and 
iii) implementation of breastfeeding related-services in community pharmacy settings. 
Overall perspectives of participants were positive about the potential for role expansion of 
community pharmacists to meet their breastfeeding-related needs. Whilst most participants 
perceived community pharmacies as convenient sources of trusted information, some 
recognised barriers to an increased role of pharmacists. Several breastfeeding support 
services perceived to be useful in community pharmacy settings were identified. 
 
Conclusions 
Issues raised by breastfeeding women highlighted areas of pharmacy practice which 
required improvement and revealed opportunities for expansion of community 
pharmacists’ role to better support women and promote breastfeeding in the community. 
 
Keywords 







Breastfeeding has been shown to contribute to the improvement of nutrition and well-being 
of infants and mothers, leading to positive health outcomes.[1] Besides offering tailored 
nourishment to the infants, breastfeeding also plays a role in reducing the risk and incidence 
of many diseases including otitis media, diabetes mellitus, hypersensitivity reactions and 
Sudden Infant Death Syndrome.[1-3] In addition to the physiological health advantages, 
breastfeeding may also contribute to some psychological benefits through promoting the 
relationships between mothers and their breastfed infants.[4] Based on many published 
studies over the years, breastfeeding is now widely recommended as the best feeding choice 
for most mother-infant dyads.[5-9] 
 
The use of complementary and alternative medicines (CAMs) by women during pregnancy 
and breastfeeding is growing, as is the case with CAMs use amongst the general 
population.[10-13] A recent Western Australian study reported that 59.9% of 304 survey 
respondents had used one or more herbal medicine during breastfeeding, which further 
highlighted the prevalence of CAMs use amongst this specific population group.[13] Taking 
into consideration the potential safety aspects and impact on breastfeeding performance, 
caution should be exercised and the use of all medicines or xenobiotics, including CAMs, 
during breastfeeding should be considered on a case-by-case basis. 
 
Community pharmacies represent one of the major providers of CAMs in Australia.[14] 
Therefore, community pharmacists are in a unique position to influence the public’s use of 
CAMs as evidenced by the positive consumer satisfaction and expectations from previous 
Australian as well as international studies.[15-17] Being  one of  the major providers of 
CAMs provides opportunity for pharmacists and pharmacy staff to intervene and provide 
advice about their safe and effective use during breastfeeding. 
 
A 2011 systematic review of consumers’ views regarding the provision of health care in 
pharmacies revealed that community pharmacists were assumed to meet the expectations of 
the public as having adequate levels of knowledge.[18] A recent Australian study 
demonstrated the high expectations of the general public towards community pharmacists’ 
knowledge and ability to provide information related to CAMs products.[17] Similarly, 
information from pharmacists  may  affect women’s experience, decision and choice of 
therapy whilst breastfeeding. Understanding the perspectives of breastfeeding women, their 
views and expectations of community pharmacists and whether they believe there could be a 
bigger role for community pharmacists in CAMs use may lead to an expansion of the current 
332 
 
role of pharmacists, whilst contributing towards positive breastfeeding and infant outcomes. 
Identifying the facilitators and barriers of breastfeeding women in utilising the expertise of 
community pharmacists in providing breastfeeding-related health advice and care in a 
community pharmacy setting will identify areas of pharmacy practice which could be 
improved or expanded. 
  
Several studies reported the perspectives and attitudes of health professionals as well as 
breastfeeding women towards the use of medications during breastfeeding.[19-21] 
Nevertheless, there has been limited research to explore the perspectives of women towards 
the role of community pharmacists on this topic. This study aimed to explore experiences 
and perspectives of breastfeeding women on community pharmacists’ role and whether there 
is potential for role expansion as well as the facilitators and barriers in meeting breastfeeding 




This exploratory research was conducted through in-depth semi-structured interviews with 
breastfeeding women who were using one or more herbal medicines to increase 
breastfeeding performance. This study was approved by the Curtin University Human 
Research Ethics Committee in September 2012 (approval number HR85/2012). 
 
Recruitment 
Purposeful sampling was used to recruit participants, targeting breastfeeding women who 
had experience in using herbal medicines to enhance milk supply. The inclusion criteria 
included women aged 18 years or older who had been breastfeeding in the previous 12 
months at the time of interview, and had used one or more herbal medicines during 
breastfeeding. According to Patton,[22] purposeful sampling method is powerful as it 
involves selection of information-rich cases which allows in-depth inquiry into the topic. 
Hence, careful selection of participants with experience using herbal medicines to enhance 
milk supply was considered appropriate to enable relevant and quality data to be collected, 
improving reliability and credibility of the findings. 
 
Four different approaches were employed to recruit participants. Firstly, recruitment was  
done through promoting the study at naturopathic clinics with a focus on breastfeeding and 
CAMs use. Posters with details of the study were displayed at a health centre that agreed to 
collaborate in the recruitment process. This health centre was located in a metropolitan area 
in Western Australia and the clinic staff supported the regulation of Western herbal medicine 
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through the Therapeutic Goods Administration (TGA) to ensure that products comply with 
specific quality and safety criteria. 
 
 
Secondly, the study was promoted to the wider public through a media release prepared by a 
public relations consultant from Curtin University Corporate Relations and Development 
Department. The media release was used to promote the study in local health and parenting 
papers and was also announced via the Curtin FM 100.1 Perth radio station. Contact details 
of the primary investigator were provided to enable women who wanted to participate in the 
study to contact the research team. 
 
Thirdly, a snowball sampling technique was adopted and interested participants were 
provided with additional study information and requested to share this with other 
breastfeeding women.[22] Unlike other studies where a specific participant type may be 
identified or recruited from an organisation or setting, the use or purchase of herbal 
medicines in Australia are not required to be reported nor recorded and can be sold from 
many retail outlets, hence there was not a specific setting or location to recruit this specific 
target population. Therefore, the purposeful chain sampling technique fitted the scope of this 
study.[22, 23] 
 
Fourthly, through the snowballing effect, participants suggested community pharmacies 
where more participants were likely to be recruited and two community pharmacies were 
subsequently identified for further recruitment. Both of these community pharmacies had a 
focus on naturopathy and CAMs and provided a range of breastfeeding-related services. 
Participants were then recruited from these pharmacies through expression of interest in 
response to study posters and participant information sheets. The recruitment of participants 
ceased when the point of saturation was considered achieved.[23, 24] 
 
Design and conduct of interviews 
The interviews were conducted on a one-to-one basis, either face-to-face at a place 
convenient to each participant or via telephone if preferred by the participant. An interview 
guide was developed with a mix of closed (10) and open-ended (7) questions to gather 
information about the use of herbal medicines during breastfeeding, and explore the 
perspectives of breastfeeding women towards the role of pharmacists in meeting their 
breastfeeding-related health care needs in the community pharmacy setting. The interview 
guide was piloted through two breastfeeding women. Taking into consideration the 
variability between participants and at the same time ensuring that the topic of discussion 
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could be thoroughly covered, the interviewer (TFS) adhered to a sensitive and flexible 
approach throughout the interview process. As participants were mothers with a young child, 
all of them were reassured that priority would be given to their infant or child if they needed 
to be attended to, and interviews were stopped and resumed when convenient for the 
participant. Qualitative narrative data were collected through recordings of the dialogues 
between the researcher and the individual participant. 
 
Data analysis 
All interviews were audio-recorded and manually transcribed verbatim. Participants were de- 
identified and codes used in the analysis. For example: the first interviewee was given a code 
“BW1”. The  seven  open-ended  questions  in  the  interview  guide  which  explored  the  
experiences  and perspectives of participants were analysed using thematic analysis.[25] 
Firstly, contents of the transcriptions were read repeatedly by the primary investigator to 
attain a thorough understanding of topics that emerged from the interviews. Emerged “ideas” 
or themes were recorded and supporting quotes documented under each theme category. 
Different “units of ideas” were then reclassified as subthemes under a specific “collective 
idea” or theme. These themes were then regrouped under distinctive headings addressing the 
research questions. To ensure reliability of the process of analysis, project supervisors (LH, 




A total of 20 in-depth semi-structured interviews were undertaken with breastfeeding women 
living in the Perth metropolitan area between October 2012 and April 2013. Saturation of 
data was reached after 15 interviews but a decision was made to continue until all 20 
participants were interviewed, after which the research team was confident that no new 
themes were emerging. Ten interviews were conducted face-to-face and ten via telephone. 
Out of the 20 participants, 17 were of Caucasian descent, two of Asian descent and one of 
Middle-Eastern descent. Interviews took an average of 33.9 minutes (range: 18 - 78 
minutes). 
 
Three major themes emerged as the participants described their perspectives. Although their 
views varied widely, participants perceived community pharmacy in general as a convenient 
source of information which can be trusted. When asked whether they believed that there 
was a role for community pharmacists to play in the area of herbal medicines and 
breastfeeding, common facilitating factors and barriers were identified. Throughout the 
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interviews, participants identified several breastfeeding support services perceived to be 
useful and beneficial in the community pharmacy setting. These are summarised in Table 1. 
 
Facilitators to an increased role of pharmacists 
Participants identified several facilitating factors which supported the increased role of 
community pharmacists, including convenience and accessibility, client-pharmacist 
relationship, staff knowledge and credibility, and cost factors. These facilitators are 
summarised in Table 2 and explored below. Participant quotes are included to illustrate the 
concepts. 
 
Convenience and accessibility 
Participants highlighted the convenience and accessibility of community pharmacy as a 
facilitator to expand the role of community pharmacists in supporting breastfeeding, whilst at 
the same time promoting safe and effective use of medicines, mainly non-prescription 
medicines including CAMs, during breastfeeding. Participants perceived community 
pharmacy as an easily accessible source of information and supply of a wide range of 
products. 
 
In the context of convenience and accessibility, locality emerged as an underlying theme. 
Community pharmacies are spread out in the Perth metropolitan area and were perceived as 
“everywhere” and “local” by participants. 
 
“My local chemist is very near my house, it is literally just behind us, I can walk there. I 
think that is the case for most people as there are so many pharmacies around. You don’t 
have to make [an] appointment, and you can ask to speak to a pharmacist.” (BW 18) 
 
Participants felt at ease and comfortable to discuss issues relating to breastfeeding with their 
local trusted community pharmacists. 
 
“… it is just another avenue that new mothers can use. As a new mum, we are so confused 
and so bombarded with information that we do look for recommendations and if I knew of 
one that was close to me that is easy for me to get to, I think I would use them the same as 
how I would use my child health nurses to answer my questions… The fact that they are near 





In addition to locality, availability was recognised as a facilitator by some participants. The 
opening hours and the “no appointments required” common practice of community 
pharmacies were valued, especially for those who labelled themselves as “busy mums”. 
 
“I know I can go anytime, they are open quite late, and you can get the support and advice 
when needed because often when you are breastfeeding with the young child it is very 
difficult to get a doctor’s appointment or another appointment. So it’s not easy having that 
accessibility.” (BW 9) 
 
Participants labelled community pharmacy as a one-stop destination involved in many 
aspects of their health, from a source of information, to a source of supply and to monitoring 
of medical conditions in the community or an “alternative to doctors”. Some had utilised 
community pharmacies as the source of breastfeeding-related information, source of herbal 
galactagogue supply and source of advice regarding breastfeeding performance and infants’ 
health. 
 
“...it is convenient because you can just buy the products or whatever they recommend at the 
products. It’s just easier to go to one place, especially when you know you can get most of 
the things from one place when you are so busy with baby and other stuff.” (BW 14) 
 
Participants experienced community pharmacy as a provider of a vast range of health-related 
products and facilities. Pharmacists were expected to play the role of health and medicine-
related information provider and product supplier. There was an expectation that community 
pharmacists should set aside their personal opinions, follow ethical obligations and have an 
adequate knowledge of all products available at the pharmacy. 
 
“I would ask more questions at the place where I get my products. For example, if I go to the 
chemist and get my fenugreek, I would ask the pharmacist or the staff questions about the 
product, because I would assume they would know best because they have it in their store. I 
would trust the information because they are trained in that area and from my past 
experience, they have always been quite helpful.” (BW 12) 
 
Client-pharmacist relationship 
Participants who managed to build a trusting relationship with their local community 





“I just notice that my local chemist is very good with all the over-the-counter medicines, 
asking about what I am taking and you know, any contraindications with other medicines 
and things…” (BW 10) 
 
Staff knowledge and credibility 
Information attained from pharmacists was seen as trust-worthy and credible. As some 
participants were concerned about the reliability of information obtained from non-reputable 
sources such as the internet, participants appreciated the value of information given by the 
pharmacists. 
 
“I think getting information or recommendation from a pharmacist would be more reputable 
than your own internet search, because you don’t know how reliable that website is, it may 
be leading you down the wrong path, so I think a pharmacist might have the advantage of 




Cost factors were quoted as a reason for the role of community pharmacists to be expanded. 
Visits to a doctor or other health professional(s) were seen as costly to some participants, 
while many believed that similar information could be obtained from a pharmacist without a 
charge. 
 
“…it would be less expensive this way, knowing that starting a family would cost some 




Barriers to an increased role of community pharmacists 
 
A number of potential barriers were identified, which included the lack of advertisement, 
publicity and promotions, inconsistent approach, breastfeeding-related inexperience and low 
awareness, pharmacists’ pre-conceived perception towards herbal medicines, overlap of role 






Although many community pharmacies may be involved in expanding their services to the 
public, the lack of advertisement, publicity and promotions were identified by participants as 
a barrier. Participants commented that many women were unaware of the services currently 
available in community pharmacies. As the conventional scope of a community pharmacy 
was predominantly dispensing of prescription medicines and the supply of medicinal 
products, in the absence of adequate publicity, breastfeeding women were not aware of and 
utilising these other services. The lack of a consistent approach along with some enquiries 
handled by pharmacy assistants was seen as a hindrance to building a trusting relationship 
with the pharmacist. A lack of some pharmacists’ personal breastfeeding-related experience, 
knowledge and awareness was also identified as prohibitive in breastfeeding women seeking 
and accepting advice. 
 
Some participants appeared to believe that pharmacists may have pre-conceived negative 
perceptions towards herbal medicines and alternative therapies. Participants who believed 
that there was a limited role for pharmacists to be involved in natural or herbal remedies 
perceived pharmacists as “over- cautious” and fearful to recommend herbal medicines with 
little or no scientific evidence to support their efficacy and safety during breastfeeding, 
which was seen by regular users of herbal remedies as a lack of willingness to supply and 
inadequate knowledge in the area of CAMs. 
 
Some further expressed their concerns with regards to privacy when discussing 
breastfeeding-related issues in the pharmacy. The layout of some pharmacies was seen as not 
facilitating privacy. Despite the availability of a vast range of products and brands across 
pharmacies, some participants expressed their frustrations in terms of the availability of 
herbal galactagogues specifically. Despite the lack of confidence in some, many participants 
still believed that it would be promising and favourable if community pharmacists were 




This study highlighted the role of community pharmacists through provision of information 
and advice on the efficacy and safety aspects of CAMs use and other alternative therapies 
during breastfeeding. Besides information on conventional medicines and CAMs, 
breastfeeding women also expect pharmacists to have a basic knowledge of breastfeeding 





The interviews provided an understanding of women who are regular users of herbal 
medicines and their perspectives of community pharmacists as suppliers of CAMs in 
Australia. Convenience and accessibility, client-pharmacist relationship, knowledge and 
credibility of pharmacists, as well as cost factors all represent important factors when women 
decide the source of breastfeeding advice. Several barriers to expanding community 
pharmacists’ role were identified by participants that, once addressed, could expand 
pharmacy practice into breastfeeding services. 
 
This study has limitations. The method and process of recruitment may have resulted in 
selection bias. Participants were self-selected throughout expression of interest and hence 
may not represent all breastfeeding women who were regular users of herbal medicines. 
Furthermore, all participants of this study were users of herbal galactagogues, and may not 
represent users of other herbal products. However, this method was deemed most appropriate 
to identify or contact potential participants. The interviewer (TFS) is a pharmacist which 
may have influenced the interviews and affected the analysis. In an attempt to 
counterbalance the potential bias, TFS had regular meetings throughout the interview period 
with the third and last authors, both of whom have different disciplinary backgrounds and 
have no affiliations with any community pharmacies. Data were also analysed and cross-
checked with the other authors to improve validity of the findings.[26, 27] 
 
Breastfeeding women regarded pharmacists as a trusted health professional, an expert in 
medicines, and the first port of call for questions relating to medicines use during 
breastfeeding. Although pharmacists were not reported to be actively recommending the use 
of herbal galactagogues during breastfeeding, being one of the major suppliers of CAMs, 
women expect pharmacists to play a substantial role in providing advice and 
recommendations regarding CAMs use. This finding was in accordance with previous 
studies which explored consumers’ views on CAMs and their expectations of 
pharmacists.[17, 18] 
  
The characteristics and values of both the community pharmacies and the staff (pharmacists 
and assistants) are factors which influence breastfeeding women to utilise their services. 
Women in the study appreciated the convenience and accessibility of community pharmacies 
as facilitators to obtain advice in a timely manner. This aspect, in contrast to the 
appointment-based services provided by most other health professionals, enhanced the role 
of community pharmacies in providing health care services to breastfeeding women. Women 
perceived pharmacies as a convenient one-stop health destination, to obtain health and 
medicine-related advice, purchase products, and receive monitoring services as well as an 
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alternative to their local general practitioners. This finding demonstrated a switch from the 
traditional ‘shopkeeper’ image of pharmacists to the ‘health care provider’ image.[28] 
Besides contributing to the expansion of pharmacists’ role in the community, this reduces the 
burden on the health care system and potentially frees up general practitioners for other 
consultations or reduces appointment waiting times. 
 
As community pharmacies are local this facilitates the development of trusting relationships 
between pharmacists and breastfeeding women and their family members. As observed from 
this study, client- pharmacists’ relationships play an important role in allowing breastfeeding 
women to discuss breastfeeding issues freely and comfortably. Building rapport between 
client and pharmacist is indeed fundamental in many aspects of health care promotion in the 
community pharmacy setting. This is particularly the case with breastfeeding which could be 
seen as a very personal issue. 
 
In many previous studies, pharmacists’ knowledge and credibility were identified as one of 
the facilitating factors driving consumers or clients to community pharmacies.[18, 19, 28-30] 
In this study, the knowledge and credibility of both pharmacists and pharmacy staff were 
cited as facilitators. However, the context of discussion was often more focused on 
pharmacists’ knowledge on general health conditions and the use of conventional medicines 
and less on the use of CAMs including herbal galactagogues. 
 
Some participants expressed their desire for pharmacists to be more ‘open’ to discuss various 
issues related to breastfeeding and to offer more information on CAMs and alternative 
therapies during breastfeeding. Consistent with the literature, the women expected 
pharmacists to be knowledgeable of CAMs.[17] They also expressed a need to have a greater 
level of engagement and interaction with pharmacists.[17] Taking into consideration the 
scope of practice and skills of pharmacists, it is therefore vital that pharmacists are clear 
about their role and be able to identify the need to refer breastfeeding women to other health 
professionals, for example child health nurses or lactation consultants for 
further breastfeeding-related advice when necessary. This would also help foster inter-
professional collaboration and relationships. 
  
The perceived lack of a consistent approach at pharmacies in the provision of CAMs was 
considered a hindrance to building a trusting relationship between the breastfeeding woman 
and the pharmacist. Time constraints were identified as barrier to appropriate pharmacists’ 
advice. In a study conducted by Jones and Brown,[31] only 11% of the 820 surveyed 
breastfeeding women who had purchased over- the-counter medications from pharmacies 
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were asked their breastfeeding status or whether they were breastfeeding by the pharmacists 
or pharmacy staff. Hussainy and Dermele[19] further commented that this issue should be 
addressed to enable accurate information and advice be provided to breastfeeding women. 
All pharmacists and pharmacy staff have an ethical obligation to provide relevant as well as 
accurate advice to clients, including breastfeeding women. This may be facilitated by staff 
enquiring, as part of the standard process, of all women of childbearing age whether they are 
pregnant or breastfeeding. 
 
Taking into consideration the potential sensitivity issues related to breastfeeding, the lack of 
pharmacists’ personal breastfeeding-related experience was identified as a barrier. 
Nevertheless, the gender of pharmacists was not one of the issues raised by the participants. 
Need for improved privacy was also identified as a barrier which could be overcome by staff 
having a basic knowledge about breastfeeding in order to communicate sensitively with 
breastfeeding women. As a primary care provider, effective communication is indeed 
essential to enable holistic care and appreciate and recognise breastfeeding women’s 
needs.[32] 
 
Some women believed that pharmacists may have a pre-conceived negative perception 
towards herbal medicines and alternative therapies, and expressed a need for pharmacists to 
consider their use during breastfeeding. On the other hand, some saw the supply of herbal 
medicines and breastfeeding advice as outside the scope of pharmacy practice, causing a 
barrier to obtain pharmacists’ advice. However, a study conducted by Bushett et al[33] in 
2010 which investigated rural Australian community pharmacists’ perspectives towards 
CAMs found that despite the varied views on CAMs, most pharmacists acknowledged the 
popularity of these alternative medicines amongst consumers and the important role of 
pharmacists in promoting the safe and effective use of these medicines. 
 
One of the challenges to providing advice to consumers regarding the use of CAMs is the 
lack of awareness or access to high quality resources and information.[33, 34] To address 
this issue, further studies are warranted to explore pharmacists’ knowledge of and 
perspectives regarding the resources and information available to them. Further studies to 
explore community pharmacists’ opinions will enhance understanding and identify initiatives 
or strategies required to address this gap, for example continuous professional development 
targeted towards breastfeeding and CAMs. 
  
From the perspectives of breastfeeding women, the findings of this study have enhanced our 
understanding of the current and potential roles of pharmacists and pharmacy staff. While 
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many studies have investigated the role of other health professionals in promoting 
breastfeeding, few studies and initiatives have examined the role of community 
pharmacists.[19, 35-37] Taking into account the facilitators and the views of breastfeeding 





The current study highlighted an opportunity for community pharmacists to expand their role 
through the provision of breastfeeding specific advice and services. Unlike some 
conventional medicines, herbal galactagogues and other CAMs are readily available over-
the-counter. Pharmacists and staff should therefore enquire women if they are breastfeeding 
prior to providing advice or supply products to ensure appropriate recommendations can be 
provided. More research into CAMs use and breastfeeding will allow health professionals 
like pharmacists to provide evidence-based advice to their clients. 
 
The results from this study have identified a need for community pharmacy staff to provide 
breastfeeding related services and advice and provides an opportunity for community 
pharmacy to expand the scope of practice. 
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Appendix L: Stage 2 Participant Information Sheet 
 
Breastfeeding is widely recommended as the best feeding choice for most infants and 
their mothers. Despite all efforts to promote breastfeeding, some women may still 
experience difficulty breastfeeding with perceived low or insufficient milk supply being the 
most commonly reported reason for unsuccessful breastfeeding and early weaning. Many 
herbal medicines and galactagogues have gained their reputation and recognition by the 
public and health professionals as alternative approaches to enhance breastfeeding 
performance. Taking into consideration that herbal galactagogues are available in Australia 
in various different dosage forms for administration and the fact that choice of dosage forms 
may directly affect their safety and efficacy, efforts should be made to investigate and 
document the dosage forms and directions that breastfeeding women in Australia have 
followed. Despite the increasing popularity, currently very little is known about the use, safety 
and efficacy of these medicines during breastfeeding. 
 
Purpose of Research 
We aim to investigate and document the use, safety and efficacy of herbal galactagogues 
during breastfeeding based on participants’ personal experience and observations including 
their perceptions and opinions, observed efficacy, adverse effects experienced and dosages 
administered. 
 
We are seeking for women who are 18 years or older, currently breastfeeding or have 
breastfed in the past 12 months, have used one or more herbal galactagogues during 
breastfeeding to participate in a semi-structured interview to share their experiences. This 
interview will take approximately 20 minutes. 
 
Consent to Participate and Confidentiality 
This survey is entirely voluntary and you may withdraw at any time. This survey will most 
likely not benefit you immediately, but the information gained from this study may help us to 
understand more on the efficacy and safety on the use of herbal medicines in breastfeeding 
mothers and to their infants. 
Only staff and students who are directly involved in this study will have access to the data 
collected. If you sign the consent form I will assume that you agree to participate and have 
agreed to use the data in this research. Data collected from this study may be published; 




Further information on the study can be obtained from Miss Tin Fei Sim at the Curtin 
University (phone: 9266 1875 or mobile: 0401 649 800) or supervisor A/Prof Lisa Tee 
(phone: 9266 2526). This study has been approved by Curtin University Human Research 
Ethics Committee (Approval number: HR85/2012). The Committee is comprised of members 
of the public, academics, lawyers, doctors and pastoral carers. Its main role is to protect 
participants. If needed, verification of approval can be obtained either by writing to the Curtin 
University HREC, C/- Office of Research and Development, Curtin University of Technology, 
GPO Box U1987, Perth WA 6845, or phone 08-9266 2784 or email  hrec@curtin.edu.au. 
 
 
Thank you sincerely for your involvement in this research. 
 
Your participation is greatly appreciated. 
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Appendix M: Stage 2 Consent Form 
 
I have been given a Participant Information Sheet. 
 
I have read and understood the information given to me. I understand the purpose and 
procedures of the study. 
 
I have been given opportunity to ask questions and any questions I have asked have been 
answered to my satisfaction. 
 
I understand that my participation is voluntary. I understand that I may withdraw at any stage 
of the study without prejudice and withdrawal will not interfere with routine care. 
 
I understand that all data and information will be securely stored for 5 years before being 
destroyed. 
 
I agree that research data gathered from the results of this study may be published; however 
any information which may potentially identify me will not be used in any published materials. 
 
I agree to participate in the study outlined to me. 
 
Name of participant: ……………………………………………………………………………….. 
Dated ................................. day of ........................................20…………………………. 
Signature .............................................Contact (Tel/email): ……………………………….. 
 
I, …………………………………………………have explained the above to the 
                  (Investigator’s full name) 


















Document use, safety and efficacy of herbal galactagogues during breastfeeding 
based on participants’ personal experience and observations 
 
Investigatethe types of herbal galactagogues used, the dosage forms and 
administration (ie tabs/caps, tea, seed etc), dosages or amount/frequency of 
consumption, period and duration of administration since immediate post-partum 
 
Explore reasons for use and who recommended the use 
 
Determine their perception or opinions regarding safety and efficacy of herbal 
galactagogues, whether it worked or if they have experienced any side effects 
themselves or noticed any adverse events or changes in behaviour in their breastfed 
infants, based on their personal experience with the herbal galactagogue(s) 
 
Provide direction to guide future clinical research to confirm safety and efficacy of 





1. Which herbal galactagogue(s) have you used during breastfeeding? 
2. Can you tell me why you have used/are using a herbal galactagogue? 
a. Can you share your experiences in this area and tell me more about that? 
(for investigator’s note: This question is to further explore reasons for use - 
for example whether it is due to perceived or diagnosed insufficient milk 
supply, tradition etc etc) 
3. Can you tell me who has recommended the use? 
4. How did you or have you been administering this herbal galactagoue (for 
example taking commercially available products in capsules or tablets 
formulation, in tea, or raw material)? 
5. At what dosages and directions have you taken them? (or if taking tea/seed/raw 
materials etc – how much do you take?) 
6. How often do you take them? 
7. When have you started taking the herbal galactagogues (how many days/weeks 
since post- partum)? 
8. How long did you or have you been taking them? 
9. Have you found this herbal galactagogue effective in increasing breastmilk 
production or enhancing breastfeeding performance? 
a. If yes, how long after the first administration of this herb did you find 
that it started working? 
b. Can you give me an idea of how much more it has increased your 
milk supply (e.g. number of feeds per day, duration of each feeding 
session, or volume of milk if expressed and measured, infant’s 
perceived satisfaction and behaviour?) 
c. Have you continued or discontinued using this herb after it started working? 
 
 
10. Have you experienced any side effects both in yourself or noticed in your 
breastfed infant? If yes, can you tell me more about that? 
11. Can you tell me more about your experience and opinion on this herbal galactagogue? 
12. What do you think or what is your perception on the use of herbal medicines in 
general during breastfeeding? 
13. Can you comment on the available resources available to you in Australia as a 
breastfeeding woman in terms of the safety and efficacy of using herbal 
medicines during breastfeeding? 
a. Where have you obtained your herbal medicines or products? 
b. Where have you or would you seek information concerning the use of herbal 
medicines during breastfeeding? Do you think that there is a role for 
community pharmacists to play to this area? 
c. Do you agree that currently there is a lack of resources available to you 
regarding the use of herbal medicines during breastfeeding? 
d. Do you think that using herbal medicines is safer than using 
conventional/prescribed drugs during breastfeeding? 
e. In the past, have you refused or avoided any drug treatments during 
breastfeeding due to concerns regarding safety of your breastfed infant(s) 
and/or breastfeeding performance? 
Do you have any other comments on the use of herbal medicines during breastfeeding? What would 




























































Although there are several textbooks and numerous studies on the safety of medications in 
breastfeeding, many of these references have inconclusive data on a number of medications. This 
often places the advising health care professional and the patient in a challenging situation as they 
base their decision to use or not use the medication on the information available to them at the time. 
Results from a previous study have shown that breastfeeding women are most likely to seek 
information and advice regarding use of herbal medicines (classified as non-prescription medicines) 
during breastfeeding from their pharmacists and doctors. Health professionals have an ethical 
obligation to continuously improve their professional knowledge and skills to ensure optimum health 
outcomes of patients. Hence, this research examines whether there is sufficient evidence and reliable 
information resources available to pharmacists, how confident are community pharmacists in giving 
advice on the use of non-prescription medicines during breastfeeding, and their experiences, views 
and perceptions on their role in promoting safe and effective use of non-prescription medicines during 
breastfeeding. 
 
Purpose of Research 
We aim to examine the role of community pharmacists in supplying, recommending and giving advice 
to breastfeeding women regarding the use of non-prescription medicines during breastfeeding, 
investigate the factors facilitating or inhibiting the provision of high-quality professional advice to 
breastfeeding women in a community pharmacy health-care setting and explore the perspectives of 
community pharmacists. 
 
We are seeking community pharmacists to participate in a semi-structured interview to share their 
views and experiences. This interview will take approximately 20 minutes. 
 
 
Consent to Participate and Confidentiality 
This study is entirely voluntary and you may withdraw at any time. This study will most likely not benefit 
you immediately, but the information gained from this study may help us to further explore the potential 
role of community pharmacists and how the profession can play a role in promoting the health of 
breastfeeding women and their infants. Only staff and students who are directly involved in this study 
will have access to the data collected. If you sign the consent form I will assume that you agree to 
participate and have agreed to use the data in this research. Data collected from this study may be 




Further information on the study can be obtained from Miss Tin Fei Sim at the Curtin University 
(mobile: 0401 649 800) or supervisor Dr Laetitia Hattingh (phone: 9266 7376). This study has been 
approved by Curtin University Human Research Ethics Committee (Approval number: PH-24-12). The 
Committee is comprised of members of the public, academics, lawyers, doctors and pastoral carers. Its 
main role is  to protect participants. If needed, verification of approval can be obtained either by writing 
to the Curtin University HREC, C/- Office of Research and Development, Curtin University of 
Technology, GPO Box U1987, Perth WA 6845, or phone 08-9266 2784 or email hrec@curtin.edu.au. 
 
 
Thank you sincerely for your involvement in this research. 
 
Your participation is greatly appreciated. 
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I have been given a Participant Information Sheet. 
 
I have read and understood the information given to me. I understand the purpose and 
procedures of the study. 
 
I have been given opportunity to ask questions and any questions I have asked have been 
answered to my satisfaction. 
 
I understand that my participation is voluntary. I understand that I may withdraw at any stage 
of the study without prejudice and withdrawal will not interfere with routine care. 
 
I agree for this interview to be audio-recorded. 
 
I understand that all data and information will be securely stored for 5 years before being 
destroyed. 
 
I agree that research data gathered from the results of this study may be published; however 
any information which may potentially identify me will not be used in any published materials. 
 




Name of participant: ………………………………………………………………………………….. 
Dated ................................. day of ........................................20…………………………………… 
Signature .............................................Contact (Tel/email): ………………………………………. 
 
I, …………………………………………………have explained the above to the 
                  (Investigator’s full name) 
signatory who stated that she understood the same. 
 
Signature: …………………………………………………………………………………............................. 
